Ligand source activities (1 row/activity)





Ligands (move mouse cursor over ligand name to see structure) Receptor Activity Chemical information
Sel. page Common
name
GPCRdb
ID
Reference
ligand
Vendors

Species

Assay
Type

Activity
Type
Activity
Relation
Activity
Value
p-value
(-log)
Fold
selectivity
Tested
GPCRs
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

56593480 145982 None 0 Human Functional pEC50 = 10.4 10.4 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 459 8 3 9 2.5 CNC(=O)c1cc(CSc2nc(N)c(C#N)c(-c3ccc(OCCN)cc3)c2C#N)ccn1 nan
CHEMBL3917744 145982 None 0 Human Functional pEC50 = 10.4 10.4 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 459 8 3 9 2.5 CNC(=O)c1cc(CSc2nc(N)c(C#N)c(-c3ccc(OCCN)cc3)c2C#N)ccn1 nan
68619417 151574 None 0 Human Functional pEC50 = 10.4 10.4 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 523 8 2 10 2.3 CNC(=O)c1cc(CSc2nc(N)c(C#N)c(-c3ccc(OS(=O)(=O)N(C)C)cc3)c2C#N)ccn1 nan
CHEMBL3962333 151574 None 0 Human Functional pEC50 = 10.4 10.4 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 523 8 2 10 2.3 CNC(=O)c1cc(CSc2nc(N)c(C#N)c(-c3ccc(OS(=O)(=O)N(C)C)cc3)c2C#N)ccn1 nan
68597393 151528 None 0 Human Functional pEC50 = 10.2 10.2 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 458 5 2 9 2.9 CNC(=O)c1cc(CSc2nc(N)c(C#N)c(-c3ccc4c(c3)OCCO4)c2C#N)ccn1 nan
CHEMBL3961898 151528 None 0 Human Functional pEC50 = 10.2 10.2 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 458 5 2 9 2.9 CNC(=O)c1cc(CSc2nc(N)c(C#N)c(-c3ccc4c(c3)OCCO4)c2C#N)ccn1 nan
68613928 152036 None 0 Human Functional pEC50 = 10.1 10.1 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 426 6 2 7 3.7 N#Cc1c(N)nc(SCc2ccnc(C(=O)NC3CC3)c2)c(C#N)c1-c1ccccc1 nan
CHEMBL3966416 152036 None 0 Human Functional pEC50 = 10.1 10.1 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 426 6 2 7 3.7 N#Cc1c(N)nc(SCc2ccnc(C(=O)NC3CC3)c2)c(C#N)c1-c1ccccc1 nan
11221 791 None 45 Human Functional pEC50 = 10 10.0 - 1
Agonist activity at adenosine A1 receptor (unknown origin) expressed in CHO cells assessed as increase in intracellular cAMP level by RIAAgonist activity at adenosine A1 receptor (unknown origin) expressed in CHO cells assessed as increase in intracellular cAMP level by RIA
ChEMBL 519 8 2 9 5.5 OCCOc1ccc(cc1)c1c(C#N)c(SCc2csc(n2)c2ccc(cc2)Cl)nc(c1C#N)N 10.1021/jm401643m
9936489 791 None 45 Human Functional pEC50 = 10 10.0 - 1
Agonist activity at adenosine A1 receptor (unknown origin) expressed in CHO cells assessed as increase in intracellular cAMP level by RIAAgonist activity at adenosine A1 receptor (unknown origin) expressed in CHO cells assessed as increase in intracellular cAMP level by RIA
ChEMBL 519 8 2 9 5.5 OCCOc1ccc(cc1)c1c(C#N)c(SCc2csc(n2)c2ccc(cc2)Cl)nc(c1C#N)N 10.1021/jm401643m
CHEMBL3235279 791 None 45 Human Functional pEC50 = 10 10.0 - 1
Agonist activity at adenosine A1 receptor (unknown origin) expressed in CHO cells assessed as increase in intracellular cAMP level by RIAAgonist activity at adenosine A1 receptor (unknown origin) expressed in CHO cells assessed as increase in intracellular cAMP level by RIA
ChEMBL 519 8 2 9 5.5 OCCOc1ccc(cc1)c1c(C#N)c(SCc2csc(n2)c2ccc(cc2)Cl)nc(c1C#N)N 10.1021/jm401643m
DB16118 791 None 45 Human Functional pEC50 = 10 10.0 - 1
Agonist activity at adenosine A1 receptor (unknown origin) expressed in CHO cells assessed as increase in intracellular cAMP level by RIAAgonist activity at adenosine A1 receptor (unknown origin) expressed in CHO cells assessed as increase in intracellular cAMP level by RIA
ChEMBL 519 8 2 9 5.5 OCCOc1ccc(cc1)c1c(C#N)c(SCc2csc(n2)c2ccc(cc2)Cl)nc(c1C#N)N 10.1021/jm401643m
168273986 190285 None 0 Human Functional pEC50 = 10 10.0 234422 2
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 505 6 4 10 1.6 OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4Oc4cccc(Br)c4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
CHEMBL5174052 190285 None 0 Human Functional pEC50 = 10 10.0 234422 2
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 505 6 4 10 1.6 OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4Oc4cccc(Br)c4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
68597350 148203 None 0 Human Functional pEC50 = 10 10.0 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 488 8 3 9 3.3 CNC(=O)c1cc(CSc2nc(N)c(C#N)c(-c3ccc(OCC(C)(C)O)cc3)c2C#N)ccn1 nan
CHEMBL3935252 148203 None 0 Human Functional pEC50 = 10 10.0 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 488 8 3 9 3.3 CNC(=O)c1cc(CSc2nc(N)c(C#N)c(-c3ccc(OCC(C)(C)O)cc3)c2C#N)ccn1 nan
68617624 153437 None 0 Human Functional pEC50 = 10 10.0 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 505 11 4 11 1.7 CNC(=O)c1cc(CSc2nc(NCCO)c(C#N)c(-c3ccc(OCCO)nc3)c2C#N)ccn1 nan
CHEMBL3978419 153437 None 0 Human Functional pEC50 = 10 10.0 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 505 11 4 11 1.7 CNC(=O)c1cc(CSc2nc(NCCO)c(C#N)c(-c3ccc(OCCO)nc3)c2C#N)ccn1 nan
377 2758 None 42 Human Functional pEC50 = 9.9 9.9 3 10
Agonist activity at human A1A adenosine receptor expressed in HEK cell membranes incubated for 60 mins by [35S]GTPgammaS binding assayAgonist activity at human A1A adenosine receptor expressed in HEK cell membranes incubated for 60 mins by [35S]GTPgammaS binding assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.8b01662
425 2758 None 42 Human Functional pEC50 = 9.9 9.9 3 10
Agonist activity at human A1A adenosine receptor expressed in HEK cell membranes incubated for 60 mins by [35S]GTPgammaS binding assayAgonist activity at human A1A adenosine receptor expressed in HEK cell membranes incubated for 60 mins by [35S]GTPgammaS binding assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.8b01662
448222 2758 None 42 Human Functional pEC50 = 9.9 9.9 3 10
Agonist activity at human A1A adenosine receptor expressed in HEK cell membranes incubated for 60 mins by [35S]GTPgammaS binding assayAgonist activity at human A1A adenosine receptor expressed in HEK cell membranes incubated for 60 mins by [35S]GTPgammaS binding assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.8b01662
CHEMBL464859 2758 None 42 Human Functional pEC50 = 9.9 9.9 3 10
Agonist activity at human A1A adenosine receptor expressed in HEK cell membranes incubated for 60 mins by [35S]GTPgammaS binding assayAgonist activity at human A1A adenosine receptor expressed in HEK cell membranes incubated for 60 mins by [35S]GTPgammaS binding assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.8b01662
168288912 191737 None 0 Human Functional pEC50 = 9.9 9.9 812 4
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 502 7 4 10 1.6 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4Oc4ccccc4Cl)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
CHEMBL5195714 191737 None 0 Human Functional pEC50 = 9.9 9.9 812 4
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 502 7 4 10 1.6 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4Oc4ccccc4Cl)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
168283120 191170 None 0 Human Functional pEC50 = 9.9 9.9 20892 4
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 498 8 4 11 1.0 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4Oc4cccc(OC)c4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
CHEMBL5187330 191170 None 0 Human Functional pEC50 = 9.9 9.9 20892 4
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 498 8 4 11 1.0 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4Oc4cccc(OC)c4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
168270204 190172 None 0 Human Functional pEC50 = 9.9 9.9 19498 2
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 560 8 4 10 1.9 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4OCc4cccc(Br)c4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
CHEMBL5172389 190172 None 0 Human Functional pEC50 = 9.9 9.9 19498 2
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 560 8 4 10 1.9 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4OCc4cccc(Br)c4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
380 1287 None 37 Human Functional pEC50 = 9.7 9.7 6 5
Compound was evaluated for the Adenosine A1 receptor agonist potency.Compound was evaluated for the Adenosine A1 receptor agonist potency.
ChEMBL 335 4 4 9 -0.2 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NC1CCCC1 10.1016/0960-894X(96)00111-4
657378 1287 None 37 Human Functional pEC50 = 9.7 9.7 6 5
Compound was evaluated for the Adenosine A1 receptor agonist potency.Compound was evaluated for the Adenosine A1 receptor agonist potency.
ChEMBL 335 4 4 9 -0.2 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NC1CCCC1 10.1016/0960-894X(96)00111-4
CHEMBL68738 1287 None 37 Human Functional pEC50 = 9.7 9.7 6 5
Compound was evaluated for the Adenosine A1 receptor agonist potency.Compound was evaluated for the Adenosine A1 receptor agonist potency.
ChEMBL 335 4 4 9 -0.2 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NC1CCCC1 10.1016/0960-894X(96)00111-4
68606791 146457 None 0 Human Functional pEC50 = 9.7 9.7 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 444 7 2 8 3.5 CCOc1ccc(-c2c(C#N)c(N)nc(SCc3ccnc(C(=O)NC)c3)c2C#N)cc1 nan
CHEMBL3921473 146457 None 0 Human Functional pEC50 = 9.7 9.7 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 444 7 2 8 3.5 CCOc1ccc(-c2c(C#N)c(N)nc(SCc3ccnc(C(=O)NC)c3)c2C#N)cc1 nan
56592181 146589 None 0 Human Functional pEC50 = 9.7 9.7 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 456 6 2 8 2.7 CNC(=O)c1cc(CSc2nc(N3CC(O)C3)c(C#N)c(-c3ccccc3)c2C#N)ccn1 nan
CHEMBL3922438 146589 None 0 Human Functional pEC50 = 9.7 9.7 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 456 6 2 8 2.7 CNC(=O)c1cc(CSc2nc(N3CC(O)C3)c(C#N)c(-c3ccccc3)c2C#N)ccn1 nan
68612245 147241 None 0 Human Functional pEC50 = 9.7 9.7 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 436 5 2 7 3.4 CNC(=O)c1cc(CSc2nc(N)c(C#N)c(-c3cc(F)cc(F)c3)c2C#N)ccn1 nan
CHEMBL3927775 147241 None 0 Human Functional pEC50 = 9.7 9.7 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 436 5 2 7 3.4 CNC(=O)c1cc(CSc2nc(N)c(C#N)c(-c3cc(F)cc(F)c3)c2C#N)ccn1 nan
68619112 148234 None 0 Human Functional pEC50 = 9.7 9.7 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 430 6 2 8 3.1 CNC(=O)c1cc(CSc2nc(N)c(C#N)c(-c3ccc(OC)cc3)c2C#N)ccn1 nan
CHEMBL3935524 148234 None 0 Human Functional pEC50 = 9.7 9.7 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 430 6 2 8 3.1 CNC(=O)c1cc(CSc2nc(N)c(C#N)c(-c3ccc(OC)cc3)c2C#N)ccn1 nan
66631260 150203 None 0 Human Functional pEC50 = 9.7 9.7 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 458 8 2 8 3.0 CNC(=O)c1cc(CSc2nc(N(C)CCO)c(C#N)c(-c3ccccc3)c2C#N)ccn1 nan
CHEMBL3951148 150203 None 0 Human Functional pEC50 = 9.7 9.7 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 458 8 2 8 3.0 CNC(=O)c1cc(CSc2nc(N(C)CCO)c(C#N)c(-c3ccccc3)c2C#N)ccn1 nan
68613195 151973 None 0 Human Functional pEC50 = 9.7 9.7 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 474 9 4 9 2.3 CNC(=O)c1cc(CSc2nc(NC[C@H](O)CO)c(C#N)c(-c3ccccc3)c2C#N)ccn1 nan
CHEMBL3965792 151973 None 0 Human Functional pEC50 = 9.7 9.7 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 474 9 4 9 2.3 CNC(=O)c1cc(CSc2nc(NC[C@H](O)CO)c(C#N)c(-c3ccccc3)c2C#N)ccn1 nan
66633776 153071 None 0 Human Functional pEC50 = 9.7 9.7 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 428 7 3 7 3.1 N#Cc1c(N)nc(SCc2cccc(C(=O)NCCN)c2)c(C#N)c1-c1ccccc1 nan
CHEMBL3975241 153071 None 0 Human Functional pEC50 = 9.7 9.7 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 428 7 3 7 3.1 N#Cc1c(N)nc(SCc2cccc(C(=O)NCCN)c2)c(C#N)c1-c1ccccc1 nan
66631463 159955 None 0 Human Functional pEC50 = 9.7 9.7 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 529 9 3 9 3.1 CNC(=O)c1cccc(CSc2nc(N3CC[C@@H](O)C3)c(C#N)c(-c3ccc(OCCO)cc3)c2C#N)c1 nan
CHEMBL4106705 159955 None 0 Human Functional pEC50 = 9.7 9.7 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 529 9 3 9 3.1 CNC(=O)c1cccc(CSc2nc(N3CC[C@@H](O)C3)c(C#N)c(-c3ccc(OCCO)cc3)c2C#N)c1 nan
68605677 160753 None 0 Human Functional pEC50 = 9.7 9.7 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 528 6 2 10 2.9 CNC(=O)c1cc(CSc2nc(N3CC[C@@H](O)C3)c(C#N)c(-c3ccc4c(c3)OCCO4)c2C#N)ccn1 nan
CHEMBL4113343 160753 None 0 Human Functional pEC50 = 9.7 9.7 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 528 6 2 10 2.9 CNC(=O)c1cc(CSc2nc(N3CC[C@@H](O)C3)c(C#N)c(-c3ccc4c(c3)OCCO4)c2C#N)ccn1 nan
168293442 192244 None 0 Human Functional pEC50 = 9.6 9.6 12589 4
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 546 7 4 10 1.8 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4Oc4cccc(Br)c4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
CHEMBL5203632 192244 None 0 Human Functional pEC50 = 9.6 9.6 12589 4
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 546 7 4 10 1.8 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4Oc4cccc(Br)c4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
168269866 190097 None 0 Human Functional pEC50 = 9.5 9.5 229 4
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 468 7 4 10 1.0 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4Oc4ccccc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
CHEMBL5171042 190097 None 0 Human Functional pEC50 = 9.5 9.5 229 4
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 468 7 4 10 1.0 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4Oc4ccccc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
68615669 143550 None 0 Human Functional pEC50 = 9.5 9.5 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 385 5 2 6 3.5 N#Cc1c(N)nc(SCc2cccc(C(N)=O)c2)c(C#N)c1-c1ccccc1 nan
CHEMBL3898414 143550 None 0 Human Functional pEC50 = 9.5 9.5 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 385 5 2 6 3.5 N#Cc1c(N)nc(SCc2cccc(C(N)=O)c2)c(C#N)c1-c1ccccc1 nan
68617983 144660 None 0 Human Functional pEC50 = 9.5 9.5 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 418 5 2 7 3.3 CNC(=O)c1cc(CSc2nc(N)c(C#N)c(-c3ccc(F)cc3)c2C#N)ccn1 nan
CHEMBL3907580 144660 None 0 Human Functional pEC50 = 9.5 9.5 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 418 5 2 7 3.3 CNC(=O)c1cc(CSc2nc(N)c(C#N)c(-c3ccc(F)cc3)c2C#N)ccn1 nan
66631991 145422 None 0 Human Functional pEC50 = 9.5 9.5 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 527 10 2 8 4.5 CCNC(=O)c1cccc(CSc2nc(N3CCCC3)c(C#N)c(-c3ccc(OCCO)cc3)c2C#N)c1 nan
CHEMBL3913385 145422 None 0 Human Functional pEC50 = 9.5 9.5 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 527 10 2 8 4.5 CCNC(=O)c1cccc(CSc2nc(N3CCCC3)c(C#N)c(-c3ccc(OCCO)cc3)c2C#N)c1 nan
68611206 146133 None 0 Human Functional pEC50 = 9.5 9.5 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 458 8 2 8 3.9 CCCOc1cccc(-c2c(C#N)c(N)nc(SCc3ccnc(C(=O)NC)c3)c2C#N)c1 nan
CHEMBL3918844 146133 None 0 Human Functional pEC50 = 9.5 9.5 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 458 8 2 8 3.9 CCCOc1cccc(-c2c(C#N)c(N)nc(SCc3ccnc(C(=O)NC)c3)c2C#N)c1 nan
56592011 146284 None 0 Human Functional pEC50 = 9.5 9.5 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 436 5 2 7 3.4 CNC(=O)c1cc(CSc2nc(N)c(C#N)c(-c3ccc(F)c(F)c3)c2C#N)ccn1 nan
CHEMBL3920083 146284 None 0 Human Functional pEC50 = 9.5 9.5 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 436 5 2 7 3.4 CNC(=O)c1cc(CSc2nc(N)c(C#N)c(-c3ccc(F)c(F)c3)c2C#N)ccn1 nan
56592092 147326 None 0 Human Functional pEC50 = 9.5 9.5 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 473 8 3 8 3.7 CNC(=O)c1cccc(C(C)Sc2nc(N)c(C#N)c(-c3ccc(OCCO)cc3)c2C#N)c1 nan
CHEMBL3928443 147326 None 0 Human Functional pEC50 = 9.5 9.5 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 473 8 3 8 3.7 CNC(=O)c1cccc(C(C)Sc2nc(N)c(C#N)c(-c3ccc(OCCO)cc3)c2C#N)c1 nan
68604809 150371 None 0 Human Functional pEC50 = 9.5 9.5 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 448 6 2 8 3.3 CNC(=O)c1cc(CSc2nc(N)c(C#N)c(-c3ccc(F)c(OC)c3)c2C#N)ccn1 nan
CHEMBL3952679 150371 None 0 Human Functional pEC50 = 9.5 9.5 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 448 6 2 8 3.3 CNC(=O)c1cc(CSc2nc(N)c(C#N)c(-c3ccc(F)c(OC)c3)c2C#N)ccn1 nan
377 2758 None 42 Human Functional pEC50 = 9.4 9.4 3 10
Activity at human adenosine A1 receptor assessed as inhibition of forskolin-stimulated cAMP accumulation in CHO cellsActivity at human adenosine A1 receptor assessed as inhibition of forskolin-stimulated cAMP accumulation in CHO cells
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm061279i
425 2758 None 42 Human Functional pEC50 = 9.4 9.4 3 10
Activity at human adenosine A1 receptor assessed as inhibition of forskolin-stimulated cAMP accumulation in CHO cellsActivity at human adenosine A1 receptor assessed as inhibition of forskolin-stimulated cAMP accumulation in CHO cells
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm061279i
448222 2758 None 42 Human Functional pEC50 = 9.4 9.4 3 10
Activity at human adenosine A1 receptor assessed as inhibition of forskolin-stimulated cAMP accumulation in CHO cellsActivity at human adenosine A1 receptor assessed as inhibition of forskolin-stimulated cAMP accumulation in CHO cells
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm061279i
CHEMBL464859 2758 None 42 Human Functional pEC50 = 9.4 9.4 3 10
Activity at human adenosine A1 receptor assessed as inhibition of forskolin-stimulated cAMP accumulation in CHO cellsActivity at human adenosine A1 receptor assessed as inhibition of forskolin-stimulated cAMP accumulation in CHO cells
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm061279i
377 2758 None 42 Human Functional pEC50 = 9.4 9.4 3 10
Agonist activity at adenosine A1 receptor assessed as inhibition of forskolin-stimulated [3H]cAMP accumulation in CHO cellsAgonist activity at adenosine A1 receptor assessed as inhibition of forskolin-stimulated [3H]cAMP accumulation in CHO cells
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm061279i
425 2758 None 42 Human Functional pEC50 = 9.4 9.4 3 10
Agonist activity at adenosine A1 receptor assessed as inhibition of forskolin-stimulated [3H]cAMP accumulation in CHO cellsAgonist activity at adenosine A1 receptor assessed as inhibition of forskolin-stimulated [3H]cAMP accumulation in CHO cells
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm061279i
448222 2758 None 42 Human Functional pEC50 = 9.4 9.4 3 10
Agonist activity at adenosine A1 receptor assessed as inhibition of forskolin-stimulated [3H]cAMP accumulation in CHO cellsAgonist activity at adenosine A1 receptor assessed as inhibition of forskolin-stimulated [3H]cAMP accumulation in CHO cells
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm061279i
CHEMBL464859 2758 None 42 Human Functional pEC50 = 9.4 9.4 3 10
Agonist activity at adenosine A1 receptor assessed as inhibition of forskolin-stimulated [3H]cAMP accumulation in CHO cellsAgonist activity at adenosine A1 receptor assessed as inhibition of forskolin-stimulated [3H]cAMP accumulation in CHO cells
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm061279i
68612168 147249 None 0 Human Functional pEC50 = 9.4 9.4 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 410 6 2 7 2.9 N#Cc1c(N)nc(OCc2ccnc(C(=O)NC3CC3)c2)c(C#N)c1-c1ccccc1 nan
CHEMBL3927840 147249 None 0 Human Functional pEC50 = 9.4 9.4 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 410 6 2 7 2.9 N#Cc1c(N)nc(OCc2ccnc(C(=O)NC3CC3)c2)c(C#N)c1-c1ccccc1 nan
66631434 148046 None 0 Human Functional pEC50 = 9.4 9.4 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 459 8 3 8 3.4 CC(Sc1nc(N)c(C#N)c(-c2ccc(OCCO)cc2)c1C#N)c1cccc(C(N)=O)c1 nan
CHEMBL3933888 148046 None 0 Human Functional pEC50 = 9.4 9.4 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 459 8 3 8 3.4 CC(Sc1nc(N)c(C#N)c(-c2ccc(OCCO)cc2)c1C#N)c1cccc(C(N)=O)c1 nan
66633974 149061 None 0 Human Functional pEC50 = 9.4 9.4 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 530 10 4 10 2.0 CNC(=O)c1cc(CSc2nc(N)c(C#N)c(-c3ccc(OCCNC(=O)[C@H](C)N)cc3)c2C#N)ccn1 nan
CHEMBL3942193 149061 None 0 Human Functional pEC50 = 9.4 9.4 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 530 10 4 10 2.0 CNC(=O)c1cc(CSc2nc(N)c(C#N)c(-c3ccc(OCCNC(=O)[C@H](C)N)cc3)c2C#N)ccn1 nan
68614454 149971 None 0 Human Functional pEC50 = 9.4 9.4 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 385 5 1 6 3.5 CNC(=O)c1cc(CSc2ncc(C#N)c(-c3ccccc3)c2C#N)ccn1 nan
CHEMBL3949217 149971 None 0 Human Functional pEC50 = 9.4 9.4 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 385 5 1 6 3.5 CNC(=O)c1cc(CSc2ncc(C#N)c(-c3ccccc3)c2C#N)ccn1 nan
68606242 152099 None 0 Human Functional pEC50 = 9.4 9.4 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 460 7 2 9 3.1 CNC(=O)c1cc(CSc2nc(N)c(C#N)c(-c3ccc(OC)cc3OC)c2C#N)ccn1 nan
CHEMBL3966900 152099 None 0 Human Functional pEC50 = 9.4 9.4 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 460 7 2 9 3.1 CNC(=O)c1cc(CSc2nc(N)c(C#N)c(-c3ccc(OC)cc3OC)c2C#N)ccn1 nan
68611797 152936 None 0 Human Functional pEC50 = 9.4 9.4 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 474 9 3 9 3.0 CNC(=O)c1cc(CSc2nc(NCCO)c(C#N)c(-c3ccc(OC)cc3)c2C#N)ccn1 nan
CHEMBL3974140 152936 None 0 Human Functional pEC50 = 9.4 9.4 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 474 9 3 9 3.0 CNC(=O)c1cc(CSc2nc(NCCO)c(C#N)c(-c3ccc(OC)cc3)c2C#N)ccn1 nan
68047402 153006 None 0 Human Functional pEC50 = 9.4 9.4 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 445 8 2 8 2.9 CNC(=O)c1cc(CSc2ncc(C#N)c(-c3ccc(OCCO)cc3)c2C#N)ccn1 nan
CHEMBL3974782 153006 None 0 Human Functional pEC50 = 9.4 9.4 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 445 8 2 8 2.9 CNC(=O)c1cc(CSc2ncc(C#N)c(-c3ccc(OCCO)cc3)c2C#N)ccn1 nan
68604883 154328 None 0 Human Functional pEC50 = 9.4 9.4 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 429 6 3 8 3.2 CNC(=O)c1cc(CSc2nc(N)c(C#N)c(-c3ccc(NC)cc3)c2C#N)ccn1 nan
CHEMBL3986152 154328 None 0 Human Functional pEC50 = 9.4 9.4 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 429 6 3 8 3.2 CNC(=O)c1cc(CSc2nc(N)c(C#N)c(-c3ccc(NC)cc3)c2C#N)ccn1 nan
68602346 160770 None 0 Human Functional pEC50 = 9.4 9.4 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 477 8 4 8 2.6 N#Cc1c(N)nc(SCc2cccc(C(=O)NC[C@@H](O)CO)c2)c(C#N)c1-c1ccc(F)cc1 nan
CHEMBL4113450 160770 None 0 Human Functional pEC50 = 9.4 9.4 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 477 8 4 8 2.6 N#Cc1c(N)nc(SCc2cccc(C(=O)NC[C@@H](O)CO)c2)c(C#N)c1-c1ccc(F)cc1 nan
56592177 143284 None 0 Human Functional pEC50 = 9.3 9.3 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 486 5 2 7 4.3 CNC(=O)c1cc(CSc2nc(N)c(C#N)c(-c3ccc(F)c(C(F)(F)F)c3)c2C#N)ccn1 nan
CHEMBL3896255 143284 None 0 Human Functional pEC50 = 9.3 9.3 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 486 5 2 7 4.3 CNC(=O)c1cc(CSc2nc(N)c(C#N)c(-c3ccc(F)c(C(F)(F)F)c3)c2C#N)ccn1 nan
68606147 145219 None 0 Human Functional pEC50 = 9.3 9.3 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 471 6 2 7 4.0 CS(=O)(=O)Nc1cccc(CSc2nc(N)c(C#N)c(-c3ccc(F)c(F)c3)c2C#N)c1 nan
CHEMBL3911979 145219 None 0 Human Functional pEC50 = 9.3 9.3 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 471 6 2 7 4.0 CS(=O)(=O)Nc1cccc(CSc2nc(N)c(C#N)c(-c3ccc(F)c(F)c3)c2C#N)c1 nan
68047404 145356 None 0 Human Functional pEC50 = 9.3 9.3 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 460 8 3 9 2.5 CNC(=O)c1cc(CSc2nc(N)c(C#N)c(-c3cccc(OCCO)c3)c2C#N)ccn1 nan
CHEMBL3912903 145356 None 0 Human Functional pEC50 = 9.3 9.3 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 460 8 3 9 2.5 CNC(=O)c1cc(CSc2nc(N)c(C#N)c(-c3cccc(OCCO)c3)c2C#N)ccn1 nan
68614769 146426 None 0 Human Functional pEC50 = 9.3 9.3 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 486 7 2 9 2.7 CNC(=O)c1cc(CSc2nc(N3CC(O)C3)c(C#N)c(-c3ccc(OC)cc3)c2C#N)ccn1 nan
CHEMBL3921206 146426 None 0 Human Functional pEC50 = 9.3 9.3 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 486 7 2 9 2.7 CNC(=O)c1cc(CSc2nc(N3CC(O)C3)c(C#N)c(-c3ccc(OC)cc3)c2C#N)ccn1 nan
68602402 149835 None 0 Human Functional pEC50 = 9.3 9.3 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 480 7 1 7 4.7 N#Cc1c(SCc2ccnc(C(=O)NC3CC3)c2)nc(N2CCCC2)c(C#N)c1-c1ccccc1 nan
CHEMBL3948114 149835 None 0 Human Functional pEC50 = 9.3 9.3 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 480 7 1 7 4.7 N#Cc1c(SCc2ccnc(C(=O)NC3CC3)c2)nc(N2CCCC2)c(C#N)c1-c1ccccc1 nan
168276883 190309 None 0 Human Functional pEC50 = 9.3 9.3 309 4
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 502 7 4 10 1.6 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4Oc4cccc(Cl)c4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
CHEMBL5174429 190309 None 0 Human Functional pEC50 = 9.3 9.3 309 4
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 502 7 4 10 1.6 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4Oc4cccc(Cl)c4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
168292290 192074 None 0 Human Functional pEC50 = 9.3 9.3 10964 2
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 457 7 4 11 0.9 COc1cccc(O[C@@H]2CCC[C@H]2Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1 10.1021/acs.jmedchem.2c01414
CHEMBL5201013 192074 None 0 Human Functional pEC50 = 9.3 9.3 10964 2
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 457 7 4 11 0.9 COc1cccc(O[C@@H]2CCC[C@H]2Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1 10.1021/acs.jmedchem.2c01414
68600557 150893 None 0 Human Functional pEC50 = 9.2 9.2 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 512 8 3 8 3.9 CNC(=O)c1cc(CSc2nc(NCC(O)C(F)(F)F)c(C#N)c(-c3ccccc3)c2C#N)ccn1 nan
CHEMBL3956764 150893 None 0 Human Functional pEC50 = 9.2 9.2 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 512 8 3 8 3.9 CNC(=O)c1cc(CSc2nc(NCC(O)C(F)(F)F)c(C#N)c(-c3ccccc3)c2C#N)ccn1 nan
168297825 192392 None 0 Human Functional pEC50 = 9.2 9.2 251 4
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 461 6 4 10 1.5 OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4Oc4cccc(Cl)c4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
CHEMBL5205907 192392 None 0 Human Functional pEC50 = 9.2 9.2 251 4
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 461 6 4 10 1.5 OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4Oc4cccc(Cl)c4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
16109368 161681 None 0 Human Functional pEC50 = 9.2 9.2 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of forskolin-stimulated [3H]cAMP accumulation in CHO cellsAgonist activity at adenosine A1 receptor assessed as inhibition of forskolin-stimulated [3H]cAMP accumulation in CHO cells
ChEMBL 910 20 6 14 4.1 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCNC(=O)CCCCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/jm061279i
CHEMBL412931 161681 None 0 Human Functional pEC50 = 9.2 9.2 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of forskolin-stimulated [3H]cAMP accumulation in CHO cellsAgonist activity at adenosine A1 receptor assessed as inhibition of forskolin-stimulated [3H]cAMP accumulation in CHO cells
ChEMBL 910 20 6 14 4.1 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCNC(=O)CCCCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/jm061279i
68597882 149914 None 0 Human Functional pEC50 = 9.2 9.2 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 445 8 3 9 2.3 CNC(=O)c1cc(CSc2nc(NCCO)c(C#N)c(-c3ccccn3)c2C#N)ccn1 nan
CHEMBL3948814 149914 None 0 Human Functional pEC50 = 9.2 9.2 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 445 8 3 9 2.3 CNC(=O)c1cc(CSc2nc(NCCO)c(C#N)c(-c3ccccn3)c2C#N)ccn1 nan
68605180 153121 None 0 Human Functional pEC50 = 9.2 9.2 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 453 6 2 7 3.9 CS(=O)(=O)Nc1cccc(CSc2nc(N)c(C#N)c(-c3ccc(F)cc3)c2C#N)c1 nan
CHEMBL3975739 153121 None 0 Human Functional pEC50 = 9.2 9.2 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 453 6 2 7 3.9 CS(=O)(=O)Nc1cccc(CSc2nc(N)c(C#N)c(-c3ccc(F)cc3)c2C#N)c1 nan
16109369 138046 None 0 Human Functional pEC50 = 9.2 9.2 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of forskolin-stimulated [3H]cAMP accumulation in CHO cellsAgonist activity at adenosine A1 receptor assessed as inhibition of forskolin-stimulated [3H]cAMP accumulation in CHO cells
ChEMBL 938 22 6 14 4.9 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCCCNC(=O)CCCCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/jm061279i
CHEMBL376411 138046 None 0 Human Functional pEC50 = 9.2 9.2 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of forskolin-stimulated [3H]cAMP accumulation in CHO cellsAgonist activity at adenosine A1 receptor assessed as inhibition of forskolin-stimulated [3H]cAMP accumulation in CHO cells
ChEMBL 938 22 6 14 4.9 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCCCNC(=O)CCCCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/jm061279i
377 2758 None 42 Human Functional pEC50 = 9.1 9.1 3 10
Agonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assayAgonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.8b00047
425 2758 None 42 Human Functional pEC50 = 9.1 9.1 3 10
Agonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assayAgonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.8b00047
448222 2758 None 42 Human Functional pEC50 = 9.1 9.1 3 10
Agonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assayAgonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.8b00047
CHEMBL464859 2758 None 42 Human Functional pEC50 = 9.1 9.1 3 10
Agonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assayAgonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.8b00047
68596111 144676 None 0 Human Functional pEC50 = 9.1 9.1 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 371 5 1 5 4.5 N#Cc1cnc(SCc2cccc(C(=O)O)c2)c(C#N)c1-c1ccccc1 nan
CHEMBL3907703 144676 None 0 Human Functional pEC50 = 9.1 9.1 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 371 5 1 5 4.5 N#Cc1cnc(SCc2cccc(C(=O)O)c2)c(C#N)c1-c1ccccc1 nan
71716569 89069 None 0 Human Functional pEC50 = 9.1 9.1 - 1
Compound was evaluated for the Adenosine A1 receptor agonist potency.Compound was evaluated for the Adenosine A1 receptor agonist potency.
ChEMBL 375 4 4 10 -1.0 OC[C@H]1O[C@@H](n2cnc3c(N[C@H]4CC5CC4C4OC54)ncnc32)[C@H](O)[C@@H]1O 10.1016/0960-894X(96)00111-4
CHEMBL2364570 89069 None 0 Human Functional pEC50 = 9.1 9.1 - 1
Compound was evaluated for the Adenosine A1 receptor agonist potency.Compound was evaluated for the Adenosine A1 receptor agonist potency.
ChEMBL 375 4 4 10 -1.0 OC[C@H]1O[C@@H](n2cnc3c(N[C@H]4CC5CC4C4OC54)ncnc32)[C@H](O)[C@@H]1O 10.1016/0960-894X(96)00111-4
66631651 151541 None 0 Human Functional pEC50 = 9.1 9.1 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 440 6 2 8 2.0 CNC(=O)c1cc(COc2nc(N3CC(O)C3)c(C#N)c(-c3ccccc3)c2C#N)ccn1 nan
CHEMBL3962008 151541 None 0 Human Functional pEC50 = 9.1 9.1 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 440 6 2 8 2.0 CNC(=O)c1cc(COc2nc(N3CC(O)C3)c(C#N)c(-c3ccccc3)c2C#N)ccn1 nan
66631060 153441 None 0 Human Functional pEC50 = 9.1 9.1 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 402 5 2 7 2.5 CNC(=O)c1cc(COc2nc(N)c(C#N)c(-c3ccc(F)cc3)c2C#N)ccn1 nan
CHEMBL3978445 153441 None 0 Human Functional pEC50 = 9.1 9.1 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 402 5 2 7 2.5 CNC(=O)c1cc(COc2nc(N)c(C#N)c(-c3ccc(F)cc3)c2C#N)ccn1 nan
66631775 160384 None 0 Human Functional pEC50 = 9.1 9.1 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 459 9 4 8 2.6 N#Cc1c(NC[C@@H](O)CO)nc(SCc2cccc(C(N)=O)c2)c(C#N)c1-c1ccccc1 nan
CHEMBL4110342 160384 None 0 Human Functional pEC50 = 9.1 9.1 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 459 9 4 8 2.6 N#Cc1c(NC[C@@H](O)CO)nc(SCc2cccc(C(N)=O)c2)c(C#N)c1-c1ccccc1 nan
132991435 180904 None 0 Human Functional pEC50 = 9.0 9.0 70 4
Irreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as effect on forskolin-induced cAMP accumulation incubated for 30 mins by LANCE cAMP detection assayIrreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as effect on forskolin-induced cAMP accumulation incubated for 30 mins by LANCE cAMP detection assay
ChEMBL 558 8 5 12 0.8 O=C(NCc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1)c1ccc(S(=O)(=O)F)cc1 10.1021/acs.jmedchem.6b01561
CHEMBL4756472 180904 None 0 Human Functional pEC50 = 9.0 9.0 70 4
Irreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as effect on forskolin-induced cAMP accumulation incubated for 30 mins by LANCE cAMP detection assayIrreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as effect on forskolin-induced cAMP accumulation incubated for 30 mins by LANCE cAMP detection assay
ChEMBL 558 8 5 12 0.8 O=C(NCc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1)c1ccc(S(=O)(=O)F)cc1 10.1021/acs.jmedchem.6b01561
168285984 191851 None 0 Human Functional pEC50 = 9.0 9.0 199 4
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 461 6 4 10 1.5 OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4Oc4ccccc4Cl)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
CHEMBL5197358 191851 None 0 Human Functional pEC50 = 9.0 9.0 199 4
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 461 6 4 10 1.5 OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4Oc4ccccc4Cl)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
168278076 190361 None 0 Human Functional pEC50 = 9.0 9.0 -3 2
Antagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assayAntagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assay
ChEMBL 295 2 0 6 1.9 Cn1nc(-c2ccccc2)c2cnnc(N3CCOCC3)c21 10.1021/acsmedchemlett.2c00052
CHEMBL5175347 190361 None 0 Human Functional pEC50 = 9.0 9.0 -3 2
Antagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assayAntagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assay
ChEMBL 295 2 0 6 1.9 Cn1nc(-c2ccccc2)c2cnnc(N3CCOCC3)c21 10.1021/acsmedchemlett.2c00052
71456197 78602 None 0 Human Functional pEC50 = 9 9.0 - 1
Adenosine receptor agonistic activity against isoproterenol (1 uM) stimulated cAMP accumulation in DDT MF-2 cellsAdenosine receptor agonistic activity against isoproterenol (1 uM) stimulated cAMP accumulation in DDT MF-2 cells
ChEMBL 375 4 4 10 -1.0 OC[C@@H]1O[C@H](n2cnc3c(NC4CC5CC4[C@@H]4O[C@H]54)ncnc32)[C@@H](O)[C@H]1O 10.1016/s0960-894x(99)00109-2
CHEMBL2112185 78602 None 0 Human Functional pEC50 = 9 9.0 - 1
Adenosine receptor agonistic activity against isoproterenol (1 uM) stimulated cAMP accumulation in DDT MF-2 cellsAdenosine receptor agonistic activity against isoproterenol (1 uM) stimulated cAMP accumulation in DDT MF-2 cells
ChEMBL 375 4 4 10 -1.0 OC[C@@H]1O[C@H](n2cnc3c(NC4CC5CC4[C@@H]4O[C@H]54)ncnc32)[C@@H](O)[C@H]1O 10.1016/s0960-894x(99)00109-2
11527363 110120 None 0 Human Functional pEC50 = 9 9.0 3 2
Agonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level after 30 mins by EIAAgonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level after 30 mins by EIA
ChEMBL 615 13 2 10 3.7 CCN(CC)CCN1CCN(C(=O)CCc2cccc(CSc3nc(N)c(C#N)c(-c4ccc(NC(C)=O)cc4)n3)n2)CC1 10.1021/jm401643m
CHEMBL3235280 110120 None 0 Human Functional pEC50 = 9 9.0 3 2
Agonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level after 30 mins by EIAAgonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level after 30 mins by EIA
ChEMBL 615 13 2 10 3.7 CCN(CC)CCN1CCN(C(=O)CCc2cccc(CSc3nc(N)c(C#N)c(-c4ccc(NC(C)=O)cc4)n3)n2)CC1 10.1021/jm401643m
168282699 191127 None 0 Human Functional pEC50 = 9.0 9.0 1584 3
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 427 6 4 10 0.9 OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4Oc4ccccc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
CHEMBL5186757 191127 None 0 Human Functional pEC50 = 9.0 9.0 1584 3
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 427 6 4 10 0.9 OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4Oc4ccccc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
377 2758 None 42 Human Functional pEC50 = 9.0 9.0 3 10
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.2c01414
425 2758 None 42 Human Functional pEC50 = 9.0 9.0 3 10
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.2c01414
448222 2758 None 42 Human Functional pEC50 = 9.0 9.0 3 10
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.2c01414
CHEMBL464859 2758 None 42 Human Functional pEC50 = 9.0 9.0 3 10
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.2c01414
168281259 190873 None 0 Human Functional pEC50 = 9.0 9.0 -2 2
Antagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assayAntagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assay
ChEMBL 295 2 0 6 1.9 Cn1nc2c(N3CCOCC3)nncc2c1-c1ccccc1 10.1021/acsmedchemlett.2c00052
CHEMBL5183118 190873 None 0 Human Functional pEC50 = 9.0 9.0 -2 2
Antagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assayAntagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assay
ChEMBL 295 2 0 6 1.9 Cn1nc2c(N3CCOCC3)nncc2c1-c1ccccc1 10.1021/acsmedchemlett.2c00052
71457987 78580 None 0 Human Functional pEC50 = 9.0 9.0 - 1
Adenosine receptor agonistic activity against isoproterenol (1 uM) stimulated cAMP accumulation in DDT MF-2 cellsAdenosine receptor agonistic activity against isoproterenol (1 uM) stimulated cAMP accumulation in DDT MF-2 cells
ChEMBL 375 4 4 10 -1.0 OC[C@H]1O[C@H](n2cnc3c(NC4CC5CC4[C@H]4O[C@@H]54)ncnc32)[C@@H](O)[C@H]1O 10.1016/s0960-894x(99)00109-2
CHEMBL2112106 78580 None 0 Human Functional pEC50 = 9.0 9.0 - 1
Adenosine receptor agonistic activity against isoproterenol (1 uM) stimulated cAMP accumulation in DDT MF-2 cellsAdenosine receptor agonistic activity against isoproterenol (1 uM) stimulated cAMP accumulation in DDT MF-2 cells
ChEMBL 375 4 4 10 -1.0 OC[C@H]1O[C@H](n2cnc3c(NC4CC5CC4[C@H]4O[C@@H]54)ncnc32)[C@@H](O)[C@H]1O 10.1016/s0960-894x(99)00109-2
11221 791 None 45 Human Functional pEC50 = 9.0 9.0 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cell membranes by [35S]GTPgammaS binding assayAgonist activity at human adenosine A1 receptor expressed in CHO cell membranes by [35S]GTPgammaS binding assay
ChEMBL 519 8 2 9 5.5 OCCOc1ccc(cc1)c1c(C#N)c(SCc2csc(n2)c2ccc(cc2)Cl)nc(c1C#N)N 10.1016/j.ejmech.2015.07.023
9936489 791 None 45 Human Functional pEC50 = 9.0 9.0 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cell membranes by [35S]GTPgammaS binding assayAgonist activity at human adenosine A1 receptor expressed in CHO cell membranes by [35S]GTPgammaS binding assay
ChEMBL 519 8 2 9 5.5 OCCOc1ccc(cc1)c1c(C#N)c(SCc2csc(n2)c2ccc(cc2)Cl)nc(c1C#N)N 10.1016/j.ejmech.2015.07.023
CHEMBL3235279 791 None 45 Human Functional pEC50 = 9.0 9.0 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cell membranes by [35S]GTPgammaS binding assayAgonist activity at human adenosine A1 receptor expressed in CHO cell membranes by [35S]GTPgammaS binding assay
ChEMBL 519 8 2 9 5.5 OCCOc1ccc(cc1)c1c(C#N)c(SCc2csc(n2)c2ccc(cc2)Cl)nc(c1C#N)N 10.1016/j.ejmech.2015.07.023
DB16118 791 None 45 Human Functional pEC50 = 9.0 9.0 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cell membranes by [35S]GTPgammaS binding assayAgonist activity at human adenosine A1 receptor expressed in CHO cell membranes by [35S]GTPgammaS binding assay
ChEMBL 519 8 2 9 5.5 OCCOc1ccc(cc1)c1c(C#N)c(SCc2csc(n2)c2ccc(cc2)Cl)nc(c1C#N)N 10.1016/j.ejmech.2015.07.023
377 2758 None 42 Human Functional pEC50 = 8.9 8.9 3 10
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1039/C3MD00364G
425 2758 None 42 Human Functional pEC50 = 8.9 8.9 3 10
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1039/C3MD00364G
448222 2758 None 42 Human Functional pEC50 = 8.9 8.9 3 10
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1039/C3MD00364G
CHEMBL464859 2758 None 42 Human Functional pEC50 = 8.9 8.9 3 10
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1039/C3MD00364G
56592179 150110 None 0 Human Functional pEC50 = 8.9 8.9 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 414 7 2 6 3.5 N#Cc1cnc(SCc2cccc(C(=O)NCCO)c2)c(C#N)c1-c1ccccc1 nan
CHEMBL3950404 150110 None 0 Human Functional pEC50 = 8.9 8.9 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 414 7 2 6 3.5 N#Cc1cnc(SCc2cccc(C(=O)NCCO)c2)c(C#N)c1-c1ccccc1 nan
377 2758 None 42 Human Functional pEC50 = 8.9 8.9 3 10
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.2c00320
425 2758 None 42 Human Functional pEC50 = 8.9 8.9 3 10
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.2c00320
448222 2758 None 42 Human Functional pEC50 = 8.9 8.9 3 10
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.2c00320
CHEMBL464859 2758 None 42 Human Functional pEC50 = 8.9 8.9 3 10
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.2c00320
10443 969 None 0 Human Functional pEC50 = 8.9 8.9 223 2
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 390 5 1 8 3.7 COC(=O)c1cccc(c1)CSc1nc(N)c(c(c1C#N)c1ccco1)C#N 10.1021/acs.jmedchem.9b00106
139030524 969 None 0 Human Functional pEC50 = 8.9 8.9 223 2
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 390 5 1 8 3.7 COC(=O)c1cccc(c1)CSc1nc(N)c(c(c1C#N)c1ccco1)C#N 10.1021/acs.jmedchem.9b00106
CHEMBL4448894 969 None 0 Human Functional pEC50 = 8.9 8.9 223 2
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 390 5 1 8 3.7 COC(=O)c1cccc(c1)CSc1nc(N)c(c(c1C#N)c1ccco1)C#N 10.1021/acs.jmedchem.9b00106
122188747 123283 None 0 Human Functional pEC50 = 8.8 8.8 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cell membranes by [35S]GTPgammaS binding assayAgonist activity at human adenosine A1 receptor expressed in CHO cell membranes by [35S]GTPgammaS binding assay
ChEMBL 379 5 1 8 3.8 COc1ccc(-c2c(C#N)c(N)nc(SCc3cscn3)c2C#N)cc1 10.1016/j.ejmech.2015.07.023
CHEMBL3613124 123283 None 0 Human Functional pEC50 = 8.8 8.8 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cell membranes by [35S]GTPgammaS binding assayAgonist activity at human adenosine A1 receptor expressed in CHO cell membranes by [35S]GTPgammaS binding assay
ChEMBL 379 5 1 8 3.8 COc1ccc(-c2c(C#N)c(N)nc(SCc3cscn3)c2C#N)cc1 10.1016/j.ejmech.2015.07.023
168285237 191861 None 0 Human Functional pEC50 = 8.8 8.8 -3 2
Antagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assayAntagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assay
ChEMBL 315 4 1 5 3.6 Cn1nc2c(NCc3ccccc3)nncc2c1-c1ccccc1 10.1021/acsmedchemlett.2c00052
CHEMBL5197567 191861 None 0 Human Functional pEC50 = 8.8 8.8 -3 2
Antagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assayAntagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assay
ChEMBL 315 4 1 5 3.6 Cn1nc2c(NCc3ccccc3)nncc2c1-c1ccccc1 10.1021/acsmedchemlett.2c00052
1329 1472 None 53 Human Functional pEC50 = 8.8 8.8 -4 8
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 304 5 1 5 2.4 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C1CCCC1 10.1021/acs.jmedchem.9b00106
386 1472 None 53 Human Functional pEC50 = 8.8 8.8 -4 8
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 304 5 1 5 2.4 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C1CCCC1 10.1021/acs.jmedchem.9b00106
CHEMBL183 1472 None 53 Human Functional pEC50 = 8.8 8.8 -4 8
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 304 5 1 5 2.4 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C1CCCC1 10.1021/acs.jmedchem.9b00106
DB12946 1472 None 53 Human Functional pEC50 = 8.8 8.8 -4 8
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 304 5 1 5 2.4 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C1CCCC1 10.1021/acs.jmedchem.9b00106
68615584 144232 None 0 Human Functional pEC50 = 8.8 8.8 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 415 6 1 7 3.5 CNC(=O)c1cc(CSc2ncc(C#N)c(-c3ccc(OC)cc3)c2C#N)ccn1 nan
CHEMBL3903897 144232 None 0 Human Functional pEC50 = 8.8 8.8 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 415 6 1 7 3.5 CNC(=O)c1cc(CSc2ncc(C#N)c(-c3ccc(OC)cc3)c2C#N)ccn1 nan
136707040 196261 None 2 Human Functional pEC50 = 8.8 8.8 2 2
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 330 3 1 4 1.8 O=C(CC1CCCC1)N1CCc2c(nc(N3CCCC3)[nH]c2=O)C1 10.1016/j.ejmech.2023.115419
CHEMBL5419943 196261 None 2 Human Functional pEC50 = 8.8 8.8 2 2
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 330 3 1 4 1.8 O=C(CC1CCCC1)N1CCc2c(nc(N3CCCC3)[nH]c2=O)C1 10.1016/j.ejmech.2023.115419
377 2758 None 42 Human Functional pEC50 = 8.8 8.8 3 10
Irreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as effect on forskolin-induced cAMP accumulation incubated for 30 mins by LANCE cAMP detection assayIrreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as effect on forskolin-induced cAMP accumulation incubated for 30 mins by LANCE cAMP detection assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.6b01561
425 2758 None 42 Human Functional pEC50 = 8.8 8.8 3 10
Irreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as effect on forskolin-induced cAMP accumulation incubated for 30 mins by LANCE cAMP detection assayIrreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as effect on forskolin-induced cAMP accumulation incubated for 30 mins by LANCE cAMP detection assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.6b01561
448222 2758 None 42 Human Functional pEC50 = 8.8 8.8 3 10
Irreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as effect on forskolin-induced cAMP accumulation incubated for 30 mins by LANCE cAMP detection assayIrreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as effect on forskolin-induced cAMP accumulation incubated for 30 mins by LANCE cAMP detection assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.6b01561
CHEMBL464859 2758 None 42 Human Functional pEC50 = 8.8 8.8 3 10
Irreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as effect on forskolin-induced cAMP accumulation incubated for 30 mins by LANCE cAMP detection assayIrreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as effect on forskolin-induced cAMP accumulation incubated for 30 mins by LANCE cAMP detection assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.6b01561
123807 871 None 35 Rat Functional pEC50 = 8.8 8.8 -1 7
Agonist activity at rat A1A adenosine receptor expressed in CHO-K1 cell membranes incubated for 60 mins by [35S]GTPgammaS binding assayAgonist activity at rat A1A adenosine receptor expressed in CHO-K1 cell membranes incubated for 60 mins by [35S]GTPgammaS binding assay
ChEMBL 369 4 4 9 0.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1 10.1021/acs.jmedchem.8b01662
374 871 None 35 Rat Functional pEC50 = 8.8 8.8 -1 7
Agonist activity at rat A1A adenosine receptor expressed in CHO-K1 cell membranes incubated for 60 mins by [35S]GTPgammaS binding assayAgonist activity at rat A1A adenosine receptor expressed in CHO-K1 cell membranes incubated for 60 mins by [35S]GTPgammaS binding assay
ChEMBL 369 4 4 9 0.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1 10.1021/acs.jmedchem.8b01662
379 871 None 35 Rat Functional pEC50 = 8.8 8.8 -1 7
Agonist activity at rat A1A adenosine receptor expressed in CHO-K1 cell membranes incubated for 60 mins by [35S]GTPgammaS binding assayAgonist activity at rat A1A adenosine receptor expressed in CHO-K1 cell membranes incubated for 60 mins by [35S]GTPgammaS binding assay
ChEMBL 369 4 4 9 0.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1 10.1021/acs.jmedchem.8b01662
CHEMBL284969 871 None 35 Rat Functional pEC50 = 8.8 8.8 -1 7
Agonist activity at rat A1A adenosine receptor expressed in CHO-K1 cell membranes incubated for 60 mins by [35S]GTPgammaS binding assayAgonist activity at rat A1A adenosine receptor expressed in CHO-K1 cell membranes incubated for 60 mins by [35S]GTPgammaS binding assay
ChEMBL 369 4 4 9 0.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1 10.1021/acs.jmedchem.8b01662
CHEMBL5078671 217065 None 0 Human Functional pEC50 = 8.8 8.8 1 2
Agonist activity at human A1 adenosine receptorAgonist activity at human A1 adenosine receptor
ChEMBL None None None CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCCNC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](C)NC(=O)CCCCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.0c02067
90654625 110089 None 0 Human Functional pEC50 = 8.7 8.7 - 1
Agonist activity human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by radioligand addition measured after 90 mins by beta scintillation counting analysisAgonist activity human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by radioligand addition measured after 90 mins by beta scintillation counting analysis
ChEMBL 454 5 1 11 2.9 N#Cc1c(N)nc(SCc2csc(N3CCOCC3)n2)nc1-c1ccc2c(c1)OCO2 10.1021/jm401643m
CHEMBL3234964 110089 None 0 Human Functional pEC50 = 8.7 8.7 - 1
Agonist activity human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by radioligand addition measured after 90 mins by beta scintillation counting analysisAgonist activity human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by radioligand addition measured after 90 mins by beta scintillation counting analysis
ChEMBL 454 5 1 11 2.9 N#Cc1c(N)nc(SCc2csc(N3CCOCC3)n2)nc1-c1ccc2c(c1)OCO2 10.1021/jm401643m
67431601 191185 None 0 Human Functional pEC50 = 8.7 8.7 575 2
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 471 8 4 11 1.0 COc1cccc(CO[C@@H]2CCC[C@H]2Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1 10.1021/acs.jmedchem.2c01414
CHEMBL5187478 191185 None 0 Human Functional pEC50 = 8.7 8.7 575 2
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 471 8 4 11 1.0 COc1cccc(CO[C@@H]2CCC[C@H]2Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1 10.1021/acs.jmedchem.2c01414
377 2758 None 42 Human Functional pEC50 = 8.7 8.7 3 10
Antagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assayAntagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acsmedchemlett.2c00052
425 2758 None 42 Human Functional pEC50 = 8.7 8.7 3 10
Antagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assayAntagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acsmedchemlett.2c00052
448222 2758 None 42 Human Functional pEC50 = 8.7 8.7 3 10
Antagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assayAntagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acsmedchemlett.2c00052
CHEMBL464859 2758 None 42 Human Functional pEC50 = 8.7 8.7 3 10
Antagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assayAntagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acsmedchemlett.2c00052
122188748 123284 None 0 Human Functional pEC50 = 8.7 8.7 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cell membranes by [35S]GTPgammaS binding assayAgonist activity at human adenosine A1 receptor expressed in CHO cell membranes by [35S]GTPgammaS binding assay
ChEMBL 455 6 1 8 5.5 COc1ccc(-c2c(C#N)c(N)nc(SCc3csc(-c4ccccc4)n3)c2C#N)cc1 10.1016/j.ejmech.2015.07.023
CHEMBL3613125 123284 None 0 Human Functional pEC50 = 8.7 8.7 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cell membranes by [35S]GTPgammaS binding assayAgonist activity at human adenosine A1 receptor expressed in CHO cell membranes by [35S]GTPgammaS binding assay
ChEMBL 455 6 1 8 5.5 COc1ccc(-c2c(C#N)c(N)nc(SCc3csc(-c4ccccc4)n3)c2C#N)cc1 10.1016/j.ejmech.2015.07.023
122188749 123285 None 0 Human Functional pEC50 = 8.7 8.7 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cell membranes by [35S]GTPgammaS binding assayAgonist activity at human adenosine A1 receptor expressed in CHO cell membranes by [35S]GTPgammaS binding assay
ChEMBL 464 6 1 10 3.7 COc1ccc(-c2c(C#N)c(N)nc(SCc3csc(N4CCOCC4)n3)c2C#N)cc1 10.1016/j.ejmech.2015.07.023
CHEMBL3613126 123285 None 0 Human Functional pEC50 = 8.7 8.7 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cell membranes by [35S]GTPgammaS binding assayAgonist activity at human adenosine A1 receptor expressed in CHO cell membranes by [35S]GTPgammaS binding assay
ChEMBL 464 6 1 10 3.7 COc1ccc(-c2c(C#N)c(N)nc(SCc3csc(N4CCOCC4)n3)c2C#N)cc1 10.1016/j.ejmech.2015.07.023
90654614 110078 None 0 Human Functional pEC50 = 8.7 8.7 - 1
Agonist activity human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by radioligand addition measured after 90 mins by beta scintillation counting analysisAgonist activity human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by radioligand addition measured after 90 mins by beta scintillation counting analysis
ChEMBL 475 6 1 10 4.8 COc1ccc(-c2nc(CSc3nc(N)c(C#N)c(-c4ccc5c(c4)OCO5)n3)cs2)cc1 10.1021/jm401643m
CHEMBL3234952 110078 None 0 Human Functional pEC50 = 8.7 8.7 - 1
Agonist activity human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by radioligand addition measured after 90 mins by beta scintillation counting analysisAgonist activity human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by radioligand addition measured after 90 mins by beta scintillation counting analysis
ChEMBL 475 6 1 10 4.8 COc1ccc(-c2nc(CSc3nc(N)c(C#N)c(-c4ccc5c(c4)OCO5)n3)cs2)cc1 10.1021/jm401643m
1511731 38104 None 12 Human Functional pEC50 = 8.7 8.7 2 4
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 337 3 1 6 2.9 COc1ccc(C(=O)Nc2nc(C)c3cc4c(cc3n2)OCO4)cc1 10.1016/j.ejmech.2023.115419
CHEMBL1460863 38104 None 12 Human Functional pEC50 = 8.7 8.7 2 4
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 337 3 1 6 2.9 COc1ccc(C(=O)Nc2nc(C)c3cc4c(cc3n2)OCO4)cc1 10.1016/j.ejmech.2023.115419
71717167 89070 None 0 Human Functional pEC50 = 8 8.0 - 1
Compound was evaluated for the Adenosine A1 receptor agonist potency.Compound was evaluated for the Adenosine A1 receptor agonist potency.
ChEMBL 375 4 4 10 -1.0 OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CC5CC4C4OC54)ncnc32)[C@H](O)[C@@H]1O 10.1016/0960-894X(96)00111-4
CHEMBL2364571 89070 None 0 Human Functional pEC50 = 8 8.0 - 1
Compound was evaluated for the Adenosine A1 receptor agonist potency.Compound was evaluated for the Adenosine A1 receptor agonist potency.
ChEMBL 375 4 4 10 -1.0 OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CC5CC4C4OC54)ncnc32)[C@H](O)[C@@H]1O 10.1016/0960-894X(96)00111-4
118732977 118582 None 0 Human Functional pEC50 = 8.0 8.0 1 3
Agonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activityAgonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activity
ChEMBL 461 5 3 12 1.1 CCn1nnc([C@H]2O[C@@H](n3cnc4c(N[C@H]5C[C@@H]6CC[C@@H]5C6)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.5b00074
CHEMBL3414943 118582 None 0 Human Functional pEC50 = 8.0 8.0 1 3
Agonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activityAgonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activity
ChEMBL 461 5 3 12 1.1 CCn1nnc([C@H]2O[C@@H](n3cnc4c(N[C@H]5C[C@@H]6CC[C@@H]5C6)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.5b00074
118732980 118585 None 0 Human Functional pEC50 = 8.0 8.0 -1 4
Agonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activityAgonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activity
ChEMBL 461 5 3 12 1.4 CCn1nnc([C@H]2O[C@@H](n3cnc4c(Nc5ccc(Cl)cc5F)ncnc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.5b00074
CHEMBL3414946 118585 None 0 Human Functional pEC50 = 8.0 8.0 -1 4
Agonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activityAgonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activity
ChEMBL 461 5 3 12 1.4 CCn1nnc([C@H]2O[C@@H](n3cnc4c(Nc5ccc(Cl)cc5F)ncnc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.5b00074
377 2758 None 42 Human Functional pEC50 = 8.0 8.0 3 10
Agonist activity at human recombinant adenosine receptor-1 expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production preincubated for 45 mins prior forskolin-induction measured after 15 mins by immunoassayAgonist activity at human recombinant adenosine receptor-1 expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production preincubated for 45 mins prior forskolin-induction measured after 15 mins by immunoassay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/ml200114q
425 2758 None 42 Human Functional pEC50 = 8.0 8.0 3 10
Agonist activity at human recombinant adenosine receptor-1 expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production preincubated for 45 mins prior forskolin-induction measured after 15 mins by immunoassayAgonist activity at human recombinant adenosine receptor-1 expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production preincubated for 45 mins prior forskolin-induction measured after 15 mins by immunoassay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/ml200114q
448222 2758 None 42 Human Functional pEC50 = 8.0 8.0 3 10
Agonist activity at human recombinant adenosine receptor-1 expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production preincubated for 45 mins prior forskolin-induction measured after 15 mins by immunoassayAgonist activity at human recombinant adenosine receptor-1 expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production preincubated for 45 mins prior forskolin-induction measured after 15 mins by immunoassay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/ml200114q
CHEMBL464859 2758 None 42 Human Functional pEC50 = 8.0 8.0 3 10
Agonist activity at human recombinant adenosine receptor-1 expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production preincubated for 45 mins prior forskolin-induction measured after 15 mins by immunoassayAgonist activity at human recombinant adenosine receptor-1 expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production preincubated for 45 mins prior forskolin-induction measured after 15 mins by immunoassay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/ml200114q
168287894 191460 None 0 Human Functional pEC50 = 8.0 8.0 11 4
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 502 7 4 10 1.6 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4Oc4ccc(Cl)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
CHEMBL5191989 191460 None 0 Human Functional pEC50 = 8.0 8.0 11 4
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 502 7 4 10 1.6 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4Oc4ccc(Cl)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
135629993 195205 None 7 Human Functional pEC50 = 8.0 8.0 -1 2
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 322 3 1 5 3.1 O=c1[nH]c(N2CCCCC2)nc2nccc(/C=C/c3ccco3)c12 10.1016/j.ejmech.2023.115419
CHEMBL5398733 195205 None 7 Human Functional pEC50 = 8.0 8.0 -1 2
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 322 3 1 5 3.1 O=c1[nH]c(N2CCCCC2)nc2nccc(/C=C/c3ccco3)c12 10.1016/j.ejmech.2023.115419
168294594 192448 None 0 Human Functional pEC50 = 8.0 8.0 141 2
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 560 8 4 10 1.9 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4OCc4ccc(Br)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
CHEMBL5206687 192448 None 0 Human Functional pEC50 = 8.0 8.0 141 2
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 560 8 4 10 1.9 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4OCc4ccc(Br)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
56666128 64362 None 15 Human Functional pEC50 = 7 7.0 - 1
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 415 6 5 10 -0.1 O=P(O)(O)OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)[C@H](O)[C@@H]1O 10.1021/jm3004834
CHEMBL1812058 64362 None 15 Human Functional pEC50 = 7 7.0 - 1
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 415 6 5 10 -0.1 O=P(O)(O)OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)[C@H](O)[C@@H]1O 10.1021/jm3004834
CHEMBL2163558 64362 None 15 Human Functional pEC50 = 7 7.0 - 1
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 415 6 5 10 -0.1 O=P(O)(O)OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)[C@H](O)[C@@H]1O 10.1021/jm3004834
9906178 98991 None 0 Rat Functional pEC50 = 7 7.0 -4 2
Stimulation of [35S]GTP-gamma-S, binding to adenosine A1 receptor of rat cerebral cortical membraneStimulation of [35S]GTP-gamma-S, binding to adenosine A1 receptor of rat cerebral cortical membrane
ChEMBL 345 4 4 8 0.5 OC[C@@]12C[C@@H]1[C@@H](n1cnc3c(NC4CCCC4)ncnc31)[C@H](O)[C@@H]2O 10.1021/jm9905965
CHEMBL27952 98991 None 0 Rat Functional pEC50 = 7 7.0 -4 2
Stimulation of [35S]GTP-gamma-S, binding to adenosine A1 receptor of rat cerebral cortical membraneStimulation of [35S]GTP-gamma-S, binding to adenosine A1 receptor of rat cerebral cortical membrane
ChEMBL 345 4 4 8 0.5 OC[C@@]12C[C@@H]1[C@@H](n1cnc3c(NC4CCCC4)ncnc31)[C@H](O)[C@@H]2O 10.1021/jm9905965
168293183 192235 None 0 Human Functional pEC50 = 6 6.0 -1 3
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assay
ChEMBL 767 16 6 13 4.7 Nc1sc(CCC(=O)NCCCCCCNc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
CHEMBL5203535 192235 None 0 Human Functional pEC50 = 6 6.0 -1 3
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assay
ChEMBL 767 16 6 13 4.7 Nc1sc(CCC(=O)NCCCCCCNc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
44398745 11795 None 0 Human Functional pEC50 = 5 5.0 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 312 1 1 3 4.9 Cc1cc(Cl)cc(-c2ccc3c(c2)Cc2sc(N)nc2-3)c1 10.1021/jm049132j
CHEMBL1181831 11795 None 0 Human Functional pEC50 = 5 5.0 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 312 1 1 3 4.9 Cc1cc(Cl)cc(-c2ccc3c(c2)Cc2sc(N)nc2-3)c1 10.1021/jm049132j
CHEMBL193053 11795 None 0 Human Functional pEC50 = 5 5.0 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 312 1 1 3 4.9 Cc1cc(Cl)cc(-c2ccc3c(c2)Cc2sc(N)nc2-3)c1 10.1021/jm049132j
46874460 204021 None 0 Guinea pig Functional pEC50 = 4 4.0 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 365 4 4 10 -0.3 Nc1nc(OC2CCCCC2)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a014
CHEMBL605472 204021 None 0 Guinea pig Functional pEC50 = 4 4.0 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 365 4 4 10 -0.3 Nc1nc(OC2CCCCC2)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a014
137661505 159590 None 0 Human Functional pEC50 = 7.0 7.0 -2 4
Agonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assayAgonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assay
ChEMBL 815 15 6 13 6.1 Nc1sc(-c2cccc(C(=O)NCCCCCCNc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.8b00047
CHEMBL4101850 159590 None 0 Human Functional pEC50 = 7.0 7.0 -2 4
Agonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assayAgonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assay
ChEMBL 815 15 6 13 6.1 Nc1sc(-c2cccc(C(=O)NCCCCCCNc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.8b00047
168275677 190230 None 0 Human Functional pEC50 = 6.0 6.0 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assay
ChEMBL 753 15 6 13 4.3 Nc1sc(CCC(=O)NCCCCCNc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
CHEMBL5173303 190230 None 0 Human Functional pEC50 = 6.0 6.0 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assay
ChEMBL 753 15 6 13 4.3 Nc1sc(CCC(=O)NCCCCCNc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
69961639 175836 None 0 Human Functional pEC50 = 7.0 7.0 8 2
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 302 4 2 7 2.2 N#Cc1c(N)nc(SCCO)c(C#N)c1-c1cccs1 10.1021/acs.jmedchem.9b00106
CHEMBL4582726 175836 None 0 Human Functional pEC50 = 7.0 7.0 8 2
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 302 4 2 7 2.2 N#Cc1c(N)nc(SCCO)c(C#N)c1-c1cccs1 10.1021/acs.jmedchem.9b00106
168271307 190643 None 0 Human Functional pEC50 = 7.0 7.0 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assay
ChEMBL 514 7 5 10 1.4 O=C(NCCC#Cc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1)c1ccccc1 10.1021/acs.jmedchem.2c00320
CHEMBL5179664 190643 None 0 Human Functional pEC50 = 7.0 7.0 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assay
ChEMBL 514 7 5 10 1.4 O=C(NCCC#Cc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1)c1ccccc1 10.1021/acs.jmedchem.2c00320
46203501 8008 None 1 Human Functional pEC50 = 6.0 6.0 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation
ChEMBL 809 17 5 14 6.5 Nc1sc2c(c1C(=O)c1ccc(Cl)c(Cl)c1)CCN(CCCCCCCCCOc1ccc(Nc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc1)C2 10.1021/jm901252a
CHEMBL1090687 8008 None 1 Human Functional pEC50 = 6.0 6.0 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation
ChEMBL 809 17 5 14 6.5 Nc1sc2c(c1C(=O)c1ccc(Cl)c(Cl)c1)CCN(CCCCCCCCCOc1ccc(Nc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc1)C2 10.1021/jm901252a
168275677 190230 None 0 Human Functional pEC50 = 6.0 6.0 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 753 15 6 13 4.3 Nc1sc(CCC(=O)NCCCCCNc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
CHEMBL5173303 190230 None 0 Human Functional pEC50 = 6.0 6.0 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 753 15 6 13 4.3 Nc1sc(CCC(=O)NCCCCCNc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
168293183 192235 None 0 Human Functional pEC50 = 6.0 6.0 -1 3
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 767 16 6 13 4.7 Nc1sc(CCC(=O)NCCCCCCNc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
CHEMBL5203535 192235 None 0 Human Functional pEC50 = 6.0 6.0 -1 3
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 767 16 6 13 4.7 Nc1sc(CCC(=O)NCCCCCCNc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
168293564 192266 None 0 Human Functional pEC50 = 7.0 7.0 -74 4
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 849 13 6 13 6.8 Nc1sc(-c2ccc(C(=O)NCCCc3ccc(Nc4ncnc5c4ncn5[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)cc3)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
CHEMBL5203917 192266 None 0 Human Functional pEC50 = 7.0 7.0 -74 4
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 849 13 6 13 6.8 Nc1sc(-c2ccc(C(=O)NCCCc3ccc(Nc4ncnc5c4ncn5[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)cc3)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
137656845 159890 None 0 Human Functional pEC50 = 7.0 7.0 -1 3
Agonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assayAgonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assay
ChEMBL 800 15 5 12 6.5 O=C(NCCCCCCNc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)c1ccc(-c2scc(C(=O)c3ccccc3)c2-c2cccc(C(F)(F)F)c2)cc1 10.1021/acs.jmedchem.8b00047
CHEMBL4105473 159890 None 0 Human Functional pEC50 = 7.0 7.0 -1 3
Agonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assayAgonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assay
ChEMBL 800 15 5 12 6.5 O=C(NCCCCCCNc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)c1ccc(-c2scc(C(=O)c3ccccc3)c2-c2cccc(C(F)(F)F)c2)cc1 10.1021/acs.jmedchem.8b00047
9932840 77927 None 1 Rat Functional pEC50 = 7.0 7.0 10 2
Negative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atriaNegative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atria
ChEMBL 438 4 5 10 -0.8 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(C#CC(O)c4ccccc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm00037a024
CHEMBL2094083 77927 None 1 Rat Functional pEC50 = 7.0 7.0 10 2
Negative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atriaNegative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atria
ChEMBL 438 4 5 10 -0.8 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(C#CC(O)c4ccccc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm00037a024
44398843 12275 None 0 Human Functional pEC50 = 4.9 4.9 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 346 2 1 4 5.7 Nc1nc2c(s1)Cc1cc(-c3ccccc3-c3cccs3)ccc1-2 10.1021/jm049132j
CHEMBL1184744 12275 None 0 Human Functional pEC50 = 4.9 4.9 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 346 2 1 4 5.7 Nc1nc2c(s1)Cc1cc(-c3ccccc3-c3cccs3)ccc1-2 10.1021/jm049132j
CHEMBL366204 12275 None 0 Human Functional pEC50 = 4.9 4.9 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 346 2 1 4 5.7 Nc1nc2c(s1)Cc1cc(-c3ccccc3-c3cccs3)ccc1-2 10.1021/jm049132j
65085 58908 None 46 Guinea pig Functional pEC50 = 5.9 5.9 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 283 2 5 9 -2.7 Nc1nc(=O)[nH]c2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00108a014
CHEMBL1688963 58908 None 46 Guinea pig Functional pEC50 = 5.9 5.9 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 283 2 5 9 -2.7 Nc1nc(=O)[nH]c2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00108a014
46874395 204085 None 0 Guinea pig Functional pEC50 = 4.9 4.9 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 437 6 4 10 0.8 Nc1nc(OCCc2ccc3ccccc3c2)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a015
CHEMBL605878 204085 None 0 Guinea pig Functional pEC50 = 4.9 4.9 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 437 6 4 10 0.8 Nc1nc(OCCc2ccc3ccccc3c2)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a015
137661132 159268 None 0 Human Functional pEC50 = 6.9 6.9 -15 4
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATP
ChEMBL 491 6 3 12 1.7 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NCc5cccc(Cl)c5)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b00291
CHEMBL4098377 159268 None 0 Human Functional pEC50 = 6.9 6.9 -15 4
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATP
ChEMBL 491 6 3 12 1.7 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NCc5cccc(Cl)c5)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b00291
11464738 11787 None 0 Human Functional pEC50 = 4.9 4.9 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 308 1 1 5 3.7 Nc1nc2c(s1)Cc1cc(-c3ccc4c(c3)OCO4)ccc1-2 10.1021/jm049132j
CHEMBL1181760 11787 None 0 Human Functional pEC50 = 4.9 4.9 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 308 1 1 5 3.7 Nc1nc2c(s1)Cc1cc(-c3ccc4c(c3)OCO4)ccc1-2 10.1021/jm049132j
CHEMBL191217 11787 None 0 Human Functional pEC50 = 4.9 4.9 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 308 1 1 5 3.7 Nc1nc2c(s1)Cc1cc(-c3ccc4c(c3)OCO4)ccc1-2 10.1021/jm049132j
45503815 196995 None 3 Human Functional pEC50 = 6.9 6.9 -1 2
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 314 2 1 6 3.1 Cc1nnsc1C(=O)Nc1nc2c(s1)Cc1ccccc1-2 10.1016/j.ejmech.2023.115419
CHEMBL5436271 196995 None 3 Human Functional pEC50 = 6.9 6.9 -1 2
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 314 2 1 6 3.1 Cc1nnsc1C(=O)Nc1nc2c(s1)Cc1ccccc1-2 10.1016/j.ejmech.2023.115419
46874346 204046 None 0 Guinea pig Functional pEC50 = 4.9 4.9 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 393 6 4 11 -0.3 Nc1nc(OCCc2cccs2)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a015
CHEMBL605667 204046 None 0 Guinea pig Functional pEC50 = 4.9 4.9 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 393 6 4 11 -0.3 Nc1nc(OCCc2cccs2)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a015
44398798 11793 None 0 Human Functional pEC50 = 4.9 4.9 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 324 3 1 5 4.0 COc1ccc(-c2ccc3c(c2)Cc2sc(N)nc2-3)c(OC)c1 10.1021/jm049132j
CHEMBL1181814 11793 None 0 Human Functional pEC50 = 4.9 4.9 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 324 3 1 5 4.0 COc1ccc(-c2ccc3c(c2)Cc2sc(N)nc2-3)c(OC)c1 10.1021/jm049132j
CHEMBL192476 11793 None 0 Human Functional pEC50 = 4.9 4.9 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 324 3 1 5 4.0 COc1ccc(-c2ccc3c(c2)Cc2sc(N)nc2-3)c(OC)c1 10.1021/jm049132j
44398993 12398 None 0 Human Functional pEC50 = 4.9 4.9 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 354 4 1 6 4.0 COc1cc(-c2ccc3c(c2)Cc2sc(N)nc2-3)cc(OC)c1OC 10.1021/jm049132j
CHEMBL1185674 12398 None 0 Human Functional pEC50 = 4.9 4.9 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 354 4 1 6 4.0 COc1cc(-c2ccc3c(c2)Cc2sc(N)nc2-3)cc(OC)c1OC 10.1021/jm049132j
CHEMBL427156 12398 None 0 Human Functional pEC50 = 4.9 4.9 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 354 4 1 6 4.0 COc1cc(-c2ccc3c(c2)Cc2sc(N)nc2-3)cc(OC)c1OC 10.1021/jm049132j
90654602 110065 None 0 Human Functional pEC50 = 7.9 7.9 - 1
Agonist activity human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by radioligand addition measured after 90 mins by beta scintillation counting analysisAgonist activity human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by radioligand addition measured after 90 mins by beta scintillation counting analysis
ChEMBL 495 8 2 9 5.0 N#Cc1c(N)nc(SCc2csc(-c3ccc(Cl)cc3)n2)nc1-c1ccc(OCCO)cc1 10.1021/jm401643m
CHEMBL3234936 110065 None 0 Human Functional pEC50 = 7.9 7.9 - 1
Agonist activity human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by radioligand addition measured after 90 mins by beta scintillation counting analysisAgonist activity human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by radioligand addition measured after 90 mins by beta scintillation counting analysis
ChEMBL 495 8 2 9 5.0 N#Cc1c(N)nc(SCc2csc(-c3ccc(Cl)cc3)n2)nc1-c1ccc(OCCO)cc1 10.1021/jm401643m
16109360 83297 None 0 Human Functional pEC50 = 7.9 7.9 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of forskolin-stimulated [3H]cAMP accumulation in CHO cellsAgonist activity at adenosine A1 receptor assessed as inhibition of forskolin-stimulated [3H]cAMP accumulation in CHO cells
ChEMBL 980 25 6 14 6.1 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCCCCCCNC(=O)CCCCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/jm061279i
CHEMBL218786 83297 None 0 Human Functional pEC50 = 7.9 7.9 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of forskolin-stimulated [3H]cAMP accumulation in CHO cellsAgonist activity at adenosine A1 receptor assessed as inhibition of forskolin-stimulated [3H]cAMP accumulation in CHO cells
ChEMBL 980 25 6 14 6.1 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCCCCCCNC(=O)CCCCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/jm061279i
168271307 190643 None 0 Human Functional pEC50 = 7.9 7.9 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 514 7 5 10 1.4 O=C(NCCC#Cc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1)c1ccccc1 10.1021/acs.jmedchem.2c00320
CHEMBL5179664 190643 None 0 Human Functional pEC50 = 7.9 7.9 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 514 7 5 10 1.4 O=C(NCCC#Cc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1)c1ccccc1 10.1021/acs.jmedchem.2c00320
380 1287 None 37 Guinea pig Functional pEC50 = 7.9 7.9 -6 5
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 335 4 4 9 -0.2 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NC1CCCC1 10.1021/jm00108a014
657378 1287 None 37 Guinea pig Functional pEC50 = 7.9 7.9 -6 5
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 335 4 4 9 -0.2 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NC1CCCC1 10.1021/jm00108a014
CHEMBL68738 1287 None 37 Guinea pig Functional pEC50 = 7.9 7.9 -6 5
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 335 4 4 9 -0.2 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NC1CCCC1 10.1021/jm00108a014
60195013 84450 None 0 Human Functional pEC50 = 6.9 6.9 - 1
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 465 6 6 11 -0.5 O=P(O)(O)O[C@@H]1CCC[C@H]1Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm3004834
CHEMBL2163570 84450 None 0 Human Functional pEC50 = 6.9 6.9 - 1
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 465 6 6 11 -0.5 O=P(O)(O)O[C@@H]1CCC[C@H]1Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm3004834
CHEMBL2219872 84450 None 0 Human Functional pEC50 = 6.9 6.9 - 1
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 465 6 6 11 -0.5 O=P(O)(O)O[C@@H]1CCC[C@H]1Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm3004834
46876660 204422 None 0 Guinea pig Functional pEC50 = 4.9 4.9 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 513 8 5 13 0.7 CC(C)(C)OC(=O)CCc1ccc(/C=N/Nc2nc(N)c3ncn(C4O[C@H](CO)[C@@H](O)[C@H]4O)c3n2)cc1 10.1021/jm00102a008
CHEMBL607886 204422 None 0 Guinea pig Functional pEC50 = 4.9 4.9 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 513 8 5 13 0.7 CC(C)(C)OC(=O)CCc1ccc(/C=N/Nc2nc(N)c3ncn(C4O[C@H](CO)[C@@H](O)[C@H]4O)c3n2)cc1 10.1021/jm00102a008
46886345 8481 None 0 Human Functional pEC50 = 6.9 6.9 -4 3
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation countingAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting
ChEMBL 373 5 4 10 0.2 COc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1 10.1021/jm901252a
CHEMBL1093910 8481 None 0 Human Functional pEC50 = 6.9 6.9 -4 3
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation countingAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting
ChEMBL 373 5 4 10 0.2 COc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1 10.1021/jm901252a
46876648 204454 None 0 Guinea pig Functional pEC50 = 4.9 4.9 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 415 6 5 12 -0.5 COc1ccccc1/C=N/Nc1nc(N)c2ncn(C3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00102a008
CHEMBL608167 204454 None 0 Guinea pig Functional pEC50 = 4.9 4.9 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 415 6 5 12 -0.5 COc1ccccc1/C=N/Nc1nc(N)c2ncn(C3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00102a008
10320761 11796 None 0 Human Functional pEC50 = 4.9 4.9 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 307 2 1 4 4.0 CN(C)c1ccc(-c2ccc3c(c2)Cc2sc(N)nc2-3)cc1 10.1021/jm049132j
CHEMBL1181834 11796 None 0 Human Functional pEC50 = 4.9 4.9 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 307 2 1 4 4.0 CN(C)c1ccc(-c2ccc3c(c2)Cc2sc(N)nc2-3)cc1 10.1021/jm049132j
CHEMBL193107 11796 None 0 Human Functional pEC50 = 4.9 4.9 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 307 2 1 4 4.0 CN(C)c1ccc(-c2ccc3c(c2)Cc2sc(N)nc2-3)cc1 10.1021/jm049132j
420 1220 None 40 Guinea pig Functional pEC50 = 4.9 4.9 -9 2
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 358 4 5 10 -0.2 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Nc1ccccc1)nc2N 10.1021/jm00108a014
6917803 1220 None 40 Guinea pig Functional pEC50 = 4.9 4.9 -9 2
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 358 4 5 10 -0.2 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Nc1ccccc1)nc2N 10.1021/jm00108a014
CHEMBL1256672 1220 None 40 Guinea pig Functional pEC50 = 4.9 4.9 -9 2
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 358 4 5 10 -0.2 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Nc1ccccc1)nc2N 10.1021/jm00108a014
46876612 205044 None 0 Guinea pig Functional pEC50 = 4.9 4.9 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 403 5 5 11 -0.4 Nc1nc(N/N=C/c2ccc(F)cc2)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a008
CHEMBL611947 205044 None 0 Guinea pig Functional pEC50 = 4.9 4.9 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 403 5 5 11 -0.4 Nc1nc(N/N=C/c2ccc(F)cc2)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a008
46876085 204566 None 0 Guinea pig Functional pEC50 = 5.9 5.9 - 1
Agonistic activity against adenosine A1 receptor in guinea pig isolated heartsAgonistic activity against adenosine A1 receptor in guinea pig isolated hearts
ChEMBL 447 6 3 10 1.6 O[C@@H]1[C@@H](CSc2ccccc2F)OC(n2cnc3c(NC4CCOC4)ncnc32)[C@@H]1O 10.1016/j.bmcl.2004.04.096
CHEMBL608939 204566 None 0 Guinea pig Functional pEC50 = 5.9 5.9 - 1
Agonistic activity against adenosine A1 receptor in guinea pig isolated heartsAgonistic activity against adenosine A1 receptor in guinea pig isolated hearts
ChEMBL 447 6 3 10 1.6 O[C@@H]1[C@@H](CSc2ccccc2F)OC(n2cnc3c(NC4CCOC4)ncnc32)[C@@H]1O 10.1016/j.bmcl.2004.04.096
11740457 96699 None 0 Rat Functional pEC50 = 6.9 6.9 -6 2
Effective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranesEffective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranes
ChEMBL 379 6 3 9 1.6 CCSC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)[C@H](O)[C@@H]1O 10.1021/jm970508l
CHEMBL263643 96699 None 0 Rat Functional pEC50 = 6.9 6.9 -6 2
Effective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranesEffective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranes
ChEMBL 379 6 3 9 1.6 CCSC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)[C@H](O)[C@@H]1O 10.1021/jm970508l
155560649 175201 None 0 Human Functional pEC50 = 6.9 6.9 - 1
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 286 4 2 7 1.8 N#Cc1c(N)nc(SCCO)c(C#N)c1-c1ccco1 10.1021/acs.jmedchem.9b00106
CHEMBL4568832 175201 None 0 Human Functional pEC50 = 6.9 6.9 - 1
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 286 4 2 7 1.8 N#Cc1c(N)nc(SCCO)c(C#N)c1-c1ccco1 10.1021/acs.jmedchem.9b00106
137639588 156976 None 0 Human Functional pEC50 = 5.9 5.9 -4 3
Agonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assayAgonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assay
ChEMBL 815 15 6 13 6.1 Nc1sc(-c2ccccc2C(=O)NCCCCCCNc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.8b00047
CHEMBL4072009 156976 None 0 Human Functional pEC50 = 5.9 5.9 -4 3
Agonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assayAgonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assay
ChEMBL 815 15 6 13 6.1 Nc1sc(-c2ccccc2C(=O)NCCCCCCNc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.8b00047
46874326 203892 None 0 Guinea pig Functional pEC50 = 4.9 4.9 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 401 6 4 10 -0.1 Cc1cccc(CCOc2nc(N)c3ncn(C4O[C@@H](CO)[C@H](O)[C@@H]4O)c3n2)c1 10.1021/jm00108a015
CHEMBL604836 203892 None 0 Guinea pig Functional pEC50 = 4.9 4.9 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 401 6 4 10 -0.1 Cc1cccc(CCOc2nc(N)c3ncn(C4O[C@@H](CO)[C@H](O)[C@@H]4O)c3n2)c1 10.1021/jm00108a015
168297766 192618 None 0 Human Functional pEC50 = 7.9 7.9 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 475 7 4 10 1.6 OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4OCc4cccc(Cl)c4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
CHEMBL5209222 192618 None 0 Human Functional pEC50 = 7.9 7.9 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 475 7 4 10 1.6 OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4OCc4cccc(Cl)c4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
380 1287 None 37 Rat Functional pEC50 = 7.9 7.9 -23 5
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 335 4 4 9 -0.2 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NC1CCCC1 10.1021/jm9911231
657378 1287 None 37 Rat Functional pEC50 = 7.9 7.9 -23 5
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 335 4 4 9 -0.2 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NC1CCCC1 10.1021/jm9911231
CHEMBL68738 1287 None 37 Rat Functional pEC50 = 7.9 7.9 -23 5
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 335 4 4 9 -0.2 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NC1CCCC1 10.1021/jm9911231
67429143 190146 None 0 Human Functional pEC50 = 7.9 7.9 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 483 8 4 10 2.1 CC(C)c1ccc(CO[C@@H]2CCC[C@H]2Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1 10.1021/acs.jmedchem.2c01414
CHEMBL5171835 190146 None 0 Human Functional pEC50 = 7.9 7.9 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 483 8 4 10 2.1 CC(C)c1ccc(CO[C@@H]2CCC[C@H]2Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1 10.1021/acs.jmedchem.2c01414
44398827 11790 None 0 Human Functional pEC50 = 4.9 4.9 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 282 1 1 3 4.1 Nc1nc2c(s1)Cc1cc(-c3ccccc3F)ccc1-2 10.1021/jm049132j
CHEMBL1181763 11790 None 0 Human Functional pEC50 = 4.9 4.9 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 282 1 1 3 4.1 Nc1nc2c(s1)Cc1cc(-c3ccccc3F)ccc1-2 10.1021/jm049132j
CHEMBL191231 11790 None 0 Human Functional pEC50 = 4.9 4.9 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 282 1 1 3 4.1 Nc1nc2c(s1)Cc1cc(-c3ccccc3F)ccc1-2 10.1021/jm049132j
71450934 79299 None 0 Rat Functional pEC50 = 5.9 5.9 - 1
Effective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranesEffective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranes
ChEMBL 348 5 4 9 0.0 CNC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)[C@H](O)[C@@H]1O 10.1021/jm970508l
CHEMBL2113470 79299 None 0 Rat Functional pEC50 = 5.9 5.9 - 1
Effective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranesEffective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranes
ChEMBL 348 5 4 9 0.0 CNC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)[C@H](O)[C@@H]1O 10.1021/jm970508l
44398713 11777 None 0 Human Functional pEC50 = 4.9 4.9 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 294 2 1 4 4.0 COc1ccc(-c2ccc3c(c2)Cc2sc(N)nc2-3)cc1 10.1021/jm049132j
CHEMBL1181691 11777 None 0 Human Functional pEC50 = 4.9 4.9 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 294 2 1 4 4.0 COc1ccc(-c2ccc3c(c2)Cc2sc(N)nc2-3)cc1 10.1021/jm049132j
CHEMBL188856 11777 None 0 Human Functional pEC50 = 4.9 4.9 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 294 2 1 4 4.0 COc1ccc(-c2ccc3c(c2)Cc2sc(N)nc2-3)cc1 10.1021/jm049132j
137633654 156689 None 0 Human Functional pEC50 = 6.9 6.9 - 1
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of adenylyl cyclase activity in presence of [alpha-31P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of adenylyl cyclase activity in presence of [alpha-31P]ATP
ChEMBL 473 5 3 10 2.2 Cc1cc(C)n(C[C@H]2O[C@@H](n3cnc4c(NC5CC6CCC5C6)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b01399
CHEMBL4068787 156689 None 0 Human Functional pEC50 = 6.9 6.9 - 1
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of adenylyl cyclase activity in presence of [alpha-31P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of adenylyl cyclase activity in presence of [alpha-31P]ATP
ChEMBL 473 5 3 10 2.2 Cc1cc(C)n(C[C@H]2O[C@@H](n3cnc4c(NC5CC6CCC5C6)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b01399
137634052 156736 None 0 Human Functional pEC50 = 5.9 5.9 -6 3
Agonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assayAgonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assay
ChEMBL 830 15 7 14 5.7 Nc1nc(NCCCCCCNC(=O)c2ccc(-c3sc(N)c(C(=O)c4ccccc4)c3-c3cccc(C(F)(F)F)c3)cc2)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1021/acs.jmedchem.8b00047
CHEMBL4069296 156736 None 0 Human Functional pEC50 = 5.9 5.9 -6 3
Agonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assayAgonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assay
ChEMBL 830 15 7 14 5.7 Nc1nc(NCCCCCCNC(=O)c2ccc(-c3sc(N)c(C(=O)c4ccccc4)c3-c3cccc(C(F)(F)F)c3)cc2)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1021/acs.jmedchem.8b00047
493441 63237 None 0 Rat Functional pEC50 = 4.9 4.9 - 1
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 347 4 3 8 1.6 OC[C@H]1O[C@@H](n2cnc3c(NC4CCCCCC4)ncnc32)C[C@@H]1O 10.1021/jm9911231
CHEMBL1790715 63237 None 0 Rat Functional pEC50 = 4.9 4.9 - 1
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 347 4 3 8 1.6 OC[C@H]1O[C@@H](n2cnc3c(NC4CCCCCC4)ncnc32)C[C@@H]1O 10.1021/jm9911231
137650461 157348 None 0 Human Functional pEC50 = 6.9 6.9 1 4
Agonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assayAgonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assay
ChEMBL 857 16 6 13 6.4 CC(=O)Nc1sc(-c2ccc(C(=O)NCCCCCCNc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.8b00047
CHEMBL4076565 157348 None 0 Human Functional pEC50 = 6.9 6.9 1 4
Agonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assayAgonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assay
ChEMBL 857 16 6 13 6.4 CC(=O)Nc1sc(-c2ccc(C(=O)NCCCCCCNc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.8b00047
137649841 157522 None 0 Human Functional pEC50 = 6.9 6.9 1 4
Agonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assayAgonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assay
ChEMBL 656 14 5 12 3.8 O=C(NCCCCCCNc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)c1cccc(-c2cc(C(=O)c3ccccc3)cs2)c1 10.1021/acs.jmedchem.8b00047
CHEMBL4078771 157522 None 0 Human Functional pEC50 = 6.9 6.9 1 4
Agonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assayAgonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assay
ChEMBL 656 14 5 12 3.8 O=C(NCCCCCCNc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)c1cccc(-c2cc(C(=O)c3ccccc3)cs2)c1 10.1021/acs.jmedchem.8b00047
46874387 204017 None 0 Guinea pig Functional pEC50 = 4.9 4.9 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 367 8 4 10 -0.0 CCCCCCOc1nc(N)c2ncn(C3O[C@@H](CO)[C@H](O)[C@@H]3O)c2n1 10.1021/jm00108a014
CHEMBL605466 204017 None 0 Guinea pig Functional pEC50 = 4.9 4.9 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 367 8 4 10 -0.0 CCCCCCOc1nc(N)c2ncn(C3O[C@@H](CO)[C@H](O)[C@@H]3O)c2n1 10.1021/jm00108a014
10523577 79301 None 0 Rat Functional pEC50 = 4.9 4.9 - 1
Effective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranesEffective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranes
ChEMBL 376 7 4 9 0.8 CCCNC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)[C@H](O)[C@@H]1O 10.1021/jm970508l
CHEMBL2113472 79301 None 0 Rat Functional pEC50 = 4.9 4.9 - 1
Effective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranesEffective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranes
ChEMBL 376 7 4 9 0.8 CCCNC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)[C@H](O)[C@@H]1O 10.1021/jm970508l
123807 871 None 35 Human Functional pEC50 = 7.9 7.9 1 7
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 369 4 4 9 0.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1 10.1021/jm3004834
374 871 None 35 Human Functional pEC50 = 7.9 7.9 1 7
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 369 4 4 9 0.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1 10.1021/jm3004834
379 871 None 35 Human Functional pEC50 = 7.9 7.9 1 7
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 369 4 4 9 0.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1 10.1021/jm3004834
CHEMBL284969 871 None 35 Human Functional pEC50 = 7.9 7.9 1 7
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 369 4 4 9 0.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1 10.1021/jm3004834
380 1287 None 37 Rat Functional pEC50 = 7.8 7.8 -23 5
Effective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranesEffective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranes
ChEMBL 335 4 4 9 -0.2 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NC1CCCC1 10.1021/jm970508l
657378 1287 None 37 Rat Functional pEC50 = 7.8 7.8 -23 5
Effective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranesEffective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranes
ChEMBL 335 4 4 9 -0.2 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NC1CCCC1 10.1021/jm970508l
CHEMBL68738 1287 None 37 Rat Functional pEC50 = 7.8 7.8 -23 5
Effective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranesEffective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranes
ChEMBL 335 4 4 9 -0.2 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NC1CCCC1 10.1021/jm970508l
75380603 195365 None 2 Human Functional pEC50 = 7.8 7.8 1 2
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 327 6 2 6 2.4 CCOc1nc(NC(CO)c2ccco2)ncc1Br 10.1016/j.ejmech.2023.115419
CHEMBL5402079 195365 None 2 Human Functional pEC50 = 7.8 7.8 1 2
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 327 6 2 6 2.4 CCOc1nc(NC(CO)c2ccco2)ncc1Br 10.1016/j.ejmech.2023.115419
137651756 157578 None 0 Human Functional pEC50 = 6.9 6.9 91 2
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of adenylyl cyclase activity in presence of [alpha-31P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of adenylyl cyclase activity in presence of [alpha-31P]ATP
ChEMBL 355 4 3 9 -0.1 O[C@@H]1[C@@H](CCl)O[C@@H](n2cnc3c(N[C@@H]4CCOC4)ncnc32)[C@@H]1O 10.1021/acs.jmedchem.7b01399
CHEMBL4079464 157578 None 0 Human Functional pEC50 = 6.9 6.9 91 2
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of adenylyl cyclase activity in presence of [alpha-31P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of adenylyl cyclase activity in presence of [alpha-31P]ATP
ChEMBL 355 4 3 9 -0.1 O[C@@H]1[C@@H](CCl)O[C@@H](n2cnc3c(N[C@@H]4CCOC4)ncnc32)[C@@H]1O 10.1021/acs.jmedchem.7b01399
56935713 81672 None 0 Human Functional pEC50 = 5.9 5.9 - 1
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 477 8 3 12 1.9 COP(=O)(OC)OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)nc(Cl)nc32)[C@H](O)[C@@H]1O 10.1021/jm3004834
CHEMBL2163561 81672 None 0 Human Functional pEC50 = 5.9 5.9 - 1
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 477 8 3 12 1.9 COP(=O)(OC)OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)nc(Cl)nc32)[C@H](O)[C@@H]1O 10.1021/jm3004834
2844 283 None 61 Human Functional pEC50 = 5.9 5.9 1 5
Agonist activity at human A1AR assessed as induction of Ca2+ ion mobilization by orthogonal functional assayAgonist activity at human A1AR assessed as induction of Ca2+ ion mobilization by orthogonal functional assay
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm3004834
60961 283 None 61 Human Functional pEC50 = 5.9 5.9 1 5
Agonist activity at human A1AR assessed as induction of Ca2+ ion mobilization by orthogonal functional assayAgonist activity at human A1AR assessed as induction of Ca2+ ion mobilization by orthogonal functional assay
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm3004834
60961.0 283 None 61 Human Functional pEC50 = 5.9 5.9 1 5
Agonist activity at human A1AR assessed as induction of Ca2+ ion mobilization by orthogonal functional assayAgonist activity at human A1AR assessed as induction of Ca2+ ion mobilization by orthogonal functional assay
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm3004834
90 283 None 61 Human Functional pEC50 = 5.9 5.9 1 5
Agonist activity at human A1AR assessed as induction of Ca2+ ion mobilization by orthogonal functional assayAgonist activity at human A1AR assessed as induction of Ca2+ ion mobilization by orthogonal functional assay
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm3004834
CHEMBL477 283 None 61 Human Functional pEC50 = 5.9 5.9 1 5
Agonist activity at human A1AR assessed as induction of Ca2+ ion mobilization by orthogonal functional assayAgonist activity at human A1AR assessed as induction of Ca2+ ion mobilization by orthogonal functional assay
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm3004834
DB00640 283 None 61 Human Functional pEC50 = 5.9 5.9 1 5
Agonist activity at human A1AR assessed as induction of Ca2+ ion mobilization by orthogonal functional assayAgonist activity at human A1AR assessed as induction of Ca2+ ion mobilization by orthogonal functional assay
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm3004834
168277169 190744 None 0 Human Functional pEC50 = 5.9 5.9 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assay
ChEMBL 845 10 6 13 6.2 Nc1sc(-c2ccc(C(=O)NCC#Cc3ccc(Nc4ncnc5c4ncn5[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)cc3)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
CHEMBL5181245 190744 None 0 Human Functional pEC50 = 5.9 5.9 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assay
ChEMBL 845 10 6 13 6.2 Nc1sc(-c2ccc(C(=O)NCC#Cc3ccc(Nc4ncnc5c4ncn5[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)cc3)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
168284484 191862 None 0 Human Functional pEC50 = 5.9 5.9 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assay
ChEMBL 825 14 5 15 6.2 Nc1sc(-c2ccc(-c3cn(CCCCCNc4ncnc5c4ncn5[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)nn3)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
CHEMBL5197574 191862 None 0 Human Functional pEC50 = 5.9 5.9 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assay
ChEMBL 825 14 5 15 6.2 Nc1sc(-c2ccc(-c3cn(CCCCCNc4ncnc5c4ncn5[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)nn3)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
46874453 203976 None 0 Guinea pig Functional pEC50 = 4.9 4.9 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparation
ChEMBL 426 6 5 10 0.1 Nc1nc(OCCc2c[nH]c3ccccc23)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a015
CHEMBL605256 203976 None 0 Guinea pig Functional pEC50 = 4.9 4.9 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparation
ChEMBL 426 6 5 10 0.1 Nc1nc(OCCc2c[nH]c3ccccc23)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a015
46874418 203666 None 0 Guinea pig Functional pEC50 = 4.9 4.9 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 379 6 4 10 -0.0 Nc1nc(OCCC2CCCC2)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a014
CHEMBL603589 203666 None 0 Guinea pig Functional pEC50 = 4.9 4.9 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 379 6 4 10 -0.0 Nc1nc(OCCC2CCCC2)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a014
10251529 87218 None 0 Guinea pig Functional pEC50 = 4.9 4.9 -28 2
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 419 5 5 11 0.1 Nc1nc(N/N=C/c2ccc(Cl)cc2)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a008
CHEMBL2326842 87218 None 0 Guinea pig Functional pEC50 = 4.9 4.9 -28 2
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 419 5 5 11 0.1 Nc1nc(N/N=C/c2ccc(Cl)cc2)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a008
46886345 8481 None 0 Human Functional pEC50 = 6.9 6.9 -4 3
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation countingAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting
ChEMBL 373 5 4 10 0.2 COc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1 10.1021/jm901252a
CHEMBL1093910 8481 None 0 Human Functional pEC50 = 6.9 6.9 -4 3
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation countingAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting
ChEMBL 373 5 4 10 0.2 COc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1 10.1021/jm901252a
155533519 171928 None 0 Human Functional pEC50 = 6.9 6.9 - 1
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 302 4 2 7 2.2 N#Cc1c(N)nc(SCCO)c(C#N)c1-c1ccsc1 10.1021/acs.jmedchem.9b00106
CHEMBL4468557 171928 None 0 Human Functional pEC50 = 6.9 6.9 - 1
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 302 4 2 7 2.2 N#Cc1c(N)nc(SCCO)c(C#N)c1-c1ccsc1 10.1021/acs.jmedchem.9b00106
9893136 98813 None 0 Human Functional pEC50 = 6.9 6.9 -208 3
Stimulation of [35S]GTP-gamma-S, binding to human adenosine A1 receptorStimulation of [35S]GTP-gamma-S, binding to human adenosine A1 receptor
ChEMBL 527 5 4 8 2.0 OC[C@@]12C[C@@H]1[C@@H](n1cnc3c(NCc4cccc(I)c4)nc(Cl)nc31)[C@H](O)[C@@H]2O 10.1021/jm9905965
CHEMBL27809 98813 None 0 Human Functional pEC50 = 6.9 6.9 -208 3
Stimulation of [35S]GTP-gamma-S, binding to human adenosine A1 receptorStimulation of [35S]GTP-gamma-S, binding to human adenosine A1 receptor
ChEMBL 527 5 4 8 2.0 OC[C@@]12C[C@@H]1[C@@H](n1cnc3c(NCc4cccc(I)c4)nc(Cl)nc31)[C@H](O)[C@@H]2O 10.1021/jm9905965
169450494 195204 None 2 Human Functional pEC50 = 5.8 5.8 - 1
Agonist activity at human A1 adenosine receptor expressed in CHO cellsAgonist activity at human A1 adenosine receptor expressed in CHO cells
ChEMBL 443 3 1 3 6.5 CC(C)(C)Cc1c(C#Cc2ccc(F)c(F)c2)sc(N)c1C(=O)c1ccc(Cl)cc1 10.1021/acsmedchemlett.3c00315
CHEMBL5398701 195204 None 2 Human Functional pEC50 = 5.8 5.8 - 1
Agonist activity at human A1 adenosine receptor expressed in CHO cellsAgonist activity at human A1 adenosine receptor expressed in CHO cells
ChEMBL 443 3 1 3 6.5 CC(C)(C)Cc1c(C#Cc2ccc(F)c(F)c2)sc(N)c1C(=O)c1ccc(Cl)cc1 10.1021/acsmedchemlett.3c00315
118540795 164863 None 12 Human Functional pEC50 = 5.8 5.8 - 1
Agonist activity at recombinant human adenosine A1 receptor expressed in mouse BA/F3 cells assessed as increase in calcium flux by spectrophotometric methodAgonist activity at recombinant human adenosine A1 receptor expressed in mouse BA/F3 cells assessed as increase in calcium flux by spectrophotometric method
ChEMBL 719 12 3 10 7.2 N#Cc1cc(S(=O)(=O)Nc2ncns2)ccc1Oc1ccc(-c2cccc(C(F)(F)F)c2)cc1-c1ccnc(CNCCC2CCNCC2)c1 10.1016/j.bmcl.2017.09.056
CHEMBL4217988 164863 None 12 Human Functional pEC50 = 5.8 5.8 - 1
Agonist activity at recombinant human adenosine A1 receptor expressed in mouse BA/F3 cells assessed as increase in calcium flux by spectrophotometric methodAgonist activity at recombinant human adenosine A1 receptor expressed in mouse BA/F3 cells assessed as increase in calcium flux by spectrophotometric method
ChEMBL 719 12 3 10 7.2 N#Cc1cc(S(=O)(=O)Nc2ncns2)ccc1Oc1ccc(-c2cccc(C(F)(F)F)c2)cc1-c1ccnc(CNCCC2CCNCC2)c1 10.1016/j.bmcl.2017.09.056
168292867 192173 None 0 Human Functional pEC50 = 5.8 5.8 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 781 17 6 13 5.1 Nc1sc(CCC(=O)NCCCCCCCNc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
CHEMBL5202584 192173 None 0 Human Functional pEC50 = 5.8 5.8 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 781 17 6 13 5.1 Nc1sc(CCC(=O)NCCCCCCCNc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
71720352 86159 None 0 Guinea pig Functional pEC50 = 4.8 4.8 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 421 6 4 10 0.3 Nc1nc(OCCc2ccc(Cl)cc2)nc2c1ncn2[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a015
CHEMBL2311197 86159 None 0 Guinea pig Functional pEC50 = 4.8 4.8 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 421 6 4 10 0.3 Nc1nc(OCCc2ccc(Cl)cc2)nc2c1ncn2[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a015
9799990 99690 None 0 Rat Functional pEC50 = 6.8 6.8 -4 2
Stimulation of [35S]GTP-gamma-S, binding to adenosine A1 receptor of rat cerebral cortical membraneStimulation of [35S]GTP-gamma-S, binding to adenosine A1 receptor of rat cerebral cortical membrane
ChEMBL 379 4 4 8 1.1 OC[C@@]12C[C@@H]1[C@@H](n1cnc3c(NC4CCCC4)nc(Cl)nc31)[C@H](O)[C@@H]2O 10.1021/jm9905965
CHEMBL284216 99690 None 0 Rat Functional pEC50 = 6.8 6.8 -4 2
Stimulation of [35S]GTP-gamma-S, binding to adenosine A1 receptor of rat cerebral cortical membraneStimulation of [35S]GTP-gamma-S, binding to adenosine A1 receptor of rat cerebral cortical membrane
ChEMBL 379 4 4 8 1.1 OC[C@@]12C[C@@H]1[C@@H](n1cnc3c(NC4CCCC4)nc(Cl)nc31)[C@H](O)[C@@H]2O 10.1021/jm9905965
137659441 159192 None 0 Human Functional pEC50 = 6.8 6.8 -11 4
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATP
ChEMBL 441 6 3 12 0.6 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NCc5cccc(F)c5)ncnc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b00291
CHEMBL4097468 159192 None 0 Human Functional pEC50 = 6.8 6.8 -11 4
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATP
ChEMBL 441 6 3 12 0.6 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NCc5cccc(F)c5)ncnc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b00291
377 2758 None 42 Human Functional pEC50 = 5.8 5.8 3 10
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gs-mediated activation of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometryAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gs-mediated activation of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometry
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1039/C2MD00247G
425 2758 None 42 Human Functional pEC50 = 5.8 5.8 3 10
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gs-mediated activation of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometryAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gs-mediated activation of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometry
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1039/C2MD00247G
448222 2758 None 42 Human Functional pEC50 = 5.8 5.8 3 10
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gs-mediated activation of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometryAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gs-mediated activation of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometry
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1039/C2MD00247G
CHEMBL464859 2758 None 42 Human Functional pEC50 = 5.8 5.8 3 10
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gs-mediated activation of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometryAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gs-mediated activation of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometry
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1039/C2MD00247G
10449535 76962 None 0 Human Functional pEC50 = 7.8 7.8 1 3
Partial agonist activity at human A1 adenosine receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 minsPartial agonist activity at human A1 adenosine receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins
ChEMBL 334 3 4 9 -1.3 Nc1ncnc2c1ncn2[C@@H]1O[C@H](C(=O)NC2CCC2)[C@@H](O)[C@H]1O 10.1021/jm300095s
CHEMBL2070507 76962 None 0 Human Functional pEC50 = 7.8 7.8 1 3
Partial agonist activity at human A1 adenosine receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 minsPartial agonist activity at human A1 adenosine receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins
ChEMBL 334 3 4 9 -1.3 Nc1ncnc2c1ncn2[C@@H]1O[C@H](C(=O)NC2CCC2)[C@@H](O)[C@H]1O 10.1021/jm300095s
168280775 191266 None 0 Human Functional pEC50 = 7.8 7.8 15 4
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 524 7 4 10 2.3 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4Oc4ccc(C(C)(C)C)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
CHEMBL5188601 191266 None 0 Human Functional pEC50 = 7.8 7.8 15 4
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 524 7 4 10 2.3 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4Oc4ccc(C(C)(C)C)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
60195015 84460 None 0 Human Functional pEC50 = 5.8 5.8 - 1
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 515 9 6 11 0.2 O=P(O)(O)OCC(Cc1ccccc1)Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm3004834
CHEMBL2163566 84460 None 0 Human Functional pEC50 = 5.8 5.8 - 1
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 515 9 6 11 0.2 O=P(O)(O)OCC(Cc1ccccc1)Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm3004834
CHEMBL2219951 84460 None 0 Human Functional pEC50 = 5.8 5.8 - 1
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 515 9 6 11 0.2 O=P(O)(O)OCC(Cc1ccccc1)Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm3004834
46203193 8004 None 0 Human Functional pEC50 = 6.8 6.8 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation
ChEMBL 753 13 5 14 5.0 Nc1sc2c(c1C(=O)c1ccc(Cl)c(Cl)c1)CCN(CCCCCOc1ccc(Nc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc1)C2 10.1021/jm901252a
CHEMBL1090683 8004 None 0 Human Functional pEC50 = 6.8 6.8 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation
ChEMBL 753 13 5 14 5.0 Nc1sc2c(c1C(=O)c1ccc(Cl)c(Cl)c1)CCN(CCCCCOc1ccc(Nc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc1)C2 10.1021/jm901252a
10318221 79237 None 0 Rat Functional pEC50 = 6.8 6.8 - 1
Negative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atriaNegative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atria
ChEMBL 390 4 5 10 -1.7 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(C#CC(O)CC)nc32)[C@H](O)[C@@H]1O 10.1021/jm00037a024
CHEMBL2113409 79237 None 0 Rat Functional pEC50 = 6.8 6.8 - 1
Negative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atriaNegative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atria
ChEMBL 390 4 5 10 -1.7 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(C#CC(O)CC)nc32)[C@H](O)[C@@H]1O 10.1021/jm00037a024
464377 79307 None 0 Rat Functional pEC50 = 5.8 5.8 - 1
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 306 4 4 8 -0.4 OC[C@H]1O[C@@H](n2cnc3c(NC4CC4)ccnc32)[C@H](O)[C@@H]1O 10.1021/jm9911231
CHEMBL2113478 79307 None 0 Rat Functional pEC50 = 5.8 5.8 - 1
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 306 4 4 8 -0.4 OC[C@H]1O[C@@H](n2cnc3c(NC4CC4)ccnc32)[C@H](O)[C@@H]1O 10.1021/jm9911231
46203193 8004 None 0 Human Functional pEC50 = 6.8 6.8 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation
ChEMBL 753 13 5 14 5.0 Nc1sc2c(c1C(=O)c1ccc(Cl)c(Cl)c1)CCN(CCCCCOc1ccc(Nc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc1)C2 10.1021/jm901252a
CHEMBL1090683 8004 None 0 Human Functional pEC50 = 6.8 6.8 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation
ChEMBL 753 13 5 14 5.0 Nc1sc2c(c1C(=O)c1ccc(Cl)c(Cl)c1)CCN(CCCCCOc1ccc(Nc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc1)C2 10.1021/jm901252a
10618082 63252 None 5 Rat Functional pEC50 = 5.8 5.8 - 1
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 353 4 3 8 1.5 OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)nc(Cl)nc32)C[C@@H]1O 10.1021/jm9911231
CHEMBL1790734 63252 None 5 Rat Functional pEC50 = 5.8 5.8 - 1
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 353 4 3 8 1.5 OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)nc(Cl)nc32)C[C@@H]1O 10.1021/jm9911231
168295700 192473 None 0 Human Functional pEC50 = 6.8 6.8 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 532 11 5 10 2.3 O=C(NCCCCCc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1)c1ccccc1 10.1021/acs.jmedchem.2c00320
CHEMBL5207277 192473 None 0 Human Functional pEC50 = 6.8 6.8 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 532 11 5 10 2.3 O=C(NCCCCCc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1)c1ccccc1 10.1021/acs.jmedchem.2c00320
46874437 203815 None 0 Guinea pig Functional pEC50 = 4.8 4.8 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 381 8 4 10 0.2 CCC(CC)CCOc1nc(N)c2ncn(C3O[C@@H](CO)[C@H](O)[C@@H]3O)c2n1 10.1021/jm00108a014
CHEMBL604429 203815 None 0 Guinea pig Functional pEC50 = 4.8 4.8 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 381 8 4 10 0.2 CCC(CC)CCOc1nc(N)c2ncn(C3O[C@@H](CO)[C@H](O)[C@@H]3O)c2n1 10.1021/jm00108a014
380 1287 None 37 Rat Functional pEC50 = 7.8 7.8 -23 5
Agonist activity at adenosine A1 receptor in rat cortical membrane by [35S]GTPgammaS binding assayAgonist activity at adenosine A1 receptor in rat cortical membrane by [35S]GTPgammaS binding assay
ChEMBL 335 4 4 9 -0.2 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NC1CCCC1 10.1021/np010464q
657378 1287 None 37 Rat Functional pEC50 = 7.8 7.8 -23 5
Agonist activity at adenosine A1 receptor in rat cortical membrane by [35S]GTPgammaS binding assayAgonist activity at adenosine A1 receptor in rat cortical membrane by [35S]GTPgammaS binding assay
ChEMBL 335 4 4 9 -0.2 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NC1CCCC1 10.1021/np010464q
CHEMBL68738 1287 None 37 Rat Functional pEC50 = 7.8 7.8 -23 5
Agonist activity at adenosine A1 receptor in rat cortical membrane by [35S]GTPgammaS binding assayAgonist activity at adenosine A1 receptor in rat cortical membrane by [35S]GTPgammaS binding assay
ChEMBL 335 4 4 9 -0.2 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NC1CCCC1 10.1021/np010464q
246396 195457 None 5 Human Functional pEC50 = 7.8 7.8 -2 2
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 283 5 3 8 -2.2 Cn1c(=O)c2[nH]c(N(CCO)CCO)nc2n(C)c1=O 10.1016/j.ejmech.2023.115419
CHEMBL5404183 195457 None 5 Human Functional pEC50 = 7.8 7.8 -2 2
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 283 5 3 8 -2.2 Cn1c(=O)c2[nH]c(N(CCO)CCO)nc2n(C)c1=O 10.1016/j.ejmech.2023.115419
44398907 11789 None 2 Human Functional pEC50 = 5.8 5.8 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 324 3 1 5 4.0 COc1ccc(-c2ccc3c(c2)Cc2sc(N)nc2-3)cc1OC 10.1021/jm049132j
CHEMBL1181762 11789 None 2 Human Functional pEC50 = 5.8 5.8 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 324 3 1 5 4.0 COc1ccc(-c2ccc3c(c2)Cc2sc(N)nc2-3)cc1OC 10.1021/jm049132j
CHEMBL191229 11789 None 2 Human Functional pEC50 = 5.8 5.8 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 324 3 1 5 4.0 COc1ccc(-c2ccc3c(c2)Cc2sc(N)nc2-3)cc1OC 10.1021/jm049132j
46874319 203814 None 0 Guinea pig Functional pEC50 = 4.8 4.8 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 417 7 4 11 -0.4 COc1cccc(CCOc2nc(N)c3ncn(C4O[C@@H](CO)[C@H](O)[C@@H]4O)c3n2)c1 10.1021/jm00108a015
CHEMBL604422 203814 None 0 Guinea pig Functional pEC50 = 4.8 4.8 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 417 7 4 11 -0.4 COc1cccc(CCOc2nc(N)c3ncn(C4O[C@@H](CO)[C@H](O)[C@@H]4O)c3n2)c1 10.1021/jm00108a015
46874354 204082 None 0 Guinea pig Functional pEC50 = 4.8 4.8 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 421 6 4 10 0.3 Nc1nc(OCCc2cccc(Cl)c2)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a015
CHEMBL605873 204082 None 0 Guinea pig Functional pEC50 = 4.8 4.8 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 421 6 4 10 0.3 Nc1nc(OCCc2cccc(Cl)c2)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a015
46874521 203898 None 0 Rat Functional pEC50 = 6.8 6.8 2 2
Functional activity against adenosine A1 receptor from rat atria.Functional activity against adenosine A1 receptor from rat atria.
ChEMBL 422 4 4 9 -0.2 CCNC(=O)[C@H]1OC(n2cnc3c(N)nc(C#CCc4ccccc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm00009a007
CHEMBL604851 203898 None 0 Rat Functional pEC50 = 6.8 6.8 2 2
Functional activity against adenosine A1 receptor from rat atria.Functional activity against adenosine A1 receptor from rat atria.
ChEMBL 422 4 4 9 -0.2 CCNC(=O)[C@H]1OC(n2cnc3c(N)nc(C#CCc4ccccc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm00009a007
134148336 148415 None 0 Human Functional pEC50 = 6.8 6.8 6 2
Inverse agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 90 mins by beta scintillation counting methodInverse agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 90 mins by beta scintillation counting method
ChEMBL 395 4 2 4 5.7 O[C@H]1CC[C@H](Nc2ncc(-c3ccc4ccccc4c3)c(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2016.09.081
CHEMBL3937015 148415 None 0 Human Functional pEC50 = 6.8 6.8 6 2
Inverse agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 90 mins by beta scintillation counting methodInverse agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 90 mins by beta scintillation counting method
ChEMBL 395 4 2 4 5.7 O[C@H]1CC[C@H](Nc2ncc(-c3ccc4ccccc4c3)c(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2016.09.081
9996838 79278 None 0 Rat Functional pEC50 = 6.8 6.8 2 2
Functional activity against adenosine A1 receptor from rat atria.Functional activity against adenosine A1 receptor from rat atria.
ChEMBL 332 3 4 9 -1.9 C#Cc1nc(N)c2ncn([C@@H]3O[C@H](C(=O)NCC)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00009a007
CHEMBL2113449 79278 None 0 Rat Functional pEC50 = 6.8 6.8 2 2
Functional activity against adenosine A1 receptor from rat atria.Functional activity against adenosine A1 receptor from rat atria.
ChEMBL 332 3 4 9 -1.9 C#Cc1nc(N)c2ncn([C@@H]3O[C@H](C(=O)NCC)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00009a007
9996838 79278 None 0 Rat Functional pEC50 = 6.8 6.8 2 2
Negative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atriaNegative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atria
ChEMBL 332 3 4 9 -1.9 C#Cc1nc(N)c2ncn([C@@H]3O[C@H](C(=O)NCC)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00037a024
CHEMBL2113449 79278 None 0 Rat Functional pEC50 = 6.8 6.8 2 2
Negative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atriaNegative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atria
ChEMBL 332 3 4 9 -1.9 C#Cc1nc(N)c2ncn([C@@H]3O[C@H](C(=O)NCC)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00037a024
168275881 190538 None 0 Human Functional pEC50 = 6.8 6.8 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assay
ChEMBL 504 9 5 10 1.5 O=C(NCCCc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1)c1ccccc1 10.1021/acs.jmedchem.2c00320
CHEMBL5178080 190538 None 0 Human Functional pEC50 = 6.8 6.8 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assay
ChEMBL 504 9 5 10 1.5 O=C(NCCCc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1)c1ccccc1 10.1021/acs.jmedchem.2c00320
137641858 158399 None 0 Human Functional pEC50 = 6.8 6.8 -1 4
Agonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assayAgonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assay
ChEMBL 696 13 5 11 5.3 O=C(NCCCCCCNc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)c1ccc(-c2sccc2-c2cccc(C(F)(F)F)c2)cc1 10.1021/acs.jmedchem.8b00047
CHEMBL4089092 158399 None 0 Human Functional pEC50 = 6.8 6.8 -1 4
Agonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assayAgonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assay
ChEMBL 696 13 5 11 5.3 O=C(NCCCCCCNc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)c1ccc(-c2sccc2-c2cccc(C(F)(F)F)c2)cc1 10.1021/acs.jmedchem.8b00047
46876607 204373 None 0 Guinea pig Functional pEC50 = 4.8 4.8 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 399 5 5 11 -0.2 Cc1cccc(/C=N/Nc2nc(N)c3ncn(C4O[C@H](CO)[C@@H](O)[C@H]4O)c3n2)c1 10.1021/jm00102a008
CHEMBL607511 204373 None 0 Guinea pig Functional pEC50 = 4.8 4.8 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 399 5 5 11 -0.2 Cc1cccc(/C=N/Nc2nc(N)c3ncn(C4O[C@H](CO)[C@@H](O)[C@H]4O)c3n2)c1 10.1021/jm00102a008
123807 871 None 35 Mouse Functional pEC50 = 7.8 7.8 -2 7
Agonist activity at mouse adenosine A1 receptor expressed in HEK293 cell membranes assessed as inhibition of forskolin-stimulated cAMP production preincubated for 30 mins prior to forskolin-treatment measured after 15 mins by ELISAAgonist activity at mouse adenosine A1 receptor expressed in HEK293 cell membranes assessed as inhibition of forskolin-stimulated cAMP production preincubated for 30 mins prior to forskolin-treatment measured after 15 mins by ELISA
ChEMBL 369 4 4 9 0.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1 10.1021/jm4007966
374 871 None 35 Mouse Functional pEC50 = 7.8 7.8 -2 7
Agonist activity at mouse adenosine A1 receptor expressed in HEK293 cell membranes assessed as inhibition of forskolin-stimulated cAMP production preincubated for 30 mins prior to forskolin-treatment measured after 15 mins by ELISAAgonist activity at mouse adenosine A1 receptor expressed in HEK293 cell membranes assessed as inhibition of forskolin-stimulated cAMP production preincubated for 30 mins prior to forskolin-treatment measured after 15 mins by ELISA
ChEMBL 369 4 4 9 0.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1 10.1021/jm4007966
379 871 None 35 Mouse Functional pEC50 = 7.8 7.8 -2 7
Agonist activity at mouse adenosine A1 receptor expressed in HEK293 cell membranes assessed as inhibition of forskolin-stimulated cAMP production preincubated for 30 mins prior to forskolin-treatment measured after 15 mins by ELISAAgonist activity at mouse adenosine A1 receptor expressed in HEK293 cell membranes assessed as inhibition of forskolin-stimulated cAMP production preincubated for 30 mins prior to forskolin-treatment measured after 15 mins by ELISA
ChEMBL 369 4 4 9 0.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1 10.1021/jm4007966
CHEMBL284969 871 None 35 Mouse Functional pEC50 = 7.8 7.8 -2 7
Agonist activity at mouse adenosine A1 receptor expressed in HEK293 cell membranes assessed as inhibition of forskolin-stimulated cAMP production preincubated for 30 mins prior to forskolin-treatment measured after 15 mins by ELISAAgonist activity at mouse adenosine A1 receptor expressed in HEK293 cell membranes assessed as inhibition of forskolin-stimulated cAMP production preincubated for 30 mins prior to forskolin-treatment measured after 15 mins by ELISA
ChEMBL 369 4 4 9 0.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1 10.1021/jm4007966
46203501 8008 None 1 Human Functional pEC50 = 6.8 6.8 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting in presence of 10 uM allosteric modulator PD-81723Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting in presence of 10 uM allosteric modulator PD-81723
ChEMBL 809 17 5 14 6.5 Nc1sc2c(c1C(=O)c1ccc(Cl)c(Cl)c1)CCN(CCCCCCCCCOc1ccc(Nc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc1)C2 10.1021/jm901252a
CHEMBL1090687 8008 None 1 Human Functional pEC50 = 6.8 6.8 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting in presence of 10 uM allosteric modulator PD-81723Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting in presence of 10 uM allosteric modulator PD-81723
ChEMBL 809 17 5 14 6.5 Nc1sc2c(c1C(=O)c1ccc(Cl)c(Cl)c1)CCN(CCCCCCCCCOc1ccc(Nc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc1)C2 10.1021/jm901252a
168290627 192112 None 0 Human Functional pEC50 = 5.8 5.8 -6 4
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assay
ChEMBL 859 11 6 13 6.6 Nc1sc(-c2ccc(C(=O)NCCC#Cc3ccc(Nc4ncnc5c4ncn5[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)cc3)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
CHEMBL5201533 192112 None 0 Human Functional pEC50 = 5.8 5.8 -6 4
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assay
ChEMBL 859 11 6 13 6.6 Nc1sc(-c2ccc(C(=O)NCCC#Cc3ccc(Nc4ncnc5c4ncn5[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)cc3)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
168269168 190110 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 483 6 4 10 2.1 CC(C)(C)c1ccc(O[C@@H]2CCC[C@H]2Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1 10.1021/acs.jmedchem.2c01414
CHEMBL5171285 190110 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 483 6 4 10 2.1 CC(C)(C)c1ccc(O[C@@H]2CCC[C@H]2Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1 10.1021/acs.jmedchem.2c01414
168274691 190648 None 0 Human Functional pEC50 = 7.7 7.7 457 2
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 519 7 4 10 1.8 OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4OCc4cccc(Br)c4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
CHEMBL5179726 190648 None 0 Human Functional pEC50 = 7.7 7.7 457 2
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 519 7 4 10 1.8 OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4OCc4cccc(Br)c4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
44398909 11792 None 0 Human Functional pEC50 = 4.8 4.8 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 354 4 1 6 4.0 COc1ccc(-c2ccc3c(c2)Cc2sc(N)nc2-3)c(OC)c1OC 10.1021/jm049132j
CHEMBL1181777 11792 None 0 Human Functional pEC50 = 4.8 4.8 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 354 4 1 6 4.0 COc1ccc(-c2ccc3c(c2)Cc2sc(N)nc2-3)c(OC)c1OC 10.1021/jm049132j
CHEMBL191587 11792 None 0 Human Functional pEC50 = 4.8 4.8 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 354 4 1 6 4.0 COc1ccc(-c2ccc3c(c2)Cc2sc(N)nc2-3)c(OC)c1OC 10.1021/jm049132j
46203501 8008 None 1 Human Functional pEC50 = 6.7 6.7 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting in presence of 10 uM allosteric modulator PD-81723Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting in presence of 10 uM allosteric modulator PD-81723
ChEMBL 809 17 5 14 6.5 Nc1sc2c(c1C(=O)c1ccc(Cl)c(Cl)c1)CCN(CCCCCCCCCOc1ccc(Nc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc1)C2 10.1021/jm901252a
CHEMBL1090687 8008 None 1 Human Functional pEC50 = 6.7 6.7 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting in presence of 10 uM allosteric modulator PD-81723Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting in presence of 10 uM allosteric modulator PD-81723
ChEMBL 809 17 5 14 6.5 Nc1sc2c(c1C(=O)c1ccc(Cl)c(Cl)c1)CCN(CCCCCCCCCOc1ccc(Nc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc1)C2 10.1021/jm901252a
168287510 191641 None 0 Human Functional pEC50 = 5.7 5.7 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assay
ChEMBL 873 12 6 13 7.0 Nc1sc(-c2ccc(C(=O)NCCCC#Cc3ccc(Nc4ncnc5c4ncn5[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)cc3)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
CHEMBL5194272 191641 None 0 Human Functional pEC50 = 5.7 5.7 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assay
ChEMBL 873 12 6 13 7.0 Nc1sc(-c2ccc(C(=O)NCCCC#Cc3ccc(Nc4ncnc5c4ncn5[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)cc3)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
44398965 10299 None 0 Human Functional pEC50 = 4.7 4.7 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 346 2 1 4 5.7 Nc1nc2c(s1)Cc1cc(-c3cccc(-c4cccs4)c3)ccc1-2 10.1021/jm049132j
CHEMBL1161748 10299 None 0 Human Functional pEC50 = 4.7 4.7 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 346 2 1 4 5.7 Nc1nc2c(s1)Cc1cc(-c3cccc(-c4cccs4)c3)ccc1-2 10.1021/jm049132j
155553292 174292 None 0 Human Functional pEC50 = 6.7 6.7 - 1
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 380 5 1 9 3.3 COC(=O)c1ccc(CSc2nc(N)c(C#N)c(-c3ccco3)c2C#N)o1 10.1021/acs.jmedchem.9b00106
CHEMBL4547699 174292 None 0 Human Functional pEC50 = 6.7 6.7 - 1
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 380 5 1 9 3.3 COC(=O)c1ccc(CSc2nc(N)c(C#N)c(-c3ccco3)c2C#N)o1 10.1021/acs.jmedchem.9b00106
46874344 204013 None 0 Guinea pig Functional pEC50 = 4.7 4.7 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 393 6 4 11 -0.3 Nc1nc(OCCc2ccsc2)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a015
CHEMBL605461 204013 None 0 Guinea pig Functional pEC50 = 4.7 4.7 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 393 6 4 11 -0.3 Nc1nc(OCCc2ccsc2)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a015
71458067 79297 None 0 Rat Functional pEC50 = 6.7 6.7 - 1
Effective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranesEffective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranes
ChEMBL 407 7 3 9 2.2 CC(C)CSC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)[C@H](O)[C@@H]1O 10.1021/jm970508l
CHEMBL2113469 79297 None 0 Rat Functional pEC50 = 6.7 6.7 - 1
Effective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranesEffective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranes
ChEMBL 407 7 3 9 2.2 CC(C)CSC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)[C@H](O)[C@@H]1O 10.1021/jm970508l
155694834 190926 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 484 8 5 11 0.1 NC(=O)c1ccc(CO[C@@H]2CCC[C@H]2Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1 10.1021/acs.jmedchem.2c01414
CHEMBL5183907 190926 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 484 8 5 11 0.1 NC(=O)c1ccc(CO[C@@H]2CCC[C@H]2Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1 10.1021/acs.jmedchem.2c01414
56627882 118576 None 0 Human Functional pEC50 = 7.7 7.7 -5 4
Agonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activityAgonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activity
ChEMBL 367 3 3 12 -0.9 CCn1nnc([C@H]2O[C@@H](n3cnc4c(N)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.5b00074
CHEMBL3414937 118576 None 0 Human Functional pEC50 = 7.7 7.7 -5 4
Agonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activityAgonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activity
ChEMBL 367 3 3 12 -0.9 CCn1nnc([C@H]2O[C@@H](n3cnc4c(N)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.5b00074
372 58 None 56 Guinea pig Functional pEC50 = 6.7 6.7 -5 5
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 301 2 4 9 -1.3 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2N 10.1021/jm00108a014
8974 58 None 56 Guinea pig Functional pEC50 = 6.7 6.7 -5 5
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 301 2 4 9 -1.3 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2N 10.1021/jm00108a014
CHEMBL285819 58 None 56 Guinea pig Functional pEC50 = 6.7 6.7 -5 5
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 301 2 4 9 -1.3 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2N 10.1021/jm00108a014
46876613 204416 None 0 Guinea pig Functional pEC50 = 4.7 4.7 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 514 9 5 12 0.9 CC(C)(C)OC(=O)CCc1ccc(CCNc2nc(N)c3ncn(C4O[C@H](CO)[C@@H](O)[C@H]4O)c3n2)cc1 10.1021/jm00102a008
CHEMBL607872 204416 None 0 Guinea pig Functional pEC50 = 4.7 4.7 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 514 9 5 12 0.9 CC(C)(C)OC(=O)CCc1ccc(CCNc2nc(N)c3ncn(C4O[C@H](CO)[C@@H](O)[C@H]4O)c3n2)cc1 10.1021/jm00102a008
658709 29469 None 6 Human Functional pEC50 = 6.7 6.7 33 2
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 390 6 1 8 3.5 N#Cc1c(N)nc(SCC(=O)OCc2ccccc2)c(C#N)c1-c1ccco1 10.1021/acs.jmedchem.9b00106
CHEMBL1384456 29469 None 6 Human Functional pEC50 = 6.7 6.7 33 2
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 390 6 1 8 3.5 N#Cc1c(N)nc(SCC(=O)OCc2ccccc2)c(C#N)c1-c1ccco1 10.1021/acs.jmedchem.9b00106
44398751 11798 None 0 Human Functional pEC50 = 4.7 4.7 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 294 2 1 4 4.0 COc1cccc(-c2ccc3c(c2)Cc2sc(N)nc2-3)c1 10.1021/jm049132j
CHEMBL1181836 11798 None 0 Human Functional pEC50 = 4.7 4.7 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 294 2 1 4 4.0 COc1cccc(-c2ccc3c(c2)Cc2sc(N)nc2-3)c1 10.1021/jm049132j
CHEMBL193129 11798 None 0 Human Functional pEC50 = 4.7 4.7 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 294 2 1 4 4.0 COc1cccc(-c2ccc3c(c2)Cc2sc(N)nc2-3)c1 10.1021/jm049132j
168293564 192266 None 0 Human Functional pEC50 = 5.7 5.7 -74 4
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assay
ChEMBL 849 13 6 13 6.8 Nc1sc(-c2ccc(C(=O)NCCCc3ccc(Nc4ncnc5c4ncn5[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)cc3)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
CHEMBL5203917 192266 None 0 Human Functional pEC50 = 5.7 5.7 -74 4
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assay
ChEMBL 849 13 6 13 6.8 Nc1sc(-c2ccc(C(=O)NCCCc3ccc(Nc4ncnc5c4ncn5[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)cc3)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
46874384 204014 None 0 Guinea pig Functional pEC50 = 4.7 4.7 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparation
ChEMBL 417 7 4 11 -0.4 COc1ccc(CCOc2nc(N)c3ncn(C4O[C@@H](CO)[C@H](O)[C@@H]4O)c3n2)cc1 10.1021/jm00108a015
CHEMBL605463 204014 None 0 Guinea pig Functional pEC50 = 4.7 4.7 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparation
ChEMBL 417 7 4 11 -0.4 COc1ccc(CCOc2nc(N)c3ncn(C4O[C@@H](CO)[C@H](O)[C@@H]4O)c3n2)cc1 10.1021/jm00108a015
46876669 204495 None 0 Guinea pig Functional pEC50 = 4.7 4.7 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 415 6 5 12 -0.5 COc1cccc(/C=N/Nc2nc(N)c3ncn(C4O[C@H](CO)[C@@H](O)[C@H]4O)c3n2)c1 10.1021/jm00102a008
CHEMBL608451 204495 None 0 Guinea pig Functional pEC50 = 4.7 4.7 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 415 6 5 12 -0.5 COc1cccc(/C=N/Nc2nc(N)c3ncn(C4O[C@H](CO)[C@@H](O)[C@H]4O)c3n2)c1 10.1021/jm00102a008
10048927 79384 None 0 Rat Functional pEC50 = 5.7 5.7 -3 2
Activity at Adenosine A1 receptor of rat atriaActivity at Adenosine A1 receptor of rat atria
ChEMBL 441 7 5 12 0.1 COc1ccccc1/C=C/C=N/Nc1nc(N)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00018a017
CHEMBL2113554 79384 None 0 Rat Functional pEC50 = 5.7 5.7 -3 2
Activity at Adenosine A1 receptor of rat atriaActivity at Adenosine A1 receptor of rat atria
ChEMBL 441 7 5 12 0.1 COc1ccccc1/C=C/C=N/Nc1nc(N)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00018a017
71716086 86161 None 0 Guinea pig Functional pEC50 = 4.7 4.7 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparation
ChEMBL 401 7 4 10 0.0 Nc1nc(OCCCc2ccccc2)nc2c1ncn2[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a015
CHEMBL2311199 86161 None 0 Guinea pig Functional pEC50 = 4.7 4.7 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparation
ChEMBL 401 7 4 10 0.0 Nc1nc(OCCCc2ccccc2)nc2c1ncn2[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a015
46874470 204118 None 0 Guinea pig Functional pEC50 = 4.7 4.7 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparation
ChEMBL 387 6 4 10 -0.4 Nc1nc(OCCc2ccccc2)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a015
CHEMBL606092 204118 None 0 Guinea pig Functional pEC50 = 4.7 4.7 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparation
ChEMBL 387 6 4 10 -0.4 Nc1nc(OCCc2ccccc2)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a015
46876582 204794 None 0 Guinea pig Functional pEC50 = 4.7 4.7 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 297 3 6 11 -2.7 NNc1nc(N)c2ncn(C3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00102a008
CHEMBL610444 204794 None 0 Guinea pig Functional pEC50 = 4.7 4.7 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 297 3 6 11 -2.7 NNc1nc(N)c2ncn(C3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00102a008
2917099 52161 None 8 Human Functional pEC50 = 8.7 8.7 2 2
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 315 3 1 5 3.0 CC(C)C(=O)Nc1ncc2c(n1)CC(c1cccs1)CC2=O 10.1016/j.ejmech.2023.115419
CHEMBL1587915 52161 None 8 Human Functional pEC50 = 8.7 8.7 2 2
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 315 3 1 5 3.0 CC(C)C(=O)Nc1ncc2c(n1)CC(c1cccs1)CC2=O 10.1016/j.ejmech.2023.115419
168269860 190085 None 0 Human Functional pEC50 = 8.7 8.7 1949 3
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 512 9 4 11 1.1 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4OCc4cccc(OC)c4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
CHEMBL5170857 190085 None 0 Human Functional pEC50 = 8.7 8.7 1949 3
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 512 9 4 11 1.1 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4OCc4cccc(OC)c4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
168297905 192540 None 0 Human Functional pEC50 = 8.7 8.7 660 4
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 516 8 4 10 1.8 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4OCc4ccccc4Cl)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
CHEMBL5208245 192540 None 0 Human Functional pEC50 = 8.7 8.7 660 4
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 516 8 4 10 1.8 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4OCc4ccccc4Cl)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
45216745 196544 None 5 Human Functional pEC50 = 8.6 8.6 1 2
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 278 6 2 8 0.0 COCC(O)CNc1ncc(C)c(-c2ncnn2C)n1 10.1016/j.ejmech.2023.115419
CHEMBL5426384 196544 None 5 Human Functional pEC50 = 8.6 8.6 1 2
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 278 6 2 8 0.0 COCC(O)CNc1ncc(C)c(-c2ncnn2C)n1 10.1016/j.ejmech.2023.115419
168293746 192262 None 0 Human Functional pEC50 = 8.6 8.6 -2 2
Antagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assayAntagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assay
ChEMBL 281 4 1 5 3.1 CC(C)c1c2cnnc(NCc3ccccc3)c2nn1C 10.1021/acsmedchemlett.2c00052
CHEMBL5203865 192262 None 0 Human Functional pEC50 = 8.6 8.6 -2 2
Antagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assayAntagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assay
ChEMBL 281 4 1 5 3.1 CC(C)c1c2cnnc(NCc3ccccc3)c2nn1C 10.1021/acsmedchemlett.2c00052
68611912 154276 None 0 Human Functional pEC50 = 8.6 8.6 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 492 6 2 8 3.0 CNC(=O)c1cc(CSc2nc(N3CC(O)C3)c(C#N)c(-c3ccc(F)c(F)c3)c2C#N)ccn1 nan
CHEMBL3985798 154276 None 0 Human Functional pEC50 = 8.6 8.6 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 492 6 2 8 3.0 CNC(=O)c1cc(CSc2nc(N3CC(O)C3)c(C#N)c(-c3ccc(F)c(F)c3)c2C#N)ccn1 nan
56720528 195296 None 5 Human Functional pEC50 = 8.6 8.6 1 2
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 295 2 1 5 2.4 Cc1ccc2nc(C(=O)Nc3cnc4n3CCCC4)cn2c1 10.1016/j.ejmech.2023.115419
CHEMBL5400258 195296 None 5 Human Functional pEC50 = 8.6 8.6 1 2
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 295 2 1 5 2.4 Cc1ccc2nc(C(=O)Nc3cnc4n3CCCC4)cn2c1 10.1016/j.ejmech.2023.115419
56751513 195991 None 5 Human Functional pEC50 = 8.6 8.6 1 2
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 316 2 1 6 2.2 O=C(Nc1cnc2n1CCCC2)c1cn2cc(Cl)cnc2n1 10.1016/j.ejmech.2023.115419
CHEMBL5414806 195991 None 5 Human Functional pEC50 = 8.6 8.6 1 2
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 316 2 1 6 2.2 O=C(Nc1cnc2n1CCCC2)c1cn2cc(Cl)cnc2n1 10.1016/j.ejmech.2023.115419
39045556 196944 None 9 Human Functional pEC50 = 8.6 8.6 4 2
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 321 4 1 7 2.4 c1ccc(CNc2nc(N3CCCCC3)c3nccnc3n2)nc1 10.1016/j.ejmech.2023.115419
CHEMBL5435338 196944 None 9 Human Functional pEC50 = 8.6 8.6 4 2
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 321 4 1 7 2.4 c1ccc(CNc2nc(N3CCCCC3)c3nccnc3n2)nc1 10.1016/j.ejmech.2023.115419
45803129 195879 None 4 Human Functional pEC50 = 8.6 8.6 2 2
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 345 6 2 5 2.9 CC(=O)NC(CC(=O)Nc1nc(C(C)=O)cs1)c1ccc(C)cc1 10.1016/j.ejmech.2023.115419
CHEMBL5412498 195879 None 4 Human Functional pEC50 = 8.6 8.6 2 2
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 345 6 2 5 2.9 CC(=O)NC(CC(=O)Nc1nc(C(C)=O)cs1)c1ccc(C)cc1 10.1016/j.ejmech.2023.115419
45811961 195922 None 4 Human Functional pEC50 = 8.6 8.6 7 2
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 286 3 2 3 1.8 CC(C)N1CC(C(=O)Nc2nc3ccccc3[nH]2)CC1=O 10.1016/j.ejmech.2023.115419
CHEMBL5413438 195922 None 4 Human Functional pEC50 = 8.6 8.6 7 2
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 286 3 2 3 1.8 CC(C)N1CC(C(=O)Nc2nc3ccccc3[nH]2)CC1=O 10.1016/j.ejmech.2023.115419
90663729 106775 None 0 Human Functional pEC50 = 8.6 8.6 - 1
Adenosine receptor agonistic activity against isoproterenol (1 uM) stimulated cAMP accumulation in DDT MF-2 cellsAdenosine receptor agonistic activity against isoproterenol (1 uM) stimulated cAMP accumulation in DDT MF-2 cells
ChEMBL 389 5 4 10 -0.9 O=C1CC2CC(Nc3ncnc4c3ncn4C[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C1C2 10.1016/s0960-894x(99)00109-2
CHEMBL3144087 106775 None 0 Human Functional pEC50 = 8.6 8.6 - 1
Adenosine receptor agonistic activity against isoproterenol (1 uM) stimulated cAMP accumulation in DDT MF-2 cellsAdenosine receptor agonistic activity against isoproterenol (1 uM) stimulated cAMP accumulation in DDT MF-2 cells
ChEMBL 389 5 4 10 -0.9 O=C1CC2CC(Nc3ncnc4c3ncn4C[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C1C2 10.1016/s0960-894x(99)00109-2
155514696 169999 None 0 Human Functional pEC50 = 8.6 8.6 30 2
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 333 4 1 7 3.4 N#Cc1c(N)nc(SCc2cccnc2)c(C#N)c1-c1ccco1 10.1021/acs.jmedchem.9b00106
CHEMBL4440752 169999 None 0 Human Functional pEC50 = 8.6 8.6 30 2
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 333 4 1 7 3.4 N#Cc1c(N)nc(SCc2cccnc2)c(C#N)c1-c1ccco1 10.1021/acs.jmedchem.9b00106
56592178 147113 None 0 Human Functional pEC50 = 8.6 8.6 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 512 7 2 8 4.6 CNC(=O)c1cc(C(C)Sc2nc(N)c(C#N)c(-c3ccc(OCC(F)(F)F)cc3)c2C#N)ccn1 nan
CHEMBL3926704 147113 None 0 Human Functional pEC50 = 8.6 8.6 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 512 7 2 8 4.6 CNC(=O)c1cc(C(C)Sc2nc(N)c(C#N)c(-c3ccc(OCC(F)(F)F)cc3)c2C#N)ccn1 nan
29777576 195772 None 8 Human Functional pEC50 = 8.6 8.6 3 2
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 299 3 1 4 3.6 O=C(Nc1noc(-c2ccccc2)n1)c1cccc(Cl)c1 10.1016/j.ejmech.2023.115419
CHEMBL5410449 195772 None 8 Human Functional pEC50 = 8.6 8.6 3 2
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 299 3 1 4 3.6 O=C(Nc1noc(-c2ccccc2)n1)c1cccc(Cl)c1 10.1016/j.ejmech.2023.115419
155554091 175795 None 0 Human Functional pEC50 = 8.6 8.6 4 3
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 375 5 2 7 3.1 N#Cc1c(N)nc(SCc2cccc(C(N)=O)c2)c(C#N)c1-c1ccco1 10.1021/acs.jmedchem.9b00106
CHEMBL4581984 175795 None 0 Human Functional pEC50 = 8.6 8.6 4 3
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 375 5 2 7 3.1 N#Cc1c(N)nc(SCc2cccc(C(N)=O)c2)c(C#N)c1-c1ccco1 10.1021/acs.jmedchem.9b00106
122188742 123277 None 0 Human Functional pEC50 = 8.5 8.5 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cell membranes by [35S]GTPgammaS binding assayAgonist activity at human adenosine A1 receptor expressed in CHO cell membranes by [35S]GTPgammaS binding assay
ChEMBL 489 6 1 8 6.2 COc1ccc(-c2c(C#N)c(N)nc(SCc3csc(-c4ccc(Cl)cc4)n3)c2C#N)cc1 10.1016/j.ejmech.2015.07.023
CHEMBL3613119 123277 None 0 Human Functional pEC50 = 8.5 8.5 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cell membranes by [35S]GTPgammaS binding assayAgonist activity at human adenosine A1 receptor expressed in CHO cell membranes by [35S]GTPgammaS binding assay
ChEMBL 489 6 1 8 6.2 COc1ccc(-c2c(C#N)c(N)nc(SCc3csc(-c4ccc(Cl)cc4)n3)c2C#N)cc1 10.1016/j.ejmech.2015.07.023
380 1287 None 37 Rat Functional pEC50 = 7.7 7.7 -23 5
Stimulation of [35S]GTP-gamma-S, binding to adenosine A1 receptor of rat cerebral cortical membraneStimulation of [35S]GTP-gamma-S, binding to adenosine A1 receptor of rat cerebral cortical membrane
ChEMBL 335 4 4 9 -0.2 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NC1CCCC1 10.1021/jm9905965
657378 1287 None 37 Rat Functional pEC50 = 7.7 7.7 -23 5
Stimulation of [35S]GTP-gamma-S, binding to adenosine A1 receptor of rat cerebral cortical membraneStimulation of [35S]GTP-gamma-S, binding to adenosine A1 receptor of rat cerebral cortical membrane
ChEMBL 335 4 4 9 -0.2 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NC1CCCC1 10.1021/jm9905965
CHEMBL68738 1287 None 37 Rat Functional pEC50 = 7.7 7.7 -23 5
Stimulation of [35S]GTP-gamma-S, binding to adenosine A1 receptor of rat cerebral cortical membraneStimulation of [35S]GTP-gamma-S, binding to adenosine A1 receptor of rat cerebral cortical membrane
ChEMBL 335 4 4 9 -0.2 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NC1CCCC1 10.1021/jm9905965
46886345 8481 None 0 Human Functional pEC50 = 7.7 7.7 -4 3
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation
ChEMBL 373 5 4 10 0.2 COc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1 10.1021/jm901252a
CHEMBL1093910 8481 None 0 Human Functional pEC50 = 7.7 7.7 -4 3
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation
ChEMBL 373 5 4 10 0.2 COc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1 10.1021/jm901252a
46876172 204638 None 0 Guinea pig Functional pEC50 = 6.7 6.7 - 1
Agonistic activity against adenosine A1 receptor in guinea pig isolated heartsAgonistic activity against adenosine A1 receptor in guinea pig isolated hearts
ChEMBL 431 6 3 10 0.9 O[C@@H]1[C@@H](COc2ccccc2F)OC(n2cnc3c(NC4CCOC4)ncnc32)[C@@H]1O 10.1016/j.bmcl.2004.04.096
CHEMBL609539 204638 None 0 Guinea pig Functional pEC50 = 6.7 6.7 - 1
Agonistic activity against adenosine A1 receptor in guinea pig isolated heartsAgonistic activity against adenosine A1 receptor in guinea pig isolated hearts
ChEMBL 431 6 3 10 0.9 O[C@@H]1[C@@H](COc2ccccc2F)OC(n2cnc3c(NC4CCOC4)ncnc32)[C@@H]1O 10.1016/j.bmcl.2004.04.096
137642153 158460 None 0 Human Functional pEC50 = 6.7 6.7 -14 4
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATP
ChEMBL 429 6 3 13 0.5 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NCc5cccs5)ncnc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b00291
CHEMBL4089741 158460 None 0 Human Functional pEC50 = 6.7 6.7 -14 4
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATP
ChEMBL 429 6 3 13 0.5 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NCc5cccs5)ncnc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b00291
60194837 84449 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human A1AR assessed as induction of Ca2+ ion mobilization by orthogonal functional assayAgonist activity at human A1AR assessed as induction of Ca2+ ion mobilization by orthogonal functional assay
ChEMBL 449 6 5 10 0.6 O=P(O)(O)OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)nc(Cl)nc32)[C@H](O)[C@@H]1O 10.1021/jm3004834
CHEMBL2163560 84449 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human A1AR assessed as induction of Ca2+ ion mobilization by orthogonal functional assayAgonist activity at human A1AR assessed as induction of Ca2+ ion mobilization by orthogonal functional assay
ChEMBL 449 6 5 10 0.6 O=P(O)(O)OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)nc(Cl)nc32)[C@H](O)[C@@H]1O 10.1021/jm3004834
CHEMBL2219856 84449 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human A1AR assessed as induction of Ca2+ ion mobilization by orthogonal functional assayAgonist activity at human A1AR assessed as induction of Ca2+ ion mobilization by orthogonal functional assay
ChEMBL 449 6 5 10 0.6 O=P(O)(O)OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)nc(Cl)nc32)[C@H](O)[C@@H]1O 10.1021/jm3004834
75398270 196724 None 3 Human Functional pEC50 = 7.7 7.7 2 2
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 294 4 1 5 2.5 COc1cccc(C(=O)Nc2cnn(-c3ccccc3)n2)c1 10.1016/j.ejmech.2023.115419
CHEMBL5430803 196724 None 3 Human Functional pEC50 = 7.7 7.7 2 2
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 294 4 1 5 2.5 COc1cccc(C(=O)Nc2cnn(-c3ccccc3)n2)c1 10.1016/j.ejmech.2023.115419
46876987 204466 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Adenosine receptor agonistic activity against isoproterenol (1 uM) stimulated cAMP accumulation in DDT MF-2 cellsAdenosine receptor agonistic activity against isoproterenol (1 uM) stimulated cAMP accumulation in DDT MF-2 cells
ChEMBL 361 4 4 10 -1.1 OC[C@H]1OC(n2cnc3c(NC4CC5C=CC4O5)ncnc32)[C@H](O)[C@@H]1O 10.1016/s0960-894x(99)00109-2
CHEMBL608220 204466 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Adenosine receptor agonistic activity against isoproterenol (1 uM) stimulated cAMP accumulation in DDT MF-2 cellsAdenosine receptor agonistic activity against isoproterenol (1 uM) stimulated cAMP accumulation in DDT MF-2 cells
ChEMBL 361 4 4 10 -1.1 OC[C@H]1OC(n2cnc3c(NC4CC5C=CC4O5)ncnc32)[C@H](O)[C@@H]1O 10.1016/s0960-894x(99)00109-2
9906178 98991 None 0 Human Functional pEC50 = 7.7 7.7 4 2
Stimulation of [35S]GTP-gamma-S, binding to human adenosine A1 receptorStimulation of [35S]GTP-gamma-S, binding to human adenosine A1 receptor
ChEMBL 345 4 4 8 0.5 OC[C@@]12C[C@@H]1[C@@H](n1cnc3c(NC4CCCC4)ncnc31)[C@H](O)[C@@H]2O 10.1021/jm9905965
CHEMBL27952 98991 None 0 Human Functional pEC50 = 7.7 7.7 4 2
Stimulation of [35S]GTP-gamma-S, binding to human adenosine A1 receptorStimulation of [35S]GTP-gamma-S, binding to human adenosine A1 receptor
ChEMBL 345 4 4 8 0.5 OC[C@@]12C[C@@H]1[C@@H](n1cnc3c(NC4CCCC4)ncnc31)[C@H](O)[C@@H]2O 10.1021/jm9905965
9805713 162941 None 0 Human Functional pEC50 = 6.7 6.7 -309 3
Stimulation of [35S]GTP-gamma-S, binding to human adenosine A1 receptorStimulation of [35S]GTP-gamma-S, binding to human adenosine A1 receptor
ChEMBL 493 5 4 8 1.3 OC[C@@]12C[C@@H]1[C@@H](n1cnc3c(NCc4cccc(I)c4)ncnc31)[C@H](O)[C@@H]2O 10.1021/jm9905965
CHEMBL417292 162941 None 0 Human Functional pEC50 = 6.7 6.7 -309 3
Stimulation of [35S]GTP-gamma-S, binding to human adenosine A1 receptorStimulation of [35S]GTP-gamma-S, binding to human adenosine A1 receptor
ChEMBL 493 5 4 8 1.3 OC[C@@]12C[C@@H]1[C@@H](n1cnc3c(NCc4cccc(I)c4)ncnc31)[C@H](O)[C@@H]2O 10.1021/jm9905965
46874396 204086 None 0 Guinea pig Functional pEC50 = 5.7 5.7 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 327 5 5 11 -2.6 Nc1nc(OCCO)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a014
CHEMBL605879 204086 None 0 Guinea pig Functional pEC50 = 5.7 5.7 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 327 5 5 11 -2.6 Nc1nc(OCCO)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a014
46874416 203664 None 0 Guinea pig Functional pEC50 = 4.7 4.7 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparation
ChEMBL 421 6 4 10 0.3 Nc1nc(OCCc2ccccc2Cl)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a015
CHEMBL603587 203664 None 0 Guinea pig Functional pEC50 = 4.7 4.7 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparation
ChEMBL 421 6 4 10 0.3 Nc1nc(OCCc2ccccc2Cl)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a015
46886345 8481 None 0 Human Functional pEC50 = 7.7 7.7 -4 3
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation
ChEMBL 373 5 4 10 0.2 COc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1 10.1021/jm901252a
CHEMBL1093910 8481 None 0 Human Functional pEC50 = 7.7 7.7 -4 3
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation
ChEMBL 373 5 4 10 0.2 COc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1 10.1021/jm901252a
137652475 157237 None 0 Human Functional pEC50 = 7.6 7.6 4 4
Agonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assayAgonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assay
ChEMBL 829 16 6 13 6.5 Nc1sc(-c2ccc(C(=O)NCCCCCCCNc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.8b00047
CHEMBL4075186 157237 None 0 Human Functional pEC50 = 7.6 7.6 4 4
Agonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assayAgonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assay
ChEMBL 829 16 6 13 6.5 Nc1sc(-c2ccc(C(=O)NCCCCCCCNc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.8b00047
137650221 157347 None 0 Human Functional pEC50 = 6.7 6.7 -5 4
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATP
ChEMBL 463 6 3 13 1.2 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NCc5cccs5)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b00291
CHEMBL4076561 157347 None 0 Human Functional pEC50 = 6.7 6.7 -5 4
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATP
ChEMBL 463 6 3 13 1.2 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NCc5cccs5)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b00291
168296441 192348 None 0 Human Functional pEC50 = 6.7 6.7 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 863 14 6 13 7.2 Nc1sc(-c2ccc(C(=O)NCCCCc3ccc(Nc4ncnc5c4ncn5[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)cc3)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
CHEMBL5205189 192348 None 0 Human Functional pEC50 = 6.7 6.7 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 863 14 6 13 7.2 Nc1sc(-c2ccc(C(=O)NCCCCc3ccc(Nc4ncnc5c4ncn5[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)cc3)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
168279326 191199 None 0 Human Functional pEC50 = 6.7 6.7 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assay
ChEMBL 528 8 5 10 1.7 O=C(NCCCC#Cc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1)c1ccccc1 10.1021/acs.jmedchem.2c00320
CHEMBL5187670 191199 None 0 Human Functional pEC50 = 6.7 6.7 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assay
ChEMBL 528 8 5 10 1.7 O=C(NCCCC#Cc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1)c1ccccc1 10.1021/acs.jmedchem.2c00320
137649083 157399 None 0 Human Functional pEC50 = 6.7 6.7 -9 3
Agonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assayAgonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assay
ChEMBL 849 15 6 13 6.7 Nc1sc(-c2ccc(C(=O)NCCCCCCNc3nc(Cl)nc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.8b00047
CHEMBL4077152 157399 None 0 Human Functional pEC50 = 6.7 6.7 -9 3
Agonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assayAgonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assay
ChEMBL 849 15 6 13 6.7 Nc1sc(-c2ccc(C(=O)NCCCCCCNc3nc(Cl)nc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.8b00047
168282722 191151 None 0 Human Functional pEC50 = 5.7 5.7 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 877 15 6 13 7.6 Nc1sc(-c2ccc(C(=O)NCCCCCc3ccc(Nc4ncnc5c4ncn5[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)cc3)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
CHEMBL5187085 191151 None 0 Human Functional pEC50 = 5.7 5.7 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 877 15 6 13 7.6 Nc1sc(-c2ccc(C(=O)NCCCCCc3ccc(Nc4ncnc5c4ncn5[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)cc3)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
10476760 79300 None 0 Rat Functional pEC50 = 6.7 6.7 - 1
Effective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranesEffective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranes
ChEMBL 413 5 3 8 1.0 C[Se]C[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)[C@H](O)[C@@H]1O 10.1021/jm970508l
CHEMBL2113471 79300 None 0 Rat Functional pEC50 = 6.7 6.7 - 1
Effective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranesEffective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranes
ChEMBL 413 5 3 8 1.0 C[Se]C[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)[C@H](O)[C@@H]1O 10.1021/jm970508l
44276273 98532 None 0 Human Functional pEC50 = 5.6 5.6 - 1
Agonist efficacy as effective concentration to stimulate binding of [35S]GTP-gamma-S, at human Adenosine A1 receptorAgonist efficacy as effective concentration to stimulate binding of [35S]GTP-gamma-S, at human Adenosine A1 receptor
ChEMBL 363 4 3 7 2.1 OC[C@@]12C[C@@H]1[C@@H](n1cnc3c(NC4CCCC4)nc(Cl)nc31)C[C@@H]2O 10.1016/s0960-894x(01)00213-x
CHEMBL27593 98532 None 0 Human Functional pEC50 = 5.6 5.6 - 1
Agonist efficacy as effective concentration to stimulate binding of [35S]GTP-gamma-S, at human Adenosine A1 receptorAgonist efficacy as effective concentration to stimulate binding of [35S]GTP-gamma-S, at human Adenosine A1 receptor
ChEMBL 363 4 3 7 2.1 OC[C@@]12C[C@@H]1[C@@H](n1cnc3c(NC4CCCC4)nc(Cl)nc31)C[C@@H]2O 10.1016/s0960-894x(01)00213-x
46874431 203782 None 0 Guinea pig Functional pEC50 = 4.6 4.6 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 367 7 4 10 -0.2 CC(C)CCCOc1nc(N)c2ncn(C3O[C@@H](CO)[C@H](O)[C@@H]3O)c2n1 10.1021/jm00108a014
CHEMBL604223 203782 None 0 Guinea pig Functional pEC50 = 4.6 4.6 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 367 7 4 10 -0.2 CC(C)CCCOc1nc(N)c2ncn(C3O[C@@H](CO)[C@H](O)[C@@H]3O)c2n1 10.1021/jm00108a014
11742562 87215 None 0 Guinea pig Functional pEC50 = 4.6 4.6 -16 2
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 415 6 5 12 -0.5 COc1ccc(/C=N/Nc2nc(N)c3ncn([C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)c3n2)cc1 10.1021/jm00102a008
CHEMBL2326828 87215 None 0 Guinea pig Functional pEC50 = 4.6 4.6 -16 2
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 415 6 5 12 -0.5 COc1ccc(/C=N/Nc2nc(N)c3ncn([C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)c3n2)cc1 10.1021/jm00102a008
137657841 159664 None 0 Human Functional pEC50 = 6.6 6.6 -8 4
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATP
ChEMBL 475 6 3 12 1.2 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NCc5ccc(Cl)cc5F)ncnc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b00291
CHEMBL4102750 159664 None 0 Human Functional pEC50 = 6.6 6.6 -8 4
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATP
ChEMBL 475 6 3 12 1.2 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NCc5ccc(Cl)cc5F)ncnc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b00291
137643164 158193 None 0 Human Functional pEC50 = 6.6 6.6 -5 4
Agonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assayAgonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assay
ChEMBL 552 12 5 11 2.6 O=C(NCCCCCCNc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)c1cccc(-c2cccs2)c1 10.1021/acs.jmedchem.8b00047
CHEMBL4086624 158193 None 0 Human Functional pEC50 = 6.6 6.6 -5 4
Agonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assayAgonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assay
ChEMBL 552 12 5 11 2.6 O=C(NCCCCCCNc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)c1cccc(-c2cccs2)c1 10.1021/acs.jmedchem.8b00047
73350675 91878 None 0 Human Functional pEC50 = 6.6 6.6 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gs-mediated activation of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometryAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gs-mediated activation of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometry
ChEMBL 783 13 5 13 3.0 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1039/C2MD00247G
CHEMBL2413230 91878 None 0 Human Functional pEC50 = 6.6 6.6 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gs-mediated activation of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometryAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gs-mediated activation of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometry
ChEMBL 783 13 5 13 3.0 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1039/C2MD00247G
73355133 91880 None 0 Human Functional pEC50 = 5.6 5.6 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gs-mediated activation of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometryAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gs-mediated activation of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometry
ChEMBL 811 15 5 13 3.8 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1039/C2MD00247G
CHEMBL2413232 91880 None 0 Human Functional pEC50 = 5.6 5.6 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gs-mediated activation of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometryAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gs-mediated activation of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometry
ChEMBL 811 15 5 13 3.8 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1039/C2MD00247G
10046463 79230 None 0 Rat Functional pEC50 = 5.6 5.6 - 1
Negative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atriaNegative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atria
ChEMBL 399 5 4 10 -0.8 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(C#CCCCC#N)nc32)[C@H](O)[C@@H]1O 10.1021/jm00037a024
CHEMBL2113402 79230 None 0 Rat Functional pEC50 = 5.6 5.6 - 1
Negative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atriaNegative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atria
ChEMBL 399 5 4 10 -0.8 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(C#CCCCC#N)nc32)[C@H](O)[C@@H]1O 10.1021/jm00037a024
137651747 157573 None 0 Human Functional pEC50 = 6.6 6.6 -7 4
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATP
ChEMBL 475 6 3 12 1.2 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NCc5cccc(F)c5)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b00291
CHEMBL4079433 157573 None 0 Human Functional pEC50 = 6.6 6.6 -7 4
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATP
ChEMBL 475 6 3 12 1.2 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NCc5cccc(F)c5)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b00291
10003996 79226 None 0 Rat Functional pEC50 = 5.6 5.6 - 1
Negative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atriaNegative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atria
ChEMBL 452 4 5 10 -0.6 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(C#CC(C)(O)c4ccccc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm00037a024
CHEMBL2113399 79226 None 0 Rat Functional pEC50 = 5.6 5.6 - 1
Negative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atriaNegative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atria
ChEMBL 452 4 5 10 -0.6 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(C#CC(C)(O)c4ccccc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm00037a024
3086599 904 None 36 Guinea pig Functional pEC50 = 4.6 4.6 -954 6
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 499 10 6 11 -0.2 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(NCCc1ccc(cc1)CCC(=O)O)nc2N 10.1021/jm00108a014
375 904 None 36 Guinea pig Functional pEC50 = 4.6 4.6 -954 6
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 499 10 6 11 -0.2 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(NCCc1ccc(cc1)CCC(=O)O)nc2N 10.1021/jm00108a014
424 904 None 36 Guinea pig Functional pEC50 = 4.6 4.6 -954 6
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 499 10 6 11 -0.2 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(NCCc1ccc(cc1)CCC(=O)O)nc2N 10.1021/jm00108a014
CHEMBL331372 904 None 36 Guinea pig Functional pEC50 = 4.6 4.6 -954 6
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 499 10 6 11 -0.2 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(NCCc1ccc(cc1)CCC(=O)O)nc2N 10.1021/jm00108a014
92433056 195855 None 4 Human Functional pEC50 = 7.6 7.6 -2 2
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 345 5 1 6 4.3 c1cncc(CNc2ncc(-c3ccncc3)c(-c3cccs3)n2)c1 10.1016/j.ejmech.2023.115419
CHEMBL5412076 195855 None 4 Human Functional pEC50 = 7.6 7.6 -2 2
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 345 5 1 6 4.3 c1cncc(CNc2ncc(-c3ccncc3)c(-c3cccs3)n2)c1 10.1016/j.ejmech.2023.115419
118732973 118578 None 0 Human Functional pEC50 = 6.6 6.6 -32 4
Agonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activityAgonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activity
ChEMBL 381 4 3 12 -0.5 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NC)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.5b00074
CHEMBL3414939 118578 None 0 Human Functional pEC50 = 6.6 6.6 -32 4
Agonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activityAgonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activity
ChEMBL 381 4 3 12 -0.5 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NC)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.5b00074
76311194 106102 None 0 Human Functional pEC50 = 6.6 6.6 -158 4
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 525 5 5 10 -0.0 CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)nc(N)nc32)[C@H](O)[C@@H]1O 10.1039/C3MD00364G
CHEMBL3133078 106102 None 0 Human Functional pEC50 = 6.6 6.6 -158 4
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 525 5 5 10 -0.0 CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)nc(N)nc32)[C@H](O)[C@@H]1O 10.1039/C3MD00364G
76336525 106112 None 0 Human Functional pEC50 = 5.6 5.6 -251 3
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 337 4 5 10 -1.8 CCNc1nc(N)nc2c1ncn2[C@@H]1O[C@H](C(=O)NC)[C@@H](O)[C@H]1O 10.1039/C3MD00364G
CHEMBL3133154 106112 None 0 Human Functional pEC50 = 5.6 5.6 -251 3
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 337 4 5 10 -1.8 CCNc1nc(N)nc2c1ncn2[C@@H]1O[C@H](C(=O)NC)[C@@H](O)[C@H]1O 10.1039/C3MD00364G
46874371 204153 None 0 Guinea pig Functional pEC50 = 4.6 4.6 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 401 6 4 10 -0.1 Cc1ccccc1CCOc1nc(N)c2ncn(C3O[C@@H](CO)[C@H](O)[C@@H]3O)c2n1 10.1021/jm00108a015
CHEMBL606305 204153 None 0 Guinea pig Functional pEC50 = 4.6 4.6 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 401 6 4 10 -0.1 Cc1ccccc1CCOc1nc(N)c2ncn(C3O[C@@H](CO)[C@H](O)[C@@H]3O)c2n1 10.1021/jm00108a015
10024452 79241 None 0 Rat Functional pEC50 = 5.6 5.6 - 1
Negative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atriaNegative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atria
ChEMBL 408 5 4 9 -0.5 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(C#CCCCCl)nc32)[C@H](O)[C@@H]1O 10.1021/jm00037a024
CHEMBL2113412 79241 None 0 Rat Functional pEC50 = 5.6 5.6 - 1
Negative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atriaNegative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atria
ChEMBL 408 5 4 9 -0.5 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(C#CCCCCl)nc32)[C@H](O)[C@@H]1O 10.1021/jm00037a024
46874358 204114 None 0 Guinea pig Functional pEC50 = 4.6 4.6 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparation
ChEMBL 405 6 4 10 -0.2 Nc1nc(OCCc2ccc(F)cc2)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a015
CHEMBL606080 204114 None 0 Guinea pig Functional pEC50 = 4.6 4.6 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparation
ChEMBL 405 6 4 10 -0.2 Nc1nc(OCCc2ccc(F)cc2)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a015
14426726 181743 None 0 Rat Functional pEC50 = 7.6 7.6 - 1
Effective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranesEffective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranes
ChEMBL 353 4 3 8 1.0 O[C@@H]1[C@@H](CCl)O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)[C@@H]1O 10.1021/jm970508l
CHEMBL477444 181743 None 0 Rat Functional pEC50 = 7.6 7.6 - 1
Effective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranesEffective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranes
ChEMBL 353 4 3 8 1.0 O[C@@H]1[C@@H](CCl)O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)[C@@H]1O 10.1021/jm970508l
118732971 118575 None 0 Human Functional pEC50 = 7.6 7.6 -11 4
Agonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activityAgonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activity
ChEMBL 333 3 3 12 -1.6 CCn1nnc([C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.5b00074
CHEMBL3414936 118575 None 0 Human Functional pEC50 = 7.6 7.6 -11 4
Agonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activityAgonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activity
ChEMBL 333 3 3 12 -1.6 CCn1nnc([C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.5b00074
73350676 91879 None 0 Human Functional pEC50 = 6.6 6.6 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gs-mediated activation of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometryAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gs-mediated activation of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometry
ChEMBL 797 14 5 13 3.4 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1039/C2MD00247G
CHEMBL2413231 91879 None 0 Human Functional pEC50 = 6.6 6.6 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gs-mediated activation of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometryAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gs-mediated activation of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometry
ChEMBL 797 14 5 13 3.4 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1039/C2MD00247G
46874417 203665 None 0 Guinea pig Functional pEC50 = 5.6 5.6 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 421 8 4 10 1.1 Nc1nc(OCCCCC2CCCCC2)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a014
CHEMBL603588 203665 None 0 Guinea pig Functional pEC50 = 5.6 5.6 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 421 8 4 10 1.1 Nc1nc(OCCCCC2CCCCC2)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a014
46876601 205037 None 0 Guinea pig Functional pEC50 = 5.6 5.6 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 435 5 5 11 0.6 Nc1nc(N/N=C/c2ccc3ccccc3c2)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a008
CHEMBL611920 205037 None 0 Guinea pig Functional pEC50 = 5.6 5.6 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 435 5 5 11 0.6 Nc1nc(N/N=C/c2ccc3ccccc3c2)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a008
46876610 204412 None 0 Guinea pig Functional pEC50 = 4.6 4.6 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 386 5 5 12 -1.1 Nc1nc(N/N=C/c2ccncc2)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a008
CHEMBL607798 204412 None 0 Guinea pig Functional pEC50 = 4.6 4.6 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 386 5 5 12 -1.1 Nc1nc(N/N=C/c2ccncc2)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a008
168278823 190941 None 0 Human Functional pEC50 = 6.6 6.6 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 853 16 5 15 7.0 Nc1sc(-c2ccc(-c3cn(CCCCCCCNc4ncnc5c4ncn5[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)nn3)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
CHEMBL5184225 190941 None 0 Human Functional pEC50 = 6.6 6.6 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 853 16 5 15 7.0 Nc1sc(-c2ccc(-c3cn(CCCCCCCNc4ncnc5c4ncn5[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)nn3)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
46203193 8004 None 0 Human Functional pEC50 = 6.6 6.6 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation countingAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting
ChEMBL 753 13 5 14 5.0 Nc1sc2c(c1C(=O)c1ccc(Cl)c(Cl)c1)CCN(CCCCCOc1ccc(Nc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc1)C2 10.1021/jm901252a
CHEMBL1090683 8004 None 0 Human Functional pEC50 = 6.6 6.6 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation countingAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting
ChEMBL 753 13 5 14 5.0 Nc1sc2c(c1C(=O)c1ccc(Cl)c(Cl)c1)CCN(CCCCCOc1ccc(Nc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc1)C2 10.1021/jm901252a
162645916 179602 None 0 Human Functional pEC50 = 6.6 6.6 4 4
Irreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as effect on forskolin-induced cAMP accumulation incubated for 30 mins by LANCE cAMP detection assayIrreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as effect on forskolin-induced cAMP accumulation incubated for 30 mins by LANCE cAMP detection assay
ChEMBL 414 6 4 11 0.8 OC[C@H]1O[C@@H](n2cnc3c(Nc4ccc(CN=C=S)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.6b01561
CHEMBL4741079 179602 None 0 Human Functional pEC50 = 6.6 6.6 4 4
Irreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as effect on forskolin-induced cAMP accumulation incubated for 30 mins by LANCE cAMP detection assayIrreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as effect on forskolin-induced cAMP accumulation incubated for 30 mins by LANCE cAMP detection assay
ChEMBL 414 6 4 11 0.8 OC[C@H]1O[C@@H](n2cnc3c(Nc4ccc(CN=C=S)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.6b01561
137648928 157497 None 0 Human Functional pEC50 = 7.6 7.6 -11 4
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATP
ChEMBL 549 6 3 12 1.0 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NCc5cccc(I)c5)ncnc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b00291
CHEMBL4078479 157497 None 0 Human Functional pEC50 = 7.6 7.6 -11 4
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATP
ChEMBL 549 6 3 12 1.0 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NCc5cccc(I)c5)ncnc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b00291
46203193 8004 None 0 Human Functional pEC50 = 6.6 6.6 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation countingAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting
ChEMBL 753 13 5 14 5.0 Nc1sc2c(c1C(=O)c1ccc(Cl)c(Cl)c1)CCN(CCCCCOc1ccc(Nc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc1)C2 10.1021/jm901252a
CHEMBL1090683 8004 None 0 Human Functional pEC50 = 6.6 6.6 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation countingAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting
ChEMBL 753 13 5 14 5.0 Nc1sc2c(c1C(=O)c1ccc(Cl)c(Cl)c1)CCN(CCCCCOc1ccc(Nc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc1)C2 10.1021/jm901252a
134150832 152261 None 0 Human Functional pEC50 = 6.6 6.6 - 1
Inverse agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 90 mins by beta scintillation counting methodInverse agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 90 mins by beta scintillation counting method
ChEMBL 379 4 2 4 5.2 O[C@H]1CC[C@H](Nc2ncc(-c3cccc(Cl)c3)c(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2016.09.081
CHEMBL3968282 152261 None 0 Human Functional pEC50 = 6.6 6.6 - 1
Inverse agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 90 mins by beta scintillation counting methodInverse agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by [35S]GTPgammaS addition measured after 90 mins by beta scintillation counting method
ChEMBL 379 4 2 4 5.2 O[C@H]1CC[C@H](Nc2ncc(-c3cccc(Cl)c3)c(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2016.09.081
153605593 173725 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human A1A adenosine receptor expressed in HEK cell membranes incubated for 60 mins by [35S]GTPgammaS binding assayAgonist activity at human A1A adenosine receptor expressed in HEK cell membranes incubated for 60 mins by [35S]GTPgammaS binding assay
ChEMBL 389 6 4 9 0.8 OC[C@H]1O[C@@H](n2cnc3c(NC(C4CCC4)C4CCC4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.8b01662
CHEMBL4533718 173725 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human A1A adenosine receptor expressed in HEK cell membranes incubated for 60 mins by [35S]GTPgammaS binding assayAgonist activity at human A1A adenosine receptor expressed in HEK cell membranes incubated for 60 mins by [35S]GTPgammaS binding assay
ChEMBL 389 6 4 9 0.8 OC[C@H]1O[C@@H](n2cnc3c(NC(C4CCC4)C4CCC4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.8b01662
44366934 43634 None 0 Guinea pig Functional pEC50 = 5.6 5.6 - 1
Agonistic activity against adenosine A1 receptor in guinea pig isolated heartsAgonistic activity against adenosine A1 receptor in guinea pig isolated hearts
ChEMBL 394 5 4 11 -1.0 CNC(=O)OC[C@H]1OC(n2cnc3c(NC4CCOC4)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2004.04.096
CHEMBL150950 43634 None 0 Guinea pig Functional pEC50 = 5.6 5.6 - 1
Agonistic activity against adenosine A1 receptor in guinea pig isolated heartsAgonistic activity against adenosine A1 receptor in guinea pig isolated hearts
ChEMBL 394 5 4 11 -1.0 CNC(=O)OC[C@H]1OC(n2cnc3c(NC4CCOC4)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2004.04.096
44276002 98382 None 0 Human Functional pEC50 = 5.5 5.5 - 1
Agonist efficacy as effective concentration to stimulate binding of [35S]GTP-gamma-S, at human A1 adenosine receptorAgonist efficacy as effective concentration to stimulate binding of [35S]GTP-gamma-S, at human A1 adenosine receptor
ChEMBL 329 4 3 7 1.5 OC[C@@]12C[C@@H]1[C@@H](n1cnc3c(NC4CCCC4)ncnc31)C[C@@H]2O 10.1016/s0960-894x(01)00213-x
CHEMBL27502 98382 None 0 Human Functional pEC50 = 5.5 5.5 - 1
Agonist efficacy as effective concentration to stimulate binding of [35S]GTP-gamma-S, at human A1 adenosine receptorAgonist efficacy as effective concentration to stimulate binding of [35S]GTP-gamma-S, at human A1 adenosine receptor
ChEMBL 329 4 3 7 1.5 OC[C@@]12C[C@@H]1[C@@H](n1cnc3c(NC4CCCC4)ncnc31)C[C@@H]2O 10.1016/s0960-894x(01)00213-x
46886345 8481 None 0 Human Functional pEC50 = 7.5 7.5 -4 3
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting in presence of 10 uM allosteric modulator PD-81723Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting in presence of 10 uM allosteric modulator PD-81723
ChEMBL 373 5 4 10 0.2 COc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1 10.1021/jm901252a
CHEMBL1093910 8481 None 0 Human Functional pEC50 = 7.5 7.5 -4 3
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting in presence of 10 uM allosteric modulator PD-81723Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting in presence of 10 uM allosteric modulator PD-81723
ChEMBL 373 5 4 10 0.2 COc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1 10.1021/jm901252a
45875637 195990 None 3 Human Functional pEC50 = 8.5 8.5 5 2
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 300 3 1 4 3.2 O=C(Nc1nc(C2CC2)cs1)C1COc2ccccc2C1 10.1016/j.ejmech.2023.115419
CHEMBL5414803 195990 None 3 Human Functional pEC50 = 8.5 8.5 5 2
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 300 3 1 4 3.2 O=C(Nc1nc(C2CC2)cs1)C1COc2ccccc2C1 10.1016/j.ejmech.2023.115419
66631868 142697 None 0 Human Functional pEC50 = 8.5 8.5 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 370 5 1 5 3.9 N#Cc1cnc(SCc2cccc(C(N)=O)c2)c(C#N)c1-c1ccccc1 nan
CHEMBL3891469 142697 None 0 Human Functional pEC50 = 8.5 8.5 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 370 5 1 5 3.9 N#Cc1cnc(SCc2cccc(C(N)=O)c2)c(C#N)c1-c1ccccc1 nan
24241730 196416 None 3 Human Functional pEC50 = 8.5 8.5 1 2
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 275 5 1 4 3.3 CC(Sc1nnc(C(C)C)[nH]1)C(=O)c1ccccc1 10.1016/j.ejmech.2023.115419
CHEMBL5423524 196416 None 3 Human Functional pEC50 = 8.5 8.5 1 2
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 275 5 1 4 3.3 CC(Sc1nnc(C(C)C)[nH]1)C(=O)c1ccccc1 10.1016/j.ejmech.2023.115419
16109359 161872 None 0 Human Functional pEC50 = 8.5 8.5 -1 4
Activity at human adenosine A1 receptor assessed as inhibition of forskolin-stimulated cAMP accumulation in CHO cellsActivity at human adenosine A1 receptor assessed as inhibition of forskolin-stimulated cAMP accumulation in CHO cells
ChEMBL 924 21 6 14 4.5 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCCNC(=O)CCCCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/jm061279i
CHEMBL414055 161872 None 0 Human Functional pEC50 = 8.5 8.5 -1 4
Activity at human adenosine A1 receptor assessed as inhibition of forskolin-stimulated cAMP accumulation in CHO cellsActivity at human adenosine A1 receptor assessed as inhibition of forskolin-stimulated cAMP accumulation in CHO cells
ChEMBL 924 21 6 14 4.5 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCCNC(=O)CCCCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/jm061279i
16109359 161872 None 0 Human Functional pEC50 = 8.5 8.5 -1 4
Agonist activity at adenosine A1 receptor assessed as inhibition of forskolin-stimulated [3H]cAMP accumulation in CHO cellsAgonist activity at adenosine A1 receptor assessed as inhibition of forskolin-stimulated [3H]cAMP accumulation in CHO cells
ChEMBL 924 21 6 14 4.5 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCCNC(=O)CCCCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/jm061279i
CHEMBL414055 161872 None 0 Human Functional pEC50 = 8.5 8.5 -1 4
Agonist activity at adenosine A1 receptor assessed as inhibition of forskolin-stimulated [3H]cAMP accumulation in CHO cellsAgonist activity at adenosine A1 receptor assessed as inhibition of forskolin-stimulated [3H]cAMP accumulation in CHO cells
ChEMBL 924 21 6 14 4.5 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCCNC(=O)CCCCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/jm061279i
168290340 192002 None 0 Human Functional pEC50 = 8.5 8.5 1995 3
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 475 7 4 10 1.6 OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4OCc4ccccc4Cl)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
CHEMBL5199871 192002 None 0 Human Functional pEC50 = 8.5 8.5 1995 3
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 475 7 4 10 1.6 OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4OCc4ccccc4Cl)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
155519551 170472 None 0 Human Functional pEC50 = 8.5 8.5 - 1
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 333 4 1 7 3.4 N#Cc1c(N)nc(SCc2ccccn2)c(C#N)c1-c1ccco1 10.1021/acs.jmedchem.9b00106
CHEMBL4447663 170472 None 0 Human Functional pEC50 = 8.5 8.5 - 1
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 333 4 1 7 3.4 N#Cc1c(N)nc(SCc2ccccn2)c(C#N)c1-c1ccco1 10.1021/acs.jmedchem.9b00106
68597381 147813 None 0 Human Functional pEC50 = 8.5 8.5 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 404 5 2 6 4.2 N#Cc1c(N)nc(SCc2cccc(C(=O)O)c2)c(C#N)c1-c1ccc(F)cc1 nan
CHEMBL3932154 147813 None 0 Human Functional pEC50 = 8.5 8.5 - 1
Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.Luciferase Assay: The stock cultures are grown, at 37° C. and under 5% CO2, in DMEM/F12 medium containing 10% FCS (fetal calf serum) and in each case split 1:10 after 2-3 days. Test cultures are seeded in 384-well plates with 2000 cells per well and grown at 37° C. for approx. 48 hours. The medium is then replaced with a physiological sodium chloride solution (130 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 20 mM HEPES, 1 mM magnesium chloride hexahydrate, 5 mM sodium bicarbonate, pH 7.4). The substances to be tested, which are dissolved in DMSO, are pipetted into the test cultures (maximum final concentration of DMSO in the test mixture: 0.5%) in a dilution series of from 5x10-11 M to 3x10-6 M (final concentration). 10 minutes later, forskolin is added to the A1 cells and all the cultures are subsequently incubated at 37° C. for four hours. After that, 35 ul of a solution which is composed of 50% lysis reagent (30 mM disodium hydrogenphosphate, 10% glycerol, 3% TritonX100, 25 mM TrisHCl, 2 mM dithiotreitol (DTT), pH 7.8) and 50% luciferase substrate solution (2.5 mM ATP, 0.5 mM luciferin, 0.1 mM coenzyme A, 10 mM tricine, 1.35 mM magnesium sulfate, 15 mM DTT, pH 7.8) are added to the test cultures, which are shaken for approx. 1 minute and the luciferase activity is measured using a camera system.
ChEMBL 404 5 2 6 4.2 N#Cc1c(N)nc(SCc2cccc(C(=O)O)c2)c(C#N)c1-c1ccc(F)cc1 nan
118732975 118580 None 0 Human Functional pEC50 = 8.4 8.4 2 4
Agonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activityAgonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activity
ChEMBL 407 5 3 12 0.1 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NC5CC5)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.5b00074
CHEMBL3414941 118580 None 0 Human Functional pEC50 = 8.4 8.4 2 4
Agonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activityAgonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activity
ChEMBL 407 5 3 12 0.1 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NC5CC5)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.5b00074
40149613 197019 None 3 Human Functional pEC50 = 8.4 8.4 1 2
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 277 4 2 4 2.3 O=C(Nc1nc2ccccc2s1)N(CCO)C1CC1 10.1016/j.ejmech.2023.115419
CHEMBL5436964 197019 None 3 Human Functional pEC50 = 8.4 8.4 1 2
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 277 4 2 4 2.3 O=C(Nc1nc2ccccc2s1)N(CCO)C1CC1 10.1016/j.ejmech.2023.115419
16202442 138414 None 1 Human Functional pEC50 = 8.4 8.4 707 2
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 441 7 4 10 1.0 OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4OCc4ccccc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
CHEMBL3771208 138414 None 1 Human Functional pEC50 = 8.4 8.4 707 2
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 441 7 4 10 1.0 OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4OCc4ccccc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
155541051 173069 None 0 Human Functional pEC50 = 8.4 8.4 251 2
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 406 5 1 8 4.2 COC(=O)c1cccc(CSc2nc(N)c(C#N)c(-c3cccs3)c2C#N)c1 10.1021/acs.jmedchem.9b00106
CHEMBL4517597 173069 None 0 Human Functional pEC50 = 8.4 8.4 251 2
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 406 5 1 8 4.2 COC(=O)c1cccc(CSc2nc(N)c(C#N)c(-c3cccs3)c2C#N)c1 10.1021/acs.jmedchem.9b00106
90654603 110066 None 0 Human Functional pEC50 = 8.4 8.4 - 1
Agonist activity human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by radioligand addition measured after 90 mins by beta scintillation counting analysisAgonist activity human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by radioligand addition measured after 90 mins by beta scintillation counting analysis
ChEMBL 492 6 2 8 5.6 CC(=O)Nc1ccc(-c2nc(SCc3csc(-c4ccc(Cl)cc4)n3)nc(N)c2C#N)cc1 10.1021/jm401643m
CHEMBL3234937 110066 None 0 Human Functional pEC50 = 8.4 8.4 - 1
Agonist activity human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by radioligand addition measured after 90 mins by beta scintillation counting analysisAgonist activity human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by radioligand addition measured after 90 mins by beta scintillation counting analysis
ChEMBL 492 6 2 8 5.6 CC(=O)Nc1ccc(-c2nc(SCc3csc(-c4ccc(Cl)cc4)n3)nc(N)c2C#N)cc1 10.1021/jm401643m
123807 871 None 35 Rat Functional pEC50 = 7.5 7.5 -1 7
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 369 4 4 9 0.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1 10.1021/jm9911231
374 871 None 35 Rat Functional pEC50 = 7.5 7.5 -1 7
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 369 4 4 9 0.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1 10.1021/jm9911231
379 871 None 35 Rat Functional pEC50 = 7.5 7.5 -1 7
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 369 4 4 9 0.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1 10.1021/jm9911231
CHEMBL284969 871 None 35 Rat Functional pEC50 = 7.5 7.5 -1 7
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 369 4 4 9 0.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1 10.1021/jm9911231
46886345 8481 None 0 Human Functional pEC50 = 7.5 7.5 -4 3
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting in presence of 10 uM allosteric modulator PD-81723Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting in presence of 10 uM allosteric modulator PD-81723
ChEMBL 373 5 4 10 0.2 COc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1 10.1021/jm901252a
CHEMBL1093910 8481 None 0 Human Functional pEC50 = 7.5 7.5 -4 3
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting in presence of 10 uM allosteric modulator PD-81723Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting in presence of 10 uM allosteric modulator PD-81723
ChEMBL 373 5 4 10 0.2 COc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1 10.1021/jm901252a
44398764 12257 None 0 Human Functional pEC50 = 4.5 4.5 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 292 1 1 3 4.6 Cc1ccc(-c2ccc3c(c2)Cc2sc(N)nc2-3)cc1C 10.1021/jm049132j
CHEMBL1184634 12257 None 0 Human Functional pEC50 = 4.5 4.5 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 292 1 1 3 4.6 Cc1ccc(-c2ccc3c(c2)Cc2sc(N)nc2-3)cc1C 10.1021/jm049132j
CHEMBL360831 12257 None 0 Human Functional pEC50 = 4.5 4.5 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 292 1 1 3 4.6 Cc1ccc(-c2ccc3c(c2)Cc2sc(N)nc2-3)cc1C 10.1021/jm049132j
46876598 204994 None 0 Guinea pig Functional pEC50 = 5.5 5.5 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 399 5 5 11 -0.1 C/C(=N\Nc1nc(N)c2ncn(C3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1)c1ccccc1 10.1021/jm00102a008
CHEMBL611609 204994 None 0 Guinea pig Functional pEC50 = 5.5 5.5 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 399 5 5 11 -0.1 C/C(=N\Nc1nc(N)c2ncn(C3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1)c1ccccc1 10.1021/jm00102a008
46874629 203743 None 0 Rat Functional pEC50 = 6.5 6.5 -1 2
Functional activity against adenosine A1 receptor from rat atria.Functional activity against adenosine A1 receptor from rat atria.
ChEMBL 447 4 4 11 -1.4 CCNC(=O)[C@H]1OC(n2cnc3c(N)nc(C#CCN4CCSCC4)nc32)[C@H](O)[C@@H]1O 10.1021/jm00009a007
CHEMBL604026 203743 None 0 Rat Functional pEC50 = 6.5 6.5 -1 2
Functional activity against adenosine A1 receptor from rat atria.Functional activity against adenosine A1 receptor from rat atria.
ChEMBL 447 4 4 11 -1.4 CCNC(=O)[C@H]1OC(n2cnc3c(N)nc(C#CCN4CCSCC4)nc32)[C@H](O)[C@@H]1O 10.1021/jm00009a007
168272212 190540 None 0 Human Functional pEC50 = 6.5 6.5 -3 4
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assay
ChEMBL 518 10 5 10 1.9 O=C(NCCCCc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1)c1ccccc1 10.1021/acs.jmedchem.2c00320
CHEMBL5178142 190540 None 0 Human Functional pEC50 = 6.5 6.5 -3 4
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assay
ChEMBL 518 10 5 10 1.9 O=C(NCCCCc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1)c1ccccc1 10.1021/acs.jmedchem.2c00320
46876676 204386 None 0 Guinea pig Functional pEC50 = 4.5 4.5 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 457 8 6 12 -0.5 Nc1nc(N/N=C/c2ccc(CCC(=O)O)cc2)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a008
CHEMBL607604 204386 None 0 Guinea pig Functional pEC50 = 4.5 4.5 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 457 8 6 12 -0.5 Nc1nc(N/N=C/c2ccc(CCC(=O)O)cc2)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a008
9799990 99690 None 0 Human Functional pEC50 = 7.5 7.5 4 2
Stimulation of [35S]GTP-gamma-S, binding to human adenosine A1 receptorStimulation of [35S]GTP-gamma-S, binding to human adenosine A1 receptor
ChEMBL 379 4 4 8 1.1 OC[C@@]12C[C@@H]1[C@@H](n1cnc3c(NC4CCCC4)nc(Cl)nc31)[C@H](O)[C@@H]2O 10.1021/jm9905965
CHEMBL284216 99690 None 0 Human Functional pEC50 = 7.5 7.5 4 2
Stimulation of [35S]GTP-gamma-S, binding to human adenosine A1 receptorStimulation of [35S]GTP-gamma-S, binding to human adenosine A1 receptor
ChEMBL 379 4 4 8 1.1 OC[C@@]12C[C@@H]1[C@@H](n1cnc3c(NC4CCCC4)nc(Cl)nc31)[C@H](O)[C@@H]2O 10.1021/jm9905965
123683 3121 None 46 Human Functional pEC50 = 7.5 7.5 -67 5
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 510 5 4 9 0.4 CNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NCc1cccc(c1)I 10.1039/C3MD00364G
422 3121 None 46 Human Functional pEC50 = 7.5 7.5 -67 5
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 510 5 4 9 0.4 CNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NCc1cccc(c1)I 10.1039/C3MD00364G
CHEMBL119709 3121 None 46 Human Functional pEC50 = 7.5 7.5 -67 5
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 510 5 4 9 0.4 CNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NCc1cccc(c1)I 10.1039/C3MD00364G
DB05511 3121 None 46 Human Functional pEC50 = 7.5 7.5 -67 5
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 510 5 4 9 0.4 CNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NCc1cccc(c1)I 10.1039/C3MD00364G
2844 283 None 61 Human Functional pEC50 = 6.5 6.5 1 5
Agonist activity at human adenosine A1 receptor expressed in CHO cellsAgonist activity at human adenosine A1 receptor expressed in CHO cells
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1016/j.bmcl.2011.02.053
60961 283 None 61 Human Functional pEC50 = 6.5 6.5 1 5
Agonist activity at human adenosine A1 receptor expressed in CHO cellsAgonist activity at human adenosine A1 receptor expressed in CHO cells
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1016/j.bmcl.2011.02.053
60961.0 283 None 61 Human Functional pEC50 = 6.5 6.5 1 5
Agonist activity at human adenosine A1 receptor expressed in CHO cellsAgonist activity at human adenosine A1 receptor expressed in CHO cells
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1016/j.bmcl.2011.02.053
90 283 None 61 Human Functional pEC50 = 6.5 6.5 1 5
Agonist activity at human adenosine A1 receptor expressed in CHO cellsAgonist activity at human adenosine A1 receptor expressed in CHO cells
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1016/j.bmcl.2011.02.053
CHEMBL477 283 None 61 Human Functional pEC50 = 6.5 6.5 1 5
Agonist activity at human adenosine A1 receptor expressed in CHO cellsAgonist activity at human adenosine A1 receptor expressed in CHO cells
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1016/j.bmcl.2011.02.053
DB00640 283 None 61 Human Functional pEC50 = 6.5 6.5 1 5
Agonist activity at human adenosine A1 receptor expressed in CHO cellsAgonist activity at human adenosine A1 receptor expressed in CHO cells
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1016/j.bmcl.2011.02.053
2844 283 None 61 Human Functional pEC50 = 6.5 6.5 1 5
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as increase of intracellular calcium levelAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as increase of intracellular calcium level
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1016/j.bmcl.2010.05.056
60961 283 None 61 Human Functional pEC50 = 6.5 6.5 1 5
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as increase of intracellular calcium levelAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as increase of intracellular calcium level
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1016/j.bmcl.2010.05.056
60961.0 283 None 61 Human Functional pEC50 = 6.5 6.5 1 5
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as increase of intracellular calcium levelAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as increase of intracellular calcium level
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1016/j.bmcl.2010.05.056
90 283 None 61 Human Functional pEC50 = 6.5 6.5 1 5
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as increase of intracellular calcium levelAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as increase of intracellular calcium level
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1016/j.bmcl.2010.05.056
CHEMBL477 283 None 61 Human Functional pEC50 = 6.5 6.5 1 5
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as increase of intracellular calcium levelAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as increase of intracellular calcium level
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1016/j.bmcl.2010.05.056
DB00640 283 None 61 Human Functional pEC50 = 6.5 6.5 1 5
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as increase of intracellular calcium levelAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as increase of intracellular calcium level
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1016/j.bmcl.2010.05.056
2844 283 None 61 Human Functional pEC50 = 6.5 6.5 1 5
Agonist activity at human adenosine A1 receptor transfected in CHO cells assessed as changes in cAMP formation in the presence of nitrobenzylthioinosineAgonist activity at human adenosine A1 receptor transfected in CHO cells assessed as changes in cAMP formation in the presence of nitrobenzylthioinosine
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.5b00828
60961 283 None 61 Human Functional pEC50 = 6.5 6.5 1 5
Agonist activity at human adenosine A1 receptor transfected in CHO cells assessed as changes in cAMP formation in the presence of nitrobenzylthioinosineAgonist activity at human adenosine A1 receptor transfected in CHO cells assessed as changes in cAMP formation in the presence of nitrobenzylthioinosine
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.5b00828
60961.0 283 None 61 Human Functional pEC50 = 6.5 6.5 1 5
Agonist activity at human adenosine A1 receptor transfected in CHO cells assessed as changes in cAMP formation in the presence of nitrobenzylthioinosineAgonist activity at human adenosine A1 receptor transfected in CHO cells assessed as changes in cAMP formation in the presence of nitrobenzylthioinosine
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.5b00828
90 283 None 61 Human Functional pEC50 = 6.5 6.5 1 5
Agonist activity at human adenosine A1 receptor transfected in CHO cells assessed as changes in cAMP formation in the presence of nitrobenzylthioinosineAgonist activity at human adenosine A1 receptor transfected in CHO cells assessed as changes in cAMP formation in the presence of nitrobenzylthioinosine
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.5b00828
CHEMBL477 283 None 61 Human Functional pEC50 = 6.5 6.5 1 5
Agonist activity at human adenosine A1 receptor transfected in CHO cells assessed as changes in cAMP formation in the presence of nitrobenzylthioinosineAgonist activity at human adenosine A1 receptor transfected in CHO cells assessed as changes in cAMP formation in the presence of nitrobenzylthioinosine
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.5b00828
DB00640 283 None 61 Human Functional pEC50 = 6.5 6.5 1 5
Agonist activity at human adenosine A1 receptor transfected in CHO cells assessed as changes in cAMP formation in the presence of nitrobenzylthioinosineAgonist activity at human adenosine A1 receptor transfected in CHO cells assessed as changes in cAMP formation in the presence of nitrobenzylthioinosine
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.5b00828
2844 283 None 61 Human Functional pEC50 = 6.5 6.5 1 5
Agonist activity at human recombinant adenosine A1 receptor by cAMP assayAgonist activity at human recombinant adenosine A1 receptor by cAMP assay
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm4011669
60961 283 None 61 Human Functional pEC50 = 6.5 6.5 1 5
Agonist activity at human recombinant adenosine A1 receptor by cAMP assayAgonist activity at human recombinant adenosine A1 receptor by cAMP assay
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm4011669
60961.0 283 None 61 Human Functional pEC50 = 6.5 6.5 1 5
Agonist activity at human recombinant adenosine A1 receptor by cAMP assayAgonist activity at human recombinant adenosine A1 receptor by cAMP assay
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm4011669
90 283 None 61 Human Functional pEC50 = 6.5 6.5 1 5
Agonist activity at human recombinant adenosine A1 receptor by cAMP assayAgonist activity at human recombinant adenosine A1 receptor by cAMP assay
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm4011669
CHEMBL477 283 None 61 Human Functional pEC50 = 6.5 6.5 1 5
Agonist activity at human recombinant adenosine A1 receptor by cAMP assayAgonist activity at human recombinant adenosine A1 receptor by cAMP assay
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm4011669
DB00640 283 None 61 Human Functional pEC50 = 6.5 6.5 1 5
Agonist activity at human recombinant adenosine A1 receptor by cAMP assayAgonist activity at human recombinant adenosine A1 receptor by cAMP assay
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm4011669
46874604 204157 None 0 Rat Functional pEC50 = 5.5 5.5 -4 2
Functional activity against adenosine A1 receptor from rat atria.Functional activity against adenosine A1 receptor from rat atria.
ChEMBL 412 4 4 11 -1.6 CCNC(=O)[C@H]1OC(n2cnc3c(N)nc(C#CCn4ccnc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm00009a007
CHEMBL606319 204157 None 0 Rat Functional pEC50 = 5.5 5.5 -4 2
Functional activity against adenosine A1 receptor from rat atria.Functional activity against adenosine A1 receptor from rat atria.
ChEMBL 412 4 4 11 -1.6 CCNC(=O)[C@H]1OC(n2cnc3c(N)nc(C#CCn4ccnc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm00009a007
76329263 106103 None 0 Human Functional pEC50 = 6.5 6.5 -79 4
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 413 6 5 10 -0.6 CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCc4ccccc4)nc(N)nc32)[C@H](O)[C@@H]1O 10.1039/C3MD00364G
CHEMBL3133079 106103 None 0 Human Functional pEC50 = 6.5 6.5 -79 4
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 413 6 5 10 -0.6 CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCc4ccccc4)nc(N)nc32)[C@H](O)[C@@H]1O 10.1039/C3MD00364G
76336526 106113 None 0 Human Functional pEC50 = 6.5 6.5 -31 3
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 351 5 5 10 -1.4 CCCNc1nc(N)nc2c1ncn2[C@@H]1O[C@H](C(=O)NC)[C@@H](O)[C@H]1O 10.1039/C3MD00364G
CHEMBL3133155 106113 None 0 Human Functional pEC50 = 6.5 6.5 -31 3
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 351 5 5 10 -1.4 CCCNc1nc(N)nc2c1ncn2[C@@H]1O[C@H](C(=O)NC)[C@@H](O)[C@H]1O 10.1039/C3MD00364G
76336527 106119 None 0 Human Functional pEC50 = 6.5 6.5 -501 4
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 433 5 5 10 0.0 CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(Cl)c4)nc(N)nc32)[C@H](O)[C@@H]1O 10.1039/C3MD00364G
CHEMBL3133161 106119 None 0 Human Functional pEC50 = 6.5 6.5 -501 4
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 433 5 5 10 0.0 CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(Cl)c4)nc(N)nc32)[C@H](O)[C@@H]1O 10.1039/C3MD00364G
46874560 203741 None 0 Rat Functional pEC50 = 6.5 6.5 -1 2
Functional activity against adenosine A1 receptor from rat atria.Functional activity against adenosine A1 receptor from rat atria.
ChEMBL 429 4 4 10 -1.0 CCNC(=O)[C@H]1OC(n2cnc3c(N)nc(C#CCN4CCCCC4)nc32)[C@H](O)[C@@H]1O 10.1021/jm00009a007
CHEMBL604019 203741 None 0 Rat Functional pEC50 = 6.5 6.5 -1 2
Functional activity against adenosine A1 receptor from rat atria.Functional activity against adenosine A1 receptor from rat atria.
ChEMBL 429 4 4 10 -1.0 CCNC(=O)[C@H]1OC(n2cnc3c(N)nc(C#CCN4CCCCC4)nc32)[C@H](O)[C@@H]1O 10.1021/jm00009a007
46876652 204493 None 0 Guinea pig Functional pEC50 = 4.5 4.5 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 386 5 5 12 -1.1 Nc1nc(N/N=C/c2cccnc2)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a008
CHEMBL608447 204493 None 0 Guinea pig Functional pEC50 = 4.5 4.5 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 386 5 5 12 -1.1 Nc1nc(N/N=C/c2cccnc2)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a008
168284484 191862 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 825 14 5 15 6.2 Nc1sc(-c2ccc(-c3cn(CCCCCNc4ncnc5c4ncn5[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)nn3)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
CHEMBL5197574 191862 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 825 14 5 15 6.2 Nc1sc(-c2ccc(-c3cn(CCCCCNc4ncnc5c4ncn5[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)nn3)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
46874457 204019 None 0 Guinea pig Functional pEC50 = 7.5 7.5 2 2
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 385 5 3 9 1.0 CC(C)N(c1ccccc1)c1ncnc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00108a014
CHEMBL605469 204019 None 0 Guinea pig Functional pEC50 = 7.5 7.5 2 2
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 385 5 3 9 1.0 CC(C)N(c1ccccc1)c1ncnc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00108a014
168287510 191641 None 0 Human Functional pEC50 = 6.5 6.5 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 873 12 6 13 7.0 Nc1sc(-c2ccc(C(=O)NCCCC#Cc3ccc(Nc4ncnc5c4ncn5[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)cc3)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
CHEMBL5194272 191641 None 0 Human Functional pEC50 = 6.5 6.5 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 873 12 6 13 7.0 Nc1sc(-c2ccc(C(=O)NCCCC#Cc3ccc(Nc4ncnc5c4ncn5[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)cc3)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
10340281 79311 None 0 Rat Functional pEC50 = 6.5 6.5 - 1
Negative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atriaNegative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atria
ChEMBL 389 4 4 10 -1.9 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(C#CCN(C)C)nc32)[C@H](O)[C@@H]1O 10.1021/jm00037a024
CHEMBL2113482 79311 None 0 Rat Functional pEC50 = 6.5 6.5 - 1
Negative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atriaNegative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atria
ChEMBL 389 4 4 10 -1.9 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(C#CCN(C)C)nc32)[C@H](O)[C@@H]1O 10.1021/jm00037a024
2844 283 None 61 Guinea pig Functional pEC50 = 5.5 5.5 -38 5
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparation
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm00108a015
60961 283 None 61 Guinea pig Functional pEC50 = 5.5 5.5 -38 5
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparation
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm00108a015
60961.0 283 None 61 Guinea pig Functional pEC50 = 5.5 5.5 -38 5
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparation
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm00108a015
90 283 None 61 Guinea pig Functional pEC50 = 5.5 5.5 -38 5
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparation
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm00108a015
CHEMBL477 283 None 61 Guinea pig Functional pEC50 = 5.5 5.5 -38 5
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparation
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm00108a015
DB00640 283 None 61 Guinea pig Functional pEC50 = 5.5 5.5 -38 5
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparation
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm00108a015
2844 283 None 61 Guinea pig Functional pEC50 = 5.5 5.5 -38 5
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm00108a014
60961 283 None 61 Guinea pig Functional pEC50 = 5.5 5.5 -38 5
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm00108a014
60961.0 283 None 61 Guinea pig Functional pEC50 = 5.5 5.5 -38 5
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm00108a014
90 283 None 61 Guinea pig Functional pEC50 = 5.5 5.5 -38 5
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm00108a014
CHEMBL477 283 None 61 Guinea pig Functional pEC50 = 5.5 5.5 -38 5
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm00108a014
DB00640 283 None 61 Guinea pig Functional pEC50 = 5.5 5.5 -38 5
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm00108a014
10254700 205984 None 5 Rat Functional pEC50 = 6.5 6.5 -18 3
Stimulation of [35S]GTP-gamma-S, binding to adenosine A1 receptor of rat cerebral cortical membraneStimulation of [35S]GTP-gamma-S, binding to adenosine A1 receptor of rat cerebral cortical membrane
ChEMBL 483 5 4 9 0.7 OC[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)ncnc32)[C@H](O)[C@@H]1O 10.1021/jm9905965
CHEMBL66393 205984 None 5 Rat Functional pEC50 = 6.5 6.5 -18 3
Stimulation of [35S]GTP-gamma-S, binding to adenosine A1 receptor of rat cerebral cortical membraneStimulation of [35S]GTP-gamma-S, binding to adenosine A1 receptor of rat cerebral cortical membrane
ChEMBL 483 5 4 9 0.7 OC[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)ncnc32)[C@H](O)[C@@H]1O 10.1021/jm9905965
137641990 158171 None 0 Human Functional pEC50 = 6.5 6.5 -6 4
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATP
ChEMBL 447 6 3 13 0.7 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NCc5ccco5)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b00291
CHEMBL4086325 158171 None 0 Human Functional pEC50 = 6.5 6.5 -6 4
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATP
ChEMBL 447 6 3 13 0.7 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NCc5ccco5)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b00291
44398927 11785 None 0 Human Functional pEC50 = 4.5 4.5 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 278 1 1 3 4.3 Cc1ccccc1-c1ccc2c(c1)Cc1sc(N)nc1-2 10.1021/jm049132j
CHEMBL1181740 11785 None 0 Human Functional pEC50 = 4.5 4.5 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 278 1 1 3 4.3 Cc1ccccc1-c1ccc2c(c1)Cc1sc(N)nc1-2 10.1021/jm049132j
CHEMBL190588 11785 None 0 Human Functional pEC50 = 4.5 4.5 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 278 1 1 3 4.3 Cc1ccccc1-c1ccc2c(c1)Cc1sc(N)nc1-2 10.1021/jm049132j
46874359 204115 None 0 Guinea pig Functional pEC50 = 4.5 4.5 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparation
ChEMBL 405 6 4 10 -0.2 Nc1nc(OCCc2cccc(F)c2)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a015
CHEMBL606081 204115 None 0 Guinea pig Functional pEC50 = 4.5 4.5 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparation
ChEMBL 405 6 4 10 -0.2 Nc1nc(OCCc2cccc(F)c2)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a015
46874357 204084 None 0 Guinea pig Functional pEC50 = 4.5 4.5 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparation
ChEMBL 405 6 4 10 -0.2 Nc1nc(OCCc2ccccc2F)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a015
CHEMBL605876 204084 None 0 Guinea pig Functional pEC50 = 4.5 4.5 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparation
ChEMBL 405 6 4 10 -0.2 Nc1nc(OCCc2ccccc2F)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a015
46874380 203974 None 0 Guinea pig Functional pEC50 = 4.5 4.5 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 417 7 4 11 -0.4 COc1ccccc1CCOc1nc(N)c2ncn(C3O[C@@H](CO)[C@H](O)[C@@H]3O)c2n1 10.1021/jm00108a015
CHEMBL605250 203974 None 0 Guinea pig Functional pEC50 = 4.5 4.5 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 417 7 4 11 -0.4 COc1ccccc1CCOc1nc(N)c2ncn(C3O[C@@H](CO)[C@H](O)[C@@H]3O)c2n1 10.1021/jm00108a015
46874425 203739 None 0 Guinea pig Functional pEC50 = 4.5 4.5 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 367 7 4 10 -0.2 CCC(CC)COc1nc(N)c2ncn(C3O[C@@H](CO)[C@H](O)[C@@H]3O)c2n1 10.1021/jm00108a014
CHEMBL604009 203739 None 0 Guinea pig Functional pEC50 = 4.5 4.5 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 367 7 4 10 -0.2 CCC(CC)COc1nc(N)c2ncn(C3O[C@@H](CO)[C@H](O)[C@@H]3O)c2n1 10.1021/jm00108a014
46874569 203816 None 0 Rat Functional pEC50 = 6.5 6.5 1 2
Functional activity against adenosine A1 receptor from rat atria.Functional activity against adenosine A1 receptor from rat atria.
ChEMBL 431 4 4 11 -2.2 CCNC(=O)[C@H]1OC(n2cnc3c(N)nc(C#CCN4CCOCC4)nc32)[C@H](O)[C@@H]1O 10.1021/jm00009a007
CHEMBL604440 203816 None 0 Rat Functional pEC50 = 6.5 6.5 1 2
Functional activity against adenosine A1 receptor from rat atria.Functional activity against adenosine A1 receptor from rat atria.
ChEMBL 431 4 4 11 -2.2 CCNC(=O)[C@H]1OC(n2cnc3c(N)nc(C#CCN4CCOCC4)nc32)[C@H](O)[C@@H]1O 10.1021/jm00009a007
44398653 11782 None 0 Human Functional pEC50 = 4.4 4.4 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 280 1 2 4 3.7 Nc1nc2c(s1)Cc1cc(-c3ccc(O)cc3)ccc1-2 10.1021/jm049132j
CHEMBL1181723 11782 None 0 Human Functional pEC50 = 4.4 4.4 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 280 1 2 4 3.7 Nc1nc2c(s1)Cc1cc(-c3ccc(O)cc3)ccc1-2 10.1021/jm049132j
CHEMBL190122 11782 None 0 Human Functional pEC50 = 4.4 4.4 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 280 1 2 4 3.7 Nc1nc2c(s1)Cc1cc(-c3ccc(O)cc3)ccc1-2 10.1021/jm049132j
44398701 12287 None 0 Human Functional pEC50 = 4.4 4.4 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 280 1 2 4 3.7 Nc1nc2c(s1)Cc1cc(-c3cccc(O)c3)ccc1-2 10.1021/jm049132j
CHEMBL1184840 12287 None 0 Human Functional pEC50 = 4.4 4.4 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 280 1 2 4 3.7 Nc1nc2c(s1)Cc1cc(-c3cccc(O)c3)ccc1-2 10.1021/jm049132j
CHEMBL372490 12287 None 0 Human Functional pEC50 = 4.4 4.4 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 280 1 2 4 3.7 Nc1nc2c(s1)Cc1cc(-c3cccc(O)c3)ccc1-2 10.1021/jm049132j
10664838 63255 None 0 Rat Functional pEC50 = 5.4 5.4 - 1
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 339 4 3 8 1.1 OC[C@H]1O[C@@H](n2cnc3c(NC4CCC4)nc(Cl)nc32)C[C@@H]1O 10.1021/jm9911231
CHEMBL1790737 63255 None 0 Rat Functional pEC50 = 5.4 5.4 - 1
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 339 4 3 8 1.1 OC[C@H]1O[C@@H](n2cnc3c(NC4CCC4)nc(Cl)nc32)C[C@@H]1O 10.1021/jm9911231
46874383 203975 None 0 Guinea pig Functional pEC50 = 5.4 5.4 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 407 7 4 10 0.8 Nc1nc(OCCCC2CCCCC2)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a014
CHEMBL605254 203975 None 0 Guinea pig Functional pEC50 = 5.4 5.4 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 407 7 4 10 0.8 Nc1nc(OCCCC2CCCCC2)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a014
46874479 203628 None 0 Guinea pig Functional pEC50 = 4.4 4.4 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 339 6 4 10 -0.8 CCCCOc1nc(N)c2ncn(C3O[C@@H](CO)[C@H](O)[C@@H]3O)c2n1 10.1021/jm00108a014
CHEMBL603379 203628 None 0 Guinea pig Functional pEC50 = 4.4 4.4 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 339 6 4 10 -0.8 CCCCOc1nc(N)c2ncn(C3O[C@@H](CO)[C@H](O)[C@@H]3O)c2n1 10.1021/jm00108a014
137646655 157718 None 0 Human Functional pEC50 = 7.4 7.4 4 4
Agonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assayAgonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assay
ChEMBL 711 13 6 12 4.8 Nc1cc(-c2cccc(C(F)(F)F)c2)c(-c2ccc(C(=O)NCCCCCCNc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc2)s1 10.1021/acs.jmedchem.8b00047
CHEMBL4081224 157718 None 0 Human Functional pEC50 = 7.4 7.4 4 4
Agonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assayAgonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assay
ChEMBL 711 13 6 12 4.8 Nc1cc(-c2cccc(C(F)(F)F)c2)c(-c2ccc(C(=O)NCCCCCCNc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc2)s1 10.1021/acs.jmedchem.8b00047
16389231 196198 None 3 Human Functional pEC50 = 7.4 7.4 1 2
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 289 2 1 4 3.5 N#CC1(C(=O)Nc2nc3ccc(F)cc3s2)CCCC1 10.1016/j.ejmech.2023.115419
CHEMBL5418682 196198 None 3 Human Functional pEC50 = 7.4 7.4 1 2
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay (Rvb = 8.74 +/- 0.08 No_unit)
ChEMBL 289 2 1 4 3.5 N#CC1(C(=O)Nc2nc3ccc(F)cc3s2)CCCC1 10.1016/j.ejmech.2023.115419
10620597 79295 None 0 Rat Functional pEC50 = 6.4 6.4 - 1
Effective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranesEffective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranes
ChEMBL 393 7 3 9 1.9 CCCSC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)[C@H](O)[C@@H]1O 10.1021/jm970508l
CHEMBL2113467 79295 None 0 Rat Functional pEC50 = 6.4 6.4 - 1
Effective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranesEffective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranes
ChEMBL 393 7 3 9 1.9 CCCSC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)[C@H](O)[C@@H]1O 10.1021/jm970508l
46203501 8008 None 1 Human Functional pEC50 = 6.4 6.4 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation countingAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting
ChEMBL 809 17 5 14 6.5 Nc1sc2c(c1C(=O)c1ccc(Cl)c(Cl)c1)CCN(CCCCCCCCCOc1ccc(Nc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc1)C2 10.1021/jm901252a
CHEMBL1090687 8008 None 1 Human Functional pEC50 = 6.4 6.4 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation countingAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting
ChEMBL 809 17 5 14 6.5 Nc1sc2c(c1C(=O)c1ccc(Cl)c(Cl)c1)CCN(CCCCCCCCCOc1ccc(Nc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc1)C2 10.1021/jm901252a
2844 283 None 61 Human Functional pEC50 = 7.4 7.4 1 5
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm3004834
60961 283 None 61 Human Functional pEC50 = 7.4 7.4 1 5
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm3004834
60961.0 283 None 61 Human Functional pEC50 = 7.4 7.4 1 5
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm3004834
90 283 None 61 Human Functional pEC50 = 7.4 7.4 1 5
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm3004834
CHEMBL477 283 None 61 Human Functional pEC50 = 7.4 7.4 1 5
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm3004834
DB00640 283 None 61 Human Functional pEC50 = 7.4 7.4 1 5
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm3004834
168285469 191758 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 466 7 4 11 0.9 N#Cc1ccc(CO[C@@H]2CCC[C@H]2Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1 10.1021/acs.jmedchem.2c01414
CHEMBL5196040 191758 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 466 7 4 11 0.9 N#Cc1ccc(CO[C@@H]2CCC[C@H]2Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1 10.1021/acs.jmedchem.2c01414
76329265 106116 None 0 Human Functional pEC50 = 7.4 7.4 -2 4
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 377 4 5 10 -0.9 CNC(=O)[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)nc(N)nc32)[C@H](O)[C@@H]1O 10.1039/C3MD00364G
CHEMBL3133158 106116 None 0 Human Functional pEC50 = 7.4 7.4 -2 4
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 377 4 5 10 -0.9 CNC(=O)[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)nc(N)nc32)[C@H](O)[C@@H]1O 10.1039/C3MD00364G
46203501 8008 None 1 Human Functional pEC50 = 6.4 6.4 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation countingAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting
ChEMBL 809 17 5 14 6.5 Nc1sc2c(c1C(=O)c1ccc(Cl)c(Cl)c1)CCN(CCCCCCCCCOc1ccc(Nc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc1)C2 10.1021/jm901252a
CHEMBL1090687 8008 None 1 Human Functional pEC50 = 6.4 6.4 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation countingAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting
ChEMBL 809 17 5 14 6.5 Nc1sc2c(c1C(=O)c1ccc(Cl)c(Cl)c1)CCN(CCCCCCCCCOc1ccc(Nc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc1)C2 10.1021/jm901252a
76322076 106104 None 0 Human Functional pEC50 = 6.4 6.4 -79 4
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 489 7 5 10 1.0 CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(N)nc32)[C@H](O)[C@@H]1O 10.1039/C3MD00364G
CHEMBL3133080 106104 None 0 Human Functional pEC50 = 6.4 6.4 -79 4
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 489 7 5 10 1.0 CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(N)nc32)[C@H](O)[C@@H]1O 10.1039/C3MD00364G
76314797 106105 None 0 Human Functional pEC50 = 6.4 6.4 -3 3
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 391 5 5 10 -0.4 CNC(=O)[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)nc(NC)nc32)[C@H](O)[C@@H]1O 10.1039/C3MD00364G
CHEMBL3133081 106105 None 0 Human Functional pEC50 = 6.4 6.4 -3 3
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 391 5 5 10 -0.4 CNC(=O)[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)nc(NC)nc32)[C@H](O)[C@@H]1O 10.1039/C3MD00364G
21591949 188481 None 0 Rat Functional pEC50 = 5.4 5.4 - 1
Agonist activity at adenosine A1 receptor in rat cortical membrane by [35S]GTPgammaS binding assayAgonist activity at adenosine A1 receptor in rat cortical membrane by [35S]GTPgammaS binding assay
ChEMBL 862 16 13 22 -5.1 COc1cc([C@H]2OC[C@](O)(Cc3ccc(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)c(OC)c3)[C@@H]2COC[C@H]2O[C@@](CO)(O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@@H]2O)ccc1O 10.1021/np010464q
CHEMBL501388 188481 None 0 Rat Functional pEC50 = 5.4 5.4 - 1
Agonist activity at adenosine A1 receptor in rat cortical membrane by [35S]GTPgammaS binding assayAgonist activity at adenosine A1 receptor in rat cortical membrane by [35S]GTPgammaS binding assay
ChEMBL 862 16 13 22 -5.1 COc1cc([C@H]2OC[C@](O)(Cc3ccc(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)c(OC)c3)[C@@H]2COC[C@H]2O[C@@](CO)(O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@@H]2O)ccc1O 10.1021/np010464q
76332919 106111 None 0 Human Functional pEC50 = 5.4 5.4 -794 3
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 323 3 5 10 -2.2 CNC(=O)[C@H]1O[C@@H](n2cnc3c(NC)nc(N)nc32)[C@H](O)[C@@H]1O 10.1039/C3MD00364G
CHEMBL3133153 106111 None 0 Human Functional pEC50 = 5.4 5.4 -794 3
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 323 3 5 10 -2.2 CNC(=O)[C@H]1O[C@@H](n2cnc3c(NC)nc(N)nc32)[C@H](O)[C@@H]1O 10.1039/C3MD00364G
46876053 204985 None 0 Guinea pig Functional pEC50 = 4.4 4.4 -53 2
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 399 5 5 11 -0.2 Cc1ccc(/C=N/Nc2nc(N)c3ncn(C4O[C@H](CO)[C@@H](O)[C@H]4O)c3n2)cc1 10.1021/jm00102a008
CHEMBL611571 204985 None 0 Guinea pig Functional pEC50 = 4.4 4.4 -53 2
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 399 5 5 11 -0.2 Cc1ccc(/C=N/Nc2nc(N)c3ncn(C4O[C@H](CO)[C@@H](O)[C@H]4O)c3n2)cc1 10.1021/jm00102a008
380 1287 None 37 Human Functional pEC50 = 8.4 8.4 6 5
Stimulation of [35S]GTP-gamma-S, binding to human adenosine A1 receptorStimulation of [35S]GTP-gamma-S, binding to human adenosine A1 receptor
ChEMBL 335 4 4 9 -0.2 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NC1CCCC1 10.1021/jm9905965
657378 1287 None 37 Human Functional pEC50 = 8.4 8.4 6 5
Stimulation of [35S]GTP-gamma-S, binding to human adenosine A1 receptorStimulation of [35S]GTP-gamma-S, binding to human adenosine A1 receptor
ChEMBL 335 4 4 9 -0.2 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NC1CCCC1 10.1021/jm9905965
CHEMBL68738 1287 None 37 Human Functional pEC50 = 8.4 8.4 6 5
Stimulation of [35S]GTP-gamma-S, binding to human adenosine A1 receptorStimulation of [35S]GTP-gamma-S, binding to human adenosine A1 receptor
ChEMBL 335 4 4 9 -0.2 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NC1CCCC1 10.1021/jm9905965
155559070 174923 None 0 Human Functional pEC50 = 8.4 8.4 - 1
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 390 5 1 8 3.7 COC(=O)c1cccc(CSc2nc(N)c(C#N)c(-c3ccoc3)c2C#N)c1 10.1021/acs.jmedchem.9b00106
CHEMBL4562453 174923 None 0 Human Functional pEC50 = 8.4 8.4 - 1
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 390 5 1 8 3.7 COC(=O)c1cccc(CSc2nc(N)c(C#N)c(-c3ccoc3)c2C#N)c1 10.1021/acs.jmedchem.9b00106
46886345 8481 None 0 Human Functional pEC50 = 8.3 8.3 -4 3
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation in presence of 10 uM allosteric modulator PD-81723Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation in presence of 10 uM allosteric modulator PD-81723
ChEMBL 373 5 4 10 0.2 COc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1 10.1021/jm901252a
CHEMBL1093910 8481 None 0 Human Functional pEC50 = 8.3 8.3 -4 3
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation in presence of 10 uM allosteric modulator PD-81723Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation in presence of 10 uM allosteric modulator PD-81723
ChEMBL 373 5 4 10 0.2 COc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1 10.1021/jm901252a
123807 871 None 35 Human Functional pEC50 = 8.3 8.3 1 7
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 369 4 4 9 0.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1 10.1021/jm3004834
374 871 None 35 Human Functional pEC50 = 8.3 8.3 1 7
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 369 4 4 9 0.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1 10.1021/jm3004834
379 871 None 35 Human Functional pEC50 = 8.3 8.3 1 7
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 369 4 4 9 0.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1 10.1021/jm3004834
CHEMBL284969 871 None 35 Human Functional pEC50 = 8.3 8.3 1 7
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 369 4 4 9 0.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1 10.1021/jm3004834
90654616 110080 None 0 Human Functional pEC50 = 8.3 8.3 - 1
Agonist activity human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by radioligand addition measured after 90 mins by beta scintillation counting analysisAgonist activity human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by radioligand addition measured after 90 mins by beta scintillation counting analysis
ChEMBL 523 5 1 9 5.5 N#Cc1c(N)nc(SCc2csc(-c3ccc(Br)cc3)n2)nc1-c1ccc2c(c1)OCO2 10.1021/jm401643m
CHEMBL3234954 110080 None 0 Human Functional pEC50 = 8.3 8.3 - 1
Agonist activity human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by radioligand addition measured after 90 mins by beta scintillation counting analysisAgonist activity human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by radioligand addition measured after 90 mins by beta scintillation counting analysis
ChEMBL 523 5 1 9 5.5 N#Cc1c(N)nc(SCc2csc(-c3ccc(Br)cc3)n2)nc1-c1ccc2c(c1)OCO2 10.1021/jm401643m
90654623 110087 None 0 Human Functional pEC50 = 8.3 8.3 - 1
Agonist activity human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by radioligand addition measured after 90 mins by beta scintillation counting analysisAgonist activity human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by radioligand addition measured after 90 mins by beta scintillation counting analysis
ChEMBL 445 5 1 9 4.7 N#Cc1c(N)nc(SCc2csc(-c3ccccc3)n2)nc1-c1ccc2c(c1)OCO2 10.1021/jm401643m
CHEMBL3234962 110087 None 0 Human Functional pEC50 = 8.3 8.3 - 1
Agonist activity human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by radioligand addition measured after 90 mins by beta scintillation counting analysisAgonist activity human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by radioligand addition measured after 90 mins by beta scintillation counting analysis
ChEMBL 445 5 1 9 4.7 N#Cc1c(N)nc(SCc2csc(-c3ccccc3)n2)nc1-c1ccc2c(c1)OCO2 10.1021/jm401643m
118732976 118581 None 0 Human Functional pEC50 = 8.3 8.3 1 4
Agonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activityAgonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activity
ChEMBL 427 5 3 12 0.4 CCn1nnc([C@H]2O[C@@H](n3cnc4c(N[C@H]5C[C@@H]6CC[C@@H]5C6)ncnc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.5b00074
CHEMBL3414942 118581 None 0 Human Functional pEC50 = 8.3 8.3 1 4
Agonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activityAgonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activity
ChEMBL 427 5 3 12 0.4 CCn1nnc([C@H]2O[C@@H](n3cnc4c(N[C@H]5C[C@@H]6CC[C@@H]5C6)ncnc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.5b00074
155542520 173239 None 0 Human Functional pEC50 = 8.3 8.3 - 1
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 357 4 1 7 3.8 N#Cc1cccc(CSc2nc(N)c(C#N)c(-c3ccco3)c2C#N)c1 10.1021/acs.jmedchem.9b00106
CHEMBL4521115 173239 None 0 Human Functional pEC50 = 8.3 8.3 - 1
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 357 4 1 7 3.8 N#Cc1cccc(CSc2nc(N)c(C#N)c(-c3ccco3)c2C#N)c1 10.1021/acs.jmedchem.9b00106
377 2758 None 42 Human Functional pEC50 = 8.3 8.3 3 10
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.2c00320
425 2758 None 42 Human Functional pEC50 = 8.3 8.3 3 10
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.2c00320
448222 2758 None 42 Human Functional pEC50 = 8.3 8.3 3 10
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.2c00320
CHEMBL464859 2758 None 42 Human Functional pEC50 = 8.3 8.3 3 10
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.2c00320
90654607 110071 None 0 Human Functional pEC50 = 8.3 8.3 - 1
Agonist activity human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by radioligand addition measured after 90 mins by beta scintillation counting analysisAgonist activity human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by radioligand addition measured after 90 mins by beta scintillation counting analysis
ChEMBL 479 5 1 9 5.4 N#Cc1c(N)nc(SCc2csc(-c3ccc(Cl)cc3)n2)nc1-c1ccc2c(c1)OCO2 10.1021/jm401643m
CHEMBL3234945 110071 None 0 Human Functional pEC50 = 8.3 8.3 - 1
Agonist activity human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by radioligand addition measured after 90 mins by beta scintillation counting analysisAgonist activity human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by radioligand addition measured after 90 mins by beta scintillation counting analysis
ChEMBL 479 5 1 9 5.4 N#Cc1c(N)nc(SCc2csc(-c3ccc(Cl)cc3)n2)nc1-c1ccc2c(c1)OCO2 10.1021/jm401643m
155554464 174706 None 0 Human Functional pEC50 = 8.3 8.3 4 3
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 362 5 2 7 3.5 N#Cc1c(N)nc(SCc2cccc(CO)c2)c(C#N)c1-c1ccco1 10.1021/acs.jmedchem.9b00106
CHEMBL4557250 174706 None 0 Human Functional pEC50 = 8.3 8.3 4 3
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 362 5 2 7 3.5 N#Cc1c(N)nc(SCc2cccc(CO)c2)c(C#N)c1-c1ccco1 10.1021/acs.jmedchem.9b00106
70695812 73309 None 0 Human Functional pEC50 = 7.4 7.4 -6 3
Agonist activity at human recombinant adenosine receptor-1 expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production preincubated for 45 mins prior forskolin-induction measured after 15 mins by immunoassayAgonist activity at human recombinant adenosine receptor-1 expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production preincubated for 45 mins prior forskolin-induction measured after 15 mins by immunoassay
ChEMBL 375 5 3 7 2.0 O[C@@H]1[C@H](O)[C@@H]2C[C@@H]2[C@H]1n1cnc2c(NC(C3CC3)C3CC3)nc(Cl)nc21 10.1021/ml200114q
CHEMBL2012686 73309 None 0 Human Functional pEC50 = 7.4 7.4 -6 3
Agonist activity at human recombinant adenosine receptor-1 expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production preincubated for 45 mins prior forskolin-induction measured after 15 mins by immunoassayAgonist activity at human recombinant adenosine receptor-1 expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production preincubated for 45 mins prior forskolin-induction measured after 15 mins by immunoassay
ChEMBL 375 5 3 7 2.0 O[C@@H]1[C@H](O)[C@@H]2C[C@@H]2[C@H]1n1cnc2c(NC(C3CC3)C3CC3)nc(Cl)nc21 10.1021/ml200114q
168275648 190205 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 500 6 5 10 1.0 O=C(NCC#Cc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1)c1ccccc1 10.1021/acs.jmedchem.2c00320
CHEMBL5172823 190205 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 500 6 5 10 1.0 O=C(NCC#Cc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1)c1ccccc1 10.1021/acs.jmedchem.2c00320
168276791 190804 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 519 7 4 10 1.8 OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4OCc4ccc(Br)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
CHEMBL5182056 190804 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 519 7 4 10 1.8 OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4OCc4ccc(Br)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
464380 79217 None 5 Rat Functional pEC50 = 6.4 6.4 - 1
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 368 4 4 8 1.1 OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)cc(Cl)nc32)[C@H](O)[C@@H]1O 10.1021/jm9911231
CHEMBL2113390 79217 None 5 Rat Functional pEC50 = 6.4 6.4 - 1
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 368 4 4 8 1.1 OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)cc(Cl)nc32)[C@H](O)[C@@H]1O 10.1021/jm9911231
158795 3770 None 33 Guinea pig Functional pEC50 = 7.4 7.4 -5 2
Agonistic activity against adenosine A1 receptor in guinea pig isolated heartsAgonistic activity against adenosine A1 receptor in guinea pig isolated hearts
ChEMBL 337 4 4 10 -1.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N[C@H]1COCC1 10.1016/j.bmcl.2004.04.096
5592 3770 None 33 Guinea pig Functional pEC50 = 7.4 7.4 -5 2
Agonistic activity against adenosine A1 receptor in guinea pig isolated heartsAgonistic activity against adenosine A1 receptor in guinea pig isolated hearts
ChEMBL 337 4 4 10 -1.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N[C@H]1COCC1 10.1016/j.bmcl.2004.04.096
CHEMBL392149 3770 None 33 Guinea pig Functional pEC50 = 7.4 7.4 -5 2
Agonistic activity against adenosine A1 receptor in guinea pig isolated heartsAgonistic activity against adenosine A1 receptor in guinea pig isolated hearts
ChEMBL 337 4 4 10 -1.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N[C@H]1COCC1 10.1016/j.bmcl.2004.04.096
DB04954 3770 None 33 Guinea pig Functional pEC50 = 7.4 7.4 -5 2
Agonistic activity against adenosine A1 receptor in guinea pig isolated heartsAgonistic activity against adenosine A1 receptor in guinea pig isolated hearts
ChEMBL 337 4 4 10 -1.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N[C@H]1COCC1 10.1016/j.bmcl.2004.04.096
137650918 157337 None 0 Human Functional pEC50 = 7.4 7.4 6 4
Agonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assayAgonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assay
ChEMBL 671 14 6 13 3.4 Nc1sc(-c2ccc(C(=O)NCCCCCCNc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc2)cc1C(=O)c1ccccc1 10.1021/acs.jmedchem.8b00047
CHEMBL4076495 157337 None 0 Human Functional pEC50 = 7.4 7.4 6 4
Agonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assayAgonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assay
ChEMBL 671 14 6 13 3.4 Nc1sc(-c2ccc(C(=O)NCCCCCCNc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc2)cc1C(=O)c1ccccc1 10.1021/acs.jmedchem.8b00047
46874622 203704 None 0 Rat Functional pEC50 = 6.4 6.4 1 2
Functional activity against adenosine A1 receptor from rat atria.Functional activity against adenosine A1 receptor from rat atria.
ChEMBL 409 3 4 10 -1.0 CCNC(=O)[C@H]1OC(n2cnc3c(N)nc(C#Cc4cccnc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm00009a007
CHEMBL603812 203704 None 0 Rat Functional pEC50 = 6.4 6.4 1 2
Functional activity against adenosine A1 receptor from rat atria.Functional activity against adenosine A1 receptor from rat atria.
ChEMBL 409 3 4 10 -1.0 CCNC(=O)[C@H]1OC(n2cnc3c(N)nc(C#Cc4cccnc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm00009a007
46876684 204456 None 0 Guinea pig Functional pEC50 = 5.4 5.4 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 417 5 5 11 -0.0 C/C(=N\Nc1nc(N)c2ncn(C3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1)c1ccc(F)cc1 10.1021/jm00102a008
CHEMBL608174 204456 None 0 Guinea pig Functional pEC50 = 5.4 5.4 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 417 5 5 11 -0.0 C/C(=N\Nc1nc(N)c2ncn(C3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1)c1ccc(F)cc1 10.1021/jm00102a008
46876686 204458 None 0 Guinea pig Functional pEC50 = 4.4 4.4 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 391 5 5 12 -0.5 Nc1nc(N/N=C/c2cccs2)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a008
CHEMBL608176 204458 None 0 Guinea pig Functional pEC50 = 4.4 4.4 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 391 5 5 12 -0.5 Nc1nc(N/N=C/c2cccs2)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a008
46876653 204494 None 0 Guinea pig Functional pEC50 = 4.4 4.4 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 403 5 5 11 -0.4 Nc1nc(N/N=C/c2ccccc2F)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a008
CHEMBL608448 204494 None 0 Guinea pig Functional pEC50 = 4.4 4.4 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 403 5 5 11 -0.4 Nc1nc(N/N=C/c2ccccc2F)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a008
46876529 205035 None 0 Guinea pig Functional pEC50 = 4.4 4.4 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 386 5 5 12 -1.1 Nc1nc(N/N=C/c2ccccn2)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a008
CHEMBL611918 205035 None 0 Guinea pig Functional pEC50 = 4.4 4.4 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 386 5 5 12 -1.1 Nc1nc(N/N=C/c2ccccn2)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a008
71657835 159831 None 4 Human Functional pEC50 = 7.4 7.4 1 4
Agonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assayAgonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assay
ChEMBL 815 15 6 13 6.1 Nc1sc(-c2ccc(C(=O)NCCCCCCNc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.8b00047
CHEMBL4104819 159831 None 4 Human Functional pEC50 = 7.4 7.4 1 4
Agonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assayAgonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assay
ChEMBL 815 15 6 13 6.1 Nc1sc(-c2ccc(C(=O)NCCCCCCNc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.8b00047
11795830 79355 None 0 Rat Functional pEC50 = 6.4 6.4 -2 2
Adenosine A1 receptor mediated negative chronotropic activity in spontaneously beating rat atriaAdenosine A1 receptor mediated negative chronotropic activity in spontaneously beating rat atria
ChEMBL 410 5 4 9 0.3 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(/C=C/c4ccccc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm960376g
CHEMBL2113526 79355 None 0 Rat Functional pEC50 = 6.4 6.4 -2 2
Adenosine A1 receptor mediated negative chronotropic activity in spontaneously beating rat atriaAdenosine A1 receptor mediated negative chronotropic activity in spontaneously beating rat atria
ChEMBL 410 5 4 9 0.3 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(/C=C/c4ccccc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm960376g
46874386 204016 None 0 Guinea pig Functional pEC50 = 4.4 4.4 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 447 8 4 12 -0.3 COc1ccc(CCOc2nc(N)c3ncn(C4O[C@@H](CO)[C@H](O)[C@@H]4O)c3n2)cc1OC 10.1021/jm00108a015
CHEMBL605465 204016 None 0 Guinea pig Functional pEC50 = 4.4 4.4 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 447 8 4 12 -0.3 COc1ccc(CCOc2nc(N)c3ncn(C4O[C@@H](CO)[C@H](O)[C@@H]4O)c3n2)cc1OC 10.1021/jm00108a015
10254700 205984 None 5 Human Functional pEC50 = 7.4 7.4 -2 3
Stimulation of [35S]GTP-gamma-S, binding to human adenosine A1 receptorStimulation of [35S]GTP-gamma-S, binding to human adenosine A1 receptor
ChEMBL 483 5 4 9 0.7 OC[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)ncnc32)[C@H](O)[C@@H]1O 10.1021/jm9905965
CHEMBL66393 205984 None 5 Human Functional pEC50 = 7.4 7.4 -2 3
Stimulation of [35S]GTP-gamma-S, binding to human adenosine A1 receptorStimulation of [35S]GTP-gamma-S, binding to human adenosine A1 receptor
ChEMBL 483 5 4 9 0.7 OC[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)ncnc32)[C@H](O)[C@@H]1O 10.1021/jm9905965
46875542 204476 None 0 Rat Functional pEC50 = 6.4 6.4 - 1
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 397 4 4 9 1.2 OC[C@H]1OC(n2cnc3c(NC4CCCCCC4)nc(Cl)nc32)[C@H](O)[C@@H]1O 10.1021/jm9911231
CHEMBL608306 204476 None 0 Rat Functional pEC50 = 6.4 6.4 - 1
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 397 4 4 9 1.2 OC[C@H]1OC(n2cnc3c(NC4CCCCCC4)nc(Cl)nc32)[C@H](O)[C@@H]1O 10.1021/jm9911231
10046591 79385 None 0 Rat Functional pEC50 = 5.4 5.4 -5 2
Activity at Adenosine A1 receptor of rat atriaActivity at Adenosine A1 receptor of rat atria
ChEMBL 401 6 5 12 -0.3 Nc1nc(N/N=C/C=C/c2ccco2)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00018a017
CHEMBL2113555 79385 None 0 Rat Functional pEC50 = 5.4 5.4 -5 2
Activity at Adenosine A1 receptor of rat atriaActivity at Adenosine A1 receptor of rat atria
ChEMBL 401 6 5 12 -0.3 Nc1nc(N/N=C/C=C/c2ccco2)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00018a017
44398749 11797 None 0 Human Functional pEC50 = 4.4 4.4 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 294 2 1 4 4.0 COc1ccccc1-c1ccc2c(c1)Cc1sc(N)nc1-2 10.1021/jm049132j
CHEMBL1181835 11797 None 0 Human Functional pEC50 = 4.4 4.4 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 294 2 1 4 4.0 COc1ccccc1-c1ccc2c(c1)Cc1sc(N)nc1-2 10.1021/jm049132j
CHEMBL193128 11797 None 0 Human Functional pEC50 = 4.4 4.4 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 294 2 1 4 4.0 COc1ccccc1-c1ccc2c(c1)Cc1sc(N)nc1-2 10.1021/jm049132j
168277169 190744 None 0 Human Functional pEC50 = 6.4 6.4 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 845 10 6 13 6.2 Nc1sc(-c2ccc(C(=O)NCC#Cc3ccc(Nc4ncnc5c4ncn5[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)cc3)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
CHEMBL5181245 190744 None 0 Human Functional pEC50 = 6.4 6.4 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 845 10 6 13 6.2 Nc1sc(-c2ccc(C(=O)NCC#Cc3ccc(Nc4ncnc5c4ncn5[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)cc3)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
46876553 204519 None 0 Guinea pig Functional pEC50 = 4.4 4.4 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 399 5 5 11 -0.2 Cc1ccccc1/C=N/Nc1nc(N)c2ncn(C3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00102a008
CHEMBL608668 204519 None 0 Guinea pig Functional pEC50 = 4.4 4.4 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 399 5 5 11 -0.2 Cc1ccccc1/C=N/Nc1nc(N)c2ncn(C3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00102a008
41211 200841 None 31 Human Functional pEC50 = 6.4 6.4 - 1
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 347 4 5 10 -1.9 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](OP(=O)(O)O)[C@H]1O 10.1021/jm3004834
CHEMBL576739 200841 None 31 Human Functional pEC50 = 6.4 6.4 - 1
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 347 4 5 10 -1.9 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](OP(=O)(O)O)[C@H]1O 10.1021/jm3004834
60194921 81670 None 0 Human Functional pEC50 = 5.4 5.4 - 1
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 443 8 3 12 1.2 COP(=O)(OC)OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)[C@H](O)[C@@H]1O 10.1021/jm3004834
CHEMBL2163559 81670 None 0 Human Functional pEC50 = 5.4 5.4 - 1
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 443 8 3 12 1.2 COP(=O)(OC)OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)[C@H](O)[C@@H]1O 10.1021/jm3004834
168278159 190469 None 0 Human Functional pEC50 = 5.4 5.4 -186 4
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assay
ChEMBL 839 15 5 15 6.6 Nc1sc(-c2ccc(-c3cn(CCCCCCNc4ncnc5c4ncn5[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)nn3)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
CHEMBL5177040 190469 None 0 Human Functional pEC50 = 5.4 5.4 -186 4
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assay
ChEMBL 839 15 5 15 6.6 Nc1sc(-c2ccc(-c3cn(CCCCCCNc4ncnc5c4ncn5[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)nn3)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
46874411 203626 None 0 Guinea pig Functional pEC50 = 5.4 5.4 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 461 7 4 11 0.4 CC1(C)C2CCC(C(=O)CCOc3nc(N)c4ncn(C5O[C@@H](CO)[C@H](O)[C@@H]5O)c4n3)C1C2 10.1021/jm00108a014
CHEMBL603373 203626 None 0 Guinea pig Functional pEC50 = 5.4 5.4 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 461 7 4 11 0.4 CC1(C)C2CCC(C(=O)CCOc3nc(N)c4ncn(C5O[C@@H](CO)[C@H](O)[C@@H]5O)c4n3)C1C2 10.1021/jm00108a014
137647420 157793 None 0 Human Functional pEC50 = 7.4 7.4 -21 4
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATP
ChEMBL 501 6 3 12 1.2 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NCc5cccc(Br)c5)ncnc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b00291
CHEMBL4081876 157793 None 0 Human Functional pEC50 = 7.4 7.4 -21 4
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATP
ChEMBL 501 6 3 12 1.2 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NCc5cccc(Br)c5)ncnc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b00291
168275881 190538 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 504 9 5 10 1.5 O=C(NCCCc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1)c1ccccc1 10.1021/acs.jmedchem.2c00320
CHEMBL5178080 190538 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 504 9 5 10 1.5 O=C(NCCCc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1)c1ccccc1 10.1021/acs.jmedchem.2c00320
46874309 203780 None 0 Guinea pig Functional pEC50 = 5.3 5.3 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparation
ChEMBL 429 9 4 10 0.8 Nc1nc(OCCCCCc2ccccc2)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a015
CHEMBL604212 203780 None 0 Guinea pig Functional pEC50 = 5.3 5.3 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparation
ChEMBL 429 9 4 10 0.8 Nc1nc(OCCCCCc2ccccc2)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a015
46874385 204015 None 0 Guinea pig Functional pEC50 = 4.3 4.3 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 353 7 4 10 -0.4 CCCCCOc1nc(N)c2ncn(C3O[C@@H](CO)[C@H](O)[C@@H]3O)c2n1 10.1021/jm00108a014
CHEMBL605464 204015 None 0 Guinea pig Functional pEC50 = 4.3 4.3 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 353 7 4 10 -0.4 CCCCCOc1nc(N)c2ncn(C3O[C@@H](CO)[C@H](O)[C@@H]3O)c2n1 10.1021/jm00108a014
46874351 204049 None 0 Guinea pig Functional pEC50 = 4.3 4.3 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparation
ChEMBL 359 4 4 10 -0.2 Nc1nc(Oc2ccccc2)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a015
CHEMBL605672 204049 None 0 Guinea pig Functional pEC50 = 4.3 4.3 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparation
ChEMBL 359 4 4 10 -0.2 Nc1nc(Oc2ccccc2)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a015
46874448 203934 None 0 Guinea pig Functional pEC50 = 4.3 4.3 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 477 9 4 13 -0.3 COc1cc(CCOc2nc(N)c3ncn(C4O[C@@H](CO)[C@H](O)[C@@H]4O)c3n2)cc(OC)c1OC 10.1021/jm00108a015
CHEMBL605048 203934 None 0 Guinea pig Functional pEC50 = 4.3 4.3 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 477 9 4 13 -0.3 COc1cc(CCOc2nc(N)c3ncn(C4O[C@@H](CO)[C@H](O)[C@@H]4O)c3n2)cc(OC)c1OC 10.1021/jm00108a015
393595 2637 None 36 Human Functional pEC50 = 7.3 7.3 -16 3
Antagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assayAntagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assay
ChEMBL 403 4 1 6 4.4 O=C(Nc1nc2ccc(cc2c2n1nc(n2)c1ccco1)Cl)Cc1ccccc1 10.1021/acsmedchemlett.2c00052
448 2637 None 36 Human Functional pEC50 = 7.3 7.3 -16 3
Antagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assayAntagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assay
ChEMBL 403 4 1 6 4.4 O=C(Nc1nc2ccc(cc2c2n1nc(n2)c1ccco1)Cl)Cc1ccccc1 10.1021/acsmedchemlett.2c00052
CHEMBL88147 2637 None 36 Human Functional pEC50 = 7.3 7.3 -16 3
Antagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assayAntagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assay
ChEMBL 403 4 1 6 4.4 O=C(Nc1nc2ccc(cc2c2n1nc(n2)c1ccco1)Cl)Cc1ccccc1 10.1021/acsmedchemlett.2c00052
10432051 79232 None 0 Rat Functional pEC50 = 6.3 6.3 - 1
Negative chronotropic activity for A1 Adenosine receptor in spontaneously beating rat atriaNegative chronotropic activity for A1 Adenosine receptor in spontaneously beating rat atria
ChEMBL 416 3 5 10 -1.2 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(C#CC4(O)CCCC4)nc32)[C@H](O)[C@@H]1O 10.1021/jm00037a024
CHEMBL2113404 79232 None 0 Rat Functional pEC50 = 6.3 6.3 - 1
Negative chronotropic activity for A1 Adenosine receptor in spontaneously beating rat atriaNegative chronotropic activity for A1 Adenosine receptor in spontaneously beating rat atria
ChEMBL 416 3 5 10 -1.2 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(C#CC4(O)CCCC4)nc32)[C@H](O)[C@@H]1O 10.1021/jm00037a024
464381 79216 None 0 Rat Functional pEC50 = 6.3 6.3 - 1
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 334 4 4 8 0.4 OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ccnc32)[C@H](O)[C@@H]1O 10.1021/jm9911231
CHEMBL2113389 79216 None 0 Rat Functional pEC50 = 6.3 6.3 - 1
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 334 4 4 8 0.4 OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ccnc32)[C@H](O)[C@@H]1O 10.1021/jm9911231
135457558 79389 None 0 Rat Functional pEC50 = 5.3 5.3 -17 2
Activity at Adenosine A1 receptor of rat atriaActivity at Adenosine A1 receptor of rat atria
ChEMBL 457 7 6 13 -0.2 COc1cc(/C=C/C=N/Nc2nc(N)c3ncn([C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)c3n2)ccc1O 10.1021/jm00018a017
CHEMBL2113559 79389 None 0 Rat Functional pEC50 = 5.3 5.3 -17 2
Activity at Adenosine A1 receptor of rat atriaActivity at Adenosine A1 receptor of rat atria
ChEMBL 457 7 6 13 -0.2 COc1cc(/C=C/C=N/Nc2nc(N)c3ncn([C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)c3n2)ccc1O 10.1021/jm00018a017
46876677 204387 None 0 Guinea pig Functional pEC50 = 4.3 4.3 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 419 5 5 11 0.1 Nc1nc(N/N=C/c2cccc(Cl)c2)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a008
CHEMBL607605 204387 None 0 Guinea pig Functional pEC50 = 4.3 4.3 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 419 5 5 11 0.1 Nc1nc(N/N=C/c2cccc(Cl)c2)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a008
46876729 204623 None 0 Guinea pig Functional pEC50 = 4.3 4.3 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 419 5 5 11 0.1 Nc1nc(N/N=C/c2ccccc2Cl)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a008
CHEMBL609338 204623 None 0 Guinea pig Functional pEC50 = 4.3 4.3 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 419 5 5 11 0.1 Nc1nc(N/N=C/c2ccccc2Cl)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a008
94136 200554 None 35 Human Functional pEC50 = 6.3 6.3 - 1
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 347 4 5 10 -1.9 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1OP(=O)(O)O 10.1021/jm3004834
CHEMBL57445 200554 None 35 Human Functional pEC50 = 6.3 6.3 - 1
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 347 4 5 10 -1.9 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1OP(=O)(O)O 10.1021/jm3004834
57524978 91302 None 0 Mouse Functional pEC50 = 6.3 6.3 -38 2
Partial agonist activity at mouse adenosine A1 receptor expressed in HEK293 cell membranes assessed as inhibition of forskolin-stimulated cAMP production preincubated for 30 mins prior to forskolin-treatment measured after 15 mins by ELISAPartial agonist activity at mouse adenosine A1 receptor expressed in HEK293 cell membranes assessed as inhibition of forskolin-stimulated cAMP production preincubated for 30 mins prior to forskolin-treatment measured after 15 mins by ELISA
ChEMBL 608 6 5 10 1.8 CNC(=O)[C@@]12C[C@@H]1[C@@H](n1cnc3c(NCc4cccc(Cl)c4)nc(C#Cc4ccc(S(=O)(=O)O)cc4)nc31)[C@H](O)[C@@H]2O 10.1021/jm4007966
CHEMBL2401954 91302 None 0 Mouse Functional pEC50 = 6.3 6.3 -38 2
Partial agonist activity at mouse adenosine A1 receptor expressed in HEK293 cell membranes assessed as inhibition of forskolin-stimulated cAMP production preincubated for 30 mins prior to forskolin-treatment measured after 15 mins by ELISAPartial agonist activity at mouse adenosine A1 receptor expressed in HEK293 cell membranes assessed as inhibition of forskolin-stimulated cAMP production preincubated for 30 mins prior to forskolin-treatment measured after 15 mins by ELISA
ChEMBL 608 6 5 10 1.8 CNC(=O)[C@@]12C[C@@H]1[C@@H](n1cnc3c(NCc4cccc(Cl)c4)nc(C#Cc4ccc(S(=O)(=O)O)cc4)nc31)[C@H](O)[C@@H]2O 10.1021/jm4007966
46886345 8481 None 0 Human Functional pEC50 = 8.3 8.3 -4 3
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation in presence of 10 uM allosteric modulator PD-81723Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation in presence of 10 uM allosteric modulator PD-81723
ChEMBL 373 5 4 10 0.2 COc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1 10.1021/jm901252a
CHEMBL1093910 8481 None 0 Human Functional pEC50 = 8.3 8.3 -4 3
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation in presence of 10 uM allosteric modulator PD-81723Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation in presence of 10 uM allosteric modulator PD-81723
ChEMBL 373 5 4 10 0.2 COc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1 10.1021/jm901252a
16109362 137892 None 0 Human Functional pEC50 = 8.3 8.3 48 2
Agonist activity at adenosine A1 receptor assessed as inhibition of forskolin-stimulated [3H]cAMP accumulation in CHO cellsAgonist activity at adenosine A1 receptor assessed as inhibition of forskolin-stimulated [3H]cAMP accumulation in CHO cells
ChEMBL 883 20 6 14 4.3 O=C(CCCCCNC(=O)COc1ccc(/C=C/C2=[N+]3C(=Cc4ccc(-c5cccs5)n4[B-]3(F)F)C=C2)cc1)NCCCCNc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm061279i
CHEMBL375965 137892 None 0 Human Functional pEC50 = 8.3 8.3 48 2
Agonist activity at adenosine A1 receptor assessed as inhibition of forskolin-stimulated [3H]cAMP accumulation in CHO cellsAgonist activity at adenosine A1 receptor assessed as inhibition of forskolin-stimulated [3H]cAMP accumulation in CHO cells
ChEMBL 883 20 6 14 4.3 O=C(CCCCCNC(=O)COc1ccc(/C=C/C2=[N+]3C(=Cc4ccc(-c5cccs5)n4[B-]3(F)F)C=C2)cc1)NCCCCNc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm061279i
168283013 190984 None 0 Human Functional pEC50 = 8.3 8.3 288 4
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 516 8 4 10 1.8 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4OCc4cccc(Cl)c4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
CHEMBL5184828 190984 None 0 Human Functional pEC50 = 8.3 8.3 288 4
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 516 8 4 10 1.8 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4OCc4cccc(Cl)c4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
71452673 78598 None 0 Guinea pig Functional pEC50 = 8.3 8.3 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 389 4 4 9 -0.2 O=C(Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)[C@H]1C[C@H]2CC[C@@H]1C2 10.1021/jm00108a014
CHEMBL2112181 78598 None 0 Guinea pig Functional pEC50 = 8.3 8.3 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 389 4 4 9 -0.2 O=C(Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)[C@H]1C[C@H]2CC[C@@H]1C2 10.1021/jm00108a014
3288 1855 None 34 Human Functional pEC50 = 8.2 8.2 - 1
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 351 4 5 10 -1.2 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N[C@H]1CCC[C@@H]1O 10.1021/jm3004834
9884817 1855 None 34 Human Functional pEC50 = 8.2 8.2 - 1
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 351 4 5 10 -1.2 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N[C@H]1CCC[C@@H]1O 10.1021/jm3004834
CHEMBL2163568 1855 None 34 Human Functional pEC50 = 8.2 8.2 - 1
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 351 4 5 10 -1.2 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N[C@H]1CCC[C@@H]1O 10.1021/jm3004834
6083 207273 None 55 Human Functional pEC50 = 6.3 6.3 1 7
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 347 4 5 10 -1.9 Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O 10.1021/jm3004834
CHEMBL1315633 207273 None 55 Human Functional pEC50 = 6.3 6.3 1 7
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 347 4 5 10 -1.9 Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O 10.1021/jm3004834
CHEMBL752 207273 None 55 Human Functional pEC50 = 6.3 6.3 1 7
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 347 4 5 10 -1.9 Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O 10.1021/jm3004834
3086599 904 None 36 Human Functional pEC50 = 6.3 6.3 -69 6
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 499 10 6 11 -0.2 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(NCCc1ccc(cc1)CCC(=O)O)nc2N 10.1039/C3MD00364G
375 904 None 36 Human Functional pEC50 = 6.3 6.3 -69 6
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 499 10 6 11 -0.2 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(NCCc1ccc(cc1)CCC(=O)O)nc2N 10.1039/C3MD00364G
424 904 None 36 Human Functional pEC50 = 6.3 6.3 -69 6
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 499 10 6 11 -0.2 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(NCCc1ccc(cc1)CCC(=O)O)nc2N 10.1039/C3MD00364G
CHEMBL331372 904 None 36 Human Functional pEC50 = 6.3 6.3 -69 6
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 499 10 6 11 -0.2 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(NCCc1ccc(cc1)CCC(=O)O)nc2N 10.1039/C3MD00364G
76329264 106109 None 0 Human Functional pEC50 = 6.3 6.3 -12 3
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 405 6 5 10 -0.0 CCNc1nc(NC2CCCC2)c2ncn([C@@H]3O[C@H](C(=O)NC)[C@@H](O)[C@H]3O)c2n1 10.1039/C3MD00364G
CHEMBL3133151 106109 None 0 Human Functional pEC50 = 6.3 6.3 -12 3
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 405 6 5 10 -0.0 CCNc1nc(NC2CCCC2)c2ncn([C@@H]3O[C@H](C(=O)NC)[C@@H](O)[C@H]3O)c2n1 10.1039/C3MD00364G
46874389 204050 None 0 Guinea pig Functional pEC50 = 4.3 4.3 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 379 5 4 10 -0.0 Nc1nc(OCC2CCCCC2)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a014
CHEMBL605673 204050 None 0 Guinea pig Functional pEC50 = 4.3 4.3 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 379 5 4 10 -0.0 Nc1nc(OCC2CCCCC2)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a014
46203193 8004 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting in presence of 10 uM allosteric modulator PD-81723Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting in presence of 10 uM allosteric modulator PD-81723
ChEMBL 753 13 5 14 5.0 Nc1sc2c(c1C(=O)c1ccc(Cl)c(Cl)c1)CCN(CCCCCOc1ccc(Nc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc1)C2 10.1021/jm901252a
CHEMBL1090683 8004 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting in presence of 10 uM allosteric modulator PD-81723Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting in presence of 10 uM allosteric modulator PD-81723
ChEMBL 753 13 5 14 5.0 Nc1sc2c(c1C(=O)c1ccc(Cl)c(Cl)c1)CCN(CCCCCOc1ccc(Nc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc1)C2 10.1021/jm901252a
10335251 63253 None 0 Rat Functional pEC50 = 5.3 5.3 - 1
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 305 4 3 8 0.4 OC[C@H]1O[C@@H](n2cnc3c(NC4CCC4)ncnc32)C[C@@H]1O 10.1021/jm9911231
CHEMBL1790735 63253 None 0 Rat Functional pEC50 = 5.3 5.3 - 1
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 305 4 3 8 0.4 OC[C@H]1O[C@@H](n2cnc3c(NC4CCC4)ncnc32)C[C@@H]1O 10.1021/jm9911231
46203193 8004 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting in presence of 10 uM allosteric modulator PD-81723Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting in presence of 10 uM allosteric modulator PD-81723
ChEMBL 753 13 5 14 5.0 Nc1sc2c(c1C(=O)c1ccc(Cl)c(Cl)c1)CCN(CCCCCOc1ccc(Nc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc1)C2 10.1021/jm901252a
CHEMBL1090683 8004 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting in presence of 10 uM allosteric modulator PD-81723Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding by scintillation counting in presence of 10 uM allosteric modulator PD-81723
ChEMBL 753 13 5 14 5.0 Nc1sc2c(c1C(=O)c1ccc(Cl)c(Cl)c1)CCN(CCCCCOc1ccc(Nc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc1)C2 10.1021/jm901252a
56935713 81672 None 0 Human Functional pEC50 = 6.3 6.3 - 1
Agonist activity at human A1AR assessed as induction of Ca2+ ion mobilization by orthogonal functional assayAgonist activity at human A1AR assessed as induction of Ca2+ ion mobilization by orthogonal functional assay
ChEMBL 477 8 3 12 1.9 COP(=O)(OC)OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)nc(Cl)nc32)[C@H](O)[C@@H]1O 10.1021/jm3004834
CHEMBL2163561 81672 None 0 Human Functional pEC50 = 6.3 6.3 - 1
Agonist activity at human A1AR assessed as induction of Ca2+ ion mobilization by orthogonal functional assayAgonist activity at human A1AR assessed as induction of Ca2+ ion mobilization by orthogonal functional assay
ChEMBL 477 8 3 12 1.9 COP(=O)(OC)OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)nc(Cl)nc32)[C@H](O)[C@@H]1O 10.1021/jm3004834
168290627 192112 None 0 Human Functional pEC50 = 6.3 6.3 -6 4
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 859 11 6 13 6.6 Nc1sc(-c2ccc(C(=O)NCCC#Cc3ccc(Nc4ncnc5c4ncn5[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)cc3)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
CHEMBL5201533 192112 None 0 Human Functional pEC50 = 6.3 6.3 -6 4
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 859 11 6 13 6.6 Nc1sc(-c2ccc(C(=O)NCCC#Cc3ccc(Nc4ncnc5c4ncn5[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)cc3)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
60194917 81674 None 0 Human Functional pEC50 = 6.3 6.3 - 1
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 619 14 5 14 0.9 CCOC(=O)CNP(=O)(NCC(=O)OCC)OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)nc(Cl)nc32)[C@H](O)[C@@H]1O 10.1021/jm3004834
CHEMBL2163564 81674 None 0 Human Functional pEC50 = 6.3 6.3 - 1
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 619 14 5 14 0.9 CCOC(=O)CNP(=O)(NCC(=O)OCC)OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)nc(Cl)nc32)[C@H](O)[C@@H]1O 10.1021/jm3004834
137661670 159430 None 0 Human Functional pEC50 = 6.3 6.3 -5 3
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATP
ChEMBL 509 6 3 12 1.9 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NCc5ccc(Cl)cc5F)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b00291
CHEMBL4100130 159430 None 0 Human Functional pEC50 = 6.3 6.3 -5 3
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATP
ChEMBL 509 6 3 12 1.9 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NCc5ccc(Cl)cc5F)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b00291
137656913 159747 None 0 Human Functional pEC50 = 7.3 7.3 371 2
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of adenylyl cyclase activity in presence of [alpha-31P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of adenylyl cyclase activity in presence of [alpha-31P]ATP
ChEMBL 389 4 3 9 0.5 O[C@@H]1[C@@H](CCl)O[C@@H](n2cnc3c(N[C@@H]4CCOC4)nc(Cl)nc32)[C@@H]1O 10.1021/acs.jmedchem.7b01399
CHEMBL4103712 159747 None 0 Human Functional pEC50 = 7.3 7.3 371 2
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of adenylyl cyclase activity in presence of [alpha-31P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of adenylyl cyclase activity in presence of [alpha-31P]ATP
ChEMBL 389 4 3 9 0.5 O[C@@H]1[C@@H](CCl)O[C@@H](n2cnc3c(N[C@@H]4CCOC4)nc(Cl)nc32)[C@@H]1O 10.1021/acs.jmedchem.7b01399
377 2758 None 42 Rat Functional pEC50 = 7.3 7.3 -53 10
Adenosine A1 receptor mediated negative chronotropic activity in spontaneously beating rat atriaAdenosine A1 receptor mediated negative chronotropic activity in spontaneously beating rat atria
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm960376g
425 2758 None 42 Rat Functional pEC50 = 7.3 7.3 -53 10
Adenosine A1 receptor mediated negative chronotropic activity in spontaneously beating rat atriaAdenosine A1 receptor mediated negative chronotropic activity in spontaneously beating rat atria
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm960376g
448222 2758 None 42 Rat Functional pEC50 = 7.3 7.3 -53 10
Adenosine A1 receptor mediated negative chronotropic activity in spontaneously beating rat atriaAdenosine A1 receptor mediated negative chronotropic activity in spontaneously beating rat atria
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm960376g
CHEMBL464859 2758 None 42 Rat Functional pEC50 = 7.3 7.3 -53 10
Adenosine A1 receptor mediated negative chronotropic activity in spontaneously beating rat atriaAdenosine A1 receptor mediated negative chronotropic activity in spontaneously beating rat atria
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm960376g
377 2758 None 42 Rat Functional pEC50 = 7.3 7.3 -53 10
Negative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atriaNegative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atria
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm00037a024
425 2758 None 42 Rat Functional pEC50 = 7.3 7.3 -53 10
Negative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atriaNegative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atria
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm00037a024
448222 2758 None 42 Rat Functional pEC50 = 7.3 7.3 -53 10
Negative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atriaNegative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atria
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm00037a024
CHEMBL464859 2758 None 42 Rat Functional pEC50 = 7.3 7.3 -53 10
Negative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atriaNegative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atria
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm00037a024
132991434 180064 None 0 Human Functional pEC50 = 7.3 7.3 4 4
Irreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as effect on forskolin-induced cAMP accumulation incubated for 30 mins by LANCE cAMP detection assayIrreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as effect on forskolin-induced cAMP accumulation incubated for 30 mins by LANCE cAMP detection assay
ChEMBL 564 8 6 12 2.4 OC[C@H]1O[C@@H](n2cnc3c(Nc4ccc(CNC(=S)Nc5ccc(N=C=S)cc5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.6b01561
CHEMBL4746617 180064 None 0 Human Functional pEC50 = 7.3 7.3 4 4
Irreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as effect on forskolin-induced cAMP accumulation incubated for 30 mins by LANCE cAMP detection assayIrreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as effect on forskolin-induced cAMP accumulation incubated for 30 mins by LANCE cAMP detection assay
ChEMBL 564 8 6 12 2.4 OC[C@H]1O[C@@H](n2cnc3c(Nc4ccc(CNC(=S)Nc5ccc(N=C=S)cc5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.6b01561
60196083 81676 None 0 Human Functional pEC50 = 5.3 5.3 - 1
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 543 11 4 13 1.5 COP(=O)(OC)OCC(Cc1ccccc1)Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm3004834
CHEMBL2163567 81676 None 0 Human Functional pEC50 = 5.3 5.3 - 1
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 543 11 4 13 1.5 COP(=O)(OC)OCC(Cc1ccccc1)Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm3004834
137641603 158322 None 0 Human Functional pEC50 = 6.3 6.3 3 2
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of adenylyl cyclase activity in presence of [alpha-31P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of adenylyl cyclase activity in presence of [alpha-31P]ATP
ChEMBL 447 5 3 10 2.0 Cc1cc(C)n(C[C@H]2O[C@@H](n3cnc4c(NC5CCCC5)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b01399
CHEMBL4088238 158322 None 0 Human Functional pEC50 = 6.3 6.3 3 2
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of adenylyl cyclase activity in presence of [alpha-31P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of adenylyl cyclase activity in presence of [alpha-31P]ATP
ChEMBL 447 5 3 10 2.0 Cc1cc(C)n(C[C@H]2O[C@@H](n3cnc4c(NC5CCCC5)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b01399
168286257 191705 None 0 Human Functional pEC50 = 6.3 6.3 -10 4
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 863 14 6 13 6.3 Nc1sc(-c2ccc(C(=O)NCCc3ccc(CCNc4ncnc5c4ncn5[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)cc3)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
CHEMBL5195260 191705 None 0 Human Functional pEC50 = 6.3 6.3 -10 4
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 863 14 6 13 6.3 Nc1sc(-c2ccc(C(=O)NCCc3ccc(CCNc4ncnc5c4ncn5[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)cc3)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
377 2758 None 42 Rat Functional pEC50 = 7.3 7.3 -53 10
Activity at Adenosine A1 receptor of rat atriaActivity at Adenosine A1 receptor of rat atria
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm00018a017
425 2758 None 42 Rat Functional pEC50 = 7.3 7.3 -53 10
Activity at Adenosine A1 receptor of rat atriaActivity at Adenosine A1 receptor of rat atria
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm00018a017
448222 2758 None 42 Rat Functional pEC50 = 7.3 7.3 -53 10
Activity at Adenosine A1 receptor of rat atriaActivity at Adenosine A1 receptor of rat atria
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm00018a017
CHEMBL464859 2758 None 42 Rat Functional pEC50 = 7.3 7.3 -53 10
Activity at Adenosine A1 receptor of rat atriaActivity at Adenosine A1 receptor of rat atria
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm00018a017
60195011 81675 None 0 Human Functional pEC50 = 6.3 6.3 - 1
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 435 7 5 10 0.1 OCC(Cc1ccccc1)Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm3004834
CHEMBL2163565 81675 None 0 Human Functional pEC50 = 6.3 6.3 - 1
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 435 7 5 10 0.1 OCC(Cc1ccccc1)Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm3004834
137650899 157295 None 0 Human Functional pEC50 = 6.3 6.3 -10 4
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATP
ChEMBL 413 6 3 13 0.0 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NCc5ccco5)ncnc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b00291
CHEMBL4076003 157295 None 0 Human Functional pEC50 = 6.3 6.3 -10 4
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATP
ChEMBL 413 6 3 13 0.0 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NCc5ccco5)ncnc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b00291
137652383 157487 None 0 Human Functional pEC50 = 5.3 5.3 -7 2
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of adenylyl cyclase activity in presence of [alpha-31P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of adenylyl cyclase activity in presence of [alpha-31P]ATP
ChEMBL 507 5 3 10 3.1 Cc1cc(C)n(C[C@H]2O[C@@H](n3cnc4c(Nc5ccc(Cl)cc5F)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b01399
CHEMBL4078360 157487 None 0 Human Functional pEC50 = 5.3 5.3 -7 2
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of adenylyl cyclase activity in presence of [alpha-31P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of adenylyl cyclase activity in presence of [alpha-31P]ATP
ChEMBL 507 5 3 10 3.1 Cc1cc(C)n(C[C@H]2O[C@@H](n3cnc4c(Nc5ccc(Cl)cc5F)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b01399
137658761 159275 None 0 Human Functional pEC50 = 7.3 7.3 66 3
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of adenylyl cyclase activity in presence of [alpha-31P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of adenylyl cyclase activity in presence of [alpha-31P]ATP
ChEMBL 413 4 3 8 2.2 O[C@@H]1[C@@H](CCl)O[C@@H](n2cnc3c(Nc4ccc(Cl)cc4F)ncnc32)[C@@H]1O 10.1021/acs.jmedchem.7b01399
CHEMBL4098408 159275 None 0 Human Functional pEC50 = 7.3 7.3 66 3
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of adenylyl cyclase activity in presence of [alpha-31P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of adenylyl cyclase activity in presence of [alpha-31P]ATP
ChEMBL 413 4 3 8 2.2 O[C@@H]1[C@@H](CCl)O[C@@H](n2cnc3c(Nc4ccc(Cl)cc4F)ncnc32)[C@@H]1O 10.1021/acs.jmedchem.7b01399
10391971 905 None 14 Guinea pig Functional pEC50 = 5.3 5.3 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 521 9 4 11 2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NCC(c1ccccc1C)c1cc(OC)cc(c1)OC 10.1021/jm00108a014
418 905 None 14 Guinea pig Functional pEC50 = 5.3 5.3 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 521 9 4 11 2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NCC(c1ccccc1C)c1cc(OC)cc(c1)OC 10.1021/jm00108a014
CHEMBL2094089 905 None 14 Guinea pig Functional pEC50 = 5.3 5.3 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 521 9 4 11 2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NCC(c1ccccc1C)c1cc(OC)cc(c1)OC 10.1021/jm00108a014
571407 174716 None 11 Human Functional pEC50 = 7.2 7.2 - 1
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 360 5 1 7 3.6 N#Cc1c(N)nc(SCC(=O)c2ccccc2)c(C#N)c1-c1ccco1 10.1021/acs.jmedchem.9b00106
CHEMBL4557518 174716 None 11 Human Functional pEC50 = 7.2 7.2 - 1
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 360 5 1 7 3.6 N#Cc1c(N)nc(SCC(=O)c2ccccc2)c(C#N)c1-c1ccco1 10.1021/acs.jmedchem.9b00106
493442 79348 None 0 Rat Functional pEC50 = 7.2 7.2 - 1
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 341 4 4 9 -0.3 OC[C@H]1O[C@@H](n2cnc3c(NC4CC4)nc(Cl)nc32)[C@H](O)[C@@H]1O 10.1021/jm9911231
CHEMBL2113518 79348 None 0 Rat Functional pEC50 = 7.2 7.2 - 1
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 341 4 4 9 -0.3 OC[C@H]1O[C@@H](n2cnc3c(NC4CC4)nc(Cl)nc32)[C@H](O)[C@@H]1O 10.1021/jm9911231
71657835 159831 None 4 Human Functional pEC50 = 7.2 7.2 1 4
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 815 15 6 13 6.1 Nc1sc(-c2ccc(C(=O)NCCCCCCNc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
CHEMBL4104819 159831 None 4 Human Functional pEC50 = 7.2 7.2 1 4
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 815 15 6 13 6.1 Nc1sc(-c2ccc(C(=O)NCCCCCCNc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
46876609 204411 None 0 Guinea pig Functional pEC50 = 4.2 4.2 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 469 5 5 12 0.3 Nc1nc(N/N=C/c2cc(Br)cs2)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a008
CHEMBL607797 204411 None 0 Guinea pig Functional pEC50 = 4.2 4.2 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 469 5 5 12 0.3 Nc1nc(N/N=C/c2cc(Br)cs2)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a008
10041628 63251 None 14 Rat Functional pEC50 = 5.2 5.2 - 1
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 319 4 3 8 0.8 OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)C[C@@H]1O 10.1021/jm9911231
CHEMBL1790733 63251 None 14 Rat Functional pEC50 = 5.2 5.2 - 1
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 319 4 3 8 0.8 OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)C[C@@H]1O 10.1021/jm9911231
137651531 157562 None 0 Human Functional pEC50 = 6.2 6.2 3 2
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of adenylyl cyclase activity in presence of [alpha-31P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of adenylyl cyclase activity in presence of [alpha-31P]ATP
ChEMBL 517 6 3 10 3.6 Cc1cc(C)cc(-c2nc(NC3CCCC3)c3ncn([C@@H]4O[C@H](Cn5nc(C)cc5C)[C@@H](O)[C@H]4O)c3n2)c1 10.1021/acs.jmedchem.7b01399
CHEMBL4079314 157562 None 0 Human Functional pEC50 = 6.2 6.2 3 2
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of adenylyl cyclase activity in presence of [alpha-31P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of adenylyl cyclase activity in presence of [alpha-31P]ATP
ChEMBL 517 6 3 10 3.6 Cc1cc(C)cc(-c2nc(NC3CCCC3)c3ncn([C@@H]4O[C@H](Cn5nc(C)cc5C)[C@@H](O)[C@H]4O)c3n2)c1 10.1021/acs.jmedchem.7b01399
155535452 172193 None 0 Human Functional pEC50 = 7.2 7.2 14 2
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 286 4 2 7 1.8 N#Cc1c(N)nc(SCCO)c(C#N)c1-c1ccoc1 10.1021/acs.jmedchem.9b00106
CHEMBL4472401 172193 None 0 Human Functional pEC50 = 7.2 7.2 14 2
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 286 4 2 7 1.8 N#Cc1c(N)nc(SCCO)c(C#N)c1-c1ccoc1 10.1021/acs.jmedchem.9b00106
137638080 156927 None 0 Human Functional pEC50 = 7.2 7.2 -26 4
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATP
ChEMBL 457 6 3 12 1.1 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NCc5cccc(Cl)c5)ncnc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b00291
CHEMBL4071338 156927 None 0 Human Functional pEC50 = 7.2 7.2 -26 4
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATP
ChEMBL 457 6 3 12 1.1 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NCc5cccc(Cl)c5)ncnc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b00291
168272212 190540 None 0 Human Functional pEC50 = 7.2 7.2 -3 4
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 518 10 5 10 1.9 O=C(NCCCCc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1)c1ccccc1 10.1021/acs.jmedchem.2c00320
CHEMBL5178142 190540 None 0 Human Functional pEC50 = 7.2 7.2 -3 4
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 518 10 5 10 1.9 O=C(NCCCCc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1)c1ccccc1 10.1021/acs.jmedchem.2c00320
155542311 173242 None 0 Human Functional pEC50 = 8.2 8.2 - 1
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 401 5 1 8 3.5 COC(=O)c1cccc(CSc2nc(N)c(C#N)c(-c3cccnc3)c2C#N)c1 10.1021/acs.jmedchem.9b00106
CHEMBL4521162 173242 None 0 Human Functional pEC50 = 8.2 8.2 - 1
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 401 5 1 8 3.5 COC(=O)c1cccc(CSc2nc(N)c(C#N)c(-c3cccnc3)c2C#N)c1 10.1021/acs.jmedchem.9b00106
380 1287 None 37 Human Functional pEC50 = 8.2 8.2 6 5
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 335 4 4 9 -0.2 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NC1CCCC1 10.1021/jm3004834
657378 1287 None 37 Human Functional pEC50 = 8.2 8.2 6 5
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 335 4 4 9 -0.2 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NC1CCCC1 10.1021/jm3004834
CHEMBL68738 1287 None 37 Human Functional pEC50 = 8.2 8.2 6 5
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 335 4 4 9 -0.2 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NC1CCCC1 10.1021/jm3004834
155126901 190950 None 0 Human Functional pEC50 = 8.2 8.2 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 497 7 4 10 2.3 CC(C)(C)c1ccc(CO[C@@H]2CCC[C@H]2Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1 10.1021/acs.jmedchem.2c01414
CHEMBL5184329 190950 None 0 Human Functional pEC50 = 8.2 8.2 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 497 7 4 10 2.3 CC(C)(C)c1ccc(CO[C@@H]2CCC[C@H]2Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1 10.1021/acs.jmedchem.2c01414
168279634 191141 None 0 Human Functional pEC50 = 8.2 8.2 20 3
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 461 6 4 10 1.5 OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4Oc4ccc(Cl)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
CHEMBL5186981 191141 None 0 Human Functional pEC50 = 8.2 8.2 20 3
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 461 6 4 10 1.5 OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4Oc4ccc(Cl)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.2c01414
70695812 73309 None 0 Rat Functional pEC50 = 8.2 8.2 6 3
Agonist activity at rat A1A adenosine receptor expressed in CHO-K1 cell membranes incubated for 60 mins by [35S]GTPgammaS binding assayAgonist activity at rat A1A adenosine receptor expressed in CHO-K1 cell membranes incubated for 60 mins by [35S]GTPgammaS binding assay
ChEMBL 375 5 3 7 2.0 O[C@@H]1[C@H](O)[C@@H]2C[C@@H]2[C@H]1n1cnc2c(NC(C3CC3)C3CC3)nc(Cl)nc21 10.1021/acs.jmedchem.8b01662
CHEMBL2012686 73309 None 0 Rat Functional pEC50 = 8.2 8.2 6 3
Agonist activity at rat A1A adenosine receptor expressed in CHO-K1 cell membranes incubated for 60 mins by [35S]GTPgammaS binding assayAgonist activity at rat A1A adenosine receptor expressed in CHO-K1 cell membranes incubated for 60 mins by [35S]GTPgammaS binding assay
ChEMBL 375 5 3 7 2.0 O[C@@H]1[C@H](O)[C@@H]2C[C@@H]2[C@H]1n1cnc2c(NC(C3CC3)C3CC3)nc(Cl)nc21 10.1021/acs.jmedchem.8b01662
46876611 204795 None 0 Guinea pig Functional pEC50 = 4.2 4.2 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 391 5 5 12 -0.5 Nc1nc(N/N=C/c2ccsc2)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a008
CHEMBL610445 204795 None 0 Guinea pig Functional pEC50 = 4.2 4.2 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 391 5 5 12 -0.5 Nc1nc(N/N=C/c2ccsc2)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a008
10318222 79236 None 0 Rat Functional pEC50 = 5.2 5.2 - 1
Negative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atriaNegative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atria
ChEMBL 390 4 5 10 -1.7 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(C#CCC(C)O)nc32)[C@H](O)[C@@H]1O 10.1021/jm00037a024
CHEMBL2113408 79236 None 0 Rat Functional pEC50 = 5.2 5.2 - 1
Negative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atriaNegative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atria
ChEMBL 390 4 5 10 -1.7 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(C#CCC(C)O)nc32)[C@H](O)[C@@H]1O 10.1021/jm00037a024
168279326 191199 None 0 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 528 8 5 10 1.7 O=C(NCCCC#Cc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1)c1ccccc1 10.1021/acs.jmedchem.2c00320
CHEMBL5187670 191199 None 0 Human Functional pEC50 = 7.2 7.2 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 528 8 5 10 1.7 O=C(NCCCC#Cc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1)c1ccccc1 10.1021/acs.jmedchem.2c00320
60194919 81673 None 0 Human Functional pEC50 = 5.2 5.2 - 1
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 657 14 3 12 5.1 O=P(OCCc1ccccc1)(OCCc1ccccc1)OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)nc(Cl)nc32)[C@H](O)[C@@H]1O 10.1021/jm3004834
CHEMBL2163563 81673 None 0 Human Functional pEC50 = 5.2 5.2 - 1
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 657 14 3 12 5.1 O=P(OCCc1ccccc1)(OCCc1ccccc1)OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)nc(Cl)nc32)[C@H](O)[C@@H]1O 10.1021/jm3004834
493439 63257 None 4 Rat Functional pEC50 = 5.2 5.2 - 1
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 325 4 3 8 0.7 OC[C@H]1O[C@@H](n2cnc3c(NC4CC4)nc(Cl)nc32)C[C@@H]1O 10.1021/jm9911231
CHEMBL1790739 63257 None 4 Rat Functional pEC50 = 5.2 5.2 - 1
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 325 4 3 8 0.7 OC[C@H]1O[C@@H](n2cnc3c(NC4CC4)nc(Cl)nc32)C[C@@H]1O 10.1021/jm9911231
76318403 106115 None 0 Human Functional pEC50 = 7.2 7.2 -12 4
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 363 4 5 10 -1.3 CNC(=O)[C@H]1O[C@@H](n2cnc3c(NC4CCC4)nc(N)nc32)[C@H](O)[C@@H]1O 10.1039/C3MD00364G
CHEMBL3133157 106115 None 0 Human Functional pEC50 = 7.2 7.2 -12 4
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 363 4 5 10 -1.3 CNC(=O)[C@H]1O[C@@H](n2cnc3c(NC4CCC4)nc(N)nc32)[C@H](O)[C@@H]1O 10.1039/C3MD00364G
76325694 106117 None 0 Human Functional pEC50 = 7.2 7.2 1 4
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 391 4 5 10 -0.5 CNC(=O)[C@H]1O[C@@H](n2cnc3c(NC4CCCCC4)nc(N)nc32)[C@H](O)[C@@H]1O 10.1039/C3MD00364G
CHEMBL3133159 106117 None 0 Human Functional pEC50 = 7.2 7.2 1 4
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 391 4 5 10 -0.5 CNC(=O)[C@H]1O[C@@H](n2cnc3c(NC4CCCCC4)nc(N)nc32)[C@H](O)[C@@H]1O 10.1039/C3MD00364G
377 2758 None 42 Guinea pig Functional pEC50 = 7.2 7.2 -18 10
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm00108a014
425 2758 None 42 Guinea pig Functional pEC50 = 7.2 7.2 -18 10
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm00108a014
448222 2758 None 42 Guinea pig Functional pEC50 = 7.2 7.2 -18 10
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm00108a014
CHEMBL464859 2758 None 42 Guinea pig Functional pEC50 = 7.2 7.2 -18 10
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/jm00108a014
76329266 106118 None 0 Human Functional pEC50 = 5.2 5.2 -199 4
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 399 5 5 10 -0.6 CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4ccccc4)nc(N)nc32)[C@H](O)[C@@H]1O 10.1039/C3MD00364G
CHEMBL3133160 106118 None 0 Human Functional pEC50 = 5.2 5.2 -199 4
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 399 5 5 10 -0.6 CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4ccccc4)nc(N)nc32)[C@H](O)[C@@H]1O 10.1039/C3MD00364G
46874360 204116 None 0 Guinea pig Functional pEC50 = 5.2 5.2 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 373 5 4 10 -0.4 Nc1nc(OCc2ccccc2)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a015
CHEMBL606082 204116 None 0 Guinea pig Functional pEC50 = 5.2 5.2 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 373 5 4 10 -0.4 Nc1nc(OCc2ccccc2)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a015
46874412 203627 None 0 Guinea pig Functional pEC50 = 4.2 4.2 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 349 5 4 10 -1.2 CC#CCCOc1nc(N)c2ncn(C3O[C@@H](CO)[C@H](O)[C@@H]3O)c2n1 10.1021/jm00108a014
CHEMBL603374 203627 None 0 Guinea pig Functional pEC50 = 4.2 4.2 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 349 5 4 10 -1.2 CC#CCCOc1nc(N)c2ncn(C3O[C@@H](CO)[C@H](O)[C@@H]3O)c2n1 10.1021/jm00108a014
46875520 205026 None 0 Rat Functional pEC50 = 5.2 5.2 - 1
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 362 4 4 8 1.2 OC[C@H]1OC(n2cnc3c(NC4CCCCCC4)ccnc32)[C@H](O)[C@@H]1O 10.1021/jm9911231
CHEMBL611851 205026 None 0 Rat Functional pEC50 = 5.2 5.2 - 1
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 362 4 4 8 1.2 OC[C@H]1OC(n2cnc3c(NC4CCCCCC4)ccnc32)[C@H](O)[C@@H]1O 10.1021/jm9911231
118732981 118586 None 0 Human Functional pEC50 = 7.2 7.2 -2 4
Agonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activityAgonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activity
ChEMBL 495 5 3 12 2.0 CCn1nnc([C@H]2O[C@@H](n3cnc4c(Nc5ccc(Cl)cc5F)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.5b00074
CHEMBL3414947 118586 None 0 Human Functional pEC50 = 7.2 7.2 -2 4
Agonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activityAgonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activity
ChEMBL 495 5 3 12 2.0 CCn1nnc([C@H]2O[C@@H](n3cnc4c(Nc5ccc(Cl)cc5F)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.5b00074
118732982 118587 None 0 Human Functional pEC50 = 7.2 7.2 -7 4
Agonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activityAgonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activity
ChEMBL 583 6 3 12 1.7 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NCc5ccccc5I)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.5b00074
CHEMBL3414948 118587 None 0 Human Functional pEC50 = 7.2 7.2 -7 4
Agonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activityAgonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activity
ChEMBL 583 6 3 12 1.7 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NCc5ccccc5I)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.5b00074
10478926 79279 None 0 Rat Functional pEC50 = 5.2 5.2 -12 2
Functional activity against adenosine A1 receptor from rat atria.Functional activity against adenosine A1 receptor from rat atria.
ChEMBL 450 6 4 9 0.5 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(C#CCCCc4ccccc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm00009a007
CHEMBL2113450 79279 None 0 Rat Functional pEC50 = 5.2 5.2 -12 2
Functional activity against adenosine A1 receptor from rat atria.Functional activity against adenosine A1 receptor from rat atria.
ChEMBL 450 6 4 9 0.5 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(C#CCCCc4ccccc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm00009a007
10384887 79239 None 0 Rat Functional pEC50 = 6.2 6.2 - 1
Negative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atriaNegative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atria
ChEMBL 376 3 5 10 -2.1 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(C#CC(C)O)nc32)[C@H](O)[C@@H]1O 10.1021/jm00037a024
CHEMBL2113410 79239 None 0 Rat Functional pEC50 = 6.2 6.2 - 1
Negative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atriaNegative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atria
ChEMBL 376 3 5 10 -2.1 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(C#CC(C)O)nc32)[C@H](O)[C@@H]1O 10.1021/jm00037a024
44321401 106015 None 0 Rat Functional pEC50 = 5.2 5.2 - 1
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 396 4 4 8 1.8 OC[C@H]1O[C@@H](n2cnc3c(NC4CCCCCC4)cc(Cl)nc32)[C@@H](O)C1O 10.1021/jm9911231
CHEMBL312981 106015 None 0 Rat Functional pEC50 = 5.2 5.2 - 1
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 396 4 4 8 1.8 OC[C@H]1O[C@@H](n2cnc3c(NC4CCCCCC4)cc(Cl)nc32)[C@@H](O)C1O 10.1021/jm9911231
46874432 203783 None 0 Guinea pig Functional pEC50 = 4.2 4.2 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 353 6 4 10 -0.6 CC(C)CCOc1nc(N)c2ncn(C3O[C@@H](CO)[C@H](O)[C@@H]3O)c2n1 10.1021/jm00108a014
CHEMBL604224 203783 None 0 Guinea pig Functional pEC50 = 4.2 4.2 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 353 6 4 10 -0.6 CC(C)CCOc1nc(N)c2ncn(C3O[C@@H](CO)[C@H](O)[C@@H]3O)c2n1 10.1021/jm00108a014
46876681 204423 None 0 Guinea pig Functional pEC50 = 4.2 4.2 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 413 7 5 11 0.1 Nc1nc(N/N=C/CCc2ccccc2)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a008
CHEMBL607891 204423 None 0 Guinea pig Functional pEC50 = 4.2 4.2 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 413 7 5 11 0.1 Nc1nc(N/N=C/CCc2ccccc2)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a008
137653409 159129 None 0 Human Functional pEC50 = 7.2 7.2 1 4
Agonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assayAgonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assay
ChEMBL 567 12 6 12 2.2 Nc1ccc(-c2cccc(C(=O)NCCCCCCNc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2)s1 10.1021/acs.jmedchem.8b00047
CHEMBL4096796 159129 None 0 Human Functional pEC50 = 7.2 7.2 1 4
Agonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assayAgonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assay
ChEMBL 567 12 6 12 2.2 Nc1ccc(-c2cccc(C(=O)NCCCCCCNc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2)s1 10.1021/acs.jmedchem.8b00047
9893136 98813 None 0 Rat Functional pEC50 = 6.2 6.2 -1000 3
Stimulation of [35S]GTP-gamma-S, binding to adenosine A1 receptor of rat cerebral cortical membraneStimulation of [35S]GTP-gamma-S, binding to adenosine A1 receptor of rat cerebral cortical membrane
ChEMBL 527 5 4 8 2.0 OC[C@@]12C[C@@H]1[C@@H](n1cnc3c(NCc4cccc(I)c4)nc(Cl)nc31)[C@H](O)[C@@H]2O 10.1021/jm9905965
CHEMBL27809 98813 None 0 Rat Functional pEC50 = 6.2 6.2 -1000 3
Stimulation of [35S]GTP-gamma-S, binding to adenosine A1 receptor of rat cerebral cortical membraneStimulation of [35S]GTP-gamma-S, binding to adenosine A1 receptor of rat cerebral cortical membrane
ChEMBL 527 5 4 8 2.0 OC[C@@]12C[C@@H]1[C@@H](n1cnc3c(NCc4cccc(I)c4)nc(Cl)nc31)[C@H](O)[C@@H]2O 10.1021/jm9905965
2844 283 None 61 Human Functional pEC50 = 7.2 7.2 1 5
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.2c01414
60961 283 None 61 Human Functional pEC50 = 7.2 7.2 1 5
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.2c01414
60961.0 283 None 61 Human Functional pEC50 = 7.2 7.2 1 5
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.2c01414
90 283 None 61 Human Functional pEC50 = 7.2 7.2 1 5
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.2c01414
CHEMBL477 283 None 61 Human Functional pEC50 = 7.2 7.2 1 5
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.2c01414
DB00640 283 None 61 Human Functional pEC50 = 7.2 7.2 1 5
Agonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assayAgonist activity at human adenosine A1 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 30 mins by LANCE ultra assay
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.2c01414
46203501 8008 None 1 Human Functional pEC50 = 6.2 6.2 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation in presence of 10 uM allosteric modulator PD-81723Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation in presence of 10 uM allosteric modulator PD-81723
ChEMBL 809 17 5 14 6.5 Nc1sc2c(c1C(=O)c1ccc(Cl)c(Cl)c1)CCN(CCCCCCCCCOc1ccc(Nc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc1)C2 10.1021/jm901252a
CHEMBL1090687 8008 None 1 Human Functional pEC50 = 6.2 6.2 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation in presence of 10 uM allosteric modulator PD-81723Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation in presence of 10 uM allosteric modulator PD-81723
ChEMBL 809 17 5 14 6.5 Nc1sc2c(c1C(=O)c1ccc(Cl)c(Cl)c1)CCN(CCCCCCCCCOc1ccc(Nc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc1)C2 10.1021/jm901252a
168281767 191032 None 0 Human Functional pEC50 = 8.2 8.2 -7 2
Antagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assayAntagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assay
ChEMBL 281 4 1 5 3.1 CC(C)c1nn(C)c2c(NCc3ccccc3)nncc12 10.1021/acsmedchemlett.2c00052
CHEMBL5185411 191032 None 0 Human Functional pEC50 = 8.2 8.2 -7 2
Antagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assayAntagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assay
ChEMBL 281 4 1 5 3.1 CC(C)c1nn(C)c2c(NCc3ccccc3)nncc12 10.1021/acsmedchemlett.2c00052
90663727 106773 None 0 Human Functional pEC50 = 8.2 8.2 - 1
Adenosine receptor agonistic activity against isoproterenol (1 uM) stimulated cAMP accumulation in DDT MF-2 cellsAdenosine receptor agonistic activity against isoproterenol (1 uM) stimulated cAMP accumulation in DDT MF-2 cells
ChEMBL 377 5 4 10 -1.0 OC[C@H]1O[C@@H](Cn2cnc3c(NC4CC5CCC4O5)ncnc32)[C@H](O)[C@@H]1O 10.1016/s0960-894x(99)00109-2
CHEMBL3144085 106773 None 0 Human Functional pEC50 = 8.2 8.2 - 1
Adenosine receptor agonistic activity against isoproterenol (1 uM) stimulated cAMP accumulation in DDT MF-2 cellsAdenosine receptor agonistic activity against isoproterenol (1 uM) stimulated cAMP accumulation in DDT MF-2 cells
ChEMBL 377 5 4 10 -1.0 OC[C@H]1O[C@@H](Cn2cnc3c(NC4CC5CCC4O5)ncnc32)[C@H](O)[C@@H]1O 10.1016/s0960-894x(99)00109-2
118732975 118580 None 0 Human Functional pEC50 = 8.1 8.1 2 4
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATP
ChEMBL 407 5 3 12 0.1 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NC5CC5)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b00291
CHEMBL3414941 118580 None 0 Human Functional pEC50 = 8.1 8.1 2 4
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATP
ChEMBL 407 5 3 12 0.1 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NC5CC5)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b00291
137657926 159862 None 0 Human Functional pEC50 = 8.1 8.1 1 4
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATP
ChEMBL 421 6 3 12 0.3 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NCC5CC5)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b00291
CHEMBL4105164 159862 None 0 Human Functional pEC50 = 8.1 8.1 1 4
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATP
ChEMBL 421 6 3 12 0.3 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NCC5CC5)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b00291
118732979 118584 None 0 Human Functional pEC50 = 8.1 8.1 4 4
Agonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activityAgonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activity
ChEMBL 437 5 3 13 0.0 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NC5CCCO5)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.5b00074
CHEMBL3414945 118584 None 0 Human Functional pEC50 = 8.1 8.1 4 4
Agonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activityAgonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activity
ChEMBL 437 5 3 13 0.0 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NC5CCCO5)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.5b00074
122188758 123295 None 0 Human Functional pEC50 = 8.1 8.1 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cell membranes by [35S]GTPgammaS binding assayAgonist activity at human adenosine A1 receptor expressed in CHO cell membranes by [35S]GTPgammaS binding assay
ChEMBL 456 6 1 9 4.9 COc1ccc(-c2c(C#N)c(N)nc(SCc3csc(-c4ccccn4)n3)c2C#N)cc1 10.1016/j.ejmech.2015.07.023
CHEMBL3613135 123295 None 0 Human Functional pEC50 = 8.1 8.1 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cell membranes by [35S]GTPgammaS binding assayAgonist activity at human adenosine A1 receptor expressed in CHO cell membranes by [35S]GTPgammaS binding assay
ChEMBL 456 6 1 9 4.9 COc1ccc(-c2c(C#N)c(N)nc(SCc3csc(-c4ccccn4)n3)c2C#N)cc1 10.1016/j.ejmech.2015.07.023
118732974 118579 None 0 Human Functional pEC50 = 8.1 8.1 1 4
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATP
ChEMBL 373 5 3 12 -0.6 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NC5CC5)ncnc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b00291
CHEMBL3414940 118579 None 0 Human Functional pEC50 = 8.1 8.1 1 4
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATP
ChEMBL 373 5 3 12 -0.6 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NC5CC5)ncnc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b00291
137642036 158244 None 0 Human Functional pEC50 = 8.1 8.1 -2 4
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATP
ChEMBL 387 6 3 12 -0.4 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NCC5CC5)ncnc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b00291
CHEMBL4087306 158244 None 0 Human Functional pEC50 = 8.1 8.1 -2 4
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATP
ChEMBL 387 6 3 12 -0.4 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NCC5CC5)ncnc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b00291
168289948 191731 None 2 Human Functional pEC50 = 7.2 7.2 -4 2
Antagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assayAntagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assay
ChEMBL 315 4 1 5 3.6 Cn1nc(-c2ccccc2)c2cnnc(NCc3ccccc3)c21 10.1021/acsmedchemlett.2c00052
CHEMBL5195631 191731 None 2 Human Functional pEC50 = 7.2 7.2 -4 2
Antagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assayAntagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assay
ChEMBL 315 4 1 5 3.6 Cn1nc(-c2ccccc2)c2cnnc(NCc3ccccc3)c21 10.1021/acsmedchemlett.2c00052
464376 79351 None 0 Rat Functional pEC50 = 6.2 6.2 - 1
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 340 4 4 8 0.3 OC[C@H]1O[C@@H](n2cnc3c(NC4CC4)cc(Cl)nc32)[C@H](O)[C@@H]1O 10.1021/jm9911231
CHEMBL2113521 79351 None 0 Rat Functional pEC50 = 6.2 6.2 - 1
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 340 4 4 8 0.3 OC[C@H]1O[C@@H](n2cnc3c(NC4CC4)cc(Cl)nc32)[C@H](O)[C@@H]1O 10.1021/jm9911231
46874454 203977 None 0 Guinea pig Functional pEC50 = 5.2 5.2 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparation
ChEMBL 415 8 4 10 0.4 Nc1nc(OCCCCc2ccccc2)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a015
CHEMBL605257 203977 None 0 Guinea pig Functional pEC50 = 5.2 5.2 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparation
ChEMBL 415 8 4 10 0.4 Nc1nc(OCCCCc2ccccc2)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a015
493443 79252 None 6 Rat Functional pEC50 = 6.2 6.2 - 1
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 307 4 4 9 -1.0 OC[C@H]1O[C@@H](n2cnc3c(NC4CC4)ncnc32)[C@H](O)[C@@H]1O 10.1021/jm9911231
CHEMBL2113423 79252 None 6 Rat Functional pEC50 = 6.2 6.2 - 1
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 307 4 4 9 -1.0 OC[C@H]1O[C@@H](n2cnc3c(NC4CC4)ncnc32)[C@H](O)[C@@H]1O 10.1021/jm9911231
46874587 203979 None 0 Rat Functional pEC50 = 5.1 5.1 -251 2
Functional activity against adenosine A1 receptor from rat atria.Functional activity against adenosine A1 receptor from rat atria.
ChEMBL 415 3 4 11 -1.0 CCNC(=O)[C@H]1OC(n2cnc3c(N)nc(C#Cc4nccs4)nc32)[C@H](O)[C@@H]1O 10.1021/jm00009a007
CHEMBL605265 203979 None 0 Rat Functional pEC50 = 5.1 5.1 -251 2
Functional activity against adenosine A1 receptor from rat atria.Functional activity against adenosine A1 receptor from rat atria.
ChEMBL 415 3 4 11 -1.0 CCNC(=O)[C@H]1OC(n2cnc3c(N)nc(C#Cc4nccs4)nc32)[C@H](O)[C@@H]1O 10.1021/jm00009a007
60194837 84449 None 0 Human Functional pEC50 = 7.1 7.1 - 1
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 449 6 5 10 0.6 O=P(O)(O)OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)nc(Cl)nc32)[C@H](O)[C@@H]1O 10.1021/jm3004834
CHEMBL2163560 84449 None 0 Human Functional pEC50 = 7.1 7.1 - 1
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 449 6 5 10 0.6 O=P(O)(O)OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)nc(Cl)nc32)[C@H](O)[C@@H]1O 10.1021/jm3004834
CHEMBL2219856 84449 None 0 Human Functional pEC50 = 7.1 7.1 - 1
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assayAgonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of isoproterenol-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay
ChEMBL 449 6 5 10 0.6 O=P(O)(O)OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)nc(Cl)nc32)[C@H](O)[C@@H]1O 10.1021/jm3004834
168278159 190469 None 0 Human Functional pEC50 = 7.1 7.1 -186 4
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 839 15 5 15 6.6 Nc1sc(-c2ccc(-c3cn(CCCCCCNc4ncnc5c4ncn5[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)nn3)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
CHEMBL5177040 190469 None 0 Human Functional pEC50 = 7.1 7.1 -186 4
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as inhibition of forskolin stimulated cAMP accumulation incubated for 30 mins by LANCE cAMP assay
ChEMBL 839 15 5 15 6.6 Nc1sc(-c2ccc(-c3cn(CCCCCCNc4ncnc5c4ncn5[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)nn3)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
137636099 155915 None 0 Human Functional pEC50 = 7.1 7.1 -7 4
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATP
ChEMBL 535 6 3 12 1.9 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NCc5cccc(Br)c5)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b00291
CHEMBL4059961 155915 None 0 Human Functional pEC50 = 7.1 7.1 -7 4
Agonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATPAgonist activity at recombinant human adenosine A1 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-stimulated adenylyl cyclase activity after 10 mins in presence of [alpha-32P]ATP
ChEMBL 535 6 3 12 1.9 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NCc5cccc(Br)c5)nc(Cl)nc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.7b00291
10406268 79231 None 0 Rat Functional pEC50 = 6.1 6.1 - 1
Negative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atriaNegative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atria
ChEMBL 361 3 5 10 -2.5 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(C#CCN)nc32)[C@H](O)[C@@H]1O 10.1021/jm00037a024
CHEMBL2113403 79231 None 0 Rat Functional pEC50 = 6.1 6.1 - 1
Negative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atriaNegative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atria
ChEMBL 361 3 5 10 -2.5 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(C#CCN)nc32)[C@H](O)[C@@H]1O 10.1021/jm00037a024
168275648 190205 None 0 Human Functional pEC50 = 7.1 7.1 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assay
ChEMBL 500 6 5 10 1.0 O=C(NCC#Cc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1)c1ccccc1 10.1021/acs.jmedchem.2c00320
CHEMBL5172823 190205 None 0 Human Functional pEC50 = 7.1 7.1 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assay
ChEMBL 500 6 5 10 1.0 O=C(NCC#Cc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1)c1ccccc1 10.1021/acs.jmedchem.2c00320
46874347 204047 None 0 Guinea pig Functional pEC50 = 5.1 5.1 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 401 6 4 10 -0.1 Cc1ccc(CCOc2nc(N)c3ncn(C4O[C@@H](CO)[C@H](O)[C@@H]4O)c3n2)cc1 10.1021/jm00108a015
CHEMBL605668 204047 None 0 Guinea pig Functional pEC50 = 5.1 5.1 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 401 6 4 10 -0.1 Cc1ccc(CCOc2nc(N)c3ncn(C4O[C@@H](CO)[C@H](O)[C@@H]4O)c3n2)cc1 10.1021/jm00108a015
155536619 172304 None 0 Human Functional pEC50 = 6.1 6.1 - 1
Agonist activity at human A1A adenosine receptor expressed in HEK cell membranes incubated for 60 mins by [35S]GTPgammaS binding assayAgonist activity at human A1A adenosine receptor expressed in HEK cell membranes incubated for 60 mins by [35S]GTPgammaS binding assay
ChEMBL 254 3 4 7 -2.3 NC(=O)c1ncn([C@H]2[C@H](O)[C@H](O)[C@]3(CO)C[C@H]23)n1 10.1021/acs.jmedchem.8b01662
CHEMBL4473739 172304 None 0 Human Functional pEC50 = 6.1 6.1 - 1
Agonist activity at human A1A adenosine receptor expressed in HEK cell membranes incubated for 60 mins by [35S]GTPgammaS binding assayAgonist activity at human A1A adenosine receptor expressed in HEK cell membranes incubated for 60 mins by [35S]GTPgammaS binding assay
ChEMBL 254 3 4 7 -2.3 NC(=O)c1ncn([C@H]2[C@H](O)[C@H](O)[C@]3(CO)C[C@H]23)n1 10.1021/acs.jmedchem.8b01662
76311197 106114 None 0 Human Functional pEC50 = 6.1 6.1 -19 3
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 365 6 5 10 -1.0 CCCCNc1nc(N)nc2c1ncn2[C@@H]1O[C@H](C(=O)NC)[C@@H](O)[C@H]1O 10.1039/C3MD00364G
CHEMBL3133156 106114 None 0 Human Functional pEC50 = 6.1 6.1 -19 3
Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assayAgonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay
ChEMBL 365 6 5 10 -1.0 CCCCNc1nc(N)nc2c1ncn2[C@@H]1O[C@H](C(=O)NC)[C@@H](O)[C@H]1O 10.1039/C3MD00364G
71716703 86162 None 0 Guinea pig Functional pEC50 = 4.1 4.1 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 351 4 4 10 -0.7 Nc1nc(OC2CCCC2)nc2c1ncn2[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a014
CHEMBL2311200 86162 None 0 Guinea pig Functional pEC50 = 4.1 4.1 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 351 4 4 10 -0.7 Nc1nc(OC2CCCC2)nc2c1ncn2[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a014
46874445 203896 None 0 Guinea pig Functional pEC50 = 4.1 4.1 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 311 4 4 10 -1.6 CCOc1nc(N)c2ncn(C3O[C@@H](CO)[C@H](O)[C@@H]3O)c2n1 10.1021/jm00108a014
CHEMBL604844 203896 None 0 Guinea pig Functional pEC50 = 4.1 4.1 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 311 4 4 10 -1.6 CCOc1nc(N)c2ncn(C3O[C@@H](CO)[C@H](O)[C@@H]3O)c2n1 10.1021/jm00108a014
90663728 106774 None 0 Human Functional pEC50 = 8.1 8.1 - 1
Adenosine receptor agonistic activity against isoproterenol (1 uM) stimulated cAMP accumulation in DDT MF-2 cellsAdenosine receptor agonistic activity against isoproterenol (1 uM) stimulated cAMP accumulation in DDT MF-2 cells
ChEMBL 391 5 5 10 -1.1 OC[C@H]1O[C@@H](Cn2cnc3c(NC4CC5CC4CC5O)ncnc32)[C@H](O)[C@@H]1O 10.1016/s0960-894x(99)00109-2
CHEMBL3144086 106774 None 0 Human Functional pEC50 = 8.1 8.1 - 1
Adenosine receptor agonistic activity against isoproterenol (1 uM) stimulated cAMP accumulation in DDT MF-2 cellsAdenosine receptor agonistic activity against isoproterenol (1 uM) stimulated cAMP accumulation in DDT MF-2 cells
ChEMBL 391 5 5 10 -1.1 OC[C@H]1O[C@@H](Cn2cnc3c(NC4CC5CC4CC5O)ncnc32)[C@H](O)[C@@H]1O 10.1016/s0960-894x(99)00109-2
123807 871 None 35 Rat Functional pEC50 = 8.1 8.1 -1 7
Activity at Adenosine A1 receptor of rat atriaActivity at Adenosine A1 receptor of rat atria
ChEMBL 369 4 4 9 0.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1 10.1021/jm00018a017
374 871 None 35 Rat Functional pEC50 = 8.1 8.1 -1 7
Activity at Adenosine A1 receptor of rat atriaActivity at Adenosine A1 receptor of rat atria
ChEMBL 369 4 4 9 0.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1 10.1021/jm00018a017
379 871 None 35 Rat Functional pEC50 = 8.1 8.1 -1 7
Activity at Adenosine A1 receptor of rat atriaActivity at Adenosine A1 receptor of rat atria
ChEMBL 369 4 4 9 0.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1 10.1021/jm00018a017
CHEMBL284969 871 None 35 Rat Functional pEC50 = 8.1 8.1 -1 7
Activity at Adenosine A1 receptor of rat atriaActivity at Adenosine A1 receptor of rat atria
ChEMBL 369 4 4 9 0.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1 10.1021/jm00018a017
45482610 200483 None 0 Human Functional pEC50 = 8.1 8.1 -2 2
Agonistic effect at human adenosine A1 receptor in CHO cellsAgonistic effect at human adenosine A1 receptor in CHO cells
ChEMBL 406 4 4 8 0.9 CNC(=O)[C@]12C[C@@H]1[C@@H](n1cnc3c(NC4CCCC4)nc(Cl)nc31)[C@H](O)[C@@H]2O 10.1021/jm050726b
CHEMBL573937 200483 None 0 Human Functional pEC50 = 8.1 8.1 -2 2
Agonistic effect at human adenosine A1 receptor in CHO cellsAgonistic effect at human adenosine A1 receptor in CHO cells
ChEMBL 406 4 4 8 0.9 CNC(=O)[C@]12C[C@@H]1[C@@H](n1cnc3c(NC4CCCC4)nc(Cl)nc31)[C@H](O)[C@@H]2O 10.1021/jm050726b
123807 871 None 35 Rat Functional pEC50 = 8.1 8.1 -1 7
Negative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atriaNegative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atria
ChEMBL 369 4 4 9 0.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1 10.1021/jm00037a024
374 871 None 35 Rat Functional pEC50 = 8.1 8.1 -1 7
Negative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atriaNegative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atria
ChEMBL 369 4 4 9 0.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1 10.1021/jm00037a024
379 871 None 35 Rat Functional pEC50 = 8.1 8.1 -1 7
Negative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atriaNegative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atria
ChEMBL 369 4 4 9 0.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1 10.1021/jm00037a024
CHEMBL284969 871 None 35 Rat Functional pEC50 = 8.1 8.1 -1 7
Negative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atriaNegative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atria
ChEMBL 369 4 4 9 0.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1 10.1021/jm00037a024
118732974 118579 None 0 Human Functional pEC50 = 8.1 8.1 1 4
Agonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activityAgonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activity
ChEMBL 373 5 3 12 -0.6 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NC5CC5)ncnc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.5b00074
CHEMBL3414940 118579 None 0 Human Functional pEC50 = 8.1 8.1 1 4
Agonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activityAgonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activity
ChEMBL 373 5 3 12 -0.6 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NC5CC5)ncnc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.5b00074
118732978 118583 None 0 Human Functional pEC50 = 8.1 8.1 2 4
Agonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activityAgonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activity
ChEMBL 403 5 3 13 -0.6 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NC5CCCO5)ncnc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.5b00074
CHEMBL3414944 118583 None 0 Human Functional pEC50 = 8.1 8.1 2 4
Agonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activityAgonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activity
ChEMBL 403 5 3 13 -0.6 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NC5CCCO5)ncnc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.5b00074
155562096 175825 None 0 Human Functional pEC50 = 8.1 8.1 - 1
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 376 5 2 7 3.7 N#Cc1c(N)nc(SCc2cccc(C(=O)O)c2)c(C#N)c1-c1ccco1 10.1021/acs.jmedchem.9b00106
CHEMBL4582498 175825 None 0 Human Functional pEC50 = 8.1 8.1 - 1
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 376 5 2 7 3.7 N#Cc1c(N)nc(SCc2cccc(C(=O)O)c2)c(C#N)c1-c1ccco1 10.1021/acs.jmedchem.9b00106
44398830 11788 None 0 Human Functional pEC50 = 5.1 5.1 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 332 1 1 3 5.3 Nc1nc2c(s1)Cc1cc(-c3ccc(Cl)c(Cl)c3)ccc1-2 10.1021/jm049132j
CHEMBL1181761 11788 None 0 Human Functional pEC50 = 5.1 5.1 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 332 1 1 3 5.3 Nc1nc2c(s1)Cc1cc(-c3ccc(Cl)c(Cl)c3)ccc1-2 10.1021/jm049132j
CHEMBL191218 11788 None 0 Human Functional pEC50 = 5.1 5.1 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 332 1 1 3 5.3 Nc1nc2c(s1)Cc1cc(-c3ccc(Cl)c(Cl)c3)ccc1-2 10.1021/jm049132j
46203501 8008 None 1 Human Functional pEC50 = 6.1 6.1 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation in presence of 10 uM allosteric modulator PD-81723Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation in presence of 10 uM allosteric modulator PD-81723
ChEMBL 809 17 5 14 6.5 Nc1sc2c(c1C(=O)c1ccc(Cl)c(Cl)c1)CCN(CCCCCCCCCOc1ccc(Nc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc1)C2 10.1021/jm901252a
CHEMBL1090687 8008 None 1 Human Functional pEC50 = 6.1 6.1 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation in presence of 10 uM allosteric modulator PD-81723Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation in presence of 10 uM allosteric modulator PD-81723
ChEMBL 809 17 5 14 6.5 Nc1sc2c(c1C(=O)c1ccc(Cl)c(Cl)c1)CCN(CCCCCCCCCOc1ccc(Nc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc1)C2 10.1021/jm901252a
44398735 56235 None 0 Human Functional pEC50 = 5.1 5.1 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 309 2 1 5 3.9 Nc1nc2c(s1)Cc1cc(-c3ccccc3[N+](=O)[O-])ccc1-2 10.1021/jm049132j
CHEMBL1626594 56235 None 0 Human Functional pEC50 = 5.1 5.1 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 309 2 1 5 3.9 Nc1nc2c(s1)Cc1cc(-c3ccccc3[N+](=O)[O-])ccc1-2 10.1021/jm049132j
CHEMBL193158 56235 None 0 Human Functional pEC50 = 5.1 5.1 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 309 2 1 5 3.9 Nc1nc2c(s1)Cc1cc(-c3ccccc3[N+](=O)[O-])ccc1-2 10.1021/jm049132j
44398693 56240 None 0 Human Functional pEC50 = 5.1 5.1 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 309 2 1 5 3.9 Nc1nc2c(s1)Cc1cc(-c3cccc([N+](=O)[O-])c3)ccc1-2 10.1021/jm049132j
CHEMBL1626850 56240 None 0 Human Functional pEC50 = 5.1 5.1 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 309 2 1 5 3.9 Nc1nc2c(s1)Cc1cc(-c3cccc([N+](=O)[O-])c3)ccc1-2 10.1021/jm049132j
CHEMBL190197 56240 None 0 Human Functional pEC50 = 5.1 5.1 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 309 2 1 5 3.9 Nc1nc2c(s1)Cc1cc(-c3cccc([N+](=O)[O-])c3)ccc1-2 10.1021/jm049132j
46876685 204457 None 0 Guinea pig Functional pEC50 = 6.1 6.1 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 435 5 5 11 0.6 Nc1nc(N/N=C/c2cccc3ccccc23)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a008
CHEMBL608175 204457 None 0 Guinea pig Functional pEC50 = 6.1 6.1 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 435 5 5 11 0.6 Nc1nc(N/N=C/c2cccc3ccccc23)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a008
46874327 203893 None 0 Guinea pig Functional pEC50 = 5.1 5.1 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparation
ChEMBL 437 6 4 10 0.8 Nc1nc(OCCc2cccc3ccccc23)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a015
CHEMBL604837 203893 None 0 Guinea pig Functional pEC50 = 5.1 5.1 - 1
Effective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparationEffective concentration required for prolongation of the stimulus-QRS interval by 50% of the maximum response at the A1 adenosine receptor in langendorff guinea pig heart preparation
ChEMBL 437 6 4 10 0.8 Nc1nc(OCCc2cccc3ccccc23)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a015
46876622 204384 None 0 Guinea pig Functional pEC50 = 4.1 4.1 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 399 6 5 11 -0.3 Nc1nc(N/N=C/Cc2ccccc2)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a008
CHEMBL607592 204384 None 0 Guinea pig Functional pEC50 = 4.1 4.1 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 399 6 5 11 -0.3 Nc1nc(N/N=C/Cc2ccccc2)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a008
46876623 204418 None 0 Guinea pig Functional pEC50 = 4.1 4.1 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 385 5 5 11 -0.5 Nc1nc(N/N=C/c2ccccc2)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a008
CHEMBL607874 204418 None 0 Guinea pig Functional pEC50 = 4.1 4.1 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 385 5 5 11 -0.5 Nc1nc(N/N=C/c2ccccc2)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a008
9975881 79312 None 0 Rat Functional pEC50 = 7.1 7.1 - 1
Negative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atriaNegative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atria
ChEMBL 362 3 5 10 -2.5 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(C#CCO)nc32)[C@H](O)[C@@H]1O 10.1021/jm00037a024
CHEMBL2113483 79312 None 0 Rat Functional pEC50 = 7.1 7.1 - 1
Negative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atriaNegative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atria
ChEMBL 362 3 5 10 -2.5 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(C#CCO)nc32)[C@H](O)[C@@H]1O 10.1021/jm00037a024
46874547 204156 None 0 Rat Functional pEC50 = 6.1 6.1 -3 2
Functional activity against adenosine A1 receptor from rat atria.Functional activity against adenosine A1 receptor from rat atria.
ChEMBL 409 3 4 10 -1.0 CCNC(=O)[C@H]1OC(n2cnc3c(N)nc(C#Cc4ccccn4)nc32)[C@H](O)[C@@H]1O 10.1021/jm00009a007
CHEMBL606318 204156 None 0 Rat Functional pEC50 = 6.1 6.1 -3 2
Functional activity against adenosine A1 receptor from rat atria.Functional activity against adenosine A1 receptor from rat atria.
ChEMBL 409 3 4 10 -1.0 CCNC(=O)[C@H]1OC(n2cnc3c(N)nc(C#Cc4ccccn4)nc32)[C@H](O)[C@@H]1O 10.1021/jm00009a007
168295700 192473 None 0 Human Functional pEC50 = 6.1 6.1 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assay
ChEMBL 532 11 5 10 2.3 O=C(NCCCCCc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1)c1ccccc1 10.1021/acs.jmedchem.2c00320
CHEMBL5207277 192473 None 0 Human Functional pEC50 = 6.1 6.1 - 1
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assay
ChEMBL 532 11 5 10 2.3 O=C(NCCCCCc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1)c1ccccc1 10.1021/acs.jmedchem.2c00320
46874534 204051 None 0 Rat Functional pEC50 = 5.1 5.1 -2 2
Functional activity against adenosine A1 receptor from rat atria.Functional activity against adenosine A1 receptor from rat atria.
ChEMBL 422 3 4 9 -0.1 CCNC(=O)[C@H]1OC(n2cnc3c(N)nc(C#Cc4ccc(C)cc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm00009a007
CHEMBL605685 204051 None 0 Rat Functional pEC50 = 5.1 5.1 -2 2
Functional activity against adenosine A1 receptor from rat atria.Functional activity against adenosine A1 receptor from rat atria.
ChEMBL 422 3 4 9 -0.1 CCNC(=O)[C@H]1OC(n2cnc3c(N)nc(C#Cc4ccc(C)cc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm00009a007
463722 79259 None 8 Rat Functional pEC50 = 7.1 7.1 - 1
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 363 4 4 9 0.6 OC[C@H]1O[C@@H](n2cnc3c(NC4CCCCCC4)ncnc32)[C@H](O)[C@@H]1O 10.1021/jm9911231
CHEMBL2113430 79259 None 8 Rat Functional pEC50 = 7.1 7.1 - 1
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 363 4 4 9 0.6 OC[C@H]1O[C@@H](n2cnc3c(NC4CCCCCC4)ncnc32)[C@H](O)[C@@H]1O 10.1021/jm9911231
10456627 79383 None 0 Rat Functional pEC50 = 6.1 6.1 -1 2
Activity at Adenosine A1 receptor of rat atriaActivity at Adenosine A1 receptor of rat atria
ChEMBL 454 7 5 12 0.2 CN(C)c1ccc(/C=C/C=N/Nc2nc(N)c3ncn([C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)c3n2)cc1 10.1021/jm00018a017
CHEMBL2113553 79383 None 0 Rat Functional pEC50 = 6.1 6.1 -1 2
Activity at Adenosine A1 receptor of rat atriaActivity at Adenosine A1 receptor of rat atria
ChEMBL 454 7 5 12 0.2 CN(C)c1ccc(/C=C/C=N/Nc2nc(N)c3ncn([C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)c3n2)cc1 10.1021/jm00018a017
46874337 203973 None 0 Guinea pig Functional pEC50 = 5.1 5.1 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 433 7 4 11 -0.2 Nc1nc(OCCC(=O)[C@H]2CC3CCC2C3)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a014
CHEMBL605247 203973 None 0 Guinea pig Functional pEC50 = 5.1 5.1 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 433 7 4 11 -0.2 Nc1nc(OCCC(=O)[C@H]2CC3CCC2C3)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a014
46874471 204119 None 0 Guinea pig Functional pEC50 = 5.1 5.1 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 393 6 4 10 0.4 Nc1nc(OCCC2CCCCC2)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a014
CHEMBL606093 204119 None 0 Guinea pig Functional pEC50 = 5.1 5.1 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 393 6 4 10 0.4 Nc1nc(OCCC2CCCCC2)nc2c1ncn2C1O[C@@H](CO)[C@H](O)[C@@H]1O 10.1021/jm00108a014
46874556 203703 None 0 Rat Functional pEC50 = 6.1 6.1 -2 2
Functional activity against adenosine A1 receptor from rat atria.Functional activity against adenosine A1 receptor from rat atria.
ChEMBL 444 4 4 11 -2.2 CCNC(=O)[C@H]1OC(n2cnc3c(N)nc(C#CCN4CCN(C)CC4)nc32)[C@H](O)[C@@H]1O 10.1021/jm00009a007
CHEMBL603809 203703 None 0 Rat Functional pEC50 = 6.1 6.1 -2 2
Functional activity against adenosine A1 receptor from rat atria.Functional activity against adenosine A1 receptor from rat atria.
ChEMBL 444 4 4 11 -2.2 CCNC(=O)[C@H]1OC(n2cnc3c(N)nc(C#CCN4CCN(C)CC4)nc32)[C@H](O)[C@@H]1O 10.1021/jm00009a007
44398645 12255 None 0 Human Functional pEC50 = 5.1 5.1 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 399 4 0 3 6.4 C[N+](C)(C)c1nc2c(s1)Cc1cc(-c3ccc(Oc4ccccc4)cc3)ccc1-2 10.1021/jm049132j
CHEMBL1184625 12255 None 0 Human Functional pEC50 = 5.1 5.1 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 399 4 0 3 6.4 C[N+](C)(C)c1nc2c(s1)Cc1cc(-c3ccc(Oc4ccccc4)cc3)ccc1-2 10.1021/jm049132j
CHEMBL359799 12255 None 0 Human Functional pEC50 = 5.1 5.1 - 1
Antagonist activity against adenosine A1 receptorAntagonist activity against adenosine A1 receptor
ChEMBL 399 4 0 3 6.4 C[N+](C)(C)c1nc2c(s1)Cc1cc(-c3ccc(Oc4ccccc4)cc3)ccc1-2 10.1021/jm049132j
46203193 8004 None 0 Human Functional pEC50 = 7.1 7.1 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation in presence of 10 uM allosteric modulator PD-81723Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation in presence of 10 uM allosteric modulator PD-81723
ChEMBL 753 13 5 14 5.0 Nc1sc2c(c1C(=O)c1ccc(Cl)c(Cl)c1)CCN(CCCCCOc1ccc(Nc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc1)C2 10.1021/jm901252a
CHEMBL1090683 8004 None 0 Human Functional pEC50 = 7.1 7.1 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation in presence of 10 uM allosteric modulator PD-81723Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation in presence of 10 uM allosteric modulator PD-81723
ChEMBL 753 13 5 14 5.0 Nc1sc2c(c1C(=O)c1ccc(Cl)c(Cl)c1)CCN(CCCCCOc1ccc(Nc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc1)C2 10.1021/jm901252a
46203193 8004 None 0 Human Functional pEC50 = 7.1 7.1 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation in presence of 10 uM allosteric modulator PD-81723Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation in presence of 10 uM allosteric modulator PD-81723
ChEMBL 753 13 5 14 5.0 Nc1sc2c(c1C(=O)c1ccc(Cl)c(Cl)c1)CCN(CCCCCOc1ccc(Nc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc1)C2 10.1021/jm901252a
CHEMBL1090683 8004 None 0 Human Functional pEC50 = 7.1 7.1 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation in presence of 10 uM allosteric modulator PD-81723Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation in presence of 10 uM allosteric modulator PD-81723
ChEMBL 753 13 5 14 5.0 Nc1sc2c(c1C(=O)c1ccc(Cl)c(Cl)c1)CCN(CCCCCOc1ccc(Nc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc1)C2 10.1021/jm901252a
46876620 204383 None 0 Guinea pig Functional pEC50 = 5.1 5.1 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 405 5 5 12 -0.1 C/C(=N\Nc1nc(N)c2ncn(C3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1)c1cccs1 10.1021/jm00102a008
CHEMBL607590 204383 None 0 Guinea pig Functional pEC50 = 5.1 5.1 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 405 5 5 12 -0.1 C/C(=N\Nc1nc(N)c2ncn(C3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1)c1cccs1 10.1021/jm00102a008
46876986 204465 None 0 Human Functional pEC50 = 8.0 8.0 - 1
Adenosine receptor agonistic activity against isoproterenol (1 uM) stimulated cAMP accumulation in DDT MF-2 cellsAdenosine receptor agonistic activity against isoproterenol (1 uM) stimulated cAMP accumulation in DDT MF-2 cells
ChEMBL 377 4 5 10 -1.0 OC[C@H]1OC(n2cnc3c(NC4CC5CC(O)C4C5)ncnc32)[C@H](O)[C@@H]1O 10.1016/s0960-894x(99)00109-2
CHEMBL608219 204465 None 0 Human Functional pEC50 = 8.0 8.0 - 1
Adenosine receptor agonistic activity against isoproterenol (1 uM) stimulated cAMP accumulation in DDT MF-2 cellsAdenosine receptor agonistic activity against isoproterenol (1 uM) stimulated cAMP accumulation in DDT MF-2 cells
ChEMBL 377 4 5 10 -1.0 OC[C@H]1OC(n2cnc3c(NC4CC5CC(O)C4C5)ncnc32)[C@H](O)[C@@H]1O 10.1016/s0960-894x(99)00109-2
90654617 110081 None 0 Human Functional pEC50 = 8.0 8.0 - 1
Agonist activity human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by radioligand addition measured after 90 mins by beta scintillation counting analysisAgonist activity human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by radioligand addition measured after 90 mins by beta scintillation counting analysis
ChEMBL 571 5 1 9 5.3 N#Cc1c(N)nc(SCc2csc(-c3ccc(I)cc3)n2)nc1-c1ccc2c(c1)OCO2 10.1021/jm401643m
CHEMBL3234955 110081 None 0 Human Functional pEC50 = 8.0 8.0 - 1
Agonist activity human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by radioligand addition measured after 90 mins by beta scintillation counting analysisAgonist activity human adenosine A1 receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 30 mins followed by radioligand addition measured after 90 mins by beta scintillation counting analysis
ChEMBL 571 5 1 9 5.3 N#Cc1c(N)nc(SCc2csc(-c3ccc(I)cc3)n2)nc1-c1ccc2c(c1)OCO2 10.1021/jm401643m
46876605 204372 None 0 Guinea pig Functional pEC50 = 5.0 5.0 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 403 5 5 11 -0.4 Nc1nc(N/N=C/c2cccc(F)c2)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a008
CHEMBL607508 204372 None 0 Guinea pig Functional pEC50 = 5.0 5.0 - 1
Tested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum responseTested for adenosine A1 receptor agonistic activity by determining concentration needed to prolong the stimulus-QRS interval by 50% of the maximum response
ChEMBL 403 5 5 11 -0.4 Nc1nc(N/N=C/c2cccc(F)c2)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a008
71657835 159831 None 4 Human Functional pEC50 = 6.0 6.0 1 4
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assay
ChEMBL 815 15 6 13 6.1 Nc1sc(-c2ccc(C(=O)NCCCCCCNc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
CHEMBL4104819 159831 None 4 Human Functional pEC50 = 6.0 6.0 1 4
Agonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assayAgonist activity at human A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of calcium mobilization by calcium mobilization assay
ChEMBL 815 15 6 13 6.1 Nc1sc(-c2ccc(C(=O)NCCCCCCNc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.2c00320
1329 1472 None 53 Human Functional pEC50 = 6.0 6.0 -4 8
Antagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assayAntagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assay
ChEMBL 304 5 1 5 2.4 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C1CCCC1 10.1021/acsmedchemlett.2c00052
386 1472 None 53 Human Functional pEC50 = 6.0 6.0 -4 8
Antagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assayAntagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assay
ChEMBL 304 5 1 5 2.4 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C1CCCC1 10.1021/acsmedchemlett.2c00052
CHEMBL183 1472 None 53 Human Functional pEC50 = 6.0 6.0 -4 8
Antagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assayAntagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assay
ChEMBL 304 5 1 5 2.4 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C1CCCC1 10.1021/acsmedchemlett.2c00052
DB12946 1472 None 53 Human Functional pEC50 = 6.0 6.0 -4 8
Antagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assayAntagonist activity at human wild type A1R expressed in CHO-K1 cells assessed as inhibition of forskolin/ NECA-stimulated cAMP accumulation by measuring NECA-mediated cAMP stimulation at 1 uM incubated with NECA for 30 mins by LANCE cAMP detection assay
ChEMBL 304 5 1 5 2.4 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C1CCCC1 10.1021/acsmedchemlett.2c00052
71717298 86160 None 0 Guinea pig Functional pEC50 = 5.0 5.0 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 297 3 4 10 -2.0 COc1nc(N)c2ncn([C@H]3O[C@@H](CO)[C@H](O)[C@@H]3O)c2n1 10.1021/jm00108a014
CHEMBL2311198 86160 None 0 Guinea pig Functional pEC50 = 5.0 5.0 - 1
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparationProlongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparation
ChEMBL 297 3 4 10 -2.0 COc1nc(N)c2ncn([C@H]3O[C@@H](CO)[C@H](O)[C@@H]3O)c2n1 10.1021/jm00108a014
28622387 170829 None 0 Human Functional pEC50 = 7.0 7.0 - 1
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 297 4 2 7 1.6 N#Cc1c(N)nc(SCCO)c(C#N)c1-c1cccnc1 10.1021/acs.jmedchem.9b00106
CHEMBL4452140 170829 None 0 Human Functional pEC50 = 7.0 7.0 - 1
Inverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assayInverse agonist activity at human A1AR expressed in CHO cells assessed as increase in forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 297 4 2 7 1.6 N#Cc1c(N)nc(SCCO)c(C#N)c1-c1cccnc1 10.1021/acs.jmedchem.9b00106
9805713 162941 None 0 Rat Functional pEC50 = 6.0 6.0 -1318 3
Stimulation of [35S]GTP-gamma-S, binding to adenosine A1 receptor of rat cerebral cortical membraneStimulation of [35S]GTP-gamma-S, binding to adenosine A1 receptor of rat cerebral cortical membrane
ChEMBL 493 5 4 8 1.3 OC[C@@]12C[C@@H]1[C@@H](n1cnc3c(NCc4cccc(I)c4)ncnc31)[C@H](O)[C@@H]2O 10.1021/jm9905965
CHEMBL417292 162941 None 0 Rat Functional pEC50 = 6.0 6.0 -1318 3
Stimulation of [35S]GTP-gamma-S, binding to adenosine A1 receptor of rat cerebral cortical membraneStimulation of [35S]GTP-gamma-S, binding to adenosine A1 receptor of rat cerebral cortical membrane
ChEMBL 493 5 4 8 1.3 OC[C@@]12C[C@@H]1[C@@H](n1cnc3c(NCc4cccc(I)c4)ncnc31)[C@H](O)[C@@H]2O 10.1021/jm9905965
137634444 156254 None 0 Human Functional pEC50 = 7.0 7.0 -1 3
Agonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assayAgonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assay
ChEMBL 801 14 6 13 5.7 Nc1sc(-c2ccc(C(=O)NCCCCCNc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.8b00047
CHEMBL4063841 156254 None 0 Human Functional pEC50 = 7.0 7.0 -1 3
Agonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assayAgonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assay
ChEMBL 801 14 6 13 5.7 Nc1sc(-c2ccc(C(=O)NCCCCCNc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1 10.1021/acs.jmedchem.8b00047
46203501 8008 None 1 Human Functional pEC50 = 6.0 6.0 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation
ChEMBL 809 17 5 14 6.5 Nc1sc2c(c1C(=O)c1ccc(Cl)c(Cl)c1)CCN(CCCCCCCCCOc1ccc(Nc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc1)C2 10.1021/jm901252a
CHEMBL1090687 8008 None 1 Human Functional pEC50 = 6.0 6.0 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation
ChEMBL 809 17 5 14 6.5 Nc1sc2c(c1C(=O)c1ccc(Cl)c(Cl)c1)CCN(CCCCCCCCCOc1ccc(Nc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc1)C2 10.1021/jm901252a
10246230 63249 None 0 Rat Functional pEC50 = 5.0 5.0 - 1
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 333 4 3 8 1.2 OC[C@H]1O[C@@H](n2cnc3c(NC4CCCCC4)ncnc32)C[C@@H]1O 10.1021/jm9911231
CHEMBL1790730 63249 None 0 Rat Functional pEC50 = 5.0 5.0 - 1
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activationStimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation
ChEMBL 333 4 3 8 1.2 OC[C@H]1O[C@@H](n2cnc3c(NC4CCCCC4)ncnc32)C[C@@H]1O 10.1021/jm9911231
118732972 118577 None 0 Human Functional pEC50 = 7.0 7.0 -15 4
Agonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activityAgonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activity
ChEMBL 347 4 3 12 -1.1 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NC)ncnc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.5b00074
CHEMBL3414938 118577 None 0 Human Functional pEC50 = 7.0 7.0 -15 4
Agonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activityAgonist activity at human recombinant adenosine A1 receptor transfected in CHO cells assessed as inhibition of forskolin-induced adenylyl cyclase activity
ChEMBL 347 4 3 12 -1.1 CCn1nnc([C@H]2O[C@@H](n3cnc4c(NC)ncnc43)[C@H](O)[C@@H]2O)n1 10.1021/acs.jmedchem.5b00074
137646828 158098 None 0 Human Functional pEC50 = 7.0 7.0 -1 4
Agonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assayAgonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assay
ChEMBL 856 16 6 13 6.2 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCCCCNC(=O)c4ccc(-c5sc(N)c(C(=O)c6ccccc6)c5-c5cccc(C(F)(F)F)c5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.8b00047
CHEMBL4085418 158098 None 0 Human Functional pEC50 = 7.0 7.0 -1 4
Agonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assayAgonist activity at human A1AR expressed in FlpIn-CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 mins followed by forskolin addition measured after 30 mins by Alphascreen assay
ChEMBL 856 16 6 13 6.2 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCCCCNC(=O)c4ccc(-c5sc(N)c(C(=O)c6ccccc6)c5-c5cccc(C(F)(F)F)c5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.8b00047
10248282 79296 None 0 Rat Functional pEC50 = 7 7.0 - 1
Effective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranesEffective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranes
ChEMBL 365 5 3 9 1.2 CSC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)[C@H](O)[C@@H]1O 10.1021/jm970508l
CHEMBL2113468 79296 None 0 Rat Functional pEC50 = 7 7.0 - 1
Effective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranesEffective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranes
ChEMBL 365 5 3 9 1.2 CSC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)[C@H](O)[C@@H]1O 10.1021/jm970508l
127025959 138366 None 0 Human Functional pIC50 = 10.5 10.5 50 3
Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysisAgonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis
ChEMBL 482 8 4 10 1.1 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4OCc4ccccc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.5b01402
CHEMBL3770679 138366 None 0 Human Functional pIC50 = 10.5 10.5 50 3
Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysisAgonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis
ChEMBL 482 8 4 10 1.1 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4OCc4ccccc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.5b01402
44452562 160637 None 0 Human Functional pIC50 = 9.9 9.9 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 432 5 4 10 -0.1 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@@H]5C[C@@H]4C4SC45)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmc.2007.11.010
CHEMBL411245 160637 None 0 Human Functional pIC50 = 9.9 9.9 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 432 5 4 10 -0.1 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@@H]5C[C@@H]4C4SC45)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmc.2007.11.010
153605593 173725 None 0 Human Functional pIC50 = 9.9 9.9 - 1
Agonist activity at human A1A adenosine receptor expressed in HEK cells assessed as inhibition of forskolin-stimulated cAMP production after 60 minsAgonist activity at human A1A adenosine receptor expressed in HEK cells assessed as inhibition of forskolin-stimulated cAMP production after 60 mins
ChEMBL 389 6 4 9 0.8 OC[C@H]1O[C@@H](n2cnc3c(NC(C4CCC4)C4CCC4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.8b01662
CHEMBL4533718 173725 None 0 Human Functional pIC50 = 9.9 9.9 - 1
Agonist activity at human A1A adenosine receptor expressed in HEK cells assessed as inhibition of forskolin-stimulated cAMP production after 60 minsAgonist activity at human A1A adenosine receptor expressed in HEK cells assessed as inhibition of forskolin-stimulated cAMP production after 60 mins
ChEMBL 389 6 4 9 0.8 OC[C@H]1O[C@@H](n2cnc3c(NC(C4CCC4)C4CCC4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.8b01662
377 2758 None 42 Human Functional pIC50 = 9.7 9.7 3 10
Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysisAgonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.5b01402
425 2758 None 42 Human Functional pIC50 = 9.7 9.7 3 10
Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysisAgonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.5b01402
448222 2758 None 42 Human Functional pIC50 = 9.7 9.7 3 10
Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysisAgonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.5b01402
CHEMBL464859 2758 None 42 Human Functional pIC50 = 9.7 9.7 3 10
Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysisAgonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.5b01402
44452530 95852 None 0 Human Functional pIC50 = 9.5 9.5 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 409 4 3 9 1.0 O[C@@H]1[C@@H](CCl)O[C@@H](n2cnc3c(N[C@H]4C[C@@H]5C[C@@H]4C4SC45)ncnc32)[C@@H]1O 10.1016/j.bmc.2007.11.010
CHEMBL258759 95852 None 0 Human Functional pIC50 = 9.5 9.5 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 409 4 3 9 1.0 O[C@@H]1[C@@H](CCl)O[C@@H](n2cnc3c(N[C@H]4C[C@@H]5C[C@@H]4C4SC45)ncnc32)[C@@H]1O 10.1016/j.bmc.2007.11.010
57387337 75502 None 0 Human Functional pIC50 = 9.4 9.4 6 4
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation
ChEMBL 326 3 4 9 -1.7 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(F)nc32)[C@H](O)[C@@H]1O 10.1021/jm300206u
CHEMBL2042297 75502 None 0 Human Functional pIC50 = 9.4 9.4 6 4
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation
ChEMBL 326 3 4 9 -1.7 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(F)nc32)[C@H](O)[C@@H]1O 10.1021/jm300206u
127025957 138413 None 0 Human Functional pIC50 = 9.4 9.4 - 1
Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysisAgonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis
ChEMBL 442 5 4 9 0.8 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NC4C5CC6CC(C5)CC4C6)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.5b01402
CHEMBL3771184 138413 None 0 Human Functional pIC50 = 9.4 9.4 - 1
Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysisAgonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis
ChEMBL 442 5 4 9 0.8 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NC4C5CC6CC(C5)CC4C6)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.5b01402
73350676 91879 None 0 Human Functional pIC50 = 9.3 9.3 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometryAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometry
ChEMBL 797 14 5 13 3.4 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1039/C2MD00247G
CHEMBL2413231 91879 None 0 Human Functional pIC50 = 9.3 9.3 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometryAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometry
ChEMBL 797 14 5 13 3.4 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1039/C2MD00247G
123807 871 None 35 Human Functional pIC50 = 9.3 9.3 1 7
Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysisAgonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis
ChEMBL 369 4 4 9 0.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1 10.1021/acs.jmedchem.5b01402
374 871 None 35 Human Functional pIC50 = 9.3 9.3 1 7
Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysisAgonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis
ChEMBL 369 4 4 9 0.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1 10.1021/acs.jmedchem.5b01402
379 871 None 35 Human Functional pIC50 = 9.3 9.3 1 7
Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysisAgonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis
ChEMBL 369 4 4 9 0.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1 10.1021/acs.jmedchem.5b01402
CHEMBL284969 871 None 35 Human Functional pIC50 = 9.3 9.3 1 7
Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysisAgonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis
ChEMBL 369 4 4 9 0.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1 10.1021/acs.jmedchem.5b01402
10452110 205189 None 0 Guinea pig Functional pIC50 = 9.3 9.3 30 2
Inhibition of adenosine induced negative inotropic activity against guinea-pig atria (Adenosine A1 receptor)Inhibition of adenosine induced negative inotropic activity against guinea-pig atria (Adenosine A1 receptor)
ChEMBL 375 5 1 4 3.8 O=C(/C=C/c1c(-c2ccccc2)nn2ccccc12)N1CCCC[C@H]1CCO 10.1016/0960-894X(96)00368-X
CHEMBL61845 205189 None 0 Guinea pig Functional pIC50 = 9.3 9.3 30 2
Inhibition of adenosine induced negative inotropic activity against guinea-pig atria (Adenosine A1 receptor)Inhibition of adenosine induced negative inotropic activity against guinea-pig atria (Adenosine A1 receptor)
ChEMBL 375 5 1 4 3.8 O=C(/C=C/c1c(-c2ccccc2)nn2ccccc12)N1CCCC[C@H]1CCO 10.1016/0960-894X(96)00368-X
44631910 17810 None 0 Human Functional pIC50 = 9.2 9.2 - 1
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 453 5 2 6 5.7 Cc1ccccc1-n1nc(C)c(-c2cc(F)c3nccnc3c2)c1Nc1ccccc1C(=O)O 10.1016/j.bmcl.2010.07.095
CHEMBL1258850 17810 None 0 Human Functional pIC50 = 9.2 9.2 - 1
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 453 5 2 6 5.7 Cc1ccccc1-n1nc(C)c(-c2cc(F)c3nccnc3c2)c1Nc1ccccc1C(=O)O 10.1016/j.bmcl.2010.07.095
16202442 138414 None 1 Human Functional pIC50 = 9.2 9.2 707 2
Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysisAgonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis
ChEMBL 441 7 4 10 1.0 OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4OCc4ccccc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.5b01402
CHEMBL3771208 138414 None 1 Human Functional pIC50 = 9.2 9.2 707 2
Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysisAgonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis
ChEMBL 441 7 4 10 1.0 OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4OCc4ccccc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.5b01402
377 2758 None 42 Human Functional pIC50 = 9.1 9.1 3 10
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometryAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometry
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1039/C2MD00247G
425 2758 None 42 Human Functional pIC50 = 9.1 9.1 3 10
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometryAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometry
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1039/C2MD00247G
448222 2758 None 42 Human Functional pIC50 = 9.1 9.1 3 10
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometryAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometry
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1039/C2MD00247G
CHEMBL464859 2758 None 42 Human Functional pIC50 = 9.1 9.1 3 10
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometryAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometry
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1039/C2MD00247G
44452508 159675 None 0 Human Functional pIC50 = 9.1 9.1 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 421 5 3 10 1.1 CSC[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@@H]5C[C@@H]4C4SC45)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmc.2007.11.010
CHEMBL410288 159675 None 0 Human Functional pIC50 = 9.1 9.1 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 421 5 3 10 1.1 CSC[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@@H]5C[C@@H]4C4SC45)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmc.2007.11.010
377 2758 None 42 Human Functional pIC50 = 9.0 9.0 3 10
Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 minsAntagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.2c01123
425 2758 None 42 Human Functional pIC50 = 9.0 9.0 3 10
Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 minsAntagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.2c01123
448222 2758 None 42 Human Functional pIC50 = 9.0 9.0 3 10
Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 minsAntagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.2c01123
CHEMBL464859 2758 None 42 Human Functional pIC50 = 9.0 9.0 3 10
Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 minsAntagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.2c01123
1329 1472 None 53 Guinea pig Functional pIC50 = 8.9 8.9 3 8
Inhibition of adenosine induced negative inotropic activity against guinea-pig atria (Adenosine A1 receptor)Inhibition of adenosine induced negative inotropic activity against guinea-pig atria (Adenosine A1 receptor)
ChEMBL 304 5 1 5 2.4 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C1CCCC1 10.1016/0960-894X(96)00368-X
386 1472 None 53 Guinea pig Functional pIC50 = 8.9 8.9 3 8
Inhibition of adenosine induced negative inotropic activity against guinea-pig atria (Adenosine A1 receptor)Inhibition of adenosine induced negative inotropic activity against guinea-pig atria (Adenosine A1 receptor)
ChEMBL 304 5 1 5 2.4 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C1CCCC1 10.1016/0960-894X(96)00368-X
CHEMBL183 1472 None 53 Guinea pig Functional pIC50 = 8.9 8.9 3 8
Inhibition of adenosine induced negative inotropic activity against guinea-pig atria (Adenosine A1 receptor)Inhibition of adenosine induced negative inotropic activity against guinea-pig atria (Adenosine A1 receptor)
ChEMBL 304 5 1 5 2.4 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C1CCCC1 10.1016/0960-894X(96)00368-X
DB12946 1472 None 53 Guinea pig Functional pIC50 = 8.9 8.9 3 8
Inhibition of adenosine induced negative inotropic activity against guinea-pig atria (Adenosine A1 receptor)Inhibition of adenosine induced negative inotropic activity against guinea-pig atria (Adenosine A1 receptor)
ChEMBL 304 5 1 5 2.4 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C1CCCC1 10.1016/0960-894X(96)00368-X
52943163 17502 None 0 Human Functional pIC50 = 8.9 8.9 - 1
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 431 6 2 5 5.7 COc1ccc(Nc2c(-c3ccc(F)cc3)c(C)nn2-c2ccccc2C)c(C(=O)O)c1 10.1016/j.bmcl.2010.07.095
CHEMBL1257826 17502 None 0 Human Functional pIC50 = 8.9 8.9 - 1
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 431 6 2 5 5.7 COc1ccc(Nc2c(-c3ccc(F)cc3)c(C)nn2-c2ccccc2C)c(C(=O)O)c1 10.1016/j.bmcl.2010.07.095
168278037 190318 None 0 Human Functional pIC50 = 8.9 8.9 3 2
Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 minsAntagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins
ChEMBL 364 4 3 5 4.4 Cn1nc(NC(=O)Nc2ccccc2)c2ccnc(NC3CCCCC3)c21 10.1021/acs.jmedchem.2c01123
CHEMBL5174600 190318 None 0 Human Functional pIC50 = 8.9 8.9 3 2
Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 minsAntagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins
ChEMBL 364 4 3 5 4.4 Cn1nc(NC(=O)Nc2ccccc2)c2ccnc(NC3CCCCC3)c21 10.1021/acs.jmedchem.2c01123
44435353 91261 None 0 Human Functional pIC50 = 8.7 8.7 - 1
Agonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulationAgonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulation
ChEMBL 401 4 4 9 -0.8 OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CC[Se]C4)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2007.10.028
CHEMBL240065 91261 None 0 Human Functional pIC50 = 8.7 8.7 - 1
Agonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulationAgonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulation
ChEMBL 401 4 4 9 -0.8 OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CC[Se]C4)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2007.10.028
134140759 147412 None 0 Human Functional pIC50 = 8.7 8.7 2 2
Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 minsAntagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins
ChEMBL 376 6 2 6 4.4 COc1cc(Nc2nccc3c(-c4ccccc4)n[nH]c23)cc(OC)c1OC 10.1021/acs.jmedchem.2c01123
CHEMBL3929143 147412 None 0 Human Functional pIC50 = 8.7 8.7 2 2
Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 minsAntagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins
ChEMBL 376 6 2 6 4.4 COc1cc(Nc2nccc3c(-c4ccccc4)n[nH]c23)cc(OC)c1OC 10.1021/acs.jmedchem.2c01123
57387594 75509 None 0 Human Functional pIC50 = 8 8.0 -11 4
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation
ChEMBL 506 8 4 9 2.0 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(F)nc32)[C@H](O)[C@@H]1O 10.1021/jm300206u
CHEMBL2042304 75509 None 0 Human Functional pIC50 = 8 8.0 -11 4
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation
ChEMBL 506 8 4 9 2.0 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(F)nc32)[C@H](O)[C@@H]1O 10.1021/jm300206u
168283522 191187 None 0 Human Functional pIC50 = 8.0 8.0 -5 2
Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 minsAntagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins
ChEMBL 325 5 2 7 2.6 COc1cc(Nc2nc(C#N)cc3cn[nH]c23)cc(OC)c1OC 10.1021/acs.jmedchem.2c01123
CHEMBL5187501 191187 None 0 Human Functional pIC50 = 8.0 8.0 -5 2
Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 minsAntagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins
ChEMBL 325 5 2 7 2.6 COc1cc(Nc2nc(C#N)cc3cn[nH]c23)cc(OC)c1OC 10.1021/acs.jmedchem.2c01123
57388054 75510 None 0 Human Functional pIC50 = 6 6.0 -15 4
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation
ChEMBL 607 12 5 10 3.5 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(NCCc4ccccc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm300206u
CHEMBL2042305 75510 None 0 Human Functional pIC50 = 6 6.0 -15 4
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation
ChEMBL 607 12 5 10 3.5 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(NCCc4ccccc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm300206u
127046493 139884 None 0 Human Functional pIC50 = 7.0 7.0 -17 3
Antagonist activity at human adenosine A1 receptor expressed in CHO cell membranes assessed as suppression of CCPA-mediated inhibition of cAMP level by scintillation counting method in presence of [3H]-cyclic AMPAntagonist activity at human adenosine A1 receptor expressed in CHO cell membranes assessed as suppression of CCPA-mediated inhibition of cAMP level by scintillation counting method in presence of [3H]-cyclic AMP
ChEMBL 321 4 1 7 2.7 COc1ccccc1Cn1cc2nc(-c3ccco3)nc(N)c2n1 10.1016/j.bmc.2016.04.048
CHEMBL3798766 139884 None 0 Human Functional pIC50 = 7.0 7.0 -17 3
Antagonist activity at human adenosine A1 receptor expressed in CHO cell membranes assessed as suppression of CCPA-mediated inhibition of cAMP level by scintillation counting method in presence of [3H]-cyclic AMPAntagonist activity at human adenosine A1 receptor expressed in CHO cell membranes assessed as suppression of CCPA-mediated inhibition of cAMP level by scintillation counting method in presence of [3H]-cyclic AMP
ChEMBL 321 4 1 7 2.7 COc1ccccc1Cn1cc2nc(-c3ccco3)nc(N)c2n1 10.1016/j.bmc.2016.04.048
145962529 161485 None 0 Human Functional pIC50 = 7.0 7.0 -1 3
Antagonist activity at human A1 adenosine receptor expressed in CHO cells assessed as inhibition of CCPA-induced reduction of forskolin-stimulated cAMP level after 30 mins by Alphascreen assayAntagonist activity at human A1 adenosine receptor expressed in CHO cells assessed as inhibition of CCPA-induced reduction of forskolin-stimulated cAMP level after 30 mins by Alphascreen assay
ChEMBL 291 4 2 7 2.7 Cc1nc2c(N)nc(NCCc3cccs3)nc2s1 10.1016/j.bmc.2018.05.048
CHEMBL4126427 161485 None 0 Human Functional pIC50 = 7.0 7.0 -1 3
Antagonist activity at human A1 adenosine receptor expressed in CHO cells assessed as inhibition of CCPA-induced reduction of forskolin-stimulated cAMP level after 30 mins by Alphascreen assayAntagonist activity at human A1 adenosine receptor expressed in CHO cells assessed as inhibition of CCPA-induced reduction of forskolin-stimulated cAMP level after 30 mins by Alphascreen assay
ChEMBL 291 4 2 7 2.7 Cc1nc2c(N)nc(NCCc3cccs3)nc2s1 10.1016/j.bmc.2018.05.048
25230949 6007 None 0 Human Functional pIC50 = 6.0 6.0 -74 4
Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.
ChEMBL 367 5 2 8 3.6 Nc1cc2nc(NCc3cccnc3)nc(C(=O)c3cccs3)c2s1 nan
CHEMBL1080241 6007 None 0 Human Functional pIC50 = 6.0 6.0 -74 4
Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.
ChEMBL 367 5 2 8 3.6 Nc1cc2nc(NCc3cccnc3)nc(C(=O)c3cccs3)c2s1 nan
149362 75503 None 4 Human Functional pIC50 = 7.0 7.0 -9 4
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation
ChEMBL 427 7 5 10 -0.2 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(NCCc4ccccc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm300206u
CHEMBL2042298 75503 None 4 Human Functional pIC50 = 7.0 7.0 -9 4
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation
ChEMBL 427 7 5 10 -0.2 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(NCCc4ccccc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm300206u
155547390 173710 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human A1AR expressed in CHO cells assessed as suppression of CCPA-induced inhibition of forskolin-stimulated cAMP production by alphascreen assayAntagonist activity at human A1AR expressed in CHO cells assessed as suppression of CCPA-induced inhibition of forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 326 6 2 7 2.7 N#Cc1c(NC2CC2)nc(SCCO)c(C#N)c1-c1ccco1 10.1021/acs.jmedchem.9b00106
CHEMBL4533472 173710 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human A1AR expressed in CHO cells assessed as suppression of CCPA-induced inhibition of forskolin-stimulated cAMP production by alphascreen assayAntagonist activity at human A1AR expressed in CHO cells assessed as suppression of CCPA-induced inhibition of forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 326 6 2 7 2.7 N#Cc1c(NC2CC2)nc(SCCO)c(C#N)c1-c1ccco1 10.1021/acs.jmedchem.9b00106
25230948 6037 None 0 Human Functional pIC50 = 6.9 6.9 -10 4
Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.
ChEMBL 395 7 2 8 4.4 CCNc1cc2nc(NCc3cccnc3)nc(C(=O)c3cccs3)c2s1 nan
CHEMBL1080421 6037 None 0 Human Functional pIC50 = 6.9 6.9 -10 4
Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.
ChEMBL 395 7 2 8 4.4 CCNc1cc2nc(NCc3cccnc3)nc(C(=O)c3cccs3)c2s1 nan
5606 1644 None 20 Guinea pig Functional pIC50 = 5.9 5.9 5 7
Inhibition of adenosine induced negative inotropic activity against guinea-pig atria (Adenosine A1 receptor)Inhibition of adenosine induced negative inotropic activity against guinea-pig atria (Adenosine A1 receptor)
ChEMBL 375 5 1 4 3.8 OCC[C@H]1CCCCN1C(=O)/C=C/c1c(nn2c1cccc2)c1ccccc1 10.1016/0960-894X(96)00368-X
6439091 1644 None 20 Guinea pig Functional pIC50 = 5.9 5.9 5 7
Inhibition of adenosine induced negative inotropic activity against guinea-pig atria (Adenosine A1 receptor)Inhibition of adenosine induced negative inotropic activity against guinea-pig atria (Adenosine A1 receptor)
ChEMBL 375 5 1 4 3.8 OCC[C@H]1CCCCN1C(=O)/C=C/c1c(nn2c1cccc2)c1ccccc1 10.1016/0960-894X(96)00368-X
CHEMBL440115 1644 None 20 Guinea pig Functional pIC50 = 5.9 5.9 5 7
Inhibition of adenosine induced negative inotropic activity against guinea-pig atria (Adenosine A1 receptor)Inhibition of adenosine induced negative inotropic activity against guinea-pig atria (Adenosine A1 receptor)
ChEMBL 375 5 1 4 3.8 OCC[C@H]1CCCCN1C(=O)/C=C/c1c(nn2c1cccc2)c1ccccc1 10.1016/0960-894X(96)00368-X
57388055 75511 None 0 Human Functional pIC50 = 5.9 5.9 -186 4
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation
ChEMBL 622 12 6 11 3.1 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(NCCc4ccc(N)cc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm300206u
CHEMBL2042306 75511 None 0 Human Functional pIC50 = 5.9 5.9 -186 4
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation
ChEMBL 622 12 6 11 3.1 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(NCCc4ccc(N)cc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm300206u
44452489 161372 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 469 5 3 9 0.9 C[Se]C[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@@H]5C[C@@H]4C4SC45)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmc.2007.11.010
CHEMBL412104 161372 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 469 5 3 9 0.9 C[Se]C[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@@H]5C[C@@H]4C4SC45)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmc.2007.11.010
118708235 113428 None 0 Human Functional pIC50 = 7.9 7.9 32 2
Antagonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of CCPA-stimulated cAMP level by scintillation counting analysisAntagonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of CCPA-stimulated cAMP level by scintillation counting analysis
ChEMBL 359 6 1 6 3.6 COc1ccccc1CCCc1nc(N)c2nn(-c3ccccc3)cc2n1 10.1016/j.ejmech.2014.07.060
CHEMBL3317575 113428 None 0 Human Functional pIC50 = 7.9 7.9 32 2
Antagonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of CCPA-stimulated cAMP level by scintillation counting analysisAntagonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of CCPA-stimulated cAMP level by scintillation counting analysis
ChEMBL 359 6 1 6 3.6 COc1ccccc1CCCc1nc(N)c2nn(-c3ccccc3)cc2n1 10.1016/j.ejmech.2014.07.060
168282045 191313 None 0 Human Functional pIC50 = 7.9 7.9 -1 2
Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 minsAntagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins
ChEMBL 496 10 3 8 5.1 COc1cc(Nc2nc(CNCc3cccnc3)cc3c(-c4ccccc4)n[nH]c23)cc(OC)c1OC 10.1021/acs.jmedchem.2c01123
CHEMBL5189470 191313 None 0 Human Functional pIC50 = 7.9 7.9 -1 2
Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 minsAntagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins
ChEMBL 496 10 3 8 5.1 COc1cc(Nc2nc(CNCc3cccnc3)cc3c(-c4ccccc4)n[nH]c23)cc(OC)c1OC 10.1021/acs.jmedchem.2c01123
57387596 75516 None 0 Human Functional pIC50 = 6.9 6.9 -61 4
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation
ChEMBL 492 7 4 9 1.6 CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(F)nc32)[C@H](O)[C@@H]1O 10.1021/jm300206u
CHEMBL2042311 75516 None 0 Human Functional pIC50 = 6.9 6.9 -61 4
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation
ChEMBL 492 7 4 9 1.6 CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(F)nc32)[C@H](O)[C@@H]1O 10.1021/jm300206u
1350383 171000 None 7 Human Functional pIC50 = 5.9 5.9 - 1
Antagonist activity at human A1AR expressed in CHO-K1 cells assessed as reduction in NECA-induced inhibition of forskolin-stimulated cAMP accumulation incubated for 30 mins by fluorescence based assayAntagonist activity at human A1AR expressed in CHO-K1 cells assessed as reduction in NECA-induced inhibition of forskolin-stimulated cAMP accumulation incubated for 30 mins by fluorescence based assay
ChEMBL 379 3 1 4 4.6 COc1ccc(-c2cc(-c3cccc(Br)c3)c(C#N)c(N)n2)cc1 10.1016/j.ejmech.2019.111936
CHEMBL4454608 171000 None 7 Human Functional pIC50 = 5.9 5.9 - 1
Antagonist activity at human A1AR expressed in CHO-K1 cells assessed as reduction in NECA-induced inhibition of forskolin-stimulated cAMP accumulation incubated for 30 mins by fluorescence based assayAntagonist activity at human A1AR expressed in CHO-K1 cells assessed as reduction in NECA-induced inhibition of forskolin-stimulated cAMP accumulation incubated for 30 mins by fluorescence based assay
ChEMBL 379 3 1 4 4.6 COc1ccc(-c2cc(-c3cccc(Br)c3)c(C#N)c(N)n2)cc1 10.1016/j.ejmech.2019.111936
73349104 91882 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometryAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometry
ChEMBL 909 22 5 13 6.5 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCCCCCCCCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1039/C2MD00247G
CHEMBL2413234 91882 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometryAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometry
ChEMBL 909 22 5 13 6.5 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCCCCCCCCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1039/C2MD00247G
52948995 17772 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 449 6 2 6 5.8 CCc1nn(-c2ccccc2C)c(Nc2ccccc2C(=O)O)c1-c1ccc2nccnc2c1 10.1016/j.bmcl.2010.07.095
CHEMBL1258730 17772 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 449 6 2 6 5.8 CCc1nn(-c2ccccc2C)c(Nc2ccccc2C(=O)O)c1-c1ccc2nccnc2c1 10.1016/j.bmcl.2010.07.095
145962355 161530 None 0 Human Functional pIC50 = 7.9 7.9 -2 3
Antagonist activity at human A1 adenosine receptor expressed in CHO cells assessed as inhibition of CCPA-induced reduction of forskolin-stimulated cAMP level after 30 mins by Alphascreen assayAntagonist activity at human A1 adenosine receptor expressed in CHO cells assessed as inhibition of CCPA-induced reduction of forskolin-stimulated cAMP level after 30 mins by Alphascreen assay
ChEMBL 363 5 2 7 4.0 COc1ccccc1CNc1nc(N)c2nc(-c3ccccc3)sc2n1 10.1016/j.bmc.2018.05.048
CHEMBL4127213 161530 None 0 Human Functional pIC50 = 7.9 7.9 -2 3
Antagonist activity at human A1 adenosine receptor expressed in CHO cells assessed as inhibition of CCPA-induced reduction of forskolin-stimulated cAMP level after 30 mins by Alphascreen assayAntagonist activity at human A1 adenosine receptor expressed in CHO cells assessed as inhibition of CCPA-induced reduction of forskolin-stimulated cAMP level after 30 mins by Alphascreen assay
ChEMBL 363 5 2 7 4.0 COc1ccccc1CNc1nc(N)c2nc(-c3ccccc3)sc2n1 10.1016/j.bmc.2018.05.048
168272324 190685 None 0 Human Functional pIC50 = 7.9 7.9 4 2
Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 minsAntagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins
ChEMBL 311 3 2 4 4.2 N#Cc1cc2c(-c3ccccc3)n[nH]c2c(Nc2ccccc2)n1 10.1021/acs.jmedchem.2c01123
CHEMBL5180268 190685 None 0 Human Functional pIC50 = 7.9 7.9 4 2
Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 minsAntagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins
ChEMBL 311 3 2 4 4.2 N#Cc1cc2c(-c3ccccc3)n[nH]c2c(Nc2ccccc2)n1 10.1021/acs.jmedchem.2c01123
46875432 204839 None 0 Rat Functional pIC50 = 4.9 4.9 - 1
Inhibition of adenylate cyclase via Adenosine A1 receptor in rat fat cell membranesInhibition of adenylate cyclase via Adenosine A1 receptor in rat fat cell membranes
ChEMBL 402 6 4 9 0.1 CCCCCC#Cc1nc(N)c2ncn(C3O[C@H](C(=O)NCC)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00091a003
CHEMBL610655 204839 None 0 Rat Functional pIC50 = 4.9 4.9 - 1
Inhibition of adenylate cyclase via Adenosine A1 receptor in rat fat cell membranesInhibition of adenylate cyclase via Adenosine A1 receptor in rat fat cell membranes
ChEMBL 402 6 4 9 0.1 CCCCCC#Cc1nc(N)c2ncn(C3O[C@H](C(=O)NCC)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00091a003
127046050 140178 None 0 Human Functional pIC50 = 6.9 6.9 -20 3
Antagonist activity at human adenosine A1 receptor expressed in CHO cell membranes assessed as suppression of CCPA-mediated inhibition of cAMP level by scintillation counting method in presence of [3H]-cyclic AMPAntagonist activity at human adenosine A1 receptor expressed in CHO cell membranes assessed as suppression of CCPA-mediated inhibition of cAMP level by scintillation counting method in presence of [3H]-cyclic AMP
ChEMBL 335 4 1 7 3.0 COc1cccc(Cn2cc3nc(-c4ccc(C)o4)nc(N)c3n2)c1 10.1016/j.bmc.2016.04.048
CHEMBL3800587 140178 None 0 Human Functional pIC50 = 6.9 6.9 -20 3
Antagonist activity at human adenosine A1 receptor expressed in CHO cell membranes assessed as suppression of CCPA-mediated inhibition of cAMP level by scintillation counting method in presence of [3H]-cyclic AMPAntagonist activity at human adenosine A1 receptor expressed in CHO cell membranes assessed as suppression of CCPA-mediated inhibition of cAMP level by scintillation counting method in presence of [3H]-cyclic AMP
ChEMBL 335 4 1 7 3.0 COc1cccc(Cn2cc3nc(-c4ccc(C)o4)nc(N)c3n2)c1 10.1016/j.bmc.2016.04.048
11587409 163091 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity at recombinant human adenosine A1 receptor transfected in CHO cells assessed as inhibition of CCPA-induced cAMP accumulation preincubated for 10 mins followed by CCPA addition by GloSensor cAMP assayAntagonist activity at recombinant human adenosine A1 receptor transfected in CHO cells assessed as inhibition of CCPA-induced cAMP accumulation preincubated for 10 mins followed by CCPA addition by GloSensor cAMP assay
ChEMBL 293 3 1 5 3.4 Cn1c(-c2ccccc2)nc2c(NC3CCCC3)ncnc21 10.1016/j.ejmech.2018.03.067
CHEMBL4175366 163091 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity at recombinant human adenosine A1 receptor transfected in CHO cells assessed as inhibition of CCPA-induced cAMP accumulation preincubated for 10 mins followed by CCPA addition by GloSensor cAMP assayAntagonist activity at recombinant human adenosine A1 receptor transfected in CHO cells assessed as inhibition of CCPA-induced cAMP accumulation preincubated for 10 mins followed by CCPA addition by GloSensor cAMP assay
ChEMBL 293 3 1 5 3.4 Cn1c(-c2ccccc2)nc2c(NC3CCCC3)ncnc21 10.1016/j.ejmech.2018.03.067
44451923 96180 None 1 Human Functional pIC50 = 5.9 5.9 - 1
Activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of CPA-induced decrease in forskolin-stimulated cAMP production by TR-FRET assayActivity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of CPA-induced decrease in forskolin-stimulated cAMP production by TR-FRET assay
ChEMBL 412 4 1 6 4.5 N#Cc1c(NC(=O)C2CCCC2)nc(-c2ccccc2)nc1-c1ccc2c(c1)OCO2 10.1016/j.bmc.2008.01.013
CHEMBL260396 96180 None 1 Human Functional pIC50 = 5.9 5.9 - 1
Activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of CPA-induced decrease in forskolin-stimulated cAMP production by TR-FRET assayActivity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of CPA-induced decrease in forskolin-stimulated cAMP production by TR-FRET assay
ChEMBL 412 4 1 6 4.5 N#Cc1c(NC(=O)C2CCCC2)nc(-c2ccccc2)nc1-c1ccc2c(c1)OCO2 10.1016/j.bmc.2008.01.013
46391804 171050 None 8 Human Functional pIC50 = 5.8 5.8 - 1
Antagonist activity at human A1AR expressed in CHO-K1 cells assessed as reduction in NECA-induced inhibition of forskolin-stimulated cAMP accumulation incubated for 30 mins by fluorescence based assayAntagonist activity at human A1AR expressed in CHO-K1 cells assessed as reduction in NECA-induced inhibition of forskolin-stimulated cAMP accumulation incubated for 30 mins by fluorescence based assay
ChEMBL 375 4 3 2 4.7 Cc1ccc(C(=O)Nc2c(C(=O)NC3CCCC3)[nH]c3ccc(C)cc23)cc1 10.1016/j.ejmech.2019.111936
CHEMBL4455491 171050 None 8 Human Functional pIC50 = 5.8 5.8 - 1
Antagonist activity at human A1AR expressed in CHO-K1 cells assessed as reduction in NECA-induced inhibition of forskolin-stimulated cAMP accumulation incubated for 30 mins by fluorescence based assayAntagonist activity at human A1AR expressed in CHO-K1 cells assessed as reduction in NECA-induced inhibition of forskolin-stimulated cAMP accumulation incubated for 30 mins by fluorescence based assay
ChEMBL 375 4 3 2 4.7 Cc1ccc(C(=O)Nc2c(C(=O)NC3CCCC3)[nH]c3ccc(C)cc23)cc1 10.1016/j.ejmech.2019.111936
44452533 95898 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 419 7 3 9 2.2 CCCSC[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@H]5CC[C@H]4C5)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmc.2007.11.010
CHEMBL258972 95898 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 419 7 3 9 2.2 CCCSC[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@H]5CC[C@H]4C5)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmc.2007.11.010
24939231 96064 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of CPA-induced decrease in forskolin-stimulated cAMP production by TR-FRET assayActivity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of CPA-induced decrease in forskolin-stimulated cAMP production by TR-FRET assay
ChEMBL 368 4 1 4 4.8 N#Cc1c(-c2ccccc2)nc(NC(=O)C2CCCC2)nc1-c1ccccc1 10.1016/j.bmc.2008.01.013
CHEMBL259704 96064 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of CPA-induced decrease in forskolin-stimulated cAMP production by TR-FRET assayActivity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of CPA-induced decrease in forskolin-stimulated cAMP production by TR-FRET assay
ChEMBL 368 4 1 4 4.8 N#Cc1c(-c2ccccc2)nc(NC(=O)C2CCCC2)nc1-c1ccccc1 10.1016/j.bmc.2008.01.013
127046495 139882 None 0 Human Functional pIC50 = 6.8 6.8 -13 2
Antagonist activity at human adenosine A1 receptor expressed in CHO cell membranes assessed as suppression of CCPA-mediated inhibition of cAMP level by scintillation counting method in presence of [3H]-cyclic AMPAntagonist activity at human adenosine A1 receptor expressed in CHO cell membranes assessed as suppression of CCPA-mediated inhibition of cAMP level by scintillation counting method in presence of [3H]-cyclic AMP
ChEMBL 305 3 1 6 3.0 Cc1ccc(-c2nc(N)c3nn(Cc4ccccc4)cc3n2)o1 10.1016/j.bmc.2016.04.048
CHEMBL3798754 139882 None 0 Human Functional pIC50 = 6.8 6.8 -13 2
Antagonist activity at human adenosine A1 receptor expressed in CHO cell membranes assessed as suppression of CCPA-mediated inhibition of cAMP level by scintillation counting method in presence of [3H]-cyclic AMPAntagonist activity at human adenosine A1 receptor expressed in CHO cell membranes assessed as suppression of CCPA-mediated inhibition of cAMP level by scintillation counting method in presence of [3H]-cyclic AMP
ChEMBL 305 3 1 6 3.0 Cc1ccc(-c2nc(N)c3nn(Cc4ccccc4)cc3n2)o1 10.1016/j.bmc.2016.04.048
46175652 17628 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 469 5 2 6 6.2 Cc1ccccc1-n1nc(C)c(-c2ccc3nccnc3c2)c1Nc1ccc(Cl)cc1C(=O)O 10.1016/j.bmcl.2010.07.095
CHEMBL1258283 17628 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 469 5 2 6 6.2 Cc1ccccc1-n1nc(C)c(-c2ccc3nccnc3c2)c1Nc1ccc(Cl)cc1C(=O)O 10.1016/j.bmcl.2010.07.095
25230950 152834 None 0 Human Functional pIC50 = 6.8 6.8 -3 4
Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.
ChEMBL 378 6 1 7 4.6 C=Cc1cc2nc(NCc3cccnc3)nc(C(=O)c3cccs3)c2s1 nan
CHEMBL3973260 152834 None 0 Human Functional pIC50 = 6.8 6.8 -3 4
Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.
ChEMBL 378 6 1 7 4.6 C=Cc1cc2nc(NCc3cccnc3)nc(C(=O)c3cccs3)c2s1 nan
46269815 190428 None 5 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at human adenosine A1A receptor expressed in CHO cells and measured by AlphaScreencAMP assayAntagonist activity at human adenosine A1A receptor expressed in CHO cells and measured by AlphaScreencAMP assay
ChEMBL 328 3 1 6 2.9 COc1cccc(C(=O)n2nc(-c3ccccc3Cl)nc2N)c1 10.1016/j.ejmech.2021.113907
CHEMBL5176292 190428 None 5 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at human adenosine A1A receptor expressed in CHO cells and measured by AlphaScreencAMP assayAntagonist activity at human adenosine A1A receptor expressed in CHO cells and measured by AlphaScreencAMP assay
ChEMBL 328 3 1 6 2.9 COc1cccc(C(=O)n2nc(-c3ccccc3Cl)nc2N)c1 10.1016/j.ejmech.2021.113907
6709746 166272 None 2 Rat Functional pIC50 = 7.8 7.8 1 2
Agonistic activity against adenosine A1 receptorAgonistic activity against adenosine A1 receptor
ChEMBL 356 7 2 6 3.6 COc1cc(-c2oc3c(OC)cc(CCCO)cc3c2C=O)ccc1O 10.1016/S0960-894X(00)80445-X
CHEMBL42639 166272 None 2 Rat Functional pIC50 = 7.8 7.8 1 2
Agonistic activity against adenosine A1 receptorAgonistic activity against adenosine A1 receptor
ChEMBL 356 7 2 6 3.6 COc1cc(-c2oc3c(OC)cc(CCCO)cc3c2C=O)ccc1O 10.1016/S0960-894X(00)80445-X
16109435 2379 None 10 Human Functional pIC50 = 5.8 5.8 - 1
Activity at human adenosine A1 receptor in CHO cells assessed as effect on CPA induced inhibition of forskolin-stimulated cAMP productionActivity at human adenosine A1 receptor in CHO cells assessed as effect on CPA induced inhibition of forskolin-stimulated cAMP production
ChEMBL 353 3 1 2 6.3 C1CCC(CC1)c1nc2c([nH]1)nc(cc2c1ccccc1)c1ccccc1 10.1021/jm0607956
5607 2379 None 10 Human Functional pIC50 = 5.8 5.8 - 1
Activity at human adenosine A1 receptor in CHO cells assessed as effect on CPA induced inhibition of forskolin-stimulated cAMP productionActivity at human adenosine A1 receptor in CHO cells assessed as effect on CPA induced inhibition of forskolin-stimulated cAMP production
ChEMBL 353 3 1 2 6.3 C1CCC(CC1)c1nc2c([nH]1)nc(cc2c1ccccc1)c1ccccc1 10.1021/jm0607956
CHEMBL219160 2379 None 10 Human Functional pIC50 = 5.8 5.8 - 1
Activity at human adenosine A1 receptor in CHO cells assessed as effect on CPA induced inhibition of forskolin-stimulated cAMP productionActivity at human adenosine A1 receptor in CHO cells assessed as effect on CPA induced inhibition of forskolin-stimulated cAMP production
ChEMBL 353 3 1 2 6.3 C1CCC(CC1)c1nc2c([nH]1)nc(cc2c1ccccc1)c1ccccc1 10.1021/jm0607956
135646528 170952 None 12 Human Functional pIC50 = 5.7 5.7 - 1
Antagonist activity at human A1AR expressed in CHO-K1 cells assessed as reduction in NECA-induced inhibition of forskolin-stimulated cAMP accumulation incubated for 30 mins by fluorescence based assayAntagonist activity at human A1AR expressed in CHO-K1 cells assessed as reduction in NECA-induced inhibition of forskolin-stimulated cAMP accumulation incubated for 30 mins by fluorescence based assay
ChEMBL 326 2 1 4 3.2 O=c1[nH]c(N2CCCC2)nc2nccc(-c3ccc(Cl)cc3)c12 10.1016/j.ejmech.2019.111936
CHEMBL4453937 170952 None 12 Human Functional pIC50 = 5.7 5.7 - 1
Antagonist activity at human A1AR expressed in CHO-K1 cells assessed as reduction in NECA-induced inhibition of forskolin-stimulated cAMP accumulation incubated for 30 mins by fluorescence based assayAntagonist activity at human A1AR expressed in CHO-K1 cells assessed as reduction in NECA-induced inhibition of forskolin-stimulated cAMP accumulation incubated for 30 mins by fluorescence based assay
ChEMBL 326 2 1 4 3.2 O=c1[nH]c(N2CCCC2)nc2nccc(-c3ccc(Cl)cc3)c12 10.1016/j.ejmech.2019.111936
10179175 138417 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysisAgonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis
ChEMBL 401 4 4 9 0.8 OC[C@H]1O[C@@H](n2cnc3c(NC45CC6CC(CC(C6)C4)C5)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.5b01402
CHEMBL3771290 138417 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysisAgonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis
ChEMBL 401 4 4 9 0.8 OC[C@H]1O[C@@H](n2cnc3c(NC45CC6CC(CC(C6)C4)C5)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.5b01402
25230881 6179 None 0 Human Functional pIC50 = 7.7 7.7 -1 4
Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.
ChEMBL 395 6 1 8 4.1 CN(C)c1cc2nc(NCc3cccnc3)nc(C(=O)c3cccs3)c2s1 nan
CHEMBL1081160 6179 None 0 Human Functional pIC50 = 7.7 7.7 -1 4
Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.
ChEMBL 395 6 1 8 4.1 CN(C)c1cc2nc(NCc3cccnc3)nc(C(=O)c3cccs3)c2s1 nan
90667757 109582 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometryAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometry
ChEMBL 915 22 5 16 3.1 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCOCCOCCOCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1039/C2MD00247G
CHEMBL3221341 109582 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometryAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometry
ChEMBL 915 22 5 16 3.1 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCOCCOCCOCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1039/C2MD00247G
168277716 190339 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Antagonist activity at human adenosine A1A receptor expressed in CHO cells and measured by AlphaScreencAMP assayAntagonist activity at human adenosine A1A receptor expressed in CHO cells and measured by AlphaScreencAMP assay
ChEMBL 331 2 1 4 4.1 Nc1nc(-c2ccccc2Cl)cn1C(=O)c1cccc(Cl)c1 10.1016/j.ejmech.2021.113907
CHEMBL5174932 190339 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Antagonist activity at human adenosine A1A receptor expressed in CHO cells and measured by AlphaScreencAMP assayAntagonist activity at human adenosine A1A receptor expressed in CHO cells and measured by AlphaScreencAMP assay
ChEMBL 331 2 1 4 4.1 Nc1nc(-c2ccccc2Cl)cn1C(=O)c1cccc(Cl)c1 10.1016/j.ejmech.2021.113907
167312186 190781 None 3 Human Functional pIC50 = 6.7 6.7 -2 2
Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 minsAntagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins
ChEMBL 401 6 2 7 4.3 COc1cc(Nc2nc(C#N)cc3c(-c4ccccc4)n[nH]c23)cc(OC)c1OC 10.1021/acs.jmedchem.2c01123
CHEMBL5181728 190781 None 3 Human Functional pIC50 = 6.7 6.7 -2 2
Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 minsAntagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins
ChEMBL 401 6 2 7 4.3 COc1cc(Nc2nc(C#N)cc3c(-c4ccccc4)n[nH]c23)cc(OC)c1OC 10.1021/acs.jmedchem.2c01123
73350675 91878 None 0 Human Functional pIC50 = 8.7 8.7 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometryAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometry
ChEMBL 783 13 5 13 3.0 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1039/C2MD00247G
CHEMBL2413230 91878 None 0 Human Functional pIC50 = 8.7 8.7 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometryAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometry
ChEMBL 783 13 5 13 3.0 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1039/C2MD00247G
2844 283 None 61 Human Functional pIC50 = 8.6 8.6 1 5
Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysisAgonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.5b01402
60961 283 None 61 Human Functional pIC50 = 8.6 8.6 1 5
Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysisAgonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.5b01402
60961.0 283 None 61 Human Functional pIC50 = 8.6 8.6 1 5
Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysisAgonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.5b01402
90 283 None 61 Human Functional pIC50 = 8.6 8.6 1 5
Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysisAgonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.5b01402
CHEMBL477 283 None 61 Human Functional pIC50 = 8.6 8.6 1 5
Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysisAgonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.5b01402
DB00640 283 None 61 Human Functional pIC50 = 8.6 8.6 1 5
Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysisAgonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.5b01402
118708236 113429 None 0 Human Functional pIC50 = 8.6 8.6 138 2
Antagonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of CCPA-stimulated cAMP level by scintillation counting analysisAntagonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of CCPA-stimulated cAMP level by scintillation counting analysis
ChEMBL 359 6 1 6 3.6 COc1cccc(CCCc2nc(N)c3nn(-c4ccccc4)cc3n2)c1 10.1016/j.ejmech.2014.07.060
CHEMBL3317576 113429 None 0 Human Functional pIC50 = 8.6 8.6 138 2
Antagonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of CCPA-stimulated cAMP level by scintillation counting analysisAntagonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of CCPA-stimulated cAMP level by scintillation counting analysis
ChEMBL 359 6 1 6 3.6 COc1cccc(CCCc2nc(N)c3nn(-c4ccccc4)cc3n2)c1 10.1016/j.ejmech.2014.07.060
44435358 91408 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Agonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulationAgonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulation
ChEMBL 462 4 4 11 0.4 CC(C)(C)OC(=O)N1[C@H]2CC[C@H]1[C@H](Nc1ncnc3c1ncn3[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)C2 10.1016/j.bmcl.2007.10.028
CHEMBL240279 91408 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Agonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulationAgonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulation
ChEMBL 462 4 4 11 0.4 CC(C)(C)OC(=O)N1[C@H]2CC[C@H]1[C@H](Nc1ncnc3c1ncn3[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)C2 10.1016/j.bmcl.2007.10.028
44452606 166524 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 379 4 3 8 1.3 O[C@@H]1[C@@H](CCl)O[C@@H](n2cnc3c(N[C@H]4C[C@H]5CC[C@H]4C5)ncnc32)[C@@H]1O 10.1016/j.bmc.2007.11.010
CHEMBL427737 166524 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 379 4 3 8 1.3 O[C@@H]1[C@@H](CCl)O[C@@H](n2cnc3c(N[C@H]4C[C@H]5CC[C@H]4C5)ncnc32)[C@@H]1O 10.1016/j.bmc.2007.11.010
168271362 190668 None 0 Human Functional pIC50 = 8.6 8.6 4 2
Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 minsAntagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins
ChEMBL 372 6 3 6 3.8 Cn1nc(NC(=O)CNc2ccccc2)c2cc(Nc3ccccc3)ncc21 10.1021/acs.jmedchem.2c01123
CHEMBL5180010 190668 None 0 Human Functional pIC50 = 8.6 8.6 4 2
Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 minsAntagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins
ChEMBL 372 6 3 6 3.8 Cn1nc(NC(=O)CNc2ccccc2)c2cc(Nc3ccccc3)ncc21 10.1021/acs.jmedchem.2c01123
380 1287 None 37 Human Functional pIC50 = 8.6 8.6 6 5
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 335 4 4 9 -0.2 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NC1CCCC1 10.1016/j.bmc.2007.11.010
657378 1287 None 37 Human Functional pIC50 = 8.6 8.6 6 5
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 335 4 4 9 -0.2 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NC1CCCC1 10.1016/j.bmc.2007.11.010
CHEMBL68738 1287 None 37 Human Functional pIC50 = 8.6 8.6 6 5
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 335 4 4 9 -0.2 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2NC1CCCC1 10.1016/j.bmc.2007.11.010
52947525 17666 None 0 Human Functional pIC50 = 8.6 8.6 389 3
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 451 6 2 7 5.2 COc1ccc(Nc2c(-c3ccc4nccnc4c3)c(C)nn2-c2ccccc2)c(C(=O)O)c1 10.1016/j.bmcl.2010.07.095
CHEMBL1258397 17666 None 0 Human Functional pIC50 = 8.6 8.6 389 3
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 451 6 2 7 5.2 COc1ccc(Nc2c(-c3ccc4nccnc4c3)c(C)nn2-c2ccccc2)c(C(=O)O)c1 10.1016/j.bmcl.2010.07.095
118708239 113432 None 0 Human Functional pIC50 = 8.5 8.5 109 2
Antagonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of CCPA-stimulated cAMP level by scintillation counting analysisAntagonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of CCPA-stimulated cAMP level by scintillation counting analysis
ChEMBL 345 5 2 6 3.3 Nc1nc(CCCc2cccc(O)c2)nc2cn(-c3ccccc3)nc12 10.1016/j.ejmech.2014.07.060
CHEMBL3317579 113432 None 0 Human Functional pIC50 = 8.5 8.5 109 2
Antagonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of CCPA-stimulated cAMP level by scintillation counting analysisAntagonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of CCPA-stimulated cAMP level by scintillation counting analysis
ChEMBL 345 5 2 6 3.3 Nc1nc(CCCc2cccc(O)c2)nc2cn(-c3ccccc3)nc12 10.1016/j.ejmech.2014.07.060
127026251 138362 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysisAgonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis
ChEMBL 442 5 4 9 1.0 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NC45CC6CC(CC(C6)C4)C5)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.5b01402
CHEMBL3770664 138362 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysisAgonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis
ChEMBL 442 5 4 9 1.0 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NC45CC6CC(CC(C6)C4)C5)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.5b01402
134138939 147495 None 0 Human Functional pIC50 = 8.5 8.5 4 2
Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 minsAntagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins
ChEMBL 410 6 2 6 5.0 COc1cc(Nc2nc(Cl)cc3c(-c4ccccc4)n[nH]c23)cc(OC)c1OC 10.1021/acs.jmedchem.2c01123
CHEMBL3929812 147495 None 0 Human Functional pIC50 = 8.5 8.5 4 2
Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 minsAntagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins
ChEMBL 410 6 2 6 5.0 COc1cc(Nc2nc(Cl)cc3c(-c4ccccc4)n[nH]c23)cc(OC)c1OC 10.1021/acs.jmedchem.2c01123
118723511 116401 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at human recombinant adenosine A1 receptor expressed in CHO cells assessed as inhibition of NECA-induced cAMP accumulation after 15 mins by liquid scintillation spectrometryAntagonist activity at human recombinant adenosine A1 receptor expressed in CHO cells assessed as inhibition of NECA-induced cAMP accumulation after 15 mins by liquid scintillation spectrometry
ChEMBL 435 5 0 6 5.0 CCc1nc2c(=O)n(Cc3ccccc3)nc(C3CCC3)c2c2cc(-c3ccccc3)nn12 10.1016/j.ejmech.2014.10.020
CHEMBL3359414 116401 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at human recombinant adenosine A1 receptor expressed in CHO cells assessed as inhibition of NECA-induced cAMP accumulation after 15 mins by liquid scintillation spectrometryAntagonist activity at human recombinant adenosine A1 receptor expressed in CHO cells assessed as inhibition of NECA-induced cAMP accumulation after 15 mins by liquid scintillation spectrometry
ChEMBL 435 5 0 6 5.0 CCc1nc2c(=O)n(Cc3ccccc3)nc(C3CCC3)c2c2cc(-c3ccccc3)nn12 10.1016/j.ejmech.2014.10.020
69612603 163213 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at recombinant human adenosine A1 receptor transfected in CHO cells assessed as inhibition of CCPA-induced cAMP accumulation preincubated for 10 mins followed by CCPA addition by GloSensor cAMP assayAntagonist activity at recombinant human adenosine A1 receptor transfected in CHO cells assessed as inhibition of CCPA-induced cAMP accumulation preincubated for 10 mins followed by CCPA addition by GloSensor cAMP assay
ChEMBL 304 5 2 4 2.5 CCCC1CCC(CCC)(n2c(=O)[nH]c3nc[nH]c3c2=O)C1 10.1016/j.ejmech.2018.03.067
CHEMBL4177295 163213 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at recombinant human adenosine A1 receptor transfected in CHO cells assessed as inhibition of CCPA-induced cAMP accumulation preincubated for 10 mins followed by CCPA addition by GloSensor cAMP assayAntagonist activity at recombinant human adenosine A1 receptor transfected in CHO cells assessed as inhibition of CCPA-induced cAMP accumulation preincubated for 10 mins followed by CCPA addition by GloSensor cAMP assay
ChEMBL 304 5 2 4 2.5 CCCC1CCC(CCC)(n2c(=O)[nH]c3nc[nH]c3c2=O)C1 10.1016/j.ejmech.2018.03.067
57387825 75505 None 0 Human Functional pIC50 = 5.7 5.7 -50 4
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation
ChEMBL 505 7 5 10 0.6 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(NCCc4ccc(Br)cc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm300206u
CHEMBL2042300 75505 None 0 Human Functional pIC50 = 5.7 5.7 -50 4
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation
ChEMBL 505 7 5 10 0.6 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(NCCc4ccc(Br)cc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm300206u
44452532 95853 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 471 6 3 9 3.0 O[C@@H]1[C@@H](CSc2ccccc2F)O[C@@H](n2cnc3c(N[C@H]4C[C@H]5CC[C@H]4C5)ncnc32)[C@@H]1O 10.1016/j.bmc.2007.11.010
CHEMBL258760 95853 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 471 6 3 9 3.0 O[C@@H]1[C@@H](CSc2ccccc2F)O[C@@H](n2cnc3c(N[C@H]4C[C@H]5CC[C@H]4C5)ncnc32)[C@@H]1O 10.1016/j.bmc.2007.11.010
11740457 96699 None 0 Human Functional pIC50 = 7.7 7.7 6 2
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 379 6 3 9 1.6 CCSC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmc.2007.11.010
CHEMBL263643 96699 None 0 Human Functional pIC50 = 7.7 7.7 6 2
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 379 6 3 9 1.6 CCSC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmc.2007.11.010
127046496 139976 None 0 Human Functional pIC50 = 7.7 7.7 -4 2
Antagonist activity at human adenosine A1 receptor expressed in CHO cell membranes assessed as suppression of CCPA-mediated inhibition of cAMP level by scintillation counting method in presence of [3H]-cyclic AMPAntagonist activity at human adenosine A1 receptor expressed in CHO cell membranes assessed as suppression of CCPA-mediated inhibition of cAMP level by scintillation counting method in presence of [3H]-cyclic AMP
ChEMBL 335 4 1 7 3.0 COc1ccccc1Cn1cc2nc(-c3ccc(C)o3)nc(N)c2n1 10.1016/j.bmc.2016.04.048
CHEMBL3799351 139976 None 0 Human Functional pIC50 = 7.7 7.7 -4 2
Antagonist activity at human adenosine A1 receptor expressed in CHO cell membranes assessed as suppression of CCPA-mediated inhibition of cAMP level by scintillation counting method in presence of [3H]-cyclic AMPAntagonist activity at human adenosine A1 receptor expressed in CHO cell membranes assessed as suppression of CCPA-mediated inhibition of cAMP level by scintillation counting method in presence of [3H]-cyclic AMP
ChEMBL 335 4 1 7 3.0 COc1ccccc1Cn1cc2nc(-c3ccc(C)o3)nc(N)c2n1 10.1016/j.bmc.2016.04.048
57384289 75508 None 0 Human Functional pIC50 = 5.7 5.7 -323 4
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation
ChEMBL 630 13 6 13 2.5 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(NCCc4ccc(NC(=O)CCCC[C@H]5CCSS5)cc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm300206u
CHEMBL2042303 75508 None 0 Human Functional pIC50 = 5.7 5.7 -323 4
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation
ChEMBL 630 13 6 13 2.5 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(NCCc4ccc(NC(=O)CCCC[C@H]5CCSS5)cc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm300206u
25230951 150387 None 0 Human Functional pIC50 = 6.7 6.7 -5 4
Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.
ChEMBL 380 6 1 7 4.6 CCc1cc2nc(NCc3cccnc3)nc(C(=O)c3cccs3)c2s1 nan
CHEMBL3952824 150387 None 0 Human Functional pIC50 = 6.7 6.7 -5 4
Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.
ChEMBL 380 6 1 7 4.6 CCc1cc2nc(NCc3cccnc3)nc(C(=O)c3cccs3)c2s1 nan
168286347 191801 None 0 Human Functional pIC50 = 7.6 7.6 -4 2
Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 minsAntagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins
ChEMBL 405 7 3 7 3.9 COc1cc(Nc2nc(CN)cc3c(-c4ccccc4)n[nH]c23)cc(OC)c1OC 10.1021/acs.jmedchem.2c01123
CHEMBL5196781 191801 None 0 Human Functional pIC50 = 7.6 7.6 -4 2
Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 minsAntagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins
ChEMBL 405 7 3 7 3.9 COc1cc(Nc2nc(CN)cc3c(-c4ccccc4)n[nH]c23)cc(OC)c1OC 10.1021/acs.jmedchem.2c01123
57384543 75513 None 0 Human Functional pIC50 = 5.7 5.7 -6 4
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation
ChEMBL 838 14 6 11 7.3 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(NCCc4ccc(NC(=O)c5cc(C(C)(C)C)cc(C(C)(C)C)c5)cc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm300206u
CHEMBL2042308 75513 None 0 Human Functional pIC50 = 5.7 5.7 -6 4
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation
ChEMBL 838 14 6 11 7.3 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(NCCc4ccc(NC(=O)c5cc(C(C)(C)C)cc(C(C)(C)C)c5)cc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm300206u
44452604 96154 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 377 4 4 9 1.0 O[C@@H]1[C@@H](CS)O[C@@H](n2cnc3c(N[C@H]4C[C@H]5CC[C@H]4C5)ncnc32)[C@@H]1O 10.1016/j.bmc.2007.11.010
CHEMBL260205 96154 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 377 4 4 9 1.0 O[C@@H]1[C@@H](CS)O[C@@H](n2cnc3c(N[C@H]4C[C@H]5CC[C@H]4C5)ncnc32)[C@@H]1O 10.1016/j.bmc.2007.11.010
10020580 108029 None 3 Rat Functional pIC50 = 5.6 5.6 -229 4
Inhibition of adenylate cyclase via adenosine A1 receptors in rat fat cell membranesInhibition of adenylate cyclase via adenosine A1 receptors in rat fat cell membranes
ChEMBL 347 4 4 9 -0.4 CCCCC#Cc1nc(N)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00091a003
CHEMBL319387 108029 None 3 Rat Functional pIC50 = 5.6 5.6 -229 4
Inhibition of adenylate cyclase via adenosine A1 receptors in rat fat cell membranesInhibition of adenylate cyclase via adenosine A1 receptors in rat fat cell membranes
ChEMBL 347 4 4 9 -0.4 CCCCC#Cc1nc(N)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00091a003
52942160 17564 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 457 6 2 7 5.3 COc1ccc(Nc2c(-c3ccc4c(c3)OCO4)c(C)nn2-c2ccccc2C)c(C(=O)O)c1 10.1016/j.bmcl.2010.07.095
CHEMBL1258053 17564 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 457 6 2 7 5.3 COc1ccc(Nc2c(-c3ccc4c(c3)OCO4)c(C)nn2-c2ccccc2C)c(C(=O)O)c1 10.1016/j.bmcl.2010.07.095
57384287 75506 None 0 Human Functional pIC50 = 5.6 5.6 -52 4
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation
ChEMBL 658 9 6 11 3.7 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(NCCc4ccc(NC(=O)c5cc(C(C)(C)C)cc(C(C)(C)C)c5)cc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm300206u
CHEMBL2042301 75506 None 0 Human Functional pIC50 = 5.6 5.6 -52 4
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation
ChEMBL 658 9 6 11 3.7 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(NCCc4ccc(NC(=O)c5cc(C(C)(C)C)cc(C(C)(C)C)c5)cc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm300206u
52947034 17563 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 473 8 2 7 5.6 COc1ccc(Nc2c(-c3ccc(OC)c(OC)c3)c(C)nn2-c2ccccc2C)c(C(=O)O)c1 10.1016/j.bmcl.2010.07.095
CHEMBL1258052 17563 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 473 8 2 7 5.6 COc1ccc(Nc2c(-c3ccc(OC)c(OC)c3)c(C)nn2-c2ccccc2C)c(C(=O)O)c1 10.1016/j.bmcl.2010.07.095
CHEMBL5075422 216860 None 4 Human Functional pIC50 = 7.6 7.6 -4 4
Antagonist activity at human recombinant adenosine A1 receptor transfected in HEK293 cells co-transfected with Galpha15/16 assessed as intracellular calcium change incubated for 10 mins by microplate reader methodAntagonist activity at human recombinant adenosine A1 receptor transfected in HEK293 cells co-transfected with Galpha15/16 assessed as intracellular calcium change incubated for 10 mins by microplate reader method
ChEMBL None None None Cn1cc(-c2cnc(N)n3nc(-c4ccco4)nc23)ccc1=O 10.1021/acsmedchemlett.1c00599
44435360 147162 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Agonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulationAgonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulation
ChEMBL 530 6 4 11 1.4 O=C(OCc1ccccc1Cl)N1[C@H]2CC[C@H]1[C@H](Nc1ncnc3c1ncn3[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)C2 10.1016/j.bmcl.2007.10.028
CHEMBL392720 147162 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Agonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulationAgonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulation
ChEMBL 530 6 4 11 1.4 O=C(OCc1ccccc1Cl)N1[C@H]2CC[C@H]1[C@H](Nc1ncnc3c1ncn3[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)C2 10.1016/j.bmcl.2007.10.028
25230952 146640 None 0 Human Functional pIC50 = 6.6 6.6 -3 4
Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.
ChEMBL 458 8 2 9 5.0 O=C(c1cccs1)c1nc(NCc2cccnc2)nc2cc(NCc3cccnc3)sc12 nan
CHEMBL3922797 146640 None 0 Human Functional pIC50 = 6.6 6.6 -3 4
Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.
ChEMBL 458 8 2 9 5.0 O=C(c1cccs1)c1nc(NCc2cccnc2)nc2cc(NCc3cccnc3)sc12 nan
73346045 91881 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometryAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometry
ChEMBL 867 19 5 13 5.4 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCCCCCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1039/C2MD00247G
CHEMBL2413233 91881 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometryAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometry
ChEMBL 867 19 5 13 5.4 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCCCCCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1039/C2MD00247G
73349125 92003 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonist activity at human adenosine A1 receptor expressed in CHO cells coexpressing cAMP response element assessed as inhibition of agonist-induced response after 1 hr by SPAP reporter gene assay in presence of forskolinAntagonist activity at human adenosine A1 receptor expressed in CHO cells coexpressing cAMP response element assessed as inhibition of agonist-induced response after 1 hr by SPAP reporter gene assay in presence of forskolin
ChEMBL 768 18 6 12 1.6 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCCNC(=O)CCCCCNC(=O)CCC4=CC5Cc6c(C)cc(C)n6[B-](F)(F)[N+]5=C4)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2012.10.112
CHEMBL2414812 92003 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonist activity at human adenosine A1 receptor expressed in CHO cells coexpressing cAMP response element assessed as inhibition of agonist-induced response after 1 hr by SPAP reporter gene assay in presence of forskolinAntagonist activity at human adenosine A1 receptor expressed in CHO cells coexpressing cAMP response element assessed as inhibition of agonist-induced response after 1 hr by SPAP reporter gene assay in presence of forskolin
ChEMBL 768 18 6 12 1.6 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCCNC(=O)CCCCCNC(=O)CCC4=CC5Cc6c(C)cc(C)n6[B-](F)(F)[N+]5=C4)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2012.10.112
52941354 17597 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 471 6 2 7 5.4 COc1ccc(Nc2c(-c3ccc4c(c3)OCCO4)c(C)nn2-c2ccccc2C)c(C(=O)O)c1 10.1016/j.bmcl.2010.07.095
CHEMBL1258169 17597 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 471 6 2 7 5.4 COc1ccc(Nc2c(-c3ccc4c(c3)OCCO4)c(C)nn2-c2ccccc2C)c(C(=O)O)c1 10.1016/j.bmcl.2010.07.095
11516306 79338 None 0 Rat Functional pIC50 = 5.6 5.6 - 1
Inhibition of adenylate cyclase via A1 receptors in rat fat cell membranesInhibition of adenylate cyclase via A1 receptors in rat fat cell membranes
ChEMBL 374 4 4 9 -0.7 CCCC#Cc1nc(N)c2ncn([C@@H]3O[C@H](C(=O)NCC)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00091a003
CHEMBL2113509 79338 None 0 Rat Functional pIC50 = 5.6 5.6 - 1
Inhibition of adenylate cyclase via A1 receptors in rat fat cell membranesInhibition of adenylate cyclase via A1 receptors in rat fat cell membranes
ChEMBL 374 4 4 9 -0.7 CCCC#Cc1nc(N)c2ncn([C@@H]3O[C@H](C(=O)NCC)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00091a003
46175914 17773 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 421 5 2 6 5.2 Cc1ccccc1-n1ncc(-c2ccc3nccnc3c2)c1Nc1ccccc1C(=O)O 10.1016/j.bmcl.2010.07.095
CHEMBL1258731 17773 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 421 5 2 6 5.2 Cc1ccccc1-n1ncc(-c2ccc3nccnc3c2)c1Nc1ccccc1C(=O)O 10.1016/j.bmcl.2010.07.095
44452564 96224 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 405 6 3 9 1.8 CCSC[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@H]5CC[C@H]4C5)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmc.2007.11.010
CHEMBL260631 96224 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 405 6 3 9 1.8 CCSC[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@H]5CC[C@H]4C5)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmc.2007.11.010
53131655 176250 None 7 Human Functional pIC50 = 5.6 5.6 - 1
Antagonist activity at human A1AR expressed in CHO-K1 cells assessed as reduction in NECA-induced inhibition of forskolin-stimulated cAMP accumulation incubated for 30 mins by fluorescence based assayAntagonist activity at human A1AR expressed in CHO-K1 cells assessed as reduction in NECA-induced inhibition of forskolin-stimulated cAMP accumulation incubated for 30 mins by fluorescence based assay
ChEMBL 416 6 1 5 3.7 O=C(Cn1cc(-c2ccccc2)c2ncn(C3CC3)c(=O)c21)NCc1ccc(F)cc1 10.1016/j.ejmech.2019.111936
CHEMBL4592514 176250 None 7 Human Functional pIC50 = 5.6 5.6 - 1
Antagonist activity at human A1AR expressed in CHO-K1 cells assessed as reduction in NECA-induced inhibition of forskolin-stimulated cAMP accumulation incubated for 30 mins by fluorescence based assayAntagonist activity at human A1AR expressed in CHO-K1 cells assessed as reduction in NECA-induced inhibition of forskolin-stimulated cAMP accumulation incubated for 30 mins by fluorescence based assay
ChEMBL 416 6 1 5 3.7 O=C(Cn1cc(-c2ccccc2)c2ncn(C3CC3)c(=O)c21)NCc1ccc(F)cc1 10.1016/j.ejmech.2019.111936
73350967 92666 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonist activity at human recombinant adenosine A1 receptor expressed in CHO cells assessed as inhibition of NECA-mediated reduction of intracellular [3H]-cAMP accumulation incubated for 15 mins prior to NECA induction measured after 30 mins by liquid scintillation spectrometric analysis in presence of forskolinAntagonist activity at human recombinant adenosine A1 receptor expressed in CHO cells assessed as inhibition of NECA-mediated reduction of intracellular [3H]-cAMP accumulation incubated for 15 mins prior to NECA induction measured after 30 mins by liquid scintillation spectrometric analysis in presence of forskolin
ChEMBL 329 5 0 4 4.3 O=C(C(=O)c1cn(Cc2ccccc2)c2ccccc12)c1ccco1 10.1016/j.ejmech.2013.09.001
CHEMBL2435537 92666 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonist activity at human recombinant adenosine A1 receptor expressed in CHO cells assessed as inhibition of NECA-mediated reduction of intracellular [3H]-cAMP accumulation incubated for 15 mins prior to NECA induction measured after 30 mins by liquid scintillation spectrometric analysis in presence of forskolinAntagonist activity at human recombinant adenosine A1 receptor expressed in CHO cells assessed as inhibition of NECA-mediated reduction of intracellular [3H]-cAMP accumulation incubated for 15 mins prior to NECA induction measured after 30 mins by liquid scintillation spectrometric analysis in presence of forskolin
ChEMBL 329 5 0 4 4.3 O=C(C(=O)c1cn(Cc2ccccc2)c2ccccc12)c1ccco1 10.1016/j.ejmech.2013.09.001
146207 79325 None 17 Rat Functional pIC50 = 5.5 5.5 - 1
Inhibition of adenylate cyclase via adenosine A1 receptors in rat fat cell membranesInhibition of adenylate cyclase via adenosine A1 receptors in rat fat cell membranes
ChEMBL 375 6 4 9 0.3 CCCCCCC#Cc1nc(N)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00091a003
CHEMBL2113496 79325 None 17 Rat Functional pIC50 = 5.5 5.5 - 1
Inhibition of adenylate cyclase via adenosine A1 receptors in rat fat cell membranesInhibition of adenylate cyclase via adenosine A1 receptors in rat fat cell membranes
ChEMBL 375 6 4 9 0.3 CCCCCCC#Cc1nc(N)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00091a003
52945627 17534 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 449 6 2 5 5.9 COc1ccc(Nc2c(-c3ccc(F)c(F)c3)c(C)nn2-c2ccccc2C)c(C(=O)O)c1 10.1016/j.bmcl.2010.07.095
CHEMBL1257941 17534 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 449 6 2 5 5.9 COc1ccc(Nc2c(-c3ccc(F)c(F)c3)c(C)nn2-c2ccccc2C)c(C(=O)O)c1 10.1016/j.bmcl.2010.07.095
52942696 17466 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 427 6 2 5 5.9 COc1ccc(Nc2c(-c3ccc(C)cc3)c(C)nn2-c2ccccc2C)c(C(=O)O)c1 10.1016/j.bmcl.2010.07.095
CHEMBL1257703 17466 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 427 6 2 5 5.9 COc1ccc(Nc2c(-c3ccc(C)cc3)c(C)nn2-c2ccccc2C)c(C(=O)O)c1 10.1016/j.bmcl.2010.07.095
44435356 91407 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Agonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulationAgonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulation
ChEMBL 470 6 4 11 0.3 O=C(OCc1ccccc1)N1CC[C@@H](Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C1 10.1016/j.bmcl.2007.10.028
CHEMBL240278 91407 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Agonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulationAgonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulation
ChEMBL 470 6 4 11 0.3 O=C(OCc1ccccc1)N1CC[C@@H](Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C1 10.1016/j.bmcl.2007.10.028
52946211 17598 None 0 Human Functional pIC50 = 8.5 8.5 3981 2
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 465 6 2 7 5.6 COc1ccc(Nc2c(-c3ccc4nccnc4c3)c(C)nn2-c2ccccc2C)c(C(=O)O)c1 10.1016/j.bmcl.2010.07.095
CHEMBL1258170 17598 None 0 Human Functional pIC50 = 8.5 8.5 3981 2
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 465 6 2 7 5.6 COc1ccc(Nc2c(-c3ccc4nccnc4c3)c(C)nn2-c2ccccc2C)c(C(=O)O)c1 10.1016/j.bmcl.2010.07.095
168276434 190227 None 0 Human Functional pIC50 = 8.5 8.5 1 2
Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 minsAntagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins
ChEMBL 367 6 2 7 3.7 COc1cc(Nc2nc(C#N)cc3c(C(C)C)n[nH]c23)cc(OC)c1OC 10.1021/acs.jmedchem.2c01123
CHEMBL5173159 190227 None 0 Human Functional pIC50 = 8.5 8.5 1 2
Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 minsAntagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins
ChEMBL 367 6 2 7 3.7 COc1cc(Nc2nc(C#N)cc3c(C(C)C)n[nH]c23)cc(OC)c1OC 10.1021/acs.jmedchem.2c01123
168278837 191005 None 0 Human Functional pIC50 = 8.4 8.4 1 2
Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 minsAntagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins
ChEMBL 495 10 3 7 5.7 COc1cc(Nc2nc(CNCc3ccccc3)cc3c(-c4ccccc4)n[nH]c23)cc(OC)c1OC 10.1021/acs.jmedchem.2c01123
CHEMBL5185003 191005 None 0 Human Functional pIC50 = 8.4 8.4 1 2
Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 minsAntagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins
ChEMBL 495 10 3 7 5.7 COc1cc(Nc2nc(CNCc3ccccc3)cc3c(-c4ccccc4)n[nH]c23)cc(OC)c1OC 10.1021/acs.jmedchem.2c01123
9797705 79340 None 4 Rat Functional pIC50 = 5.5 5.5 - 1
Inhibition of adenylate cyclase via adenosine A1 receptors in rat fat cell membranesInhibition of adenylate cyclase via adenosine A1 receptors in rat fat cell membranes
ChEMBL 333 3 4 9 -0.8 CCCC#Cc1nc(N)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00091a003
CHEMBL2113510 79340 None 4 Rat Functional pIC50 = 5.5 5.5 - 1
Inhibition of adenylate cyclase via adenosine A1 receptors in rat fat cell membranesInhibition of adenylate cyclase via adenosine A1 receptors in rat fat cell membranes
ChEMBL 333 3 4 9 -0.8 CCCC#Cc1nc(N)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00091a003
52941986 17535 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 443 7 2 6 5.6 COc1ccc(-c2c(C)nn(-c3ccccc3C)c2Nc2ccc(OC)cc2C(=O)O)cc1 10.1016/j.bmcl.2010.07.095
CHEMBL1257942 17535 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 443 7 2 6 5.6 COc1ccc(-c2c(C)nn(-c3ccccc3C)c2Nc2ccc(OC)cc2C(=O)O)cc1 10.1016/j.bmcl.2010.07.095
11536894 163208 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at recombinant human adenosine A1 receptor transfected in CHO cells assessed as inhibition of CCPA-induced cAMP accumulation preincubated for 10 mins followed by CCPA addition by GloSensor cAMP assayAntagonist activity at recombinant human adenosine A1 receptor transfected in CHO cells assessed as inhibition of CCPA-induced cAMP accumulation preincubated for 10 mins followed by CCPA addition by GloSensor cAMP assay
ChEMBL 311 3 1 5 3.5 Cn1c(-c2ccc(F)cc2)nc2c(NC3CCCC3)ncnc21 10.1016/j.ejmech.2018.03.067
CHEMBL4177249 163208 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at recombinant human adenosine A1 receptor transfected in CHO cells assessed as inhibition of CCPA-induced cAMP accumulation preincubated for 10 mins followed by CCPA addition by GloSensor cAMP assayAntagonist activity at recombinant human adenosine A1 receptor transfected in CHO cells assessed as inhibition of CCPA-induced cAMP accumulation preincubated for 10 mins followed by CCPA addition by GloSensor cAMP assay
ChEMBL 311 3 1 5 3.5 Cn1c(-c2ccc(F)cc2)nc2c(NC3CCCC3)ncnc21 10.1016/j.ejmech.2018.03.067
57387824 75504 None 0 Human Functional pIC50 = 6.5 6.5 -22 4
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation
ChEMBL 442 7 6 11 -0.6 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(NCCc4ccc(N)cc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm300206u
CHEMBL2042299 75504 None 0 Human Functional pIC50 = 6.5 6.5 -22 4
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation
ChEMBL 442 7 6 11 -0.6 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(NCCc4ccc(N)cc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm300206u
13830114 79336 None 0 Rat Functional pIC50 = 5.5 5.5 - 1
Inhibition of adenylate cyclase via adenosine A1 receptors in rat fat cell membranesInhibition of adenylate cyclase via adenosine A1 receptors in rat fat cell membranes
ChEMBL 361 5 4 9 -0.0 CCCCCC#Cc1nc(N)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00091a003
CHEMBL2113507 79336 None 0 Rat Functional pIC50 = 5.5 5.5 - 1
Inhibition of adenylate cyclase via adenosine A1 receptors in rat fat cell membranesInhibition of adenylate cyclase via adenosine A1 receptors in rat fat cell membranes
ChEMBL 361 5 4 9 -0.0 CCCCCC#Cc1nc(N)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00091a003
44435357 145021 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Agonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulationAgonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulation
ChEMBL 362 4 5 10 -1.3 OC[C@H]1O[C@@H](n2cnc3c(NC4CC5CCC4N5)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2007.10.028
CHEMBL391031 145021 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Agonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulationAgonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulation
ChEMBL 362 4 5 10 -1.3 OC[C@H]1O[C@@H](n2cnc3c(NC4CC5CCC4N5)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2007.10.028
44452488 96972 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 360 4 4 9 0.0 NC[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@H]5CC[C@H]4C5)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmc.2007.11.010
CHEMBL265947 96972 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 360 4 4 9 0.0 NC[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@H]5CC[C@H]4C5)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmc.2007.11.010
145962202 161632 None 0 Human Functional pIC50 = 7.4 7.4 1 3
Antagonist activity at human A1 adenosine receptor expressed in CHO cells assessed as inhibition of CCPA-induced reduction of forskolin-stimulated cAMP level after 30 mins by Alphascreen assayAntagonist activity at human A1 adenosine receptor expressed in CHO cells assessed as inhibition of CCPA-induced reduction of forskolin-stimulated cAMP level after 30 mins by Alphascreen assay
ChEMBL 363 5 2 7 4.0 COc1cccc(CNc2nc(N)c3nc(-c4ccccc4)sc3n2)c1 10.1016/j.bmc.2018.05.048
CHEMBL4128596 161632 None 0 Human Functional pIC50 = 7.4 7.4 1 3
Antagonist activity at human A1 adenosine receptor expressed in CHO cells assessed as inhibition of CCPA-induced reduction of forskolin-stimulated cAMP level after 30 mins by Alphascreen assayAntagonist activity at human A1 adenosine receptor expressed in CHO cells assessed as inhibition of CCPA-induced reduction of forskolin-stimulated cAMP level after 30 mins by Alphascreen assay
ChEMBL 363 5 2 7 4.0 COc1cccc(CNc2nc(N)c3nc(-c4ccccc4)sc3n2)c1 10.1016/j.bmc.2018.05.048
127026252 138273 None 0 Human Functional pIC50 = 7.4 7.4 -24 2
Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysisAgonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis
ChEMBL 458 5 5 10 0.1 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NC45CC6CC(CC(O)(C6)C4)C5)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.5b01402
CHEMBL3769641 138273 None 0 Human Functional pIC50 = 7.4 7.4 -24 2
Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysisAgonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis
ChEMBL 458 5 5 10 0.1 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NC45CC6CC(CC(O)(C6)C4)C5)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.5b01402
44435354 91406 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Agonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulationAgonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulation
ChEMBL 436 4 4 11 -0.1 CC(C)(C)OC(=O)N1CC[C@@H](Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C1 10.1016/j.bmcl.2007.10.028
CHEMBL240277 91406 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Agonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulationAgonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulation
ChEMBL 436 4 4 11 -0.1 CC(C)(C)OC(=O)N1CC[C@@H](Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C1 10.1016/j.bmcl.2007.10.028
57385043 75515 None 0 Human Functional pIC50 = 5.4 5.4 -43 4
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation
ChEMBL 810 18 6 13 6.1 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(NCCc4ccc(NC(=O)CCCC[C@H]5CCSS5)cc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm300206u
CHEMBL2042310 75515 None 0 Human Functional pIC50 = 5.4 5.4 -43 4
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation
ChEMBL 810 18 6 13 6.1 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(NCCc4ccc(NC(=O)CCCC[C@H]5CCSS5)cc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm300206u
57384288 75507 None 0 Human Functional pIC50 = 5.4 5.4 -281 4
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation
ChEMBL 674 9 7 12 3.4 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(NCCc4ccc(NC(=O)c5cc(C(C)(C)C)c(O)c(C(C)(C)C)c5)cc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm300206u
CHEMBL2042302 75507 None 0 Human Functional pIC50 = 5.4 5.4 -281 4
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation
ChEMBL 674 9 7 12 3.4 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(NCCc4ccc(NC(=O)c5cc(C(C)(C)C)c(O)c(C(C)(C)C)c5)cc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm300206u
118708238 113431 None 0 Human Functional pIC50 = 8.4 8.4 57 2
Antagonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of CCPA-stimulated cAMP level by scintillation counting analysisAntagonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of CCPA-stimulated cAMP level by scintillation counting analysis
ChEMBL 345 5 2 6 3.3 Nc1nc(CCCc2ccccc2O)nc2cn(-c3ccccc3)nc12 10.1016/j.ejmech.2014.07.060
CHEMBL3317578 113431 None 0 Human Functional pIC50 = 8.4 8.4 57 2
Antagonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of CCPA-stimulated cAMP level by scintillation counting analysisAntagonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of CCPA-stimulated cAMP level by scintillation counting analysis
ChEMBL 345 5 2 6 3.3 Nc1nc(CCCc2ccccc2O)nc2cn(-c3ccccc3)nc12 10.1016/j.ejmech.2014.07.060
44343895 10534 None 1 Human Functional pIC50 = 8.4 8.4 -1 2
Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysisAgonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis
ChEMBL 351 4 5 10 -1.2 OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4O)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.5b01402
CHEMBL116903 10534 None 1 Human Functional pIC50 = 8.4 8.4 -1 2
Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysisAgonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis
ChEMBL 351 4 5 10 -1.2 OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4O)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.5b01402
168281982 191305 None 0 Human Functional pIC50 = 8.3 8.3 -1 2
Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 minsAntagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins
ChEMBL 516 10 3 8 4.8 COc1cc(Nc2nc(CNCC3CCN(C)CC3)cc3c(-c4ccccc4)n[nH]c23)cc(OC)c1OC 10.1021/acs.jmedchem.2c01123
CHEMBL5189274 191305 None 0 Human Functional pIC50 = 8.3 8.3 -1 2
Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 minsAntagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins
ChEMBL 516 10 3 8 4.8 COc1cc(Nc2nc(CNCC3CCN(C)CC3)cc3c(-c4ccccc4)n[nH]c23)cc(OC)c1OC 10.1021/acs.jmedchem.2c01123
52941463 17465 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 455 7 2 6 5.8 COc1ccc(Nc2c(-c3ccc(C(C)=O)cc3)c(C)nn2-c2ccccc2C)c(C(=O)O)c1 10.1016/j.bmcl.2010.07.095
CHEMBL1257702 17465 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 455 7 2 6 5.8 COc1ccc(Nc2c(-c3ccc(C(C)=O)cc3)c(C)nn2-c2ccccc2C)c(C(=O)O)c1 10.1016/j.bmcl.2010.07.095
73347862 92665 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity at human recombinant adenosine A1 receptor expressed in CHO cells assessed as inhibition of NECA-mediated reduction of intracellular [3H]-cAMP accumulation incubated for 15 mins prior to NECA induction measured after 30 mins by liquid scintillation spectrometric analysis in presence of forskolinAntagonist activity at human recombinant adenosine A1 receptor expressed in CHO cells assessed as inhibition of NECA-mediated reduction of intracellular [3H]-cAMP accumulation incubated for 15 mins prior to NECA induction measured after 30 mins by liquid scintillation spectrometric analysis in presence of forskolin
ChEMBL 339 5 0 3 4.8 O=C(C(=O)c1cn(Cc2ccccc2)c2ccccc12)c1ccccc1 10.1016/j.ejmech.2013.09.001
CHEMBL2435536 92665 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity at human recombinant adenosine A1 receptor expressed in CHO cells assessed as inhibition of NECA-mediated reduction of intracellular [3H]-cAMP accumulation incubated for 15 mins prior to NECA induction measured after 30 mins by liquid scintillation spectrometric analysis in presence of forskolinAntagonist activity at human recombinant adenosine A1 receptor expressed in CHO cells assessed as inhibition of NECA-mediated reduction of intracellular [3H]-cAMP accumulation incubated for 15 mins prior to NECA induction measured after 30 mins by liquid scintillation spectrometric analysis in presence of forskolin
ChEMBL 339 5 0 3 4.8 O=C(C(=O)c1cn(Cc2ccccc2)c2ccccc12)c1ccccc1 10.1016/j.ejmech.2013.09.001
44452690 98944 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 434 4 4 11 0.1 CNC(=O)O[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@@H]5C[C@@H]4C4SC45)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmc.2007.11.010
CHEMBL279161 98944 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 434 4 4 11 0.1 CNC(=O)O[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@@H]5C[C@@H]4C4SC45)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmc.2007.11.010
679358 172135 None 12 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity at human A1AR expressed in CHO-K1 cells assessed as reduction in NECA-induced inhibition of forskolin-stimulated cAMP accumulation incubated for 30 mins by fluorescence based assayAntagonist activity at human A1AR expressed in CHO-K1 cells assessed as reduction in NECA-induced inhibition of forskolin-stimulated cAMP accumulation incubated for 30 mins by fluorescence based assay
ChEMBL 293 1 1 5 2.8 N#Cc1c(N)nc2c(c1-c1ccc3c(c1)OCO3)CCCC2 10.1016/j.ejmech.2019.111936
CHEMBL4471671 172135 None 12 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity at human A1AR expressed in CHO-K1 cells assessed as reduction in NECA-induced inhibition of forskolin-stimulated cAMP accumulation incubated for 30 mins by fluorescence based assayAntagonist activity at human A1AR expressed in CHO-K1 cells assessed as reduction in NECA-induced inhibition of forskolin-stimulated cAMP accumulation incubated for 30 mins by fluorescence based assay
ChEMBL 293 1 1 5 2.8 N#Cc1c(N)nc2c(c1-c1ccc3c(c1)OCO3)CCCC2 10.1016/j.ejmech.2019.111936
44452381 160923 None 0 Human Functional pIC50 = 5.4 5.4 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 388 5 3 9 0.6 CN(C)C[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@H]5CC[C@H]4C5)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmc.2007.11.010
CHEMBL411463 160923 None 0 Human Functional pIC50 = 5.4 5.4 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 388 5 3 9 0.6 CN(C)C[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@H]5CC[C@H]4C5)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmc.2007.11.010
57388056 75512 None 0 Human Functional pIC50 = 6.4 6.4 -13 4
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation
ChEMBL 685 12 5 10 4.2 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(NCCc4ccc(Br)cc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm300206u
CHEMBL2042307 75512 None 0 Human Functional pIC50 = 6.4 6.4 -13 4
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation
ChEMBL 685 12 5 10 4.2 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(NCCc4ccc(Br)cc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm300206u
118708234 113427 None 0 Human Functional pIC50 = 7.4 7.4 10 3
Antagonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of CCPA-stimulated cAMP level by scintillation counting analysisAntagonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of CCPA-stimulated cAMP level by scintillation counting analysis
ChEMBL 329 5 1 5 3.6 Nc1nc(CCCc2ccccc2)nc2cn(-c3ccccc3)nc12 10.1016/j.ejmech.2014.07.060
CHEMBL3317574 113427 None 0 Human Functional pIC50 = 7.4 7.4 10 3
Antagonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of CCPA-stimulated cAMP level by scintillation counting analysisAntagonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of CCPA-stimulated cAMP level by scintillation counting analysis
ChEMBL 329 5 1 5 3.6 Nc1nc(CCCc2ccccc2)nc2cn(-c3ccccc3)nc12 10.1016/j.ejmech.2014.07.060
11681092 162806 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at recombinant human adenosine A1 receptor transfected in CHO cells assessed as inhibition of CCPA-induced cAMP accumulation preincubated for 10 mins followed by CCPA addition by GloSensor cAMP assayAntagonist activity at recombinant human adenosine A1 receptor transfected in CHO cells assessed as inhibition of CCPA-induced cAMP accumulation preincubated for 10 mins followed by CCPA addition by GloSensor cAMP assay
ChEMBL 307 3 1 5 3.7 Cc1cccc(-c2nc3c(NC4CCCC4)ncnc3n2C)c1 10.1016/j.ejmech.2018.03.067
CHEMBL4170850 162806 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at recombinant human adenosine A1 receptor transfected in CHO cells assessed as inhibition of CCPA-induced cAMP accumulation preincubated for 10 mins followed by CCPA addition by GloSensor cAMP assayAntagonist activity at recombinant human adenosine A1 receptor transfected in CHO cells assessed as inhibition of CCPA-induced cAMP accumulation preincubated for 10 mins followed by CCPA addition by GloSensor cAMP assay
ChEMBL 307 3 1 5 3.7 Cc1cccc(-c2nc3c(NC4CCCC4)ncnc3n2C)c1 10.1016/j.ejmech.2018.03.067
52941478 17701 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 457 6 2 7 5.8 COc1ccc(Nc2c(-c3ccc4nccnc4c3)c(C)nn2C2CCCCC2)c(C(=O)O)c1 10.1016/j.bmcl.2010.07.095
CHEMBL1258505 17701 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 457 6 2 7 5.8 COc1ccc(Nc2c(-c3ccc4nccnc4c3)c(C)nn2C2CCCCC2)c(C(=O)O)c1 10.1016/j.bmcl.2010.07.095
164437 64 None 20 Rat Functional pIC50 = 5.4 5.4 -7 2
Inhibition of adenylate cyclase via adenosine A1 receptors in rat fat cell membranesInhibition of adenylate cyclase via adenosine A1 receptors in rat fat cell membranes
ChEMBL 388 5 4 9 -0.3 CCCCC#Cc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)C(=O)NCC 10.1021/jm00091a003
373 64 None 20 Rat Functional pIC50 = 5.4 5.4 -7 2
Inhibition of adenylate cyclase via adenosine A1 receptors in rat fat cell membranesInhibition of adenylate cyclase via adenosine A1 receptors in rat fat cell membranes
ChEMBL 388 5 4 9 -0.3 CCCCC#Cc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)C(=O)NCC 10.1021/jm00091a003
CHEMBL410873 64 None 20 Rat Functional pIC50 = 5.4 5.4 -7 2
Inhibition of adenylate cyclase via adenosine A1 receptors in rat fat cell membranesInhibition of adenylate cyclase via adenosine A1 receptors in rat fat cell membranes
ChEMBL 388 5 4 9 -0.3 CCCCC#Cc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)C(=O)NCC 10.1021/jm00091a003
393595 2637 None 36 Human Functional pIC50 = 7.3 7.3 -16 3
Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 minsAntagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins
ChEMBL 403 4 1 6 4.4 O=C(Nc1nc2ccc(cc2c2n1nc(n2)c1ccco1)Cl)Cc1ccccc1 10.1021/acs.jmedchem.2c01123
448 2637 None 36 Human Functional pIC50 = 7.3 7.3 -16 3
Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 minsAntagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins
ChEMBL 403 4 1 6 4.4 O=C(Nc1nc2ccc(cc2c2n1nc(n2)c1ccco1)Cl)Cc1ccccc1 10.1021/acs.jmedchem.2c01123
CHEMBL88147 2637 None 36 Human Functional pIC50 = 7.3 7.3 -16 3
Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 minsAntagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins
ChEMBL 403 4 1 6 4.4 O=C(Nc1nc2ccc(cc2c2n1nc(n2)c1ccco1)Cl)Cc1ccccc1 10.1021/acs.jmedchem.2c01123
11523232 77129 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Activity against human adenosine A1 receptor in CHO cells assessed by the antagonizing effect of 100 nM CPA on forskolin-induced cAMP productionActivity against human adenosine A1 receptor in CHO cells assessed by the antagonizing effect of 100 nM CPA on forskolin-induced cAMP production
ChEMBL 354 3 1 3 5.7 c1ccc(-c2nc(-c3ccccc3)c3nc(C4CCCCC4)nc-3[nH]2)cc1 10.1021/jm050640i
CHEMBL207529 77129 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Activity against human adenosine A1 receptor in CHO cells assessed by the antagonizing effect of 100 nM CPA on forskolin-induced cAMP productionActivity against human adenosine A1 receptor in CHO cells assessed by the antagonizing effect of 100 nM CPA on forskolin-induced cAMP production
ChEMBL 354 3 1 3 5.7 c1ccc(-c2nc(-c3ccccc3)c3nc(C4CCCCC4)nc-3[nH]2)cc1 10.1021/jm050640i
44452509 96591 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 439 5 3 8 1.2 C[Se]C[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@H]5CC[C@H]4C5)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmc.2007.11.010
CHEMBL262876 96591 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 439 5 3 8 1.2 C[Se]C[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@H]5CC[C@H]4C5)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmc.2007.11.010
44452429 160687 None 0 Human Functional pIC50 = 5.3 5.3 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 402 7 4 9 1.0 CCCNC[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@H]5CC[C@H]4C5)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmc.2007.11.010
CHEMBL411279 160687 None 0 Human Functional pIC50 = 5.3 5.3 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 402 7 4 9 1.0 CCCNC[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@H]5CC[C@H]4C5)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmc.2007.11.010
134141301 147145 None 0 Human Functional pIC50 = 8.3 8.3 -1 2
Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 minsAntagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins
ChEMBL 376 6 2 6 4.5 COc1cc(Nc2nc(Cl)cc3c(C(C)C)n[nH]c23)cc(OC)c1OC 10.1021/acs.jmedchem.2c01123
CHEMBL3927012 147145 None 0 Human Functional pIC50 = 8.3 8.3 -1 2
Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 minsAntagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins
ChEMBL 376 6 2 6 4.5 COc1cc(Nc2nc(Cl)cc3c(C(C)C)n[nH]c23)cc(OC)c1OC 10.1021/acs.jmedchem.2c01123
168280255 191081 None 0 Human Functional pIC50 = 8.3 8.3 1 2
Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 minsAntagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins
ChEMBL 343 4 2 5 4.0 Cn1nc(NC(=O)c2ccccc2)c2cc(Nc3ccccc3)ncc21 10.1021/acs.jmedchem.2c01123
CHEMBL5186062 191081 None 0 Human Functional pIC50 = 8.3 8.3 1 2
Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 minsAntagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins
ChEMBL 343 4 2 5 4.0 Cn1nc(NC(=O)c2ccccc2)c2cc(Nc3ccccc3)ncc21 10.1021/acs.jmedchem.2c01123
46175736 17629 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 449 5 2 6 5.9 Cc1ccc(Nc2c(-c3ccc4nccnc4c3)c(C)nn2-c2ccccc2C)c(C(=O)O)c1 10.1016/j.bmcl.2010.07.095
CHEMBL1258284 17629 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 449 5 2 6 5.9 Cc1ccc(Nc2c(-c3ccc4nccnc4c3)c(C)nn2-c2ccccc2C)c(C(=O)O)c1 10.1016/j.bmcl.2010.07.095
11850295 139391 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Antagonist activity at human recombinant adenosine A1 receptor expressed in CHO cells assessed as inhibition of NECA-induced cAMP accumulation after 15 mins by liquid scintillation spectrometryAntagonist activity at human recombinant adenosine A1 receptor expressed in CHO cells assessed as inhibition of NECA-induced cAMP accumulation after 15 mins by liquid scintillation spectrometry
ChEMBL 435 4 0 6 5.1 Cc1nc2c(=O)n(Cc3ccccc3)nc(C3CCCC3)c2c2cc(-c3ccccc3)nn12 10.1016/j.ejmech.2014.10.020
CHEMBL379204 139391 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Antagonist activity at human recombinant adenosine A1 receptor expressed in CHO cells assessed as inhibition of NECA-induced cAMP accumulation after 15 mins by liquid scintillation spectrometryAntagonist activity at human recombinant adenosine A1 receptor expressed in CHO cells assessed as inhibition of NECA-induced cAMP accumulation after 15 mins by liquid scintillation spectrometry
ChEMBL 435 4 0 6 5.1 Cc1nc2c(=O)n(Cc3ccccc3)nc(C3CCCC3)c2c2cc(-c3ccccc3)nn12 10.1016/j.ejmech.2014.10.020
73355133 91880 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometryAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometry
ChEMBL 811 15 5 13 3.8 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1039/C2MD00247G
CHEMBL2413232 91880 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometryAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometry
ChEMBL 811 15 5 13 3.8 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1039/C2MD00247G
44435352 145017 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Agonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulationAgonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulation
ChEMBL 353 4 4 10 -0.6 OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCSC4)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2007.10.028
CHEMBL391029 145017 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Agonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulationAgonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulation
ChEMBL 353 4 4 10 -0.6 OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCSC4)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2007.10.028
145960813 161444 None 0 Human Functional pIC50 = 7.3 7.3 -1 3
Antagonist activity at human A1 adenosine receptor expressed in CHO cells assessed as inhibition of CCPA-induced reduction of forskolin-stimulated cAMP level after 30 mins by Alphascreen assayAntagonist activity at human A1 adenosine receptor expressed in CHO cells assessed as inhibition of CCPA-induced reduction of forskolin-stimulated cAMP level after 30 mins by Alphascreen assay
ChEMBL 339 4 2 7 4.0 Nc1nc(NCc2cccs2)nc2sc(-c3ccccc3)nc12 10.1016/j.bmc.2018.05.048
CHEMBL4125975 161444 None 0 Human Functional pIC50 = 7.3 7.3 -1 3
Antagonist activity at human A1 adenosine receptor expressed in CHO cells assessed as inhibition of CCPA-induced reduction of forskolin-stimulated cAMP level after 30 mins by Alphascreen assayAntagonist activity at human A1 adenosine receptor expressed in CHO cells assessed as inhibition of CCPA-induced reduction of forskolin-stimulated cAMP level after 30 mins by Alphascreen assay
ChEMBL 339 4 2 7 4.0 Nc1nc(NCc2cccs2)nc2sc(-c3ccccc3)nc12 10.1016/j.bmc.2018.05.048
135438480 163013 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at recombinant human adenosine A1 receptor transfected in CHO cells assessed as inhibition of CCPA-induced cAMP accumulation preincubated for 10 mins followed by CCPA addition by GloSensor cAMP assayAntagonist activity at recombinant human adenosine A1 receptor transfected in CHO cells assessed as inhibition of CCPA-induced cAMP accumulation preincubated for 10 mins followed by CCPA addition by GloSensor cAMP assay
ChEMBL 309 3 2 6 3.1 Cn1c(-c2ccc(O)cc2)nc2c(NC3CCCC3)ncnc21 10.1016/j.ejmech.2018.03.067
CHEMBL4174108 163013 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at recombinant human adenosine A1 receptor transfected in CHO cells assessed as inhibition of CCPA-induced cAMP accumulation preincubated for 10 mins followed by CCPA addition by GloSensor cAMP assayAntagonist activity at recombinant human adenosine A1 receptor transfected in CHO cells assessed as inhibition of CCPA-induced cAMP accumulation preincubated for 10 mins followed by CCPA addition by GloSensor cAMP assay
ChEMBL 309 3 2 6 3.1 Cn1c(-c2ccc(O)cc2)nc2c(NC3CCCC3)ncnc21 10.1016/j.ejmech.2018.03.067
57384544 75514 None 0 Human Functional pIC50 = 5.3 5.3 -7 4
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation
ChEMBL 854 14 7 12 7.0 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(NCCc4ccc(NC(=O)c5cc(C(C)(C)C)c(O)c(C(C)(C)C)c5)cc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm300206u
CHEMBL2042309 75514 None 0 Human Functional pIC50 = 5.3 5.3 -7 4
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation
ChEMBL 854 14 7 12 7.0 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(NCCc4ccc(NC(=O)c5cc(C(C)(C)C)c(O)c(C(C)(C)C)c5)cc4)nc32)[C@H](O)[C@@H]1O 10.1021/jm300206u
52940754 17501 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 441 6 2 5 6.2 COc1ccc(Nc2c(-c3ccc(C)c(C)c3)c(C)nn2-c2ccccc2C)c(C(=O)O)c1 10.1016/j.bmcl.2010.07.095
CHEMBL1257825 17501 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 441 6 2 5 6.2 COc1ccc(Nc2c(-c3ccc(C)c(C)c3)c(C)nn2-c2ccccc2C)c(C(=O)O)c1 10.1016/j.bmcl.2010.07.095
25207803 5687 None 0 Human Functional pIC50 = 7.2 7.2 -26 4
Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.
ChEMBL 381 6 2 8 4.0 CNc1cc2nc(NCc3cccnc3)nc(C(=O)c3cccs3)c2s1 nan
CHEMBL1077943 5687 None 0 Human Functional pIC50 = 7.2 7.2 -26 4
Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.Fluorometric Imaging Plate Reader (FLIPR) Asssay: The use of a Fluorometric Imaging Plate Reader (FLIPR) to measure calcium flux in Adenosine-receptor expressing cells is a well-established technique. In this assay calcium flux is triggered by receptor activation and measured through the fluorescence of an incorporated calcium-sensitive dye. The potencies shown were determined using expressed human adenosine A2B receptors in mammalian cell lines. Selectivity values were obtained by using mammalian cell lines expressing the human adenosine A1, A2A and A3 receptors.
ChEMBL 381 6 2 8 4.0 CNc1cc2nc(NCc3cccnc3)nc(C(=O)c3cccs3)c2s1 nan
1329 1472 None 53 Rat Functional pIC50 = 8.2 8.2 -3 8
Antagonist activity at adenosine A1 receptor in rat cortical membrane assessed as reduction of [35S]GTPgammaS bindingAntagonist activity at adenosine A1 receptor in rat cortical membrane assessed as reduction of [35S]GTPgammaS binding
ChEMBL 304 5 1 5 2.4 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C1CCCC1 10.1021/np010464q
386 1472 None 53 Rat Functional pIC50 = 8.2 8.2 -3 8
Antagonist activity at adenosine A1 receptor in rat cortical membrane assessed as reduction of [35S]GTPgammaS bindingAntagonist activity at adenosine A1 receptor in rat cortical membrane assessed as reduction of [35S]GTPgammaS binding
ChEMBL 304 5 1 5 2.4 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C1CCCC1 10.1021/np010464q
CHEMBL183 1472 None 53 Rat Functional pIC50 = 8.2 8.2 -3 8
Antagonist activity at adenosine A1 receptor in rat cortical membrane assessed as reduction of [35S]GTPgammaS bindingAntagonist activity at adenosine A1 receptor in rat cortical membrane assessed as reduction of [35S]GTPgammaS binding
ChEMBL 304 5 1 5 2.4 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C1CCCC1 10.1021/np010464q
DB12946 1472 None 53 Rat Functional pIC50 = 8.2 8.2 -3 8
Antagonist activity at adenosine A1 receptor in rat cortical membrane assessed as reduction of [35S]GTPgammaS bindingAntagonist activity at adenosine A1 receptor in rat cortical membrane assessed as reduction of [35S]GTPgammaS binding
ChEMBL 304 5 1 5 2.4 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C1CCCC1 10.1021/np010464q
127026257 138329 None 0 Human Functional pIC50 = 8.2 8.2 -19 3
Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysisAgonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis
ChEMBL 392 5 5 10 -1.1 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4O)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.5b01402
CHEMBL3770310 138329 None 0 Human Functional pIC50 = 8.2 8.2 -19 3
Agonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysisAgonist activity at human Adenosine A1 receptor transfected in CHO-K1 cells assessed as inhibition of forskolin-stimulated cAMP production after 30 mins by multimode microplate reader analysis
ChEMBL 392 5 5 10 -1.1 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4O)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.5b01402
46176000 17736 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 479 7 2 7 5.8 CCc1ccccc1-n1nc(C)c(-c2ccc3nccnc3c2)c1Nc1ccc(OC)cc1C(=O)O 10.1016/j.bmcl.2010.07.095
CHEMBL1258621 17736 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 479 7 2 7 5.8 CCc1ccccc1-n1nc(C)c(-c2ccc3nccnc3c2)c1Nc1ccc(OC)cc1C(=O)O 10.1016/j.bmcl.2010.07.095
168291120 192131 None 0 Human Functional pIC50 = 8.2 8.2 -2 2
Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 minsAntagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins
ChEMBL 358 6 4 5 3.8 O=C(CNc1ccccc1)Nc1n[nH]c2cnc(Nc3ccccc3)cc12 10.1021/acs.jmedchem.2c01123
CHEMBL5201810 192131 None 0 Human Functional pIC50 = 8.2 8.2 -2 2
Antagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 minsAntagonist activity at wild type A1R (unknown origin) expressed in CHO-K1 cells assessed as inhibition of NECA reduced forskolin stimulated cAMP accumulation incubated for 30 mins
ChEMBL 358 6 4 5 3.8 O=C(CNc1ccccc1)Nc1n[nH]c2cnc(Nc3ccccc3)cc12 10.1021/acs.jmedchem.2c01123
44452401 96584 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 402 5 4 9 0.2 CC(=O)NC[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@H]5CC[C@H]4C5)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmc.2007.11.010
CHEMBL262850 96584 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 402 5 4 9 0.2 CC(=O)NC[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@H]5CC[C@H]4C5)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmc.2007.11.010
11709311 162784 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at recombinant human adenosine A1 receptor transfected in CHO cells assessed as inhibition of CCPA-induced cAMP accumulation preincubated for 10 mins followed by CCPA addition by GloSensor cAMP assayAntagonist activity at recombinant human adenosine A1 receptor transfected in CHO cells assessed as inhibition of CCPA-induced cAMP accumulation preincubated for 10 mins followed by CCPA addition by GloSensor cAMP assay
ChEMBL 307 3 1 5 3.7 Cc1ccc(-c2nc3c(NC4CCCC4)ncnc3n2C)cc1 10.1016/j.ejmech.2018.03.067
CHEMBL4170460 162784 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at recombinant human adenosine A1 receptor transfected in CHO cells assessed as inhibition of CCPA-induced cAMP accumulation preincubated for 10 mins followed by CCPA addition by GloSensor cAMP assayAntagonist activity at recombinant human adenosine A1 receptor transfected in CHO cells assessed as inhibition of CCPA-induced cAMP accumulation preincubated for 10 mins followed by CCPA addition by GloSensor cAMP assay
ChEMBL 307 3 1 5 3.7 Cc1ccc(-c2nc3c(NC4CCCC4)ncnc3n2C)cc1 10.1016/j.ejmech.2018.03.067
44452582 95811 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 391 5 3 9 1.4 CSC[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@H]5CC[C@H]4C5)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmc.2007.11.010
CHEMBL258489 95811 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 391 5 3 9 1.4 CSC[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@H]5CC[C@H]4C5)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmc.2007.11.010
44435359 91579 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Agonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulationAgonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulation
ChEMBL 496 6 4 11 0.8 O=C(OCc1ccccc1)N1[C@H]2CC[C@H]1[C@H](Nc1ncnc3c1ncn3[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)C2 10.1016/j.bmcl.2007.10.028
CHEMBL240487 91579 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Agonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulationAgonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulation
ChEMBL 496 6 4 11 0.8 O=C(OCc1ccccc1)N1[C@H]2CC[C@H]1[C@H](Nc1ncnc3c1ncn3[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)C2 10.1016/j.bmcl.2007.10.028
44452625 96565 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 363 4 3 8 1.0 O[C@@H]1[C@@H](CF)O[C@@H](n2cnc3c(N[C@H]4C[C@H]5CC[C@H]4C5)ncnc32)[C@@H]1O 10.1016/j.bmc.2007.11.010
CHEMBL262604 96565 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 363 4 3 8 1.0 O[C@@H]1[C@@H](CF)O[C@@H](n2cnc3c(N[C@H]4C[C@H]5CC[C@H]4C5)ncnc32)[C@@H]1O 10.1016/j.bmc.2007.11.010
46175738 17702 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 485 6 2 7 5.9 COc1ccc(Nc2c(-c3ccc4nccnc4c3)c(C)nn2-c2ccccc2Cl)c(C(=O)O)c1 10.1016/j.bmcl.2010.07.095
CHEMBL1258506 17702 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 485 6 2 7 5.9 COc1ccc(Nc2c(-c3ccc4nccnc4c3)c(C)nn2-c2ccccc2Cl)c(C(=O)O)c1 10.1016/j.bmcl.2010.07.095
44452673 161330 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 464 4 3 11 0.6 CN(C)C(=S)O[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@@H]5C[C@@H]4C4SC45)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmc.2007.11.010
CHEMBL411859 161330 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 464 4 3 11 0.6 CN(C)C(=S)O[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@@H]5C[C@@H]4C4SC45)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmc.2007.11.010
73349105 91883 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometryAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometry
ChEMBL 871 19 5 15 3.1 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCOCCOCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1039/C2MD00247G
CHEMBL2413235 91883 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometryAgonist activity at human adenosine A1 receptor expressed in CHO cells assessed as Gi-mediated inhibition of forskolin-stimulated SPAP secretion incubated for 10 mins prior to forskolin challenge measured after 5 hrs by spectrophotometry
ChEMBL 871 19 5 15 3.1 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCOCCOCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1039/C2MD00247G
155558172 174861 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human A1AR expressed in CHO cells assessed as suppression of CCPA-induced inhibition of forskolin-stimulated cAMP production by alphascreen assayAntagonist activity at human A1AR expressed in CHO cells assessed as suppression of CCPA-induced inhibition of forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 376 7 2 7 3.8 N#Cc1c(NCc2ccccc2)nc(SCCO)c(C#N)c1-c1ccco1 10.1021/acs.jmedchem.9b00106
CHEMBL4560929 174861 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human A1AR expressed in CHO cells assessed as suppression of CCPA-induced inhibition of forskolin-stimulated cAMP production by alphascreen assayAntagonist activity at human A1AR expressed in CHO cells assessed as suppression of CCPA-induced inhibition of forskolin-stimulated cAMP production by alphascreen assay
ChEMBL 376 7 2 7 3.8 N#Cc1c(NCc2ccccc2)nc(SCCO)c(C#N)c1-c1ccco1 10.1021/acs.jmedchem.9b00106
7162129 170765 None 5 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity at human A1AR expressed in CHO-K1 cells assessed as reduction in NECA-induced inhibition of forskolin-stimulated cAMP accumulation incubated for 30 mins by fluorescence based assayAntagonist activity at human A1AR expressed in CHO-K1 cells assessed as reduction in NECA-induced inhibition of forskolin-stimulated cAMP accumulation incubated for 30 mins by fluorescence based assay
ChEMBL 348 5 1 5 3.8 C=CCn1c(SCc2ccccn2)nc2c([nH]c3ccccc32)c1=O 10.1016/j.ejmech.2019.111936
CHEMBL4451522 170765 None 5 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity at human A1AR expressed in CHO-K1 cells assessed as reduction in NECA-induced inhibition of forskolin-stimulated cAMP accumulation incubated for 30 mins by fluorescence based assayAntagonist activity at human A1AR expressed in CHO-K1 cells assessed as reduction in NECA-induced inhibition of forskolin-stimulated cAMP accumulation incubated for 30 mins by fluorescence based assay
ChEMBL 348 5 1 5 3.8 C=CCn1c(SCc2ccccn2)nc2c([nH]c3ccccc32)c1=O 10.1016/j.ejmech.2019.111936
46175737 17665 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 435 5 2 6 5.5 Cc1ccccc1-n1nc(C)c(-c2ccc3nccnc3c2)c1Nc1ccccc1C(=O)O 10.1016/j.bmcl.2010.07.095
CHEMBL1258396 17665 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 435 5 2 6 5.5 Cc1ccccc1-n1nc(C)c(-c2ccc3nccnc3c2)c1Nc1ccccc1C(=O)O 10.1016/j.bmcl.2010.07.095
158795 3770 None 33 Human Functional pIC50 = 8.1 8.1 5 2
Agonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulationAgonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulation
ChEMBL 337 4 4 10 -1.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N[C@H]1COCC1 10.1016/j.bmcl.2007.10.028
5592 3770 None 33 Human Functional pIC50 = 8.1 8.1 5 2
Agonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulationAgonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulation
ChEMBL 337 4 4 10 -1.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N[C@H]1COCC1 10.1016/j.bmcl.2007.10.028
CHEMBL392149 3770 None 33 Human Functional pIC50 = 8.1 8.1 5 2
Agonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulationAgonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulation
ChEMBL 337 4 4 10 -1.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N[C@H]1COCC1 10.1016/j.bmcl.2007.10.028
DB04954 3770 None 33 Human Functional pIC50 = 8.1 8.1 5 2
Agonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulationAgonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulation
ChEMBL 337 4 4 10 -1.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N[C@H]1COCC1 10.1016/j.bmcl.2007.10.028
44435355 145019 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Agonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulationAgonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulation
ChEMBL 378 4 4 10 -1.5 CC(=O)N1CC[C@@H](Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C1 10.1016/j.bmcl.2007.10.028
CHEMBL391030 145019 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Agonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulationAgonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulation
ChEMBL 378 4 4 10 -1.5 CC(=O)N1CC[C@@H](Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C1 10.1016/j.bmcl.2007.10.028
44452450 169528 None 0 Human Functional pIC50 = 6.1 6.1 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 374 5 4 9 0.3 CNC[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@H]5CC[C@H]4C5)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmc.2007.11.010
CHEMBL442468 169528 None 0 Human Functional pIC50 = 6.1 6.1 - 1
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cellsAgonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells
ChEMBL 374 5 4 9 0.3 CNC[C@H]1O[C@@H](n2cnc3c(N[C@H]4C[C@H]5CC[C@H]4C5)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmc.2007.11.010
155536619 172304 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Agonist activity at human A1A adenosine receptor expressed in HEK cells assessed as inhibition of forskolin-stimulated cAMP production after 60 minsAgonist activity at human A1A adenosine receptor expressed in HEK cells assessed as inhibition of forskolin-stimulated cAMP production after 60 mins
ChEMBL 254 3 4 7 -2.3 NC(=O)c1ncn([C@H]2[C@H](O)[C@H](O)[C@]3(CO)C[C@H]23)n1 10.1021/acs.jmedchem.8b01662
CHEMBL4473739 172304 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Agonist activity at human A1A adenosine receptor expressed in HEK cells assessed as inhibition of forskolin-stimulated cAMP production after 60 minsAgonist activity at human A1A adenosine receptor expressed in HEK cells assessed as inhibition of forskolin-stimulated cAMP production after 60 mins
ChEMBL 254 3 4 7 -2.3 NC(=O)c1ncn([C@H]2[C@H](O)[C@H](O)[C@]3(CO)C[C@H]23)n1 10.1021/acs.jmedchem.8b01662
44435361 167871 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Agonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulationAgonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulation
ChEMBL 574 6 4 11 1.6 O=C(OCc1ccccc1Br)N1[C@H]2CC[C@H]1[C@H](Nc1ncnc3c1ncn3[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)C2 10.1016/j.bmcl.2007.10.028
CHEMBL430374 167871 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Agonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulationAgonist activity at adenosine A1 receptor expressed in DDT1 MF2 cells assessed as inhibition of (-)-isoproterenol-stimulated cAMP accumulation
ChEMBL 574 6 4 11 1.6 O=C(OCc1ccccc1Br)N1[C@H]2CC[C@H]1[C@H](Nc1ncnc3c1ncn3[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)C2 10.1016/j.bmcl.2007.10.028
52948788 17737 None 0 Human Functional pIC50 = 8.1 8.1 2137 2
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 489 5 2 6 6.3 Cc1ccccc1-n1nc(C(F)(F)F)c(-c2ccc3nccnc3c2)c1Nc1ccccc1C(=O)O 10.1016/j.bmcl.2010.07.095
CHEMBL1258622 17737 None 0 Human Functional pIC50 = 8.1 8.1 2137 2
Antagonist activity at adenosine A1 receptor by cAMP assayAntagonist activity at adenosine A1 receptor by cAMP assay
ChEMBL 489 5 2 6 6.3 Cc1ccccc1-n1nc(C(F)(F)F)c(-c2ccc3nccnc3c2)c1Nc1ccccc1C(=O)O 10.1016/j.bmcl.2010.07.095
10091184 205587 None 0 Guinea pig Functional pIC50 = 7.0 7.0 - 1
Inhibition of adenosine induced negative inotropic activity against guinea-pig atria (Adenosine A1 receptor) at 10 nMInhibition of adenosine induced negative inotropic activity against guinea-pig atria (Adenosine A1 receptor) at 10 nM
ChEMBL 380 4 0 5 4.6 CCC1CCCCN1C(=O)/C=C/c1c(-c2ccccc2)nc2sc(C)nn12 10.1016/0960-894X(96)00368-X
CHEMBL64108 205587 None 0 Guinea pig Functional pIC50 = 7.0 7.0 - 1
Inhibition of adenosine induced negative inotropic activity against guinea-pig atria (Adenosine A1 receptor) at 10 nMInhibition of adenosine induced negative inotropic activity against guinea-pig atria (Adenosine A1 receptor) at 10 nM
ChEMBL 380 4 0 5 4.6 CCC1CCCCN1C(=O)/C=C/c1c(-c2ccccc2)nc2sc(C)nn12 10.1016/0960-894X(96)00368-X
45258867 91884 None 0 Human Functional pIC50 = 6.0 6.0 - 1
Antagonist activity at human adenosine A1 receptor expressed in CHO cells coexpressing cAMP response element assessed as inhibition of agonist-induced response after 1 hr by SPAP reporter gene assay in presence of forskolinAntagonist activity at human adenosine A1 receptor expressed in CHO cells coexpressing cAMP response element assessed as inhibition of agonist-induced response after 1 hr by SPAP reporter gene assay in presence of forskolin
ChEMBL 653 12 5 11 1.4 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCCNC(=O)CCC4=[N+]5C(=Cc6c(C)cc(C)n6[B-]5(F)F)C=C4)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2012.10.112
CHEMBL2413236 91884 None 0 Human Functional pIC50 = 6.0 6.0 - 1
Antagonist activity at human adenosine A1 receptor expressed in CHO cells coexpressing cAMP response element assessed as inhibition of agonist-induced response after 1 hr by SPAP reporter gene assay in presence of forskolinAntagonist activity at human adenosine A1 receptor expressed in CHO cells coexpressing cAMP response element assessed as inhibition of agonist-induced response after 1 hr by SPAP reporter gene assay in presence of forskolin
ChEMBL 653 12 5 11 1.4 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCCNC(=O)CCC4=[N+]5C(=Cc6c(C)cc(C)n6[B-]5(F)F)C=C4)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2012.10.112
135428630 81614 None 0 Rat Functional pKd = 9.9 9.9 - 0
Intrinsic activity at adenosine A1 receptor assessed as blockade of CPA in isolated spontaneously beating rat atriaIntrinsic activity at adenosine A1 receptor assessed as blockade of CPA in isolated spontaneously beating rat atria
ChEMBL 385 4 2 4 3.2 CCCN1C(=O)N2C[C@@H](C(C)C)N=C2c2[nH]c(C34CCC(O)(CC3)CC4)nc21 10.1021/jm060539t
CHEMBL216269 81614 None 0 Rat Functional pKd = 9.9 9.9 - 0
Intrinsic activity at adenosine A1 receptor assessed as blockade of CPA in isolated spontaneously beating rat atriaIntrinsic activity at adenosine A1 receptor assessed as blockade of CPA in isolated spontaneously beating rat atria
ChEMBL 385 4 2 4 3.2 CCCN1C(=O)N2C[C@@H](C(C)C)N=C2c2[nH]c(C34CCC(O)(CC3)CC4)nc21 10.1021/jm060539t
216466 3845 None 27 Rat Functional pKd = 9.8 9.8 - 0
Intrinsic activity at adenosine A1 receptor assessed as blockade of CPA in isolated spontaneously beating rat atriaIntrinsic activity at adenosine A1 receptor assessed as blockade of CPA in isolated spontaneously beating rat atria
ChEMBL 416 8 2 6 3.2 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C12CCC(CC1)(CC2)CCC(=O)O 10.1021/jm060539t
5605 3845 None 27 Rat Functional pKd = 9.8 9.8 - 0
Intrinsic activity at adenosine A1 receptor assessed as blockade of CPA in isolated spontaneously beating rat atriaIntrinsic activity at adenosine A1 receptor assessed as blockade of CPA in isolated spontaneously beating rat atria
ChEMBL 416 8 2 6 3.2 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C12CCC(CC1)(CC2)CCC(=O)O 10.1021/jm060539t
CHEMBL386974 3845 None 27 Rat Functional pKd = 9.8 9.8 - 0
Intrinsic activity at adenosine A1 receptor assessed as blockade of CPA in isolated spontaneously beating rat atriaIntrinsic activity at adenosine A1 receptor assessed as blockade of CPA in isolated spontaneously beating rat atria
ChEMBL 416 8 2 6 3.2 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C12CCC(CC1)(CC2)CCC(=O)O 10.1021/jm060539t
CHEMBL414157 3845 None 27 Rat Functional pKd = 9.8 9.8 - 0
Intrinsic activity at adenosine A1 receptor assessed as blockade of CPA in isolated spontaneously beating rat atriaIntrinsic activity at adenosine A1 receptor assessed as blockade of CPA in isolated spontaneously beating rat atria
ChEMBL 416 8 2 6 3.2 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C12CCC(CC1)(CC2)CCC(=O)O 10.1021/jm060539t
DB12569 3845 None 27 Rat Functional pKd = 9.8 9.8 - 0
Intrinsic activity at adenosine A1 receptor assessed as blockade of CPA in isolated spontaneously beating rat atriaIntrinsic activity at adenosine A1 receptor assessed as blockade of CPA in isolated spontaneously beating rat atria
ChEMBL 416 8 2 6 3.2 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C12CCC(CC1)(CC2)CCC(=O)O 10.1021/jm060539t
135428645 172806 None 0 Rat Functional pKd = 8.9 8.9 - 0
Intrinsic activity at adenosine A1 receptor assessed as blockade of CPA in isolated spontaneously beating rat atriaIntrinsic activity at adenosine A1 receptor assessed as blockade of CPA in isolated spontaneously beating rat atria
ChEMBL 371 4 2 4 2.9 CCCN1C(=O)N2C[C@@H](CC)N=C2c2[nH]c(C34CCC(O)(CC3)CC4)nc21 10.1021/jm060539t
CHEMBL450341 172806 None 0 Rat Functional pKd = 8.9 8.9 - 0
Intrinsic activity at adenosine A1 receptor assessed as blockade of CPA in isolated spontaneously beating rat atriaIntrinsic activity at adenosine A1 receptor assessed as blockade of CPA in isolated spontaneously beating rat atria
ChEMBL 371 4 2 4 2.9 CCCN1C(=O)N2C[C@@H](CC)N=C2c2[nH]c(C34CCC(O)(CC3)CC4)nc21 10.1021/jm060539t
25099163 176970 None 10 Human Functional pKd = 8.7 8.7 - 1
Antagonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of R-PIA-mediated ERK1/2 phosphorylationAntagonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of R-PIA-mediated ERK1/2 phosphorylation
ChEMBL 349 3 1 7 2.9 CCOC(=O)c1nn(-c2cccc(Cl)c2)c(=O)c2c(N)scc12 10.1021/jm800557d
CHEMBL461432 176970 None 10 Human Functional pKd = 8.7 8.7 - 1
Antagonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of R-PIA-mediated ERK1/2 phosphorylationAntagonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of R-PIA-mediated ERK1/2 phosphorylation
ChEMBL 349 3 1 7 2.9 CCOC(=O)c1nn(-c2cccc(Cl)c2)c(=O)c2c(N)scc12 10.1021/jm800557d
21874557 3996 None 45 Human Functional pKd = 7 7.0 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHO-K1 cells by calcium mobilization-based FLIPR assayAntagonist activity at human adenosine A1 receptor expressed in CHO-K1 cells by calcium mobilization-based FLIPR assay
ChEMBL 321 3 2 8 2.0 Nc1nc(c2ccco2)c2c(n1)n(nn2)Cc1ccc(c(c1)C)N 10.1021/jm800961g
5612 3996 None 45 Human Functional pKd = 7 7.0 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHO-K1 cells by calcium mobilization-based FLIPR assayAntagonist activity at human adenosine A1 receptor expressed in CHO-K1 cells by calcium mobilization-based FLIPR assay
ChEMBL 321 3 2 8 2.0 Nc1nc(c2ccco2)c2c(n1)n(nn2)Cc1ccc(c(c1)C)N 10.1021/jm800961g
CHEMBL447664 3996 None 45 Human Functional pKd = 7 7.0 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHO-K1 cells by calcium mobilization-based FLIPR assayAntagonist activity at human adenosine A1 receptor expressed in CHO-K1 cells by calcium mobilization-based FLIPR assay
ChEMBL 321 3 2 8 2.0 Nc1nc(c2ccco2)c2c(n1)n(nn2)Cc1ccc(c(c1)C)N 10.1021/jm800961g
DB06625 3996 None 45 Human Functional pKd = 7 7.0 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHO-K1 cells by calcium mobilization-based FLIPR assayAntagonist activity at human adenosine A1 receptor expressed in CHO-K1 cells by calcium mobilization-based FLIPR assay
ChEMBL 321 3 2 8 2.0 Nc1nc(c2ccco2)c2c(n1)n(nn2)Cc1ccc(c(c1)C)N 10.1021/jm800961g
73349104 91882 None 0 Human Functional pKd = 7.9 7.9 - 1
Antagonist activity at human adenosine A1 receptor expressed in CHO cells coexpressing cAMP response element assessed as inhibition of agonist-induced response by SPAP reporter gene assay in presence of forskolinAntagonist activity at human adenosine A1 receptor expressed in CHO cells coexpressing cAMP response element assessed as inhibition of agonist-induced response by SPAP reporter gene assay in presence of forskolin
ChEMBL 909 22 5 13 6.5 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCCCCCCCCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2012.10.112
CHEMBL2413234 91882 None 0 Human Functional pKd = 7.9 7.9 - 1
Antagonist activity at human adenosine A1 receptor expressed in CHO cells coexpressing cAMP response element assessed as inhibition of agonist-induced response by SPAP reporter gene assay in presence of forskolinAntagonist activity at human adenosine A1 receptor expressed in CHO cells coexpressing cAMP response element assessed as inhibition of agonist-induced response by SPAP reporter gene assay in presence of forskolin
ChEMBL 909 22 5 13 6.5 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCCCCCCCCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2012.10.112
73346045 91881 None 0 Human Functional pKd = 7.9 7.9 - 1
Antagonist activity at human adenosine A1 receptor expressed in CHO cells coexpressing cAMP response element assessed as inhibition of agonist-induced response by SPAP reporter gene assay in presence of forskolinAntagonist activity at human adenosine A1 receptor expressed in CHO cells coexpressing cAMP response element assessed as inhibition of agonist-induced response by SPAP reporter gene assay in presence of forskolin
ChEMBL 867 19 5 13 5.4 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCCCCCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2012.10.112
CHEMBL2413233 91881 None 0 Human Functional pKd = 7.9 7.9 - 1
Antagonist activity at human adenosine A1 receptor expressed in CHO cells coexpressing cAMP response element assessed as inhibition of agonist-induced response by SPAP reporter gene assay in presence of forskolinAntagonist activity at human adenosine A1 receptor expressed in CHO cells coexpressing cAMP response element assessed as inhibition of agonist-induced response by SPAP reporter gene assay in presence of forskolin
ChEMBL 867 19 5 13 5.4 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCCCCCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2012.10.112
73350675 91878 None 0 Human Functional pKd = 7.8 7.8 - 1
Antagonist activity at human adenosine A1 receptor expressed in CHO cells coexpressing cAMP response element assessed as inhibition of agonist-induced response by SPAP reporter gene assay in presence of forskolinAntagonist activity at human adenosine A1 receptor expressed in CHO cells coexpressing cAMP response element assessed as inhibition of agonist-induced response by SPAP reporter gene assay in presence of forskolin
ChEMBL 783 13 5 13 3.0 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2012.10.112
CHEMBL2413230 91878 None 0 Human Functional pKd = 7.8 7.8 - 1
Antagonist activity at human adenosine A1 receptor expressed in CHO cells coexpressing cAMP response element assessed as inhibition of agonist-induced response by SPAP reporter gene assay in presence of forskolinAntagonist activity at human adenosine A1 receptor expressed in CHO cells coexpressing cAMP response element assessed as inhibition of agonist-induced response by SPAP reporter gene assay in presence of forskolin
ChEMBL 783 13 5 13 3.0 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2012.10.112
46939633 16740 None 0 Human Functional pKd = 6.8 6.8 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHO FlpIn cells assessed as inhibition of of N(6)-(R-phenylisopropyl)adenosine-induced ERK1/2 phosphorylationAntagonist activity at human adenosine A1 receptor expressed in CHO FlpIn cells assessed as inhibition of of N(6)-(R-phenylisopropyl)adenosine-induced ERK1/2 phosphorylation
ChEMBL 315 3 1 5 3.7 Nc1sc(-c2cncnc2)cc1C(=O)c1ccc(Cl)cc1 10.1021/jm1008538
CHEMBL1243257 16740 None 0 Human Functional pKd = 6.8 6.8 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHO FlpIn cells assessed as inhibition of of N(6)-(R-phenylisopropyl)adenosine-induced ERK1/2 phosphorylationAntagonist activity at human adenosine A1 receptor expressed in CHO FlpIn cells assessed as inhibition of of N(6)-(R-phenylisopropyl)adenosine-induced ERK1/2 phosphorylation
ChEMBL 315 3 1 5 3.7 Nc1sc(-c2cncnc2)cc1C(=O)c1ccc(Cl)cc1 10.1021/jm1008538
647821 176969 None 22 Human Functional pKd = 7.8 7.8 - 1
Antagonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of R-PIA-mediated ERK1/2 phosphorylationAntagonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of R-PIA-mediated ERK1/2 phosphorylation
ChEMBL 315 3 1 7 2.2 CCOC(=O)c1nn(-c2ccccc2)c(=O)c2c(N)scc12 10.1021/jm800557d
CHEMBL461431 176969 None 22 Human Functional pKd = 7.8 7.8 - 1
Antagonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of R-PIA-mediated ERK1/2 phosphorylationAntagonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of R-PIA-mediated ERK1/2 phosphorylation
ChEMBL 315 3 1 7 2.2 CCOC(=O)c1nn(-c2ccccc2)c(=O)c2c(N)scc12 10.1021/jm800557d
73350676 91879 None 0 Human Functional pKd = 7.8 7.8 - 1
Antagonist activity at human adenosine A1 receptor expressed in CHO cells coexpressing cAMP response element assessed as inhibition of agonist-induced response by SPAP reporter gene assay in presence of forskolinAntagonist activity at human adenosine A1 receptor expressed in CHO cells coexpressing cAMP response element assessed as inhibition of agonist-induced response by SPAP reporter gene assay in presence of forskolin
ChEMBL 797 14 5 13 3.4 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2012.10.112
CHEMBL2413231 91879 None 0 Human Functional pKd = 7.8 7.8 - 1
Antagonist activity at human adenosine A1 receptor expressed in CHO cells coexpressing cAMP response element assessed as inhibition of agonist-induced response by SPAP reporter gene assay in presence of forskolinAntagonist activity at human adenosine A1 receptor expressed in CHO cells coexpressing cAMP response element assessed as inhibition of agonist-induced response by SPAP reporter gene assay in presence of forskolin
ChEMBL 797 14 5 13 3.4 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2012.10.112
73355133 91880 None 0 Human Functional pKd = 7.8 7.8 - 1
Antagonist activity at human adenosine A1 receptor expressed in CHO cells coexpressing cAMP response element assessed as inhibition of agonist-induced response by SPAP reporter gene assay in presence of forskolinAntagonist activity at human adenosine A1 receptor expressed in CHO cells coexpressing cAMP response element assessed as inhibition of agonist-induced response by SPAP reporter gene assay in presence of forskolin
ChEMBL 811 15 5 13 3.8 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2012.10.112
CHEMBL2413232 91880 None 0 Human Functional pKd = 7.8 7.8 - 1
Antagonist activity at human adenosine A1 receptor expressed in CHO cells coexpressing cAMP response element assessed as inhibition of agonist-induced response by SPAP reporter gene assay in presence of forskolinAntagonist activity at human adenosine A1 receptor expressed in CHO cells coexpressing cAMP response element assessed as inhibition of agonist-induced response by SPAP reporter gene assay in presence of forskolin
ChEMBL 811 15 5 13 3.8 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2012.10.112
CHEMBL2024150 211593 None 0 Human Functional pKd = 6.8 6.8 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of NECA-induced increase of intracellular cAMP level after 5 hrsAntagonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of NECA-induced increase of intracellular cAMP level after 5 hrs
ChEMBL None None None COc1ccc(-n2nc3c(NC(=O)CCC(=O)NCCOCCOCCNC(=O)CCCCCNC(=O)COc4ccc(C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)nc4ccccc4n3c2=O)cc1 10.1021/jm201722y
73349105 91883 None 0 Human Functional pKd = 7.8 7.8 - 1
Antagonist activity at human adenosine A1 receptor expressed in CHO cells coexpressing cAMP response element assessed as inhibition of agonist-induced response by SPAP reporter gene assay in presence of forskolinAntagonist activity at human adenosine A1 receptor expressed in CHO cells coexpressing cAMP response element assessed as inhibition of agonist-induced response by SPAP reporter gene assay in presence of forskolin
ChEMBL 871 19 5 15 3.1 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCOCCOCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2012.10.112
CHEMBL2413235 91883 None 0 Human Functional pKd = 7.8 7.8 - 1
Antagonist activity at human adenosine A1 receptor expressed in CHO cells coexpressing cAMP response element assessed as inhibition of agonist-induced response by SPAP reporter gene assay in presence of forskolinAntagonist activity at human adenosine A1 receptor expressed in CHO cells coexpressing cAMP response element assessed as inhibition of agonist-induced response by SPAP reporter gene assay in presence of forskolin
ChEMBL 871 19 5 15 3.1 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCOCCOCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2012.10.112
46227373 202550 None 0 Human Functional pKd = 5.7 5.7 - 1
Antagonist activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as inhibition of R-PIA-induced ERK1/2 phosphorylationAntagonist activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as inhibition of R-PIA-induced ERK1/2 phosphorylation
ChEMBL 521 6 1 7 4.5 CCOC(=O)c1c(N)sc2c1CCN(C(=O)[C@@H](Cc1ccc(Cl)cc1)N(C)C(=O)OC(C)(C)C)C2 10.1016/j.bmc.2009.08.024
CHEMBL595981 202550 None 0 Human Functional pKd = 5.7 5.7 - 1
Antagonist activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as inhibition of R-PIA-induced ERK1/2 phosphorylationAntagonist activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as inhibition of R-PIA-induced ERK1/2 phosphorylation
ChEMBL 521 6 1 7 4.5 CCOC(=O)c1c(N)sc2c1CCN(C(=O)[C@@H](Cc1ccc(Cl)cc1)N(C)C(=O)OC(C)(C)C)C2 10.1016/j.bmc.2009.08.024
719449 176864 None 13 Human Functional pKd = 6.7 6.7 - 1
Antagonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of R-PIA-mediated ERK1/2 phosphorylationAntagonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of R-PIA-mediated ERK1/2 phosphorylation
ChEMBL 345 4 1 8 2.2 CCOC(=O)c1nn(-c2ccc(OC)cc2)c(=O)c2c(N)scc12 10.1021/jm800557d
CHEMBL460366 176864 None 13 Human Functional pKd = 6.7 6.7 - 1
Antagonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of R-PIA-mediated ERK1/2 phosphorylationAntagonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of R-PIA-mediated ERK1/2 phosphorylation
ChEMBL 345 4 1 8 2.2 CCOC(=O)c1nn(-c2ccc(OC)cc2)c(=O)c2c(N)scc12 10.1021/jm800557d
28325476 16621 None 2 Human Functional pKd = 6.7 6.7 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHO FlpIn cells assessed as inhibition of of N(6)-(R-phenylisopropyl)adenosine-induced ERK1/2 phosphorylationAntagonist activity at human adenosine A1 receptor expressed in CHO FlpIn cells assessed as inhibition of of N(6)-(R-phenylisopropyl)adenosine-induced ERK1/2 phosphorylation
ChEMBL 279 3 1 3 4.2 Nc1sc(-c2ccccc2)cc1C(=O)c1ccccc1 10.1021/jm1008538
CHEMBL1241077 16621 None 2 Human Functional pKd = 6.7 6.7 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHO FlpIn cells assessed as inhibition of of N(6)-(R-phenylisopropyl)adenosine-induced ERK1/2 phosphorylationAntagonist activity at human adenosine A1 receptor expressed in CHO FlpIn cells assessed as inhibition of of N(6)-(R-phenylisopropyl)adenosine-induced ERK1/2 phosphorylation
ChEMBL 279 3 1 3 4.2 Nc1sc(-c2ccccc2)cc1C(=O)c1ccccc1 10.1021/jm1008538
CHEMBL2024149 211592 None 0 Human Functional pKd = 6.6 6.6 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of NECA-induced increase of intracellular cAMP level after 5 hrsAntagonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of NECA-induced increase of intracellular cAMP level after 5 hrs
ChEMBL None None None COc1ccc(-n2nc3c(NC(=O)CCC(=O)NCCOCCOCCNC(=O)CCCCCNC(=O)COc4ccc(/C=C/C5=[N+]6C(=Cc7ccc(-c8cccs8)n7[B-]6(F)F)C=C5)cc4)nc4ccccc4n3c2=O)cc1 10.1021/jm201722y
46227370 204360 None 0 Human Functional pKd = 6.4 6.4 - 1
Antagonist activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as inhibition of R-PIA-induced ERK1/2 phosphorylationAntagonist activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as inhibition of R-PIA-induced ERK1/2 phosphorylation
ChEMBL 473 6 2 7 3.5 CCOC(=O)c1c(N)sc2c1CCN(C(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)C2 10.1016/j.bmc.2009.08.024
CHEMBL607427 204360 None 0 Human Functional pKd = 6.4 6.4 - 1
Antagonist activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as inhibition of R-PIA-induced ERK1/2 phosphorylationAntagonist activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as inhibition of R-PIA-induced ERK1/2 phosphorylation
ChEMBL 473 6 2 7 3.5 CCOC(=O)c1c(N)sc2c1CCN(C(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)C2 10.1016/j.bmc.2009.08.024
25130167 173356 None 0 Human Functional pKd = 7.4 7.4 - 1
Antagonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of R-PIA-mediated ERK1/2 phosphorylationAntagonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of R-PIA-mediated ERK1/2 phosphorylation
ChEMBL 331 3 2 8 1.9 CCOC(=O)c1nn(-c2ccc(O)cc2)c(=O)c2c(N)scc12 10.1021/jm800557d
CHEMBL452468 173356 None 0 Human Functional pKd = 7.4 7.4 - 1
Antagonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of R-PIA-mediated ERK1/2 phosphorylationAntagonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of R-PIA-mediated ERK1/2 phosphorylation
ChEMBL 331 3 2 8 1.9 CCOC(=O)c1nn(-c2ccc(O)cc2)c(=O)c2c(N)scc12 10.1021/jm800557d
25130170 177059 None 0 Human Functional pKd = 7.4 7.4 - 1
Antagonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of R-PIA-mediated ERK1/2 phosphorylationAntagonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of R-PIA-mediated ERK1/2 phosphorylation
ChEMBL 373 4 1 9 2.1 CCOC(=O)c1nn(-c2ccc(OC(C)=O)cc2)c(=O)c2c(N)scc12 10.1021/jm800557d
CHEMBL462281 177059 None 0 Human Functional pKd = 7.4 7.4 - 1
Antagonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of R-PIA-mediated ERK1/2 phosphorylationAntagonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of R-PIA-mediated ERK1/2 phosphorylation
ChEMBL 373 4 1 9 2.1 CCOC(=O)c1nn(-c2ccc(OC(C)=O)cc2)c(=O)c2c(N)scc12 10.1021/jm800557d
46939535 16620 None 13 Human Functional pKd = 6.2 6.2 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHO FlpIn cells assessed as inhibition of of N(6)-(R-phenylisopropyl)adenosine-induced ERK1/2 phosphorylationAntagonist activity at human adenosine A1 receptor expressed in CHO FlpIn cells assessed as inhibition of of N(6)-(R-phenylisopropyl)adenosine-induced ERK1/2 phosphorylation
ChEMBL 279 1 1 5 3.0 Nc1sc(-c2cncnc2)c2c1C(=O)c1ccccc1-2 10.1021/jm1008538
CHEMBL1241015 16620 None 13 Human Functional pKd = 6.2 6.2 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHO FlpIn cells assessed as inhibition of of N(6)-(R-phenylisopropyl)adenosine-induced ERK1/2 phosphorylationAntagonist activity at human adenosine A1 receptor expressed in CHO FlpIn cells assessed as inhibition of of N(6)-(R-phenylisopropyl)adenosine-induced ERK1/2 phosphorylation
ChEMBL 279 1 1 5 3.0 Nc1sc(-c2cncnc2)c2c1C(=O)c1ccccc1-2 10.1021/jm1008538
25099163 176970 None 10 Human Functional pKd = 8.1 8.1 - 1
Antagonist activity at human adenosine A1 receptor assessed as inhibition of R-PIA-mediated [35S]GTPgammaS binding to G proteinAntagonist activity at human adenosine A1 receptor assessed as inhibition of R-PIA-mediated [35S]GTPgammaS binding to G protein
ChEMBL 349 3 1 7 2.9 CCOC(=O)c1nn(-c2cccc(Cl)c2)c(=O)c2c(N)scc12 10.1021/jm800557d
CHEMBL461432 176970 None 10 Human Functional pKd = 8.1 8.1 - 1
Antagonist activity at human adenosine A1 receptor assessed as inhibition of R-PIA-mediated [35S]GTPgammaS binding to G proteinAntagonist activity at human adenosine A1 receptor assessed as inhibition of R-PIA-mediated [35S]GTPgammaS binding to G protein
ChEMBL 349 3 1 7 2.9 CCOC(=O)c1nn(-c2cccc(Cl)c2)c(=O)c2c(N)scc12 10.1021/jm800557d
25130168 172668 None 0 Human Functional pKd = 7.1 7.1 - 1
Antagonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of R-PIA-mediated ERK1/2 phosphorylationAntagonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of R-PIA-mediated ERK1/2 phosphorylation
ChEMBL 441 3 1 7 2.8 CCOC(=O)c1nn(-c2ccc(I)cc2)c(=O)c2c(N)scc12 10.1021/jm800557d
CHEMBL448624 172668 None 0 Human Functional pKd = 7.1 7.1 - 1
Antagonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of R-PIA-mediated ERK1/2 phosphorylationAntagonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of R-PIA-mediated ERK1/2 phosphorylation
ChEMBL 441 3 1 7 2.8 CCOC(=O)c1nn(-c2ccc(I)cc2)c(=O)c2c(N)scc12 10.1021/jm800557d
2794740 202266 None 51 Human Functional pKd = 6.1 6.1 - 1
Antagonist activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as inhibition of R-PIA-induced ERK1/2 phosphorylationAntagonist activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as inhibition of R-PIA-induced ERK1/2 phosphorylation
ChEMBL 326 2 1 6 2.8 CCOC(=O)c1c(N)sc2c1CCN(C(=O)OC(C)(C)C)C2 10.1016/j.bmc.2009.08.024
CHEMBL594119 202266 None 51 Human Functional pKd = 6.1 6.1 - 1
Antagonist activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as inhibition of R-PIA-induced ERK1/2 phosphorylationAntagonist activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as inhibition of R-PIA-induced ERK1/2 phosphorylation
ChEMBL 326 2 1 6 2.8 CCOC(=O)c1c(N)sc2c1CCN(C(=O)OC(C)(C)C)C2 10.1016/j.bmc.2009.08.024
137656049 158757 None 0 Human Functional pKi = 9.7 9.7 - 0
Antagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assayAntagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assay
ChEMBL 338 4 2 5 3.6 CCCn1c(-c2cccc(O)c2)nc2nc(C3CCCC3)[nH]c2c1=O 10.1016/j.bmc.2017.02.029
CHEMBL4092832 158757 None 0 Human Functional pKi = 9.7 9.7 - 0
Antagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assayAntagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assay
ChEMBL 338 4 2 5 3.6 CCCn1c(-c2cccc(O)c2)nc2nc(C3CCCC3)[nH]c2c1=O 10.1016/j.bmc.2017.02.029
52933926 156273 None 0 Human Functional pKi = 9.6 9.6 - 0
Antagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assayAntagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assay
ChEMBL 353 5 1 6 3.7 CCCn1c(Oc2cccnc2C)nc2nc(C3CCCC3)[nH]c2c1=O 10.1016/j.bmc.2017.02.029
CHEMBL4063997 156273 None 0 Human Functional pKi = 9.6 9.6 - 0
Antagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assayAntagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assay
ChEMBL 353 5 1 6 3.7 CCCn1c(Oc2cccnc2C)nc2nc(C3CCCC3)[nH]c2c1=O 10.1016/j.bmc.2017.02.029
52933926 156273 None 0 Human Functional pKi = 9.6 9.6 - 0
Antagonist activity at human adenosine A1A receptorAntagonist activity at human adenosine A1A receptor
ChEMBL 353 5 1 6 3.7 CCCn1c(Oc2cccnc2C)nc2nc(C3CCCC3)[nH]c2c1=O 10.1016/j.ejmech.2021.113907
CHEMBL4063997 156273 None 0 Human Functional pKi = 9.6 9.6 - 0
Antagonist activity at human adenosine A1A receptorAntagonist activity at human adenosine A1A receptor
ChEMBL 353 5 1 6 3.7 CCCn1c(Oc2cccnc2C)nc2nc(C3CCCC3)[nH]c2c1=O 10.1016/j.ejmech.2021.113907
10445452 8734 None 0 Human Functional pKi = 9.4 9.4 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 263 1 1 5 2.5 Nc1nc(-c2ccco2)c2c(n1)-c1ccccc1C2=O 10.1016/j.bmcl.2010.03.042
CHEMBL1095999 8734 None 0 Human Functional pKi = 9.4 9.4 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 263 1 1 5 2.5 Nc1nc(-c2ccco2)c2c(n1)-c1ccccc1C2=O 10.1016/j.bmcl.2010.03.042
3281 1370 None 43 Human Functional pKi = 9.4 9.4 - 0
Antagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of NECA-induced cAMP accumulation in presence of forskolin measured after 40 mins by alpha screen LANCE assayAntagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of NECA-induced cAMP accumulation in presence of forskolin measured after 40 mins by alpha screen LANCE assay
ChEMBL 308 3 3 4 3.3 O[C@@H]1CC[C@H](CC1)Nc1nc(nc2c1cc[nH]2)c1ccccc1 10.1021/acs.jmedchem.0c02169
9953065 1370 None 43 Human Functional pKi = 9.4 9.4 - 0
Antagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of NECA-induced cAMP accumulation in presence of forskolin measured after 40 mins by alpha screen LANCE assayAntagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of NECA-induced cAMP accumulation in presence of forskolin measured after 40 mins by alpha screen LANCE assay
ChEMBL 308 3 3 4 3.3 O[C@@H]1CC[C@H](CC1)Nc1nc(nc2c1cc[nH]2)c1ccccc1 10.1021/acs.jmedchem.0c02169
CHEMBL4204703 1370 None 43 Human Functional pKi = 9.4 9.4 - 0
Antagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of NECA-induced cAMP accumulation in presence of forskolin measured after 40 mins by alpha screen LANCE assayAntagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of NECA-induced cAMP accumulation in presence of forskolin measured after 40 mins by alpha screen LANCE assay
ChEMBL 308 3 3 4 3.3 O[C@@H]1CC[C@H](CC1)Nc1nc(nc2c1cc[nH]2)c1ccccc1 10.1021/acs.jmedchem.0c02169
CHEMBL592435 1370 None 43 Human Functional pKi = 9.4 9.4 - 0
Antagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of NECA-induced cAMP accumulation in presence of forskolin measured after 40 mins by alpha screen LANCE assayAntagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of NECA-induced cAMP accumulation in presence of forskolin measured after 40 mins by alpha screen LANCE assay
ChEMBL 308 3 3 4 3.3 O[C@@H]1CC[C@H](CC1)Nc1nc(nc2c1cc[nH]2)c1ccccc1 10.1021/acs.jmedchem.0c02169
DB12446 1370 None 43 Human Functional pKi = 9.4 9.4 - 0
Antagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of NECA-induced cAMP accumulation in presence of forskolin measured after 40 mins by alpha screen LANCE assayAntagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of NECA-induced cAMP accumulation in presence of forskolin measured after 40 mins by alpha screen LANCE assay
ChEMBL 308 3 3 4 3.3 O[C@@H]1CC[C@H](CC1)Nc1nc(nc2c1cc[nH]2)c1ccccc1 10.1021/acs.jmedchem.0c02169
10445452 8734 None 0 Human Functional pKi = 9.4 9.4 - 0
Antagonist activity at human recombinant adenosine A1 receptor by cAMP assayAntagonist activity at human recombinant adenosine A1 receptor by cAMP assay
ChEMBL 263 1 1 5 2.5 Nc1nc(-c2ccco2)c2c(n1)-c1ccccc1C2=O 10.1021/jm4011669
CHEMBL1095999 8734 None 0 Human Functional pKi = 9.4 9.4 - 0
Antagonist activity at human recombinant adenosine A1 receptor by cAMP assayAntagonist activity at human recombinant adenosine A1 receptor by cAMP assay
ChEMBL 263 1 1 5 2.5 Nc1nc(-c2ccco2)c2c(n1)-c1ccccc1C2=O 10.1021/jm4011669
1329 1472 None 53 Human Functional pKi = 9.3 9.3 -4 8
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 304 5 1 5 2.4 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C1CCCC1 10.1021/jm00169a012
386 1472 None 53 Human Functional pKi = 9.3 9.3 -4 8
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 304 5 1 5 2.4 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C1CCCC1 10.1021/jm00169a012
CHEMBL183 1472 None 53 Human Functional pKi = 9.3 9.3 -4 8
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 304 5 1 5 2.4 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C1CCCC1 10.1021/jm00169a012
DB12946 1472 None 53 Human Functional pKi = 9.3 9.3 -4 8
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 304 5 1 5 2.4 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C1CCCC1 10.1021/jm00169a012
46888889 8889 None 0 Human Functional pKi = 9.3 9.3 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 297 1 1 5 3.2 Nc1nc(-c2ccc(Cl)o2)c2c(n1)-c1ccccc1C2=O 10.1016/j.bmcl.2010.03.042
CHEMBL1097494 8889 None 0 Human Functional pKi = 9.3 9.3 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 297 1 1 5 3.2 Nc1nc(-c2ccc(Cl)o2)c2c(n1)-c1ccccc1C2=O 10.1016/j.bmcl.2010.03.042
56954252 82132 None 0 Human Functional pKi = 9.3 9.3 - 0
Antagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP productionAntagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP production
ChEMBL 398 3 1 5 4.6 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(Cc3cnccc3Cl)ccc1C2=O 10.1021/jm201640m
CHEMBL2165801 82132 None 0 Human Functional pKi = 9.3 9.3 - 0
Antagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP productionAntagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP production
ChEMBL 398 3 1 5 4.6 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(Cc3cnccc3Cl)ccc1C2=O 10.1021/jm201640m
3281 1370 None 43 Human Functional pKi = 9.3 9.3 - 0
Antagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 min followed by forskolin stimulation and further incubated for 30 mins in presence of NECA by alphascreen LANCE assayAntagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 min followed by forskolin stimulation and further incubated for 30 mins in presence of NECA by alphascreen LANCE assay
ChEMBL 308 3 3 4 3.3 O[C@@H]1CC[C@H](CC1)Nc1nc(nc2c1cc[nH]2)c1ccccc1 10.1021/acs.jmedchem.0c02169
9953065 1370 None 43 Human Functional pKi = 9.3 9.3 - 0
Antagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 min followed by forskolin stimulation and further incubated for 30 mins in presence of NECA by alphascreen LANCE assayAntagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 min followed by forskolin stimulation and further incubated for 30 mins in presence of NECA by alphascreen LANCE assay
ChEMBL 308 3 3 4 3.3 O[C@@H]1CC[C@H](CC1)Nc1nc(nc2c1cc[nH]2)c1ccccc1 10.1021/acs.jmedchem.0c02169
CHEMBL4204703 1370 None 43 Human Functional pKi = 9.3 9.3 - 0
Antagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 min followed by forskolin stimulation and further incubated for 30 mins in presence of NECA by alphascreen LANCE assayAntagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 min followed by forskolin stimulation and further incubated for 30 mins in presence of NECA by alphascreen LANCE assay
ChEMBL 308 3 3 4 3.3 O[C@@H]1CC[C@H](CC1)Nc1nc(nc2c1cc[nH]2)c1ccccc1 10.1021/acs.jmedchem.0c02169
CHEMBL592435 1370 None 43 Human Functional pKi = 9.3 9.3 - 0
Antagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 min followed by forskolin stimulation and further incubated for 30 mins in presence of NECA by alphascreen LANCE assayAntagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 min followed by forskolin stimulation and further incubated for 30 mins in presence of NECA by alphascreen LANCE assay
ChEMBL 308 3 3 4 3.3 O[C@@H]1CC[C@H](CC1)Nc1nc(nc2c1cc[nH]2)c1ccccc1 10.1021/acs.jmedchem.0c02169
DB12446 1370 None 43 Human Functional pKi = 9.3 9.3 - 0
Antagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 min followed by forskolin stimulation and further incubated for 30 mins in presence of NECA by alphascreen LANCE assayAntagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 min followed by forskolin stimulation and further incubated for 30 mins in presence of NECA by alphascreen LANCE assay
ChEMBL 308 3 3 4 3.3 O[C@@H]1CC[C@H](CC1)Nc1nc(nc2c1cc[nH]2)c1ccccc1 10.1021/acs.jmedchem.0c02169
CHEMBL5073669 216789 None 0 Human Functional pKi = 9.3 9.3 - 0
Antagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 min followed by forskolin stimulation and further incubated for 30 mins in presence of NECA by alphascreen LANCE assayAntagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 min followed by forskolin stimulation and further incubated for 30 mins in presence of NECA by alphascreen LANCE assay
ChEMBL None None None CCCCn1c(=O)c2nc(C34CCC(C(=O)NCCCN=[N+]=[N-])(CC3)CC4)[nH]c2n(CCCNC(=O)c2ccc(S(=O)(=O)F)cc2)c1=O 10.1021/acs.jmedchem.0c02169
CHEMBL5080823 217195 None 0 Human Functional pKi = 9.2 9.2 - 0
Antagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 min followed by forskolin stimulation and further incubated for 30 mins in presence of NECA by alphascreen LANCE assayAntagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 min followed by forskolin stimulation and further incubated for 30 mins in presence of NECA by alphascreen LANCE assay
ChEMBL None None None CCCn1c(=O)c2nc(C34CCC(C(=O)NCCCN=[N+]=[N-])(CC3)CC4)[nH]c2n(CCCNC(=O)c2ccc(S(=O)(=O)F)cc2)c1=O 10.1021/acs.jmedchem.0c02169
CHEMBL5092788 217879 None 0 Human Functional pKi = 9.2 9.2 - 0
Antagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 min followed by forskolin stimulation and further incubated for 30 mins in presence of NECA by alphascreen LANCE assayAntagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 min followed by forskolin stimulation and further incubated for 30 mins in presence of NECA by alphascreen LANCE assay
ChEMBL None None None C#CCCCCNC(=O)C12CCC(c3nc4c(=O)n(CCCC)c(=O)n(CCCNC(=O)c5ccc(S(=O)(=O)F)cc5)c4[nH]3)(CC1)CC2 10.1021/acs.jmedchem.0c02169
11689583 3214 None 24 Human Functional pKi = 9.2 9.2 - 0
Antagonist activity at adenosine A1 receptor (unknown origin)Antagonist activity at adenosine A1 receptor (unknown origin)
ChEMBL 386 7 2 6 2.1 OCCCn1c2[nH]c(nc2c(=O)n(c1=O)CCCC)C12CC3CC2CC(C1)C3 10.1016/j.ejmech.2021.113907
3285 3214 None 24 Human Functional pKi = 9.2 9.2 - 0
Antagonist activity at adenosine A1 receptor (unknown origin)Antagonist activity at adenosine A1 receptor (unknown origin)
ChEMBL 386 7 2 6 2.1 OCCCn1c2[nH]c(nc2c(=O)n(c1=O)CCCC)C12CC3CC2CC(C1)C3 10.1016/j.ejmech.2021.113907
CHEMBL1316674 3214 None 24 Human Functional pKi = 9.2 9.2 - 0
Antagonist activity at adenosine A1 receptor (unknown origin)Antagonist activity at adenosine A1 receptor (unknown origin)
ChEMBL 386 7 2 6 2.1 OCCCn1c2[nH]c(nc2c(=O)n(c1=O)CCCC)C12CC3CC2CC(C1)C3 10.1016/j.ejmech.2021.113907
5604 3368 None 26 Human Functional pKi = 9.2 9.2 - 0
Antagonist activity at adenosine A1 receptor (unknown origin)Antagonist activity at adenosine A1 receptor (unknown origin)
ChEMBL 356 5 1 5 2.8 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C12CC3CC2CC(C1)C3 10.1016/j.ejmech.2021.113907
64627 3368 None 26 Human Functional pKi = 9.2 9.2 - 0
Antagonist activity at adenosine A1 receptor (unknown origin)Antagonist activity at adenosine A1 receptor (unknown origin)
ChEMBL 356 5 1 5 2.8 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C12CC3CC2CC(C1)C3 10.1016/j.ejmech.2021.113907
CHEMBL52333 3368 None 26 Human Functional pKi = 9.2 9.2 - 0
Antagonist activity at adenosine A1 receptor (unknown origin)Antagonist activity at adenosine A1 receptor (unknown origin)
ChEMBL 356 5 1 5 2.8 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C12CC3CC2CC(C1)C3 10.1016/j.ejmech.2021.113907
DB05360 3368 None 26 Human Functional pKi = 9.2 9.2 - 0
Antagonist activity at adenosine A1 receptor (unknown origin)Antagonist activity at adenosine A1 receptor (unknown origin)
ChEMBL 356 5 1 5 2.8 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C12CC3CC2CC(C1)C3 10.1016/j.ejmech.2021.113907
1329 1472 None 53 Human Functional pKi = 9.1 9.1 -4 8
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 304 5 1 5 2.4 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C1CCCC1 10.1016/j.ejmech.2010.04.039
386 1472 None 53 Human Functional pKi = 9.1 9.1 -4 8
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 304 5 1 5 2.4 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C1CCCC1 10.1016/j.ejmech.2010.04.039
CHEMBL183 1472 None 53 Human Functional pKi = 9.1 9.1 -4 8
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 304 5 1 5 2.4 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C1CCCC1 10.1016/j.ejmech.2010.04.039
DB12946 1472 None 53 Human Functional pKi = 9.1 9.1 -4 8
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 304 5 1 5 2.4 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)C1CCCC1 10.1016/j.ejmech.2010.04.039
10038941 132172 None 3 Human Functional pKi = 9.0 9.0 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 273 1 1 4 2.9 Nc1nc(-c2ccccc2)c2c(n1)-c1ccccc1C2=O 10.1016/j.bmcl.2010.03.042
CHEMBL369573 132172 None 3 Human Functional pKi = 9.0 9.0 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 273 1 1 4 2.9 Nc1nc(-c2ccccc2)c2c(n1)-c1ccccc1C2=O 10.1016/j.bmcl.2010.03.042
404 4098 None 26 Rat Functional pKi = 8.9 8.9 - 2
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 428 10 3 8 0.8 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)NCCN 10.1021/jm990421v
432 4098 None 26 Rat Functional pKi = 8.9 8.9 - 2
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 428 10 3 8 0.8 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)NCCN 10.1021/jm990421v
5697 4098 None 26 Rat Functional pKi = 8.9 8.9 - 2
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 428 10 3 8 0.8 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)NCCN 10.1021/jm990421v
CHEMBL273094 4098 None 26 Rat Functional pKi = 8.9 8.9 - 2
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 428 10 3 8 0.8 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)NCCN 10.1021/jm990421v
CHEMBL5074992 216838 None 0 Human Functional pKi = 8.9 8.9 - 0
Antagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 min followed by forskolin stimulation and further incubated for 30 mins in presence of NECA by alphascreen LANCE assayAntagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 min followed by forskolin stimulation and further incubated for 30 mins in presence of NECA by alphascreen LANCE assay
ChEMBL None None None CCCCn1c(=O)c2nc(C34CCC(C(=O)NCCOCCOCCN=[N+]=[N-])(CC3)CC4)[nH]c2n(CCCNC(=O)c2ccc(S(=O)(=O)F)cc2)c1=O 10.1021/acs.jmedchem.0c02169
46889098 7642 None 0 Human Functional pKi = 8.7 8.7 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 387 4 2 7 2.3 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(CNN3CCOCC3)ccc1C2=O 10.1016/j.bmcl.2010.03.042
CHEMBL1088247 7642 None 0 Human Functional pKi = 8.7 8.7 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 387 4 2 7 2.3 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(CNN3CCOCC3)ccc1C2=O 10.1016/j.bmcl.2010.03.042
56954253 82133 None 0 Human Functional pKi = 8.7 8.7 - 0
Antagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP productionAntagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP production
ChEMBL 378 3 1 6 3.6 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(C(=O)c3cccnc3)ccc1C2=O 10.1021/jm201640m
CHEMBL2165802 82133 None 0 Human Functional pKi = 8.7 8.7 - 0
Antagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP productionAntagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP production
ChEMBL 378 3 1 6 3.6 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(C(=O)c3cccnc3)ccc1C2=O 10.1021/jm201640m
9827467 98440 None 0 Rat Functional pKi = 8.0 8.0 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 504 10 3 8 2.5 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(C(N)=O)cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL275360 98440 None 0 Rat Functional pKi = 8.0 8.0 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 504 10 3 8 2.5 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(C(N)=O)cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL5076192 216907 None 0 Human Functional pKi = 8.0 8.0 - 0
Antagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of NECA-induced cAMP accumulation in presence of forskolin measured after 40 mins by alpha screen LANCE assayAntagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of NECA-induced cAMP accumulation in presence of forskolin measured after 40 mins by alpha screen LANCE assay
ChEMBL None None None CCCCn1c(=O)c2nc(C34CCC(C(=O)NCCCCCCCCN=[N+]=[N-])(CC3)CC4)[nH]c2n(CCCNC(=O)c2ccc(S(=O)(=O)F)cc2)c1=O 10.1021/acs.jmedchem.0c02169
14788228 100743 None 0 Human Functional pKi = 7 7.0 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 348 6 2 6 1.7 CCCn1c(=O)c2nc(C3CCCC3C(=O)O)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
CHEMBL292382 100743 None 0 Human Functional pKi = 7 7.0 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 348 6 2 6 1.7 CCCn1c(=O)c2nc(C3CCCC3C(=O)O)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
45279727 109629 None 0 Human Functional pKi = 7 7.0 - 0
Antagonist activity at human recombinant adenosine A1 receptor by cAMP assayAntagonist activity at human recombinant adenosine A1 receptor by cAMP assay
ChEMBL 342 3 1 6 4.3 C[C@H]1CCC[C@@H](C)N1Cc1cc2c(N)nc(-c3ccco3)nc2s1 10.1021/jm4011669
CHEMBL3222062 109629 None 0 Human Functional pKi = 7 7.0 - 0
Antagonist activity at human recombinant adenosine A1 receptor by cAMP assayAntagonist activity at human recombinant adenosine A1 receptor by cAMP assay
ChEMBL 342 3 1 6 4.3 C[C@H]1CCC[C@@H](C)N1Cc1cc2c(N)nc(-c3ccco3)nc2s1 10.1021/jm4011669
11386134 67490 None 0 Human Functional pKi = 5 5.0 - 0
Antagonist activity at human adenosine A1 receptorAntagonist activity at human adenosine A1 receptor
ChEMBL 482 4 1 11 2.1 Cn1nc(C(F)(F)F)c(CN2CCN(c3nc(N)n4nc(-c5ccco5)nc4n3)CC2)c1Cl 10.1016/j.ejmech.2022.114378
CHEMBL189192 67490 None 0 Human Functional pKi = 5 5.0 - 0
Antagonist activity at human adenosine A1 receptorAntagonist activity at human adenosine A1 receptor
ChEMBL 482 4 1 11 2.1 Cn1nc(C(F)(F)F)c(CN2CCN(c3nc(N)n4nc(-c5ccco5)nc4n3)CC2)c1Cl 10.1016/j.ejmech.2022.114378
46889228 7446 None 0 Human Functional pKi = 7 7.0 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 417 2 1 6 2.5 CN1CCN(C(=O)c2ccc3c(c2)-c2nc(N)nc(-c4ccc(F)cc4)c2C3=O)CC1 10.1016/j.bmcl.2010.03.024
CHEMBL1086697 7446 None 0 Human Functional pKi = 7 7.0 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 417 2 1 6 2.5 CN1CCN(C(=O)c2ccc3c(c2)-c2nc(N)nc(-c4ccc(F)cc4)c2C3=O)CC1 10.1016/j.bmcl.2010.03.024
46889254 7608 None 0 Human Functional pKi = 7.0 7.0 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 388 7 1 6 3.7 CCN(CC)CCOc1ccc2c(c1)-c1nc(N)nc(-c3ccccc3)c1C2=O 10.1016/j.bmcl.2010.03.024
CHEMBL1087999 7608 None 0 Human Functional pKi = 7.0 7.0 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 388 7 1 6 3.7 CCN(CC)CCOc1ccc2c(c1)-c1nc(N)nc(-c3ccccc3)c1C2=O 10.1016/j.bmcl.2010.03.024
10839228 59885 None 0 Human Functional pKi = 7.0 7.0 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 504 8 2 8 2.1 CCCn1c(=O)c2nc(-c3ccc(/C=C/C(=O)NN4C(=O)C(C)=C(C)C4=O)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL17294 59885 None 0 Human Functional pKi = 7.0 7.0 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 504 8 2 8 2.1 CCCn1c(=O)c2nc(-c3ccc(/C=C/C(=O)NN4C(=O)C(C)=C(C)C4=O)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
45275821 89820 None 0 Human Functional pKi = 7.0 7.0 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 308 3 1 6 3.5 Nc1nc(-c2cnco2)nc2sc(Cc3ccccc3)cc12 10.1016/j.bmcl.2013.02.078
CHEMBL2377229 89820 None 0 Human Functional pKi = 7.0 7.0 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 308 3 1 6 3.5 Nc1nc(-c2cnco2)nc2sc(Cc3ccccc3)cc12 10.1016/j.bmcl.2013.02.078
46888989 7565 None 0 Human Functional pKi = 7.0 7.0 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 358 5 1 5 3.8 CCN(CC)Cc1cccc2c1-c1nc(N)nc(-c3ccccc3)c1C2=O 10.1016/j.bmcl.2010.03.042
CHEMBL1087700 7565 None 0 Human Functional pKi = 7.0 7.0 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 358 5 1 5 3.8 CCN(CC)Cc1cccc2c1-c1nc(N)nc(-c3ccccc3)c1C2=O 10.1016/j.bmcl.2010.03.042
2519 779 None 49 Human Functional pKi = 5.0 5.0 -17782 8
Antagonist activity at adenosine A1 receptor (unknown origin)Antagonist activity at adenosine A1 receptor (unknown origin)
ChEMBL 194 0 0 6 -1.0 Cn1cnc2c1c(=O)n(C)c(=O)n2C 10.1016/j.ejmech.2021.113907
2519.0 779 None 49 Human Functional pKi = 5.0 5.0 -17782 8
Antagonist activity at adenosine A1 receptor (unknown origin)Antagonist activity at adenosine A1 receptor (unknown origin)
ChEMBL 194 0 0 6 -1.0 Cn1cnc2c1c(=O)n(C)c(=O)n2C 10.1016/j.ejmech.2021.113907
407 779 None 49 Human Functional pKi = 5.0 5.0 -17782 8
Antagonist activity at adenosine A1 receptor (unknown origin)Antagonist activity at adenosine A1 receptor (unknown origin)
ChEMBL 194 0 0 6 -1.0 Cn1cnc2c1c(=O)n(C)c(=O)n2C 10.1016/j.ejmech.2021.113907
463 779 None 49 Human Functional pKi = 5.0 5.0 -17782 8
Antagonist activity at adenosine A1 receptor (unknown origin)Antagonist activity at adenosine A1 receptor (unknown origin)
ChEMBL 194 0 0 6 -1.0 Cn1cnc2c1c(=O)n(C)c(=O)n2C 10.1016/j.ejmech.2021.113907
CHEMBL113 779 None 49 Human Functional pKi = 5.0 5.0 -17782 8
Antagonist activity at adenosine A1 receptor (unknown origin)Antagonist activity at adenosine A1 receptor (unknown origin)
ChEMBL 194 0 0 6 -1.0 Cn1cnc2c1c(=O)n(C)c(=O)n2C 10.1016/j.ejmech.2021.113907
DB00201 779 None 49 Human Functional pKi = 5.0 5.0 -17782 8
Antagonist activity at adenosine A1 receptor (unknown origin)Antagonist activity at adenosine A1 receptor (unknown origin)
ChEMBL 194 0 0 6 -1.0 Cn1cnc2c1c(=O)n(C)c(=O)n2C 10.1016/j.ejmech.2021.113907
14788237 200701 None 0 Human Functional pKi = 8.0 8.0 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 290 5 1 5 1.8 CCCn1c(=O)c2nc(C3CC3C)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
CHEMBL57554 200701 None 0 Human Functional pKi = 8.0 8.0 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 290 5 1 5 1.8 CCCn1c(=O)c2nc(C3CC3C)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
9936058 59577 None 2 Rat Functional pKi = 8.0 8.0 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 508 9 2 9 1.5 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)NN4C(=O)C(C)=C(C)C4=O)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL17173 59577 None 2 Rat Functional pKi = 8.0 8.0 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 508 9 2 9 1.5 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)NN4C(=O)C(C)=C(C)C4=O)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
17035744 8846 None 3 Human Functional pKi = 7.9 7.9 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 307 1 1 4 3.6 Nc1nc(-c2ccc(Cl)cc2)c2c(n1)-c1ccccc1C2=O 10.1016/j.bmcl.2010.03.042
CHEMBL1096998 8846 None 3 Human Functional pKi = 7.9 7.9 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 307 1 1 4 3.6 Nc1nc(-c2ccc(Cl)cc2)c2c(n1)-c1ccccc1C2=O 10.1016/j.bmcl.2010.03.042
11359283 166329 None 0 Human Functional pKi = 6.0 6.0 - 0
Antagonist activity at human adenosine A1 receptorAntagonist activity at human adenosine A1 receptor
ChEMBL 325 2 1 8 1.3 Nc1nc(N2CCN3CCC[C@@H]3C2)cc2nc(-c3ccco3)nn12 10.1016/j.ejmech.2022.114378
CHEMBL426738 166329 None 0 Human Functional pKi = 6.0 6.0 - 0
Antagonist activity at human adenosine A1 receptorAntagonist activity at human adenosine A1 receptor
ChEMBL 325 2 1 8 1.3 Nc1nc(N2CCN3CCC[C@@H]3C2)cc2nc(-c3ccco3)nn12 10.1016/j.ejmech.2022.114378
46889096 7575 None 0 Human Functional pKi = 6.9 6.9 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 399 4 2 6 3.8 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(CNN3CCCCCC3)ccc1C2=O 10.1016/j.bmcl.2010.03.042
CHEMBL1087727 7575 None 0 Human Functional pKi = 6.9 6.9 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 399 4 2 6 3.8 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(CNN3CCCCCC3)ccc1C2=O 10.1016/j.bmcl.2010.03.042
59277999 89801 None 0 Human Functional pKi = 5.9 5.9 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 343 3 1 6 3.8 N#Cc1cncc(-c2nc(N)c3cc(Cc4ccccc4)sc3n2)c1 10.1016/j.bmcl.2013.02.078
CHEMBL2377107 89801 None 0 Human Functional pKi = 5.9 5.9 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 343 3 1 6 3.8 N#Cc1cncc(-c2nc(N)c3cc(Cc4ccccc4)sc3n2)c1 10.1016/j.bmcl.2013.02.078
46861769 7569 None 0 Human Functional pKi = 6.9 6.9 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 356 3 1 5 3.5 Nc1nc(-c2ccccc2)c2c(n1)-c1c(CN3CCCC3)cccc1C2=O 10.1016/j.bmcl.2010.03.042
CHEMBL1087709 7569 None 0 Human Functional pKi = 6.9 6.9 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 356 3 1 5 3.5 Nc1nc(-c2ccccc2)c2c(n1)-c1c(CN3CCCC3)cccc1C2=O 10.1016/j.bmcl.2010.03.042
46888988 7564 None 0 Human Functional pKi = 6.9 6.9 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 387 6 1 6 2.9 CN(C)CCN(C)Cc1cccc2c1-c1nc(N)nc(-c3ccccc3)c1C2=O 10.1016/j.bmcl.2010.03.042
CHEMBL1087699 7564 None 0 Human Functional pKi = 6.9 6.9 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 387 6 1 6 2.9 CN(C)CCN(C)Cc1cccc2c1-c1nc(N)nc(-c3ccccc3)c1C2=O 10.1016/j.bmcl.2010.03.042
46889206 7510 None 0 Human Functional pKi = 6.9 6.9 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 441 4 2 6 3.5 CC(C)N1CCC(NC(=O)c2ccc3c(c2)-c2nc(N)nc(-c4ccccc4)c2C3=O)CC1 10.1016/j.bmcl.2010.03.024
CHEMBL1087183 7510 None 0 Human Functional pKi = 6.9 6.9 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 441 4 2 6 3.5 CC(C)N1CCC(NC(=O)c2ccc3c(c2)-c2nc(N)nc(-c4ccccc4)c2C3=O)CC1 10.1016/j.bmcl.2010.03.024
11995352 198818 None 0 Human Functional pKi = 7.9 7.9 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 375 6 2 6 1.9 CCCn1c(=O)c2nc(C3CCC(NC(C)=O)CC3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
CHEMBL56251 198818 None 0 Human Functional pKi = 7.9 7.9 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 375 6 2 6 1.9 CCCn1c(=O)c2nc(C3CCC(NC(C)=O)CC3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
52933691 157512 None 0 Human Functional pKi = 7.9 7.9 - 0
Antagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assayAntagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assay
ChEMBL 346 5 1 6 2.7 CCCn1c(OC2CCOCC2)nc2nc(C3CCCC3)[nH]c2c1=O 10.1016/j.bmc.2017.02.029
CHEMBL4078636 157512 None 0 Human Functional pKi = 7.9 7.9 - 0
Antagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assayAntagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assay
ChEMBL 346 5 1 6 2.7 CCCn1c(OC2CCOCC2)nc2nc(C3CCCC3)[nH]c2c1=O 10.1016/j.bmc.2017.02.029
137642069 158307 None 0 Human Functional pKi = 7.9 7.9 - 0
Antagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assayAntagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assay
ChEMBL 390 4 1 4 4.9 CCCn1c(-c2cccc(C(F)(F)F)c2)nc2nc(C3CCCC3)[nH]c2c1=O 10.1016/j.bmc.2017.02.029
CHEMBL4088084 158307 None 0 Human Functional pKi = 7.9 7.9 - 0
Antagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assayAntagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assay
ChEMBL 390 4 1 4 4.9 CCCn1c(-c2cccc(C(F)(F)F)c2)nc2nc(C3CCCC3)[nH]c2c1=O 10.1016/j.bmc.2017.02.029
46889207 7511 None 0 Human Functional pKi = 7.9 7.9 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 385 2 2 6 2.0 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(C(=O)N3CCNCC3)ccc1C2=O 10.1016/j.bmcl.2010.03.024
CHEMBL1087184 7511 None 0 Human Functional pKi = 7.9 7.9 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 385 2 2 6 2.0 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(C(=O)N3CCNCC3)ccc1C2=O 10.1016/j.bmcl.2010.03.024
46889044 7572 None 0 Human Functional pKi = 7.9 7.9 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 382 5 2 6 3.8 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(CNCc3ccco3)ccc1C2=O 10.1016/j.bmcl.2010.03.042
CHEMBL1087714 7572 None 0 Human Functional pKi = 7.9 7.9 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 382 5 2 6 3.8 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(CNCc3ccco3)ccc1C2=O 10.1016/j.bmcl.2010.03.042
46888823 9016 None 0 Human Functional pKi = 7.9 7.9 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 393 5 2 6 4.0 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(NCCc3ccncc3)ccc1C2=O 10.1016/j.bmcl.2010.03.024
CHEMBL1098458 9016 None 0 Human Functional pKi = 7.9 7.9 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 393 5 2 6 4.0 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(NCCc3ccncc3)ccc1C2=O 10.1016/j.bmcl.2010.03.024
9807634 59904 None 0 Rat Functional pKi = 6.9 6.9 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 551 11 2 7 4.7 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)NC(c4ccccc4)c4ccccc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL17299 59904 None 0 Rat Functional pKi = 6.9 6.9 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 551 11 2 7 4.7 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)NC(c4ccccc4)c4ccccc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
9870396 139124 None 0 Human Functional pKi = 5.9 5.9 - 0
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 494 7 1 7 4.3 CCCn1c(=O)c2nc(-c3cnn(Cc4cc(C(F)(F)F)ccc4Cl)c3)[nH]c2n(CCC)c1=O 10.1016/j.ejmech.2010.04.039
CHEMBL378598 139124 None 0 Human Functional pKi = 5.9 5.9 - 0
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 494 7 1 7 4.3 CCCn1c(=O)c2nc(-c3cnn(Cc4cc(C(F)(F)F)ccc4Cl)c3)[nH]c2n(CCC)c1=O 10.1016/j.ejmech.2010.04.039
176408 3557 None 55 Human Functional pKi = 6.9 6.9 - 1
Antagonist activity at adenosine A1 receptor (unknown origin)Antagonist activity at adenosine A1 receptor (unknown origin)
ChEMBL 345 4 1 8 2.6 Nc1nc2n(CCc3ccccc3)ncc2c2n1nc(n2)c1ccco1 10.1016/j.ejmech.2022.114378
403 3557 None 55 Human Functional pKi = 6.9 6.9 - 1
Antagonist activity at adenosine A1 receptor (unknown origin)Antagonist activity at adenosine A1 receptor (unknown origin)
ChEMBL 345 4 1 8 2.6 Nc1nc2n(CCc3ccccc3)ncc2c2n1nc(n2)c1ccco1 10.1016/j.ejmech.2022.114378
431 3557 None 55 Human Functional pKi = 6.9 6.9 - 1
Antagonist activity at adenosine A1 receptor (unknown origin)Antagonist activity at adenosine A1 receptor (unknown origin)
ChEMBL 345 4 1 8 2.6 Nc1nc2n(CCc3ccccc3)ncc2c2n1nc(n2)c1ccco1 10.1016/j.ejmech.2022.114378
CHEMBL17127 3557 None 55 Human Functional pKi = 6.9 6.9 - 1
Antagonist activity at adenosine A1 receptor (unknown origin)Antagonist activity at adenosine A1 receptor (unknown origin)
ChEMBL 345 4 1 8 2.6 Nc1nc2n(CCc3ccccc3)ncc2c2n1nc(n2)c1ccco1 10.1016/j.ejmech.2022.114378
45275715 89803 None 0 Human Functional pKi = 6.9 6.9 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 351 4 1 6 4.4 COc1ccccc1Cc1cc2c(N)nc(-c3ccc(C)o3)nc2s1 10.1016/j.bmcl.2013.02.078
CHEMBL2377109 89803 None 0 Human Functional pKi = 6.9 6.9 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 351 4 1 6 4.4 COc1ccccc1Cc1cc2c(N)nc(-c3ccc(C)o3)nc2s1 10.1016/j.bmcl.2013.02.078
45275173 89791 None 0 Human Functional pKi = 6.9 6.9 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 335 3 1 4 4.7 Nc1nc(-c2cccc(F)c2)nc2sc(Cc3ccccc3)cc12 10.1016/j.bmcl.2013.02.078
CHEMBL2377097 89791 None 0 Human Functional pKi = 6.9 6.9 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 335 3 1 4 4.7 Nc1nc(-c2cccc(F)c2)nc2sc(Cc3ccccc3)cc12 10.1016/j.bmcl.2013.02.078
45136848 89785 None 0 Human Functional pKi = 6.9 6.9 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 372 4 1 6 4.4 COc1ccccc1Cc1cc2c(N)nc(-c3cccc(C#N)c3)nc2s1 10.1016/j.bmcl.2013.02.078
CHEMBL2377091 89785 None 0 Human Functional pKi = 6.9 6.9 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 372 4 1 6 4.4 COc1ccccc1Cc1cc2c(N)nc(-c3cccc(C#N)c3)nc2s1 10.1016/j.bmcl.2013.02.078
823558 15250 None 7 Rat Functional pKi = 5.9 5.9 - 0
Antagonist activity against rat adenosine A1 receptorAntagonist activity against rat adenosine A1 receptor
ChEMBL 271 2 2 6 0.8 COc1ccc2c(C)nc(NC3=NCC(=O)N3)nc2c1 10.1016/j.ejmech.2010.04.039
CHEMBL1210817 15250 None 7 Rat Functional pKi = 5.9 5.9 - 0
Antagonist activity against rat adenosine A1 receptorAntagonist activity against rat adenosine A1 receptor
ChEMBL 271 2 2 6 0.8 COc1ccc2c(C)nc(NC3=NCC(=O)N3)nc2c1 10.1016/j.ejmech.2010.04.039
52912216 157165 None 0 Human Functional pKi = 7.9 7.9 - 0
Antagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assayAntagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assay
ChEMBL 374 5 1 5 4.3 CCCn1c(Oc2ccc(F)c(F)c2)nc2nc(C3CCCC3)[nH]c2c1=O 10.1016/j.bmc.2017.02.029
CHEMBL4074150 157165 None 0 Human Functional pKi = 7.9 7.9 - 0
Antagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assayAntagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assay
ChEMBL 374 5 1 5 4.3 CCCn1c(Oc2ccc(F)c(F)c2)nc2nc(C3CCCC3)[nH]c2c1=O 10.1016/j.bmc.2017.02.029
52936156 158568 None 0 Human Functional pKi = 7.9 7.9 - 0
Antagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assayAntagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assay
ChEMBL 330 5 1 5 3.5 CCCn1c(OC2CCCC2)nc2nc(C3CCCC3)[nH]c2c1=O 10.1016/j.bmc.2017.02.029
CHEMBL4090857 158568 None 0 Human Functional pKi = 7.9 7.9 - 0
Antagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assayAntagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assay
ChEMBL 330 5 1 5 3.5 CCCn1c(OC2CCCC2)nc2nc(C3CCCC3)[nH]c2c1=O 10.1016/j.bmc.2017.02.029
10839296 58160 None 1 Rat Functional pKi = 7.9 7.9 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 506 10 2 9 3.3 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc([N+](=O)[O-])cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL16787 58160 None 1 Rat Functional pKi = 7.9 7.9 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 506 10 2 9 3.3 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc([N+](=O)[O-])cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
14788202 101794 None 0 Human Functional pKi = 6.9 6.9 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 376 6 1 7 2.2 CCCn1c(=O)c2nc(C3CCC(C(=O)OC)CC3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
CHEMBL299699 101794 None 0 Human Functional pKi = 6.9 6.9 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 376 6 1 7 2.2 CCCn1c(=O)c2nc(C3CCC(C(=O)OC)CC3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
2840092 203506 None 34 Rat Functional pKi = 5.9 5.9 - 0
Antagonist activity against rat adenosine A1 receptorAntagonist activity against rat adenosine A1 receptor
ChEMBL 245 3 3 4 1.6 CCOc1cccc2c(C)nc(NC(=N)N)nc12 10.1016/j.ejmech.2010.04.039
CHEMBL602578 203506 None 34 Rat Functional pKi = 5.9 5.9 - 0
Antagonist activity against rat adenosine A1 receptorAntagonist activity against rat adenosine A1 receptor
ChEMBL 245 3 3 4 1.6 CCOc1cccc2c(C)nc(NC(=N)N)nc12 10.1016/j.ejmech.2010.04.039
46888881 8569 None 0 Human Functional pKi = 6.9 6.9 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 385 2 1 6 3.1 CN1CCCN(c2ccc3c(c2)-c2nc(N)nc(-c4ccccc4)c2C3=O)CC1 10.1016/j.bmcl.2010.03.024
CHEMBL1094548 8569 None 0 Human Functional pKi = 6.9 6.9 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 385 2 1 6 3.1 CN1CCCN(c2ccc3c(c2)-c2nc(N)nc(-c4ccccc4)c2C3=O)CC1 10.1016/j.bmcl.2010.03.024
134144288 150228 None 0 Human Functional pKi = 5.9 5.9 - 0
Antagonist activity at human adenosine A1A receptorAntagonist activity at human adenosine A1A receptor
ChEMBL 395 4 3 5 4.9 Oc1ccc(-c2cnc(N[C@H]3CC[C@H](O)CC3)nc2-c2ccccc2)cc1Cl 10.1016/j.ejmech.2021.113907
CHEMBL3951351 150228 None 0 Human Functional pKi = 5.9 5.9 - 0
Antagonist activity at human adenosine A1A receptorAntagonist activity at human adenosine A1A receptor
ChEMBL 395 4 3 5 4.9 Oc1ccc(-c2cnc(N[C@H]3CC[C@H](O)CC3)nc2-c2ccccc2)cc1Cl 10.1016/j.ejmech.2021.113907
14788225 202459 None 0 Human Functional pKi = 7.9 7.9 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 333 6 2 6 2.5 CCCn1c(=O)c2nc(NC3CCCCC3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
CHEMBL59529 202459 None 0 Human Functional pKi = 7.9 7.9 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 333 6 2 6 2.5 CCCn1c(=O)c2nc(NC3CCCCC3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
11462655 122388 None 0 Human Functional pKi = 7.9 7.9 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 364 4 2 6 3.2 N#Cc1c(N)nc(SCCO)c(C#N)c1-c1cccc(C(F)(F)F)c1 10.1021/jm201706b
CHEMBL359833 122388 None 0 Human Functional pKi = 7.9 7.9 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 364 4 2 6 3.2 N#Cc1c(N)nc(SCCO)c(C#N)c1-c1cccc(C(F)(F)F)c1 10.1021/jm201706b
14788228 100743 None 0 Human Functional pKi = 6.9 6.9 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 348 6 2 6 1.7 CCCn1c(=O)c2nc(C3CCCC3C(=O)O)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
CHEMBL292382 100743 None 0 Human Functional pKi = 6.9 6.9 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 348 6 2 6 1.7 CCCn1c(=O)c2nc(C3CCCC3C(=O)O)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
443 755 None 9 Human Functional pKi = 6.9 6.9 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 382 7 2 6 2.5 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)/C=C/C(=O)O 10.1021/jm990421v
6439089 755 None 9 Human Functional pKi = 6.9 6.9 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 382 7 2 6 2.5 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)/C=C/C(=O)O 10.1021/jm990421v
CHEMBL16997 755 None 9 Human Functional pKi = 6.9 6.9 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 382 7 2 6 2.5 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)/C=C/C(=O)O 10.1021/jm990421v
46889043 7571 None 0 Human Functional pKi = 6.9 6.9 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 384 3 1 5 4.3 CC1CCC(C)N1Cc1cccc2c1-c1nc(N)nc(-c3ccccc3)c1C2=O 10.1016/j.bmcl.2010.03.042
CHEMBL1087711 7571 None 0 Human Functional pKi = 6.9 6.9 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 384 3 1 5 4.3 CC1CCC(C)N1Cc1cccc2c1-c1nc(N)nc(-c3ccccc3)c1C2=O 10.1016/j.bmcl.2010.03.042
45275818 89825 None 0 Human Functional pKi = 5.9 5.9 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 352 3 1 6 4.9 Cc1csc(-c2nc(N)c3cc(C(C)c4ccccc4)sc3n2)n1 10.1016/j.bmcl.2013.02.078
CHEMBL2377234 89825 None 0 Human Functional pKi = 5.9 5.9 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 352 3 1 6 4.9 Cc1csc(-c2nc(N)c3cc(C(C)c4ccccc4)sc3n2)n1 10.1016/j.bmcl.2013.02.078
45275716 89795 None 0 Human Functional pKi = 5.9 5.9 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 318 3 1 5 3.9 Nc1nc(-c2cccnc2)nc2sc(Cc3ccccc3)cc12 10.1016/j.bmcl.2013.02.078
CHEMBL2377101 89795 None 0 Human Functional pKi = 5.9 5.9 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 318 3 1 5 3.9 Nc1nc(-c2cccnc2)nc2sc(Cc3ccccc3)cc12 10.1016/j.bmcl.2013.02.078
46888851 8710 None 0 Human Functional pKi = 6.9 6.9 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 399 4 2 6 3.8 CCN1CCC(Nc2ccc3c(c2)-c2nc(N)nc(-c4ccccc4)c2C3=O)CC1 10.1016/j.bmcl.2010.03.024
CHEMBL1095812 8710 None 0 Human Functional pKi = 6.9 6.9 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 399 4 2 6 3.8 CCN1CCC(Nc2ccc3c(c2)-c2nc(N)nc(-c4ccccc4)c2C3=O)CC1 10.1016/j.bmcl.2010.03.024
9935943 59042 None 0 Rat Functional pKi = 6.8 6.8 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 505 10 3 8 3.1 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(C(=O)O)cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL16931 59042 None 0 Rat Functional pKi = 6.8 6.8 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 505 10 3 8 3.1 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(C(=O)O)cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
10387088 59474 None 0 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 414 10 2 7 2.6 CCCCn1c(=O)c2nc(-c3ccc(OCC(=O)O)cc3)[nH]c2n(CCCC)c1=O 10.1021/jm990421v
CHEMBL17123 59474 None 0 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 414 10 2 7 2.6 CCCCn1c(=O)c2nc(-c3ccc(OCC(=O)O)cc3)[nH]c2n(CCCC)c1=O 10.1021/jm990421v
45275717 89821 None 0 Human Functional pKi = 5.8 5.8 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 338 3 1 6 4.3 Cc1csc(-c2nc(N)c3cc(Cc4ccccc4)sc3n2)n1 10.1016/j.bmcl.2013.02.078
CHEMBL2377230 89821 None 0 Human Functional pKi = 5.8 5.8 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 338 3 1 6 4.3 Cc1csc(-c2nc(N)c3cc(Cc4ccccc4)sc3n2)n1 10.1016/j.bmcl.2013.02.078
443 755 None 9 Rat Functional pKi = 7.8 7.8 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 382 7 2 6 2.5 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)/C=C/C(=O)O 10.1021/jm990421v
6439089 755 None 9 Rat Functional pKi = 7.8 7.8 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 382 7 2 6 2.5 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)/C=C/C(=O)O 10.1021/jm990421v
CHEMBL16997 755 None 9 Rat Functional pKi = 7.8 7.8 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 382 7 2 6 2.5 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)/C=C/C(=O)O 10.1021/jm990421v
137631671 156424 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assayAntagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assay
ChEMBL 352 5 1 5 3.9 CCCn1c(-c2cccc(OC)c2)nc2nc(C3CCCC3)[nH]c2c1=O 10.1016/j.bmc.2017.02.029
CHEMBL4065762 156424 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assayAntagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assay
ChEMBL 352 5 1 5 3.9 CCCn1c(-c2cccc(OC)c2)nc2nc(C3CCCC3)[nH]c2c1=O 10.1016/j.bmc.2017.02.029
46888824 9053 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 393 5 2 6 4.0 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(NCCc3ccccn3)ccc1C2=O 10.1016/j.bmcl.2010.03.024
CHEMBL1098765 9053 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 393 5 2 6 4.0 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(NCCc3ccccn3)ccc1C2=O 10.1016/j.bmcl.2010.03.024
11801496 98800 None 0 Rat Functional pKi = 7.8 7.8 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 587 9 2 7 4.0 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(I)cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL278039 98800 None 0 Rat Functional pKi = 7.8 7.8 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 587 9 2 7 4.0 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(I)cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
44572469 179557 None 8 Human Functional pKi = 5.8 5.8 - 0
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 257 2 2 6 0.2 Nc1ncnc2c1nc(Br)n2CCO 10.1016/j.ejmech.2010.04.039
CHEMBL474058 179557 None 8 Human Functional pKi = 5.8 5.8 - 0
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 257 2 2 6 0.2 Nc1ncnc2c1nc(Br)n2CCO 10.1016/j.ejmech.2010.04.039
45275058 89782 None 0 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 317 3 1 4 4.5 Nc1nc(-c2ccccc2)nc2sc(Cc3ccccc3)cc12 10.1016/j.bmcl.2013.02.078
CHEMBL2377088 89782 None 0 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 317 3 1 4 4.5 Nc1nc(-c2ccccc2)nc2sc(Cc3ccccc3)cc12 10.1016/j.bmcl.2013.02.078
14484978 97645 None 0 Rat Functional pKi = 6.8 6.8 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 483 9 1 10 1.4 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)ON4C(=O)CCC4=O)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL27081 97645 None 0 Rat Functional pKi = 6.8 6.8 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 483 9 1 10 1.4 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)ON4C(=O)CCC4=O)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
46889019 7541 None 0 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 390 3 1 6 2.9 Nc1nc(-c2ccc(F)cc2)c2c(n1)-c1c(CN3CCOCC3)cccc1C2=O 10.1016/j.bmcl.2010.03.042
CHEMBL1087463 7541 None 0 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 390 3 1 6 2.9 Nc1nc(-c2ccc(F)cc2)c2c(n1)-c1c(CN3CCOCC3)cccc1C2=O 10.1016/j.bmcl.2010.03.042
3287 2642 None 33 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 503 10 2 8 3.6 CCCn1c2[nH]c(nc2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)Nc1ccc(cc1)C(=O)C 10.1016/j.ejmech.2010.04.039
5139184 2642 None 33 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 503 10 2 8 3.6 CCCn1c2[nH]c(nc2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)Nc1ccc(cc1)C(=O)C 10.1016/j.ejmech.2010.04.039
CHEMBL17002 2642 None 33 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 503 10 2 8 3.6 CCCn1c2[nH]c(nc2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)Nc1ccc(cc1)C(=O)C 10.1016/j.ejmech.2010.04.039
3287 2642 None 33 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 503 10 2 8 3.6 CCCn1c2[nH]c(nc2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)Nc1ccc(cc1)C(=O)C 10.1021/jm990421v
5139184 2642 None 33 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 503 10 2 8 3.6 CCCn1c2[nH]c(nc2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)Nc1ccc(cc1)C(=O)C 10.1021/jm990421v
CHEMBL17002 2642 None 33 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 503 10 2 8 3.6 CCCn1c2[nH]c(nc2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)Nc1ccc(cc1)C(=O)C 10.1021/jm990421v
135783184 8888 None 3 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity at human adenosine A1 receptor expressed in forskolin-stimulated CHO cells assessed as inhibition of NSCA-induced decrease in cAMP level pre-incubated for 15 mins by enzyme immunoassayAntagonist activity at human adenosine A1 receptor expressed in forskolin-stimulated CHO cells assessed as inhibition of NSCA-induced decrease in cAMP level pre-incubated for 15 mins by enzyme immunoassay
ChEMBL 361 5 1 6 3.6 C=CCOc1cccc(-c2nc(O)c3c4ccccc4c(=O)n(CC)n23)c1 10.1016/j.bmc.2010.03.048
CHEMBL1097489 8888 None 3 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity at human adenosine A1 receptor expressed in forskolin-stimulated CHO cells assessed as inhibition of NSCA-induced decrease in cAMP level pre-incubated for 15 mins by enzyme immunoassayAntagonist activity at human adenosine A1 receptor expressed in forskolin-stimulated CHO cells assessed as inhibition of NSCA-induced decrease in cAMP level pre-incubated for 15 mins by enzyme immunoassay
ChEMBL 361 5 1 6 3.6 C=CCOc1cccc(-c2nc(O)c3c4ccccc4c(=O)n(CC)n23)c1 10.1016/j.bmc.2010.03.048
46888784 8665 None 0 Human Functional pKi = 6.8 6.8 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 386 5 1 6 3.4 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(OCCN3CCCC3)ccc1C2=O 10.1016/j.bmcl.2010.03.024
CHEMBL1095490 8665 None 0 Human Functional pKi = 6.8 6.8 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 386 5 1 6 3.4 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(OCCN3CCCC3)ccc1C2=O 10.1016/j.bmcl.2010.03.024
46888930 7475 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 274 1 1 5 2.3 Nc1nc(-c2ccncc2)c2c(n1)-c1ccccc1C2=O 10.1016/j.bmcl.2010.03.042
CHEMBL1086977 7475 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 274 1 1 5 2.3 Nc1nc(-c2ccncc2)c2c(n1)-c1ccccc1C2=O 10.1016/j.bmcl.2010.03.042
46888852 8711 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 413 4 1 6 3.9 CCN1CCC(N(C)c2ccc3c(c2)-c2nc(N)nc(-c4ccccc4)c2C3=O)CC1 10.1016/j.bmcl.2010.03.024
CHEMBL1095813 8711 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 413 4 1 6 3.9 CCN1CCC(N(C)c2ccc3c(c2)-c2nc(N)nc(-c4ccccc4)c2C3=O)CC1 10.1016/j.bmcl.2010.03.024
449 2643 None 38 Rat Functional pKi = 7.8 7.8 - 4
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 486 9 2 8 3.3 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)Nc1ccc(cc1)C#N 10.1021/jm990421v
453 2643 None 38 Rat Functional pKi = 7.8 7.8 - 4
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 486 9 2 8 3.3 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)Nc1ccc(cc1)C#N 10.1021/jm990421v
6603931 2643 None 38 Rat Functional pKi = 7.8 7.8 - 4
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 486 9 2 8 3.3 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)Nc1ccc(cc1)C#N 10.1021/jm990421v
CHEMBL273807 2643 None 38 Rat Functional pKi = 7.8 7.8 - 4
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 486 9 2 8 3.3 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)Nc1ccc(cc1)C#N 10.1021/jm990421v
14788203 201553 None 0 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 333 5 2 6 1.7 CCCn1c(=O)c2nc(C3CCC(N)CC3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
CHEMBL58879 201553 None 0 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 333 5 2 6 1.7 CCCn1c(=O)c2nc(C3CCC(N)CC3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
9935943 59042 None 0 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 505 10 3 8 3.1 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(C(=O)O)cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL16931 59042 None 0 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 505 10 3 8 3.1 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(C(=O)O)cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
9827467 98440 None 0 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 504 10 3 8 2.5 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(C(N)=O)cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL275360 98440 None 0 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 504 10 3 8 2.5 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(C(N)=O)cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
11516306 79338 None 0 Rat Functional pKi = 5.8 5.8 - 1
Inhibition of adenylate cyclase via Adenosine A1 receptor in rat fat cell membranesInhibition of adenylate cyclase via Adenosine A1 receptor in rat fat cell membranes
ChEMBL 374 4 4 9 -0.7 CCCC#Cc1nc(N)c2ncn([C@@H]3O[C@H](C(=O)NCC)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00091a003
CHEMBL2113509 79338 None 0 Rat Functional pKi = 5.8 5.8 - 1
Inhibition of adenylate cyclase via Adenosine A1 receptor in rat fat cell membranesInhibition of adenylate cyclase via Adenosine A1 receptor in rat fat cell membranes
ChEMBL 374 4 4 9 -0.7 CCCC#Cc1nc(N)c2ncn([C@@H]3O[C@H](C(=O)NCC)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00091a003
541903 57964 None 0 Human Functional pKi = 5.8 5.8 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 382 8 2 7 1.4 C=CCn1c(=O)c2nc(-c3ccc(OCC(=O)O)cc3)[nH]c2n(CC=C)c1=O 10.1021/jm990421v
CHEMBL16724 57964 None 0 Human Functional pKi = 5.8 5.8 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 382 8 2 7 1.4 C=CCn1c(=O)c2nc(-c3ccc(OCC(=O)O)cc3)[nH]c2n(CC=C)c1=O 10.1021/jm990421v
9850900 98404 None 0 Rat Functional pKi = 6.8 6.8 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 565 12 1 7 5.0 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)N(Cc4ccccc4)Cc4ccccc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL275149 98404 None 0 Rat Functional pKi = 6.8 6.8 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 565 12 1 7 5.0 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)N(Cc4ccccc4)Cc4ccccc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
45279725 109622 None 0 Human Functional pKi = 5.8 5.8 - 0
Antagonist activity at human recombinant adenosine A1 receptor by cAMP assayAntagonist activity at human recombinant adenosine A1 receptor by cAMP assay
ChEMBL 316 3 1 7 2.4 Nc1nc(-c2ccco2)nc2sc(CN3CCOCC3)cc12 10.1021/jm4011669
CHEMBL3222055 109622 None 0 Human Functional pKi = 5.8 5.8 - 0
Antagonist activity at human recombinant adenosine A1 receptor by cAMP assayAntagonist activity at human recombinant adenosine A1 receptor by cAMP assay
ChEMBL 316 3 1 7 2.4 Nc1nc(-c2ccco2)nc2sc(CN3CCOCC3)cc12 10.1021/jm4011669
14788211 101135 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 446 9 1 7 2.0 CCCn1c(=O)c2nc(C3CCC(C(=O)N(C)CCN(C)C)CC3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
CHEMBL294869 101135 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 446 9 1 7 2.0 CCCn1c(=O)c2nc(C3CCC(C(=O)N(C)CCN(C)C)CC3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
46863665 7513 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 356 3 1 5 3.5 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(CN3CCCC3)ccc1C2=O 10.1021/jm100971t
CHEMBL1087189 7513 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 356 3 1 5 3.5 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(CN3CCCC3)ccc1C2=O 10.1021/jm100971t
CHEMBL3217142 7513 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 356 3 1 5 3.5 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(CN3CCCC3)ccc1C2=O 10.1021/jm100971t
46889125 9132 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 371 4 2 6 3.0 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(CNN3CCCC3)ccc1C2=O 10.1016/j.bmcl.2010.03.042
CHEMBL1099368 9132 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 371 4 2 6 3.0 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(CNN3CCCC3)ccc1C2=O 10.1016/j.bmcl.2010.03.042
46863665 7513 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP productionAntagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP production
ChEMBL 356 3 1 5 3.5 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(CN3CCCC3)ccc1C2=O 10.1021/jm201640m
CHEMBL1087189 7513 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP productionAntagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP production
ChEMBL 356 3 1 5 3.5 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(CN3CCCC3)ccc1C2=O 10.1021/jm201640m
CHEMBL3217142 7513 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP productionAntagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP production
ChEMBL 356 3 1 5 3.5 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(CN3CCCC3)ccc1C2=O 10.1021/jm201640m
46863665 7513 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity at human recombinant adenosine A1 receptor by cAMP assayAntagonist activity at human recombinant adenosine A1 receptor by cAMP assay
ChEMBL 356 3 1 5 3.5 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(CN3CCCC3)ccc1C2=O 10.1021/jm4011669
CHEMBL1087189 7513 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity at human recombinant adenosine A1 receptor by cAMP assayAntagonist activity at human recombinant adenosine A1 receptor by cAMP assay
ChEMBL 356 3 1 5 3.5 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(CN3CCCC3)ccc1C2=O 10.1021/jm4011669
CHEMBL3217142 7513 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity at human recombinant adenosine A1 receptor by cAMP assayAntagonist activity at human recombinant adenosine A1 receptor by cAMP assay
ChEMBL 356 3 1 5 3.5 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(CN3CCCC3)ccc1C2=O 10.1021/jm4011669
CHEMBL5088628 217656 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 min followed by forskolin stimulation and further incubated for 30 mins in presence of NECA by alphascreen LANCE assayAntagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 min followed by forskolin stimulation and further incubated for 30 mins in presence of NECA by alphascreen LANCE assay
ChEMBL None None None CCCCn1c(=O)c2nc(C34CCC(C(=O)OC)(CC3)CC4)[nH]c2n(CCCNC(=O)c2ccc(S(=O)(=O)F)cc2)c1=O 10.1021/acs.jmedchem.0c02169
44276476 168197 None 0 Rat Functional pKi = 7.8 7.8 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 475 9 2 7 3.7 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(C)cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL432664 168197 None 0 Rat Functional pKi = 7.8 7.8 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 475 9 2 7 3.7 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(C)cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
10767043 59040 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 479 9 2 7 3.5 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(F)cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL16929 59040 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 479 9 2 7 3.5 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(F)cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
11618368 3847 None 50 Human Functional pKi = 5.8 5.8 - 0
Antagonist activity at human adenosine A1 receptorAntagonist activity at human adenosine A1 receptor
ChEMBL 406 3 2 7 2.5 COc1ccc(c2c1nc(s2)NC(=O)N1CCC(CC1)(C)O)N1CCOCC1 10.1016/j.ejmech.2022.114378
5611 3847 None 50 Human Functional pKi = 5.8 5.8 - 0
Antagonist activity at human adenosine A1 receptorAntagonist activity at human adenosine A1 receptor
ChEMBL 406 3 2 7 2.5 COc1ccc(c2c1nc(s2)NC(=O)N1CCC(CC1)(C)O)N1CCOCC1 10.1016/j.ejmech.2022.114378
CHEMBL2105747 3847 None 50 Human Functional pKi = 5.8 5.8 - 0
Antagonist activity at human adenosine A1 receptorAntagonist activity at human adenosine A1 receptor
ChEMBL 406 3 2 7 2.5 COc1ccc(c2c1nc(s2)NC(=O)N1CCC(CC1)(C)O)N1CCOCC1 10.1016/j.ejmech.2022.114378
DB12203 3847 None 50 Human Functional pKi = 5.8 5.8 - 0
Antagonist activity at human adenosine A1 receptorAntagonist activity at human adenosine A1 receptor
ChEMBL 406 3 2 7 2.5 COc1ccc(c2c1nc(s2)NC(=O)N1CCC(CC1)(C)O)N1CCOCC1 10.1016/j.ejmech.2022.114378
46888987 7590 None 0 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 303 2 1 5 2.9 COc1ccccc1-c1nc(N)nc2c1C(=O)c1ccccc1-2 10.1016/j.bmcl.2010.03.042
CHEMBL1087869 7590 None 0 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 303 2 1 5 2.9 COc1ccccc1-c1nc(N)nc2c1C(=O)c1ccccc1-2 10.1016/j.bmcl.2010.03.042
126079 4100 None 29 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 386 8 2 7 1.8 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)O 10.1021/jm990421v
451 4100 None 29 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 386 8 2 7 1.8 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)O 10.1021/jm990421v
CHEMBL27041 4100 None 29 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 386 8 2 7 1.8 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)O 10.1021/jm990421v
45275170 89788 None 0 Human Functional pKi = 5.8 5.8 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 356 3 1 5 5.0 CC(c1ccccc1)c1cc2c(N)nc(-c3cccc(C#N)c3)nc2s1 10.1016/j.bmcl.2013.02.078
CHEMBL2377094 89788 None 0 Human Functional pKi = 5.8 5.8 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 356 3 1 5 5.0 CC(c1ccccc1)c1cc2c(N)nc(-c3cccc(C#N)c3)nc2s1 10.1016/j.bmcl.2013.02.078
21958762 155870 None 0 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 288 4 2 6 0.7 CCCn1c(=O)c2[nH]c(-c3cn[nH]c3)nc2n(CC)c1=O 10.1016/j.ejmech.2010.04.039
CHEMBL405901 155870 None 0 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 288 4 2 6 0.7 CCCn1c(=O)c2[nH]c(-c3cn[nH]c3)nc2n(CC)c1=O 10.1016/j.ejmech.2010.04.039
45275718 89822 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 368 4 1 7 4.3 COc1ccccc1Cc1cc2c(N)nc(-c3nc(C)cs3)nc2s1 10.1016/j.bmcl.2013.02.078
CHEMBL2377231 89822 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 368 4 1 7 4.3 COc1ccccc1Cc1cc2c(N)nc(-c3nc(C)cs3)nc2s1 10.1016/j.bmcl.2013.02.078
46889256 8581 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 416 7 1 6 4.4 CC(C)N(CCOc1ccc2c(c1)-c1nc(N)nc(-c3ccccc3)c1C2=O)C(C)C 10.1016/j.bmcl.2010.03.024
CHEMBL1094721 8581 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 416 7 1 6 4.4 CC(C)N(CCOc1ccc2c(c1)-c1nc(N)nc(-c3ccccc3)c1C2=O)C(C)C 10.1016/j.bmcl.2010.03.024
46889230 7491 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 431 3 1 6 2.9 CCN1CCN(C(=O)c2ccc3c(c2)-c2nc(N)nc(-c4ccc(F)cc4)c2C3=O)CC1 10.1016/j.bmcl.2010.03.024
CHEMBL1087085 7491 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 431 3 1 6 2.9 CCN1CCN(C(=O)c2ccc3c(c2)-c2nc(N)nc(-c4ccc(F)cc4)c2C3=O)CC1 10.1016/j.bmcl.2010.03.024
46888782 8662 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 400 5 1 6 3.8 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(OCCN3CCCCC3)ccc1C2=O 10.1016/j.bmcl.2010.03.024
CHEMBL1095487 8662 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 400 5 1 6 3.8 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(OCCN3CCCCC3)ccc1C2=O 10.1016/j.bmcl.2010.03.024
172469375 197093 None 0 Human Functional pKi = 8.7 8.7 - 0
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation by measuring equilibrium dissociation constant incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assayAntagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation by measuring equilibrium dissociation constant incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay
ChEMBL 352 5 1 6 4.1 CC1(CNc2ncc(-c3ccncc3)c(-c3cccs3)n2)CCOC1 10.1016/j.ejmech.2023.115419
CHEMBL5438526 197093 None 0 Human Functional pKi = 8.7 8.7 - 0
Antagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation by measuring equilibrium dissociation constant incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assayAntagonist activity at human A1R expressed in Flp-In-CHO cells assessed as NECA-mediated reduction in forskolin-stimulated cAMP accumulation by measuring equilibrium dissociation constant incubated for 30 to 60 mins followed by forskolin/NECA addition measured after 30 mins by LANCE cAMP assay
ChEMBL 352 5 1 6 4.1 CC1(CNc2ncc(-c3ccncc3)c(-c3cccs3)n2)CCOC1 10.1016/j.ejmech.2023.115419
52912216 157165 None 0 Human Functional pKi = 8.7 8.7 - 0
Antagonist activity at human adenosine A1A receptorAntagonist activity at human adenosine A1A receptor
ChEMBL 374 5 1 5 4.3 CCCn1c(Oc2ccc(F)c(F)c2)nc2nc(C3CCCC3)[nH]c2c1=O 10.1016/j.ejmech.2021.113907
CHEMBL4074150 157165 None 0 Human Functional pKi = 8.7 8.7 - 0
Antagonist activity at human adenosine A1A receptorAntagonist activity at human adenosine A1A receptor
ChEMBL 374 5 1 5 4.3 CCCn1c(Oc2ccc(F)c(F)c2)nc2nc(C3CCCC3)[nH]c2c1=O 10.1016/j.ejmech.2021.113907
70655981 158022 None 0 Human Functional pKi = 8.7 8.7 - 0
Antagonist activity at human adenosine A1A receptorAntagonist activity at human adenosine A1A receptor
ChEMBL 406 5 1 5 5.0 CCCn1c(Oc2cccc(C(F)(F)F)c2)nc2nc(C3CCCC3)[nH]c2c1=O 10.1016/j.ejmech.2021.113907
CHEMBL4084453 158022 None 0 Human Functional pKi = 8.7 8.7 - 0
Antagonist activity at human adenosine A1A receptorAntagonist activity at human adenosine A1A receptor
ChEMBL 406 5 1 5 5.0 CCCn1c(Oc2cccc(C(F)(F)F)c2)nc2nc(C3CCCC3)[nH]c2c1=O 10.1016/j.ejmech.2021.113907
67192741 159632 None 0 Human Functional pKi = 8.7 8.7 - 1
Antagonist activity at human adenosine A1A receptorAntagonist activity at human adenosine A1A receptor
ChEMBL 368 6 1 6 4.0 CCCn1c(Oc2cccc(OC)c2)nc2nc(C3CCCC3)[nH]c2c1=O 10.1016/j.ejmech.2021.113907
CHEMBL4102409 159632 None 0 Human Functional pKi = 8.7 8.7 - 1
Antagonist activity at human adenosine A1A receptorAntagonist activity at human adenosine A1A receptor
ChEMBL 368 6 1 6 4.0 CCCn1c(Oc2cccc(OC)c2)nc2nc(C3CCCC3)[nH]c2c1=O 10.1016/j.ejmech.2021.113907
CHEMBL5088372 217645 None 0 Human Functional pKi = 8.7 8.7 - 0
Antagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 min followed by forskolin stimulation and further incubated for 30 mins in presence of NECA by alphascreen LANCE assayAntagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 min followed by forskolin stimulation and further incubated for 30 mins in presence of NECA by alphascreen LANCE assay
ChEMBL None None None CCCCn1c(=O)c2nc(C34CCC(C(=O)NCCOCCOCCOCCN=[N+]=[N-])(CC3)CC4)[nH]c2n(CCCNC(=O)c2ccc(S(=O)(=O)F)cc2)c1=O 10.1021/acs.jmedchem.0c02169
52933191 157079 None 0 Human Functional pKi = 8.7 8.7 - 0
Antagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assayAntagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assay
ChEMBL 373 5 1 6 4.0 CCCn1c(Oc2cncc(Cl)c2)nc2nc(C3CCCC3)[nH]c2c1=O 10.1016/j.bmc.2017.02.029
CHEMBL4073088 157079 None 0 Human Functional pKi = 8.7 8.7 - 0
Antagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assayAntagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assay
ChEMBL 373 5 1 6 4.0 CCCn1c(Oc2cncc(Cl)c2)nc2nc(C3CCCC3)[nH]c2c1=O 10.1016/j.bmc.2017.02.029
67192741 159632 None 0 Human Functional pKi = 8.6 8.6 - 1
Antagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assayAntagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assay
ChEMBL 368 6 1 6 4.0 CCCn1c(Oc2cccc(OC)c2)nc2nc(C3CCCC3)[nH]c2c1=O 10.1016/j.bmc.2017.02.029
CHEMBL4102409 159632 None 0 Human Functional pKi = 8.6 8.6 - 1
Antagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assayAntagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assay
ChEMBL 368 6 1 6 4.0 CCCn1c(Oc2cccc(OC)c2)nc2nc(C3CCCC3)[nH]c2c1=O 10.1016/j.bmc.2017.02.029
25242240 82138 None 0 Human Functional pKi = 8.6 8.6 - 0
Antagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP productionAntagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP production
ChEMBL 364 3 1 5 3.9 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(Cc3cccnc3)ccc1C2=O 10.1021/jm201640m
CHEMBL2165807 82138 None 0 Human Functional pKi = 8.6 8.6 - 0
Antagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP productionAntagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP production
ChEMBL 364 3 1 5 3.9 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(Cc3cccnc3)ccc1C2=O 10.1021/jm201640m
CHEMBL5076192 216907 None 0 Human Functional pKi = 8.6 8.6 - 0
Antagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 min followed by forskolin stimulation and further incubated for 30 mins in presence of NECA by alphascreen LANCE assayAntagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 min followed by forskolin stimulation and further incubated for 30 mins in presence of NECA by alphascreen LANCE assay
ChEMBL None None None CCCCn1c(=O)c2nc(C34CCC(C(=O)NCCCCCCCCN=[N+]=[N-])(CC3)CC4)[nH]c2n(CCCNC(=O)c2ccc(S(=O)(=O)F)cc2)c1=O 10.1021/acs.jmedchem.0c02169
184691 53758 None 2 Human Functional pKi = 8.6 8.6 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 318 5 1 5 2.8 CCCn1c(=O)c2nc(C3CCCCC3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
CHEMBL160369 53758 None 2 Human Functional pKi = 8.6 8.6 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 318 5 1 5 2.8 CCCn1c(=O)c2nc(C3CCCCC3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
17035750 7476 None 7 Human Functional pKi = 8.6 8.6 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 303 2 1 5 2.9 COc1cccc(-c2nc(N)nc3c2C(=O)c2ccccc2-3)c1 10.1016/j.bmcl.2010.03.042
CHEMBL1086978 7476 None 7 Human Functional pKi = 8.6 8.6 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 303 2 1 5 2.9 COc1cccc(-c2nc(N)nc3c2C(=O)c2ccccc2-3)c1 10.1016/j.bmcl.2010.03.042
56954336 82131 None 0 Human Functional pKi = 8.6 8.6 - 0
Antagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP productionAntagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP production
ChEMBL 382 3 1 5 4.1 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(Cc3ccncc3F)ccc1C2=O 10.1021/jm201640m
CHEMBL2165800 82131 None 0 Human Functional pKi = 8.6 8.6 - 0
Antagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP productionAntagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP production
ChEMBL 382 3 1 5 4.1 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(Cc3ccncc3F)ccc1C2=O 10.1021/jm201640m
14788224 101886 None 0 Human Functional pKi = 8.6 8.6 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 305 6 2 6 1.7 CCCn1c(=O)c2nc(NC3CCC3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
CHEMBL300334 101886 None 0 Human Functional pKi = 8.6 8.6 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 305 6 2 6 1.7 CCCn1c(=O)c2nc(NC3CCC3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
CHEMBL5080823 217195 None 0 Human Functional pKi = 8.6 8.6 - 0
Antagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of NECA-induced cAMP accumulation in presence of forskolin measured after 40 mins by alpha screen LANCE assayAntagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of NECA-induced cAMP accumulation in presence of forskolin measured after 40 mins by alpha screen LANCE assay
ChEMBL None None None CCCn1c(=O)c2nc(C34CCC(C(=O)NCCCN=[N+]=[N-])(CC3)CC4)[nH]c2n(CCCNC(=O)c2ccc(S(=O)(=O)F)cc2)c1=O 10.1021/acs.jmedchem.0c02169
14788208 199060 None 0 Human Functional pKi = 7.7 7.7 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 347 6 2 6 1.9 CCCn1c(=O)c2nc(C3CCC(CN)CC3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
CHEMBL56409 199060 None 0 Human Functional pKi = 7.7 7.7 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 347 6 2 6 1.9 CCCn1c(=O)c2nc(C3CCC(CN)CC3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
541615 97578 None 0 Rat Functional pKi = 7.7 7.7 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 385 8 2 7 1.2 CCCn1c(=O)c2nc(-c3ccc(OCC(N)=O)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL27043 97578 None 0 Rat Functional pKi = 7.7 7.7 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 385 8 2 7 1.2 CCCn1c(=O)c2nc(-c3ccc(OCC(N)=O)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
46889127 7684 None 0 Human Functional pKi = 7.7 7.7 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 387 6 1 6 2.9 CN(C)CCN(C)Cc1ccc2c(c1)-c1nc(N)nc(-c3ccccc3)c1C2=O 10.1016/j.bmcl.2010.03.042
CHEMBL1088683 7684 None 0 Human Functional pKi = 7.7 7.7 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 387 6 1 6 2.9 CN(C)CCN(C)Cc1ccc2c(c1)-c1nc(N)nc(-c3ccccc3)c1C2=O 10.1016/j.bmcl.2010.03.042
46889069 7638 None 0 Human Functional pKi = 7.7 7.7 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 385 4 2 6 3.4 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(CNN3CCCCC3)ccc1C2=O 10.1016/j.bmcl.2010.03.042
CHEMBL1088236 7638 None 0 Human Functional pKi = 7.7 7.7 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 385 4 2 6 3.4 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(CNN3CCCCC3)ccc1C2=O 10.1016/j.bmcl.2010.03.042
135484064 2616 None 3 Human Functional pKi = 6.7 6.7 - 1
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 509 9 2 11 1.9 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1cc(nn1C)OCC(=O)Nc1ccc2c(c1)OCO2 10.1016/j.ejmech.2010.04.039
390 2616 None 3 Human Functional pKi = 6.7 6.7 - 1
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 509 9 2 11 1.9 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1cc(nn1C)OCC(=O)Nc1ccc2c(c1)OCO2 10.1016/j.ejmech.2010.04.039
CHEMBL260331 2616 None 3 Human Functional pKi = 6.7 6.7 - 1
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 509 9 2 11 1.9 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1cc(nn1C)OCC(=O)Nc1ccc2c(c1)OCO2 10.1016/j.ejmech.2010.04.039
137632333 156622 None 0 Human Functional pKi = 5.7 5.7 - 0
Antagonist activity at human adenosine A1 receptor expressed in HEK293 cell membranes assessed as decrease in CPA/forskolin-induced cAMP level pretreated for 15 mins followed by agonist addition for 15 mins and subsequent forskolin stimulation measured after 30 minsAntagonist activity at human adenosine A1 receptor expressed in HEK293 cell membranes assessed as decrease in CPA/forskolin-induced cAMP level pretreated for 15 mins followed by agonist addition for 15 mins and subsequent forskolin stimulation measured after 30 mins
ChEMBL 445 6 1 7 4.1 COc1ccc(N2CCOCC2)c2sc(NC(=O)C(C)(C)Oc3ccc(F)cc3)nc12 10.1021/acs.jmedchem.6b01584
CHEMBL4068032 156622 None 0 Human Functional pKi = 5.7 5.7 - 0
Antagonist activity at human adenosine A1 receptor expressed in HEK293 cell membranes assessed as decrease in CPA/forskolin-induced cAMP level pretreated for 15 mins followed by agonist addition for 15 mins and subsequent forskolin stimulation measured after 30 minsAntagonist activity at human adenosine A1 receptor expressed in HEK293 cell membranes assessed as decrease in CPA/forskolin-induced cAMP level pretreated for 15 mins followed by agonist addition for 15 mins and subsequent forskolin stimulation measured after 30 mins
ChEMBL 445 6 1 7 4.1 COc1ccc(N2CCOCC2)c2sc(NC(=O)C(C)(C)Oc3ccc(F)cc3)nc12 10.1021/acs.jmedchem.6b01584
9912946 59019 None 0 Rat Functional pKi = 6.7 6.7 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 478 7 2 6 3.7 O=C(O)/C=C/c1ccc(-c2nc3c(=O)n(Cc4ccccc4)c(=O)n(Cc4ccccc4)c3[nH]2)cc1 10.1021/jm990421v
CHEMBL16908 59019 None 0 Rat Functional pKi = 6.7 6.7 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 478 7 2 6 3.7 O=C(O)/C=C/c1ccc(-c2nc3c(=O)n(Cc4ccccc4)c(=O)n(Cc4ccccc4)c3[nH]2)cc1 10.1021/jm990421v
46888783 8664 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 420 5 1 7 2.8 Nc1nc(-c2ccc(F)cc2)c2c(n1)-c1cc(OCCN3CCOCC3)ccc1C2=O 10.1016/j.bmcl.2010.03.024
CHEMBL1095489 8664 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 420 5 1 7 2.8 Nc1nc(-c2ccc(F)cc2)c2c(n1)-c1cc(OCCN3CCOCC3)ccc1C2=O 10.1016/j.bmcl.2010.03.024
11605883 79983 None 3 Human Functional pKi = 5.7 5.7 - 1
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 508 7 2 7 2.0 CCCn1c(=O)[nH]c2nc(-c3ccc(S(=O)(=O)N4CCN(Cc5ccccc5)CC4)cc3)[nH]c2c1=O 10.1016/j.ejmech.2010.04.039
CHEMBL212625 79983 None 3 Human Functional pKi = 5.7 5.7 - 1
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 508 7 2 7 2.0 CCCn1c(=O)[nH]c2nc(-c3ccc(S(=O)(=O)N4CCN(Cc5ccccc5)CC4)cc3)[nH]c2c1=O 10.1016/j.ejmech.2010.04.039
46889171 7644 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 401 5 1 6 2.6 CN(C)CCN(C)C(=O)c1ccc2c(c1)-c1nc(N)nc(-c3ccccc3)c1C2=O 10.1016/j.bmcl.2010.03.024
CHEMBL1088259 7644 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 401 5 1 6 2.6 CN(C)CCN(C)C(=O)c1ccc2c(c1)-c1nc(N)nc(-c3ccccc3)c1C2=O 10.1016/j.bmcl.2010.03.024
46889174 7657 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 429 5 2 7 2.0 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(C(=O)NCCN3CCOCC3)ccc1C2=O 10.1016/j.bmcl.2010.03.024
CHEMBL1088393 7657 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 429 5 2 7 2.0 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(C(=O)NCCN3CCOCC3)ccc1C2=O 10.1016/j.bmcl.2010.03.024
10648228 98488 None 0 Rat Functional pKi = 6.7 6.7 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 475 9 1 7 3.4 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)N(C)c4ccccc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL275606 98488 None 0 Rat Functional pKi = 6.7 6.7 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 475 9 1 7 3.4 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)N(C)c4ccccc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
21916394 160907 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 458 6 1 7 3.2 CCn1c(=O)n(CC2CC2)c(=O)c2[nH]c(-c3cnn(Cc4cccc(C(F)(F)F)c4)c3)nc21 10.1016/j.ejmech.2010.04.039
CHEMBL411452 160907 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 458 6 1 7 3.2 CCn1c(=O)n(CC2CC2)c(=O)c2[nH]c(-c3cnn(Cc4cccc(C(F)(F)F)c4)c3)nc21 10.1016/j.ejmech.2010.04.039
19003749 198330 None 2 Human Functional pKi = 7.7 7.7 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 319 5 1 6 1.7 CCCn1c(=O)c2nc(N3CCCCC3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
CHEMBL55883 198330 None 2 Human Functional pKi = 7.7 7.7 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 319 5 1 6 1.7 CCCn1c(=O)c2nc(N3CCCCC3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
45275056 89784 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 342 3 1 5 4.4 N#Cc1cccc(-c2nc(N)c3cc(Cc4ccccc4)sc3n2)c1 10.1016/j.bmcl.2013.02.078
CHEMBL2377090 89784 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 342 3 1 5 4.4 N#Cc1cccc(-c2nc(N)c3cc(Cc4ccccc4)sc3n2)c1 10.1016/j.bmcl.2013.02.078
56954333 82137 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP productionAntagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP production
ChEMBL 382 3 1 5 4.1 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(CN3C4CCC3CC4)ccc1C2=O 10.1021/jm201640m
CHEMBL2165806 82137 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP productionAntagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP production
ChEMBL 382 3 1 5 4.1 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(CN3C4CCC3CC4)ccc1C2=O 10.1021/jm201640m
45275619 89807 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 335 4 1 5 4.7 CCc1ccc(-c2nc(N)c3cc(Cc4ccccc4)sc3n2)o1 10.1016/j.bmcl.2013.02.078
CHEMBL2377113 89807 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 335 4 1 5 4.7 CCc1ccc(-c2nc(N)c3cc(Cc4ccccc4)sc3n2)o1 10.1016/j.bmcl.2013.02.078
9936467 58109 None 1 Human Functional pKi = 6.7 6.7 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 519 10 2 9 3.2 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(C(=O)OC)cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL16741 58109 None 1 Human Functional pKi = 6.7 6.7 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 519 10 2 9 3.2 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(C(=O)OC)cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
46889095 7574 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 418 4 2 7 2.3 CN1CCN(NCc2ccc3c(c2)-c2nc(N)nc(-c4ccc(F)cc4)c2C3=O)CC1 10.1016/j.bmcl.2010.03.042
CHEMBL1087726 7574 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 418 4 2 7 2.3 CN1CCN(NCc2ccc3c(c2)-c2nc(N)nc(-c4ccc(F)cc4)c2C3=O)CC1 10.1016/j.bmcl.2010.03.042
45275820 89779 None 0 Human Functional pKi = 5.6 5.6 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 321 3 1 6 3.3 Cn1cnc(-c2nc(N)c3cc(Cc4ccccc4)sc3n2)c1 10.1016/j.bmcl.2013.02.078
CHEMBL2377085 89779 None 0 Human Functional pKi = 5.6 5.6 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 321 3 1 6 3.3 Cn1cnc(-c2nc(N)c3cc(Cc4ccccc4)sc3n2)c1 10.1016/j.bmcl.2013.02.078
9870719 57434 None 0 Human Functional pKi = 6.6 6.6 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 503 10 2 8 3.6 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4cccc(C(C)=O)c4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL16534 57434 None 0 Human Functional pKi = 6.6 6.6 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 503 10 2 8 3.6 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4cccc(C(C)=O)c4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
71603017 89781 None 0 Human Functional pKi = 6.6 6.6 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 303 2 1 4 4.6 Nc1nc(-c2ccccc2)nc2sc(-c3ccccc3)cc12 10.1016/j.bmcl.2013.02.078
CHEMBL2377087 89781 None 0 Human Functional pKi = 6.6 6.6 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 303 2 1 4 4.6 Nc1nc(-c2ccccc2)nc2sc(-c3ccccc3)cc12 10.1016/j.bmcl.2013.02.078
10476477 22980 None 4 Rat Functional pKi = 7.6 7.6 - 0
Agonistic activity against Adenosine A1 receptor on rat whole-brain membranesAgonistic activity against Adenosine A1 receptor on rat whole-brain membranes
ChEMBL 407 5 4 9 1.2 OC[C@H]1O[C@@H](n2cnc3c(NCc4cccc5ccccc45)ncnc32)[C@H](O)[C@@H]1O 10.1016/s0960-894x(00)00017-2
CHEMBL132960 22980 None 4 Rat Functional pKi = 7.6 7.6 - 0
Agonistic activity against Adenosine A1 receptor on rat whole-brain membranesAgonistic activity against Adenosine A1 receptor on rat whole-brain membranes
ChEMBL 407 5 4 9 1.2 OC[C@H]1O[C@@H](n2cnc3c(NCc4cccc5ccccc45)ncnc32)[C@H](O)[C@@H]1O 10.1016/s0960-894x(00)00017-2
9806649 59562 None 0 Rat Functional pKi = 7.6 7.6 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 518 10 3 8 2.8 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(C(=O)NC)cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL17167 59562 None 0 Rat Functional pKi = 7.6 7.6 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 518 10 3 8 2.8 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(C(=O)NC)cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
45275287 89786 None 0 Human Functional pKi = 7.6 7.6 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 376 3 1 5 5.1 N#Cc1cccc(-c2nc(N)c3cc(Cc4ccccc4Cl)sc3n2)c1 10.1016/j.bmcl.2013.02.078
CHEMBL2377092 89786 None 0 Human Functional pKi = 7.6 7.6 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 376 3 1 5 5.1 N#Cc1cccc(-c2nc(N)c3cc(Cc4ccccc4Cl)sc3n2)c1 10.1016/j.bmcl.2013.02.078
46888880 8568 None 0 Human Functional pKi = 6.6 6.6 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 411 4 1 6 3.5 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(N3CCN(CC4CC4)CC3)ccc1C2=O 10.1016/j.bmcl.2010.03.024
CHEMBL1094547 8568 None 0 Human Functional pKi = 6.6 6.6 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 411 4 1 6 3.5 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(N3CCN(CC4CC4)CC3)ccc1C2=O 10.1016/j.bmcl.2010.03.024
456309 160746 None 11 Human Functional pKi = 6.6 6.6 - 0
Antagonist activity at human adenosine A1 receptorAntagonist activity at human adenosine A1 receptor
ChEMBL 378 2 2 3 4.4 O[C@H](c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)[C@@H]1CCCCN1 10.1016/j.ejmech.2022.114378
CHEMBL411329 160746 None 11 Human Functional pKi = 6.6 6.6 - 0
Antagonist activity at human adenosine A1 receptorAntagonist activity at human adenosine A1 receptor
ChEMBL 378 2 2 3 4.4 O[C@H](c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)[C@@H]1CCCCN1 10.1016/j.ejmech.2022.114378
46861782 8527 None 0 Human Functional pKi = 6.6 6.6 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 385 3 1 6 3.1 CCN1CCN(c2ccc3c(c2)-c2nc(N)nc(-c4ccccc4)c2C3=O)CC1 10.1016/j.bmcl.2010.03.024
CHEMBL1094244 8527 None 0 Human Functional pKi = 6.6 6.6 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 385 3 1 6 3.1 CCN1CCN(c2ccc3c(c2)-c2nc(N)nc(-c4ccccc4)c2C3=O)CC1 10.1016/j.bmcl.2010.03.024
46889205 7460 None 0 Human Functional pKi = 6.6 6.6 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 427 3 1 6 3.1 CN1CCC(N(C)C(=O)c2ccc3c(c2)-c2nc(N)nc(-c4ccccc4)c2C3=O)CC1 10.1016/j.bmcl.2010.03.024
CHEMBL1086804 7460 None 0 Human Functional pKi = 6.6 6.6 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 427 3 1 6 3.1 CN1CCC(N(C)C(=O)c2ccc3c(c2)-c2nc(N)nc(-c4ccccc4)c2C3=O)CC1 10.1016/j.bmcl.2010.03.024
CHEMBL5082113 217274 None 0 Human Functional pKi = 7.6 7.6 - 0
Antagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 min followed by forskolin stimulation and further incubated for 30 mins in presence of NECA by alphascreen LANCE assayAntagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 min followed by forskolin stimulation and further incubated for 30 mins in presence of NECA by alphascreen LANCE assay
ChEMBL None None None CCCCn1c(=O)c2nc(C3CCCCC3)[nH]c2n(CCCNC(=O)c2ccc(S(=O)(=O)F)cc2)c1=O 10.1021/acs.jmedchem.0c02169
45274330 89804 None 0 Human Functional pKi = 7.6 7.6 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 355 3 1 5 5.1 Cc1ccc(-c2nc(N)c3cc(Cc4ccccc4Cl)sc3n2)o1 10.1016/j.bmcl.2013.02.078
CHEMBL2377110 89804 None 0 Human Functional pKi = 7.6 7.6 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 355 3 1 5 5.1 Cc1ccc(-c2nc(N)c3cc(Cc4ccccc4Cl)sc3n2)o1 10.1016/j.bmcl.2013.02.078
46889068 7637 None 0 Human Functional pKi = 7.6 7.6 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 393 5 2 6 3.6 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(CNCc3ccccn3)ccc1C2=O 10.1016/j.bmcl.2010.03.042
CHEMBL1088235 7637 None 0 Human Functional pKi = 7.6 7.6 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 393 5 2 6 3.6 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(CNCc3ccccn3)ccc1C2=O 10.1016/j.bmcl.2010.03.042
9915751 59146 None 0 Rat Functional pKi = 7.6 7.6 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 557 14 1 11 1.7 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)N(CC(=O)OCC)CC(=O)OCC)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL16984 59146 None 0 Rat Functional pKi = 7.6 7.6 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 557 14 1 11 1.7 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)N(CC(=O)OCC)CC(=O)OCC)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
45274228 89778 None 0 Human Functional pKi = 6.6 6.6 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 338 3 1 6 4.3 Cc1nc(-c2nc(N)c3cc(Cc4ccccc4)sc3n2)cs1 10.1016/j.bmcl.2013.02.078
CHEMBL2377084 89778 None 0 Human Functional pKi = 6.6 6.6 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 338 3 1 6 4.3 Cc1nc(-c2nc(N)c3cc(Cc4ccccc4)sc3n2)cs1 10.1016/j.bmcl.2013.02.078
45275172 89793 None 0 Human Functional pKi = 6.6 6.6 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 347 4 1 5 4.5 COc1cccc(-c2nc(N)c3cc(Cc4ccccc4)sc3n2)c1 10.1016/j.bmcl.2013.02.078
CHEMBL2377099 89793 None 0 Human Functional pKi = 6.6 6.6 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 347 4 1 5 4.5 COc1cccc(-c2nc(N)c3cc(Cc4ccccc4)sc3n2)c1 10.1016/j.bmcl.2013.02.078
9870718 60006 None 0 Rat Functional pKi = 7.6 7.6 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 503 10 2 8 3.6 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccccc4C(C)=O)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL17341 60006 None 0 Rat Functional pKi = 7.6 7.6 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 503 10 2 8 3.6 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccccc4C(C)=O)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
10767043 59040 None 0 Rat Functional pKi = 6.6 6.6 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 479 9 2 7 3.5 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(F)cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL16929 59040 None 0 Rat Functional pKi = 6.6 6.6 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 479 9 2 7 3.5 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(F)cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
45275823 89802 None 0 Human Functional pKi = 5.6 5.6 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 335 4 1 5 4.6 Cc1ccc(-c2nc(N)c3cc(CCc4ccccc4)sc3n2)o1 10.1016/j.bmcl.2013.02.078
CHEMBL2377108 89802 None 0 Human Functional pKi = 5.6 5.6 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 335 4 1 5 4.6 Cc1ccc(-c2nc(N)c3cc(CCc4ccccc4)sc3n2)o1 10.1016/j.bmcl.2013.02.078
71602961 89824 None 0 Human Functional pKi = 7.5 7.5 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 356 3 1 6 4.4 Cc1csc(-c2nc(N)c3cc(Cc4ccccc4F)sc3n2)n1 10.1016/j.bmcl.2013.02.078
CHEMBL2377233 89824 None 0 Human Functional pKi = 7.5 7.5 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 356 3 1 6 4.4 Cc1csc(-c2nc(N)c3cc(Cc4ccccc4F)sc3n2)n1 10.1016/j.bmcl.2013.02.078
45274227 89808 None 0 Human Functional pKi = 6.6 6.6 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 349 4 1 5 5.2 CC(C)c1ccc(-c2nc(N)c3cc(Cc4ccccc4)sc3n2)o1 10.1016/j.bmcl.2013.02.078
CHEMBL2377114 89808 None 0 Human Functional pKi = 6.6 6.6 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 349 4 1 5 5.2 CC(C)c1ccc(-c2nc(N)c3cc(Cc4ccccc4)sc3n2)o1 10.1016/j.bmcl.2013.02.078
56954254 82134 None 0 Human Functional pKi = 7.5 7.5 - 0
Antagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP productionAntagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP production
ChEMBL 400 3 1 5 4.5 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(C(F)(F)c3cccnc3)ccc1C2=O 10.1021/jm201640m
CHEMBL2165803 82134 None 0 Human Functional pKi = 7.5 7.5 - 0
Antagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP productionAntagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP production
ChEMBL 400 3 1 5 4.5 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(C(F)(F)c3cccnc3)ccc1C2=O 10.1021/jm201640m
45278533 109628 None 0 Human Functional pKi = 6.5 6.5 - 0
Antagonist activity at human recombinant adenosine A1 receptor by cAMP assayAntagonist activity at human recombinant adenosine A1 receptor by cAMP assay
ChEMBL 350 3 1 6 3.8 Nc1nc(-c2ccco2)nc2sc(CN3CCCC(F)(F)C3)cc12 10.1021/jm4011669
CHEMBL3222061 109628 None 0 Human Functional pKi = 6.5 6.5 - 0
Antagonist activity at human recombinant adenosine A1 receptor by cAMP assayAntagonist activity at human recombinant adenosine A1 receptor by cAMP assay
ChEMBL 350 3 1 6 3.8 Nc1nc(-c2ccco2)nc2sc(CN3CCCC(F)(F)C3)cc12 10.1021/jm4011669
11801496 98800 None 0 Human Functional pKi = 6.5 6.5 - 0
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 587 9 2 7 4.0 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(I)cc4)cc3)[nH]c2n(CCC)c1=O 10.1016/j.ejmech.2010.04.039
CHEMBL278039 98800 None 0 Human Functional pKi = 6.5 6.5 - 0
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 587 9 2 7 4.0 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(I)cc4)cc3)[nH]c2n(CCC)c1=O 10.1016/j.ejmech.2010.04.039
11801496 98800 None 0 Human Functional pKi = 6.5 6.5 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 587 9 2 7 4.0 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(I)cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL278039 98800 None 0 Human Functional pKi = 6.5 6.5 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 587 9 2 7 4.0 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(I)cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
71602914 89818 None 0 Human Functional pKi = 5.5 5.5 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 311 3 1 5 3.7 Nc1nc(C2CCCO2)nc2sc(Cc3ccccc3)cc12 10.1016/j.bmcl.2013.02.078
CHEMBL2377227 89818 None 0 Human Functional pKi = 5.5 5.5 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 311 3 1 5 3.7 Nc1nc(C2CCCO2)nc2sc(Cc3ccccc3)cc12 10.1016/j.bmcl.2013.02.078
49863226 15224 None 0 Human Functional pKi = 5.5 5.5 - 0
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 311 3 1 9 0.6 Nc1nc(-n2cncn2)c2nnn(Cc3ccccc3F)c2n1 10.1016/j.ejmech.2010.04.039
CHEMBL1210734 15224 None 0 Human Functional pKi = 5.5 5.5 - 0
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 311 3 1 9 0.6 Nc1nc(-n2cncn2)c2nnn(Cc3ccccc3F)c2n1 10.1016/j.ejmech.2010.04.039
45275517 89830 None 0 Human Functional pKi = 6.5 6.5 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 321 3 1 5 4.4 Cc1ccc(-c2nc(N)c3cc(Cc4ccccc4)sc3n2)o1 10.1016/j.bmcl.2013.02.078
CHEMBL2377239 89830 None 0 Human Functional pKi = 6.5 6.5 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 321 3 1 5 4.4 Cc1ccc(-c2nc(N)c3cc(Cc4ccccc4)sc3n2)o1 10.1016/j.bmcl.2013.02.078
45274431 89816 None 0 Human Functional pKi = 5.5 5.5 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 357 4 1 5 5.1 Nc1nc(-c2ccc(C(F)F)o2)nc2sc(Cc3ccccc3)cc12 10.1016/j.bmcl.2013.02.078
CHEMBL2377225 89816 None 0 Human Functional pKi = 5.5 5.5 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 357 4 1 5 5.1 Nc1nc(-c2ccc(C(F)F)o2)nc2sc(Cc3ccccc3)cc12 10.1016/j.bmcl.2013.02.078
9970832 7462 None 0 Human Functional pKi = 8.5 8.5 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 279 1 1 5 3.0 Nc1nc(-c2cccs2)c2c(n1)-c1ccccc1C2=O 10.1016/j.bmcl.2010.03.042
CHEMBL1086846 7462 None 0 Human Functional pKi = 8.5 8.5 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 279 1 1 5 3.0 Nc1nc(-c2cccs2)c2c(n1)-c1ccccc1C2=O 10.1016/j.bmcl.2010.03.042
CHEMBL5088372 217645 None 0 Human Functional pKi = 8.5 8.5 - 0
Antagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of NECA-induced cAMP accumulation in presence of forskolin measured after 40 mins by alpha screen LANCE assayAntagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of NECA-induced cAMP accumulation in presence of forskolin measured after 40 mins by alpha screen LANCE assay
ChEMBL None None None CCCCn1c(=O)c2nc(C34CCC(C(=O)NCCOCCOCCOCCN=[N+]=[N-])(CC3)CC4)[nH]c2n(CCCNC(=O)c2ccc(S(=O)(=O)F)cc2)c1=O 10.1021/acs.jmedchem.0c02169
CHEMBL5087305 217574 None 0 Human Functional pKi = 8.5 8.5 - 0
Antagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 min followed by forskolin stimulation and further incubated for 30 mins in presence of NECA by alphascreen LANCE assayAntagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 min followed by forskolin stimulation and further incubated for 30 mins in presence of NECA by alphascreen LANCE assay
ChEMBL None None None CCCCn1c(=O)c2nc(C34CCC(C(=O)NCCCN=[N+]=[N-])(CC3)CC4)[nH]c2n(CCC)c1=O 10.1021/acs.jmedchem.0c02169
CHEMBL5074992 216838 None 0 Human Functional pKi = 8.5 8.5 - 0
Antagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of NECA-induced cAMP accumulation in presence of forskolin measured after 40 mins by alpha screen LANCE assayAntagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of NECA-induced cAMP accumulation in presence of forskolin measured after 40 mins by alpha screen LANCE assay
ChEMBL None None None CCCCn1c(=O)c2nc(C34CCC(C(=O)NCCOCCOCCN=[N+]=[N-])(CC3)CC4)[nH]c2n(CCCNC(=O)c2ccc(S(=O)(=O)F)cc2)c1=O 10.1021/acs.jmedchem.0c02169
CHEMBL5089483 217699 None 0 Human Functional pKi = 8.4 8.4 - 0
Antagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of NECA-induced cAMP accumulation in presence of forskolin measured after 40 mins by alpha screen LANCE assayAntagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of NECA-induced cAMP accumulation in presence of forskolin measured after 40 mins by alpha screen LANCE assay
ChEMBL None None None CCCCn1c(=O)c2nc(C34CCC(C(=O)NCCCCN=[N+]=[N-])(CC3)CC4)[nH]c2n(CCCNC(=O)c2ccc(S(=O)(=O)F)cc2)c1=O 10.1021/acs.jmedchem.0c02169
CHEMBL5092788 217879 None 0 Human Functional pKi = 8.4 8.4 - 0
Antagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of NECA-induced cAMP accumulation in presence of forskolin measured after 40 mins by alpha screen LANCE assayAntagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of NECA-induced cAMP accumulation in presence of forskolin measured after 40 mins by alpha screen LANCE assay
ChEMBL None None None C#CCCCCNC(=O)C12CCC(c3nc4c(=O)n(CCCC)c(=O)n(CCCNC(=O)c5ccc(S(=O)(=O)F)cc5)c4[nH]3)(CC1)CC2 10.1021/acs.jmedchem.0c02169
10839228 59885 None 0 Rat Functional pKi = 8.4 8.4 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 504 8 2 8 2.1 CCCn1c(=O)c2nc(-c3ccc(/C=C/C(=O)NN4C(=O)C(C)=C(C)C4=O)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL17294 59885 None 0 Rat Functional pKi = 8.4 8.4 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 504 8 2 8 2.1 CCCn1c(=O)c2nc(-c3ccc(/C=C/C(=O)NN4C(=O)C(C)=C(C)C4=O)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL5089727 217713 None 0 Human Functional pKi = 7.5 7.5 - 0
Antagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of NECA-induced cAMP accumulation in presence of forskolin measured after 40 mins by alpha screen LANCE assayAntagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of NECA-induced cAMP accumulation in presence of forskolin measured after 40 mins by alpha screen LANCE assay
ChEMBL None None None C#CCNC(=O)C12CCC(c3nc4c(=O)n(CCCC)c(=O)n(CCCNC(=O)c5ccc(S(=O)(=O)F)cc5)c4[nH]3)(CC1)CC2 10.1021/acs.jmedchem.0c02169
9936058 59577 None 2 Human Functional pKi = 5.5 5.5 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 508 9 2 9 1.5 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)NN4C(=O)C(C)=C(C)C4=O)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL17173 59577 None 2 Human Functional pKi = 5.5 5.5 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 508 9 2 9 1.5 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)NN4C(=O)C(C)=C(C)C4=O)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
71602915 89819 None 0 Human Functional pKi = 6.5 6.5 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 308 3 1 6 3.5 Nc1nc(-c2ncco2)nc2sc(Cc3ccccc3)cc12 10.1016/j.bmcl.2013.02.078
CHEMBL2377228 89819 None 0 Human Functional pKi = 6.5 6.5 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 308 3 1 6 3.5 Nc1nc(-c2ncco2)nc2sc(Cc3ccccc3)cc12 10.1016/j.bmcl.2013.02.078
45275819 89815 None 0 Human Functional pKi = 5.5 5.5 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 332 3 1 6 4.0 N#Cc1ccc(-c2nc(N)c3cc(Cc4ccccc4)sc3n2)o1 10.1016/j.bmcl.2013.02.078
CHEMBL2377224 89815 None 0 Human Functional pKi = 5.5 5.5 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 332 3 1 6 4.0 N#Cc1ccc(-c2nc(N)c3cc(Cc4ccccc4)sc3n2)o1 10.1016/j.bmcl.2013.02.078
46888879 8715 None 0 Human Functional pKi = 7.5 7.5 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 358 2 1 6 2.8 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(N3CCOCC3)ccc1C2=O 10.1016/j.bmcl.2010.03.024
CHEMBL1095822 8715 None 0 Human Functional pKi = 7.5 7.5 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 358 2 1 6 2.8 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(N3CCOCC3)ccc1C2=O 10.1016/j.bmcl.2010.03.024
46861780 8642 None 0 Human Functional pKi = 7.5 7.5 - 0
Antagonist activity at human recombinant adenosine A1 receptor by cAMP assayAntagonist activity at human recombinant adenosine A1 receptor by cAMP assay
ChEMBL 401 5 2 7 2.7 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(NCCN3CCOCC3)ccc1C2=O 10.1021/jm4011669
CHEMBL1095172 8642 None 0 Human Functional pKi = 7.5 7.5 - 0
Antagonist activity at human recombinant adenosine A1 receptor by cAMP assayAntagonist activity at human recombinant adenosine A1 receptor by cAMP assay
ChEMBL 401 5 2 7 2.7 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(NCCN3CCOCC3)ccc1C2=O 10.1021/jm4011669
46861780 8642 None 0 Human Functional pKi = 7.5 7.5 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 401 5 2 7 2.7 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(NCCN3CCOCC3)ccc1C2=O 10.1016/j.bmcl.2010.03.024
CHEMBL1095172 8642 None 0 Human Functional pKi = 7.5 7.5 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 401 5 2 7 2.7 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(NCCN3CCOCC3)ccc1C2=O 10.1016/j.bmcl.2010.03.024
46861768 7540 None 0 Human Functional pKi = 7.5 7.5 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 372 3 1 6 2.8 Nc1nc(-c2ccccc2)c2c(n1)-c1c(CN3CCOCC3)cccc1C2=O 10.1016/j.bmcl.2010.03.042
CHEMBL1087462 7540 None 0 Human Functional pKi = 7.5 7.5 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 372 3 1 6 2.8 Nc1nc(-c2ccccc2)c2c(n1)-c1c(CN3CCOCC3)cccc1C2=O 10.1016/j.bmcl.2010.03.042
46889252 7688 None 0 Human Functional pKi = 7.5 7.5 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 360 5 1 6 2.9 CN(C)CCOc1ccc2c(c1)-c1nc(N)nc(-c3ccccc3)c1C2=O 10.1016/j.bmcl.2010.03.024
CHEMBL1088710 7688 None 0 Human Functional pKi = 7.5 7.5 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 360 5 1 6 2.9 CN(C)CCOc1ccc2c(c1)-c1nc(N)nc(-c3ccccc3)c1C2=O 10.1016/j.bmcl.2010.03.024
9870718 60006 None 0 Human Functional pKi = 6.5 6.5 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 503 10 2 8 3.6 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccccc4C(C)=O)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL17341 60006 None 0 Human Functional pKi = 6.5 6.5 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 503 10 2 8 3.6 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccccc4C(C)=O)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
46888821 8603 None 0 Human Functional pKi = 6.5 6.5 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 430 5 1 6 4.1 Nc1nc(-c2ccc(F)cc2)c2c(n1)-c1cc(OCCN3C4CCC3CC4)ccc1C2=O 10.1016/j.bmcl.2010.03.024
CHEMBL1094846 8603 None 0 Human Functional pKi = 6.5 6.5 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 430 5 1 6 4.1 Nc1nc(-c2ccc(F)cc2)c2c(n1)-c1cc(OCCN3C4CCC3CC4)ccc1C2=O 10.1016/j.bmcl.2010.03.024
46889017 7587 None 0 Human Functional pKi = 7.5 7.5 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 413 3 1 6 2.6 CC(=O)N1CCN(Cc2cccc3c2-c2nc(N)nc(-c4ccccc4)c2C3=O)CC1 10.1016/j.bmcl.2010.03.042
CHEMBL1087819 7587 None 0 Human Functional pKi = 7.5 7.5 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 413 3 1 6 2.6 CC(=O)N1CCN(Cc2cccc3c2-c2nc(N)nc(-c4ccccc4)c2C3=O)CC1 10.1016/j.bmcl.2010.03.042
9846447 58778 None 0 Rat Functional pKi = 7.5 7.5 - 0
Antagonist activity against rat adenosine A1 receptor in rat brain membrane using [3H]R-PIAAntagonist activity against rat adenosine A1 receptor in rat brain membrane using [3H]R-PIA
ChEMBL 447 7 2 7 2.9 CCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(C)cc4)cc3)[nH]c2n(CC)c1=O 10.1021/jm990421v
CHEMBL16866 58778 None 0 Rat Functional pKi = 7.5 7.5 - 0
Antagonist activity against rat adenosine A1 receptor in rat brain membrane using [3H]R-PIAAntagonist activity against rat adenosine A1 receptor in rat brain membrane using [3H]R-PIA
ChEMBL 447 7 2 7 2.9 CCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(C)cc4)cc3)[nH]c2n(CC)c1=O 10.1021/jm990421v
9894853 57605 None 0 Rat Functional pKi = 4.5 4.5 - 0
Antagonist activity against rat adenosine A1 receptor in rat brain membrane using [3H]R-PIAAntagonist activity against rat adenosine A1 receptor in rat brain membrane using [3H]R-PIA
ChEMBL 595 9 2 7 5.5 CC(=O)c1ccccc1NC(=O)/C=C/c1ccc(-c2nc3c(=O)n(Cc4ccccc4)c(=O)n(Cc4ccccc4)c3[nH]2)cc1 10.1021/jm990421v
CHEMBL16676 57605 None 0 Rat Functional pKi = 4.5 4.5 - 0
Antagonist activity against rat adenosine A1 receptor in rat brain membrane using [3H]R-PIAAntagonist activity against rat adenosine A1 receptor in rat brain membrane using [3H]R-PIA
ChEMBL 595 9 2 7 5.5 CC(=O)c1ccccc1NC(=O)/C=C/c1ccc(-c2nc3c(=O)n(Cc4ccccc4)c(=O)n(Cc4ccccc4)c3[nH]2)cc1 10.1021/jm990421v
46861781 8741 None 0 Human Functional pKi = 7.5 7.5 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 371 2 1 6 2.7 CN1CCN(c2ccc3c(c2)-c2nc(N)nc(-c4ccccc4)c2C3=O)CC1 10.1016/j.bmcl.2010.03.024
CHEMBL1096134 8741 None 0 Human Functional pKi = 7.5 7.5 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 371 2 1 6 2.7 CN1CCN(c2ccc3c(c2)-c2nc(N)nc(-c4ccccc4)c2C3=O)CC1 10.1016/j.bmcl.2010.03.024
71458816 82136 None 0 Human Functional pKi = 7.4 7.4 - 0
Antagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP productionAntagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP production
ChEMBL 384 3 1 5 4.3 CC1CC[C@@H](C)N1Cc1ccc2c(c1)-c1nc(N)nc(-c3ccccc3)c1C2=O 10.1021/jm201640m
CHEMBL2165805 82136 None 0 Human Functional pKi = 7.4 7.4 - 0
Antagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP productionAntagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP production
ChEMBL 384 3 1 5 4.3 CC1CC[C@@H](C)N1Cc1ccc2c(c1)-c1nc(N)nc(-c3ccccc3)c1C2=O 10.1021/jm201640m
46889253 7607 None 0 Human Functional pKi = 7.4 7.4 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 378 5 1 6 3.0 CN(C)CCOc1ccc2c(c1)-c1nc(N)nc(-c3ccc(F)cc3)c1C2=O 10.1016/j.bmcl.2010.03.024
CHEMBL1087998 7607 None 0 Human Functional pKi = 7.4 7.4 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 378 5 1 6 3.0 CN(C)CCOc1ccc2c(c1)-c1nc(N)nc(-c3ccc(F)cc3)c1C2=O 10.1016/j.bmcl.2010.03.024
3287 2642 None 33 Rat Functional pKi = 7.4 7.4 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 503 10 2 8 3.6 CCCn1c2[nH]c(nc2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)Nc1ccc(cc1)C(=O)C 10.1021/jm990421v
5139184 2642 None 33 Rat Functional pKi = 7.4 7.4 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 503 10 2 8 3.6 CCCn1c2[nH]c(nc2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)Nc1ccc(cc1)C(=O)C 10.1021/jm990421v
CHEMBL17002 2642 None 33 Rat Functional pKi = 7.4 7.4 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 503 10 2 8 3.6 CCCn1c2[nH]c(nc2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)Nc1ccc(cc1)C(=O)C 10.1021/jm990421v
71603088 89794 None 0 Human Functional pKi = 5.4 5.4 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 318 3 1 5 3.9 Nc1nc(-c2ccccn2)nc2sc(Cc3ccccc3)cc12 10.1016/j.bmcl.2013.02.078
CHEMBL2377100 89794 None 0 Human Functional pKi = 5.4 5.4 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 318 3 1 5 3.9 Nc1nc(-c2ccccn2)nc2sc(Cc3ccccc3)cc12 10.1016/j.bmcl.2013.02.078
9936467 58109 None 1 Rat Functional pKi = 7.4 7.4 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 519 10 2 9 3.2 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(C(=O)OC)cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL16741 58109 None 1 Rat Functional pKi = 7.4 7.4 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 519 10 2 9 3.2 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(C(=O)OC)cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
11186097 63291 None 0 Human Functional pKi = 7.4 7.4 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 314 4 2 6 2.3 N#Cc1c(N)nc(SCCO)c(C#N)c1-c1cccc(F)c1 10.1021/jm201706b
CHEMBL179198 63291 None 0 Human Functional pKi = 7.4 7.4 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 314 4 2 6 2.3 N#Cc1c(N)nc(SCCO)c(C#N)c1-c1cccc(F)c1 10.1021/jm201706b
11451298 130736 None 0 Human Functional pKi = 7.4 7.4 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 362 6 2 7 2.8 N#Cc1c(N)nc(SCCO)c(C#N)c1-c1cccc(OC(F)F)c1 10.1021/jm201706b
CHEMBL368237 130736 None 0 Human Functional pKi = 7.4 7.4 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 362 6 2 7 2.8 N#Cc1c(N)nc(SCCO)c(C#N)c1-c1cccc(OC(F)F)c1 10.1021/jm201706b
9825550 57609 None 0 Rat Functional pKi = 8.4 8.4 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 461 9 2 7 3.4 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccccc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL16677 57609 None 0 Rat Functional pKi = 8.4 8.4 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 461 9 2 7 3.4 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccccc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
46888890 8890 None 0 Human Functional pKi = 7.4 7.4 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 363 5 1 7 2.5 CN(C)CCN(C)c1ccc(-c2nc(N)nc3c2C(=O)c2ccccc2-3)o1 10.1016/j.bmcl.2010.03.042
CHEMBL1097495 8890 None 0 Human Functional pKi = 7.4 7.4 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 363 5 1 7 2.5 CN(C)CCN(C)c1ccc(-c2nc(N)nc3c2C(=O)c2ccccc2-3)o1 10.1016/j.bmcl.2010.03.042
9825550 57609 None 0 Human Functional pKi = 7.4 7.4 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 461 9 2 7 3.4 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccccc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL16677 57609 None 0 Human Functional pKi = 7.4 7.4 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 461 9 2 7 3.4 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccccc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
46888990 7566 None 0 Human Functional pKi = 7.4 7.4 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 370 3 1 5 3.9 Nc1nc(-c2ccccc2)c2c(n1)-c1c(CN3CCCCC3)cccc1C2=O 10.1016/j.bmcl.2010.03.042
CHEMBL1087701 7566 None 0 Human Functional pKi = 7.4 7.4 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 370 3 1 5 3.9 Nc1nc(-c2ccccc2)c2c(n1)-c1c(CN3CCCCC3)cccc1C2=O 10.1016/j.bmcl.2010.03.042
449 2643 None 38 Human Functional pKi = 6.4 6.4 - 4
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 486 9 2 8 3.3 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)Nc1ccc(cc1)C#N 10.1016/j.ejmech.2010.04.039
453 2643 None 38 Human Functional pKi = 6.4 6.4 - 4
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 486 9 2 8 3.3 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)Nc1ccc(cc1)C#N 10.1016/j.ejmech.2010.04.039
6603931 2643 None 38 Human Functional pKi = 6.4 6.4 - 4
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 486 9 2 8 3.3 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)Nc1ccc(cc1)C#N 10.1016/j.ejmech.2010.04.039
CHEMBL273807 2643 None 38 Human Functional pKi = 6.4 6.4 - 4
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 486 9 2 8 3.3 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)Nc1ccc(cc1)C#N 10.1016/j.ejmech.2010.04.039
449 2643 None 38 Human Functional pKi = 6.4 6.4 - 4
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 486 9 2 8 3.3 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)Nc1ccc(cc1)C#N 10.1021/jm990421v
453 2643 None 38 Human Functional pKi = 6.4 6.4 - 4
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 486 9 2 8 3.3 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)Nc1ccc(cc1)C#N 10.1021/jm990421v
6603931 2643 None 38 Human Functional pKi = 6.4 6.4 - 4
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 486 9 2 8 3.3 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)Nc1ccc(cc1)C#N 10.1021/jm990421v
CHEMBL273807 2643 None 38 Human Functional pKi = 6.4 6.4 - 4
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 486 9 2 8 3.3 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)Nc1ccc(cc1)C#N 10.1021/jm990421v
14788206 101971 None 0 Human Functional pKi = 7.4 7.4 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 375 6 2 6 1.9 CCCn1c(=O)c2nc(C3CCCC(NC(C)=O)C3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
CHEMBL300983 101971 None 0 Human Functional pKi = 7.4 7.4 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 375 6 2 6 1.9 CCCn1c(=O)c2nc(C3CCCC(NC(C)=O)C3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
137661874 159396 None 0 Human Functional pKi = 7.4 7.4 - 0
Antagonist activity at human adenosine A1 receptor expressed in HEK293 cell membranes assessed as decrease in CPA/forskolin-induced cAMP level pretreated for 15 mins followed by agonist addition for 15 mins and subsequent forskolin stimulation measured after 30 minsAntagonist activity at human adenosine A1 receptor expressed in HEK293 cell membranes assessed as decrease in CPA/forskolin-induced cAMP level pretreated for 15 mins followed by agonist addition for 15 mins and subsequent forskolin stimulation measured after 30 mins
ChEMBL 405 4 2 7 3.0 COc1ccc(N2CCOCC2)c2sc(NC(=O)C3(C)CCC(O)CC3)nc12 10.1021/acs.jmedchem.6b01584
CHEMBL4099688 159396 None 0 Human Functional pKi = 7.4 7.4 - 0
Antagonist activity at human adenosine A1 receptor expressed in HEK293 cell membranes assessed as decrease in CPA/forskolin-induced cAMP level pretreated for 15 mins followed by agonist addition for 15 mins and subsequent forskolin stimulation measured after 30 minsAntagonist activity at human adenosine A1 receptor expressed in HEK293 cell membranes assessed as decrease in CPA/forskolin-induced cAMP level pretreated for 15 mins followed by agonist addition for 15 mins and subsequent forskolin stimulation measured after 30 mins
ChEMBL 405 4 2 7 3.0 COc1ccc(N2CCOCC2)c2sc(NC(=O)C3(C)CCC(O)CC3)nc12 10.1021/acs.jmedchem.6b01584
46889255 7621 None 0 Human Functional pKi = 6.4 6.4 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 406 7 1 6 3.8 CCN(CC)CCOc1ccc2c(c1)-c1nc(N)nc(-c3ccc(F)cc3)c1C2=O 10.1016/j.bmcl.2010.03.024
CHEMBL1088132 7621 None 0 Human Functional pKi = 6.4 6.4 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 406 7 1 6 3.8 CCN(CC)CCOc1ccc2c(c1)-c1nc(N)nc(-c3ccc(F)cc3)c1C2=O 10.1016/j.bmcl.2010.03.024
21874755 176997 None 1 Human Functional pKi = 5.4 5.4 - 0
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 336 4 2 8 1.8 Nc1nc(-c2ccco2)c2nnn(Cc3cccc(C(=O)O)c3)c2n1 10.1016/j.ejmech.2010.04.039
CHEMBL461656 176997 None 1 Human Functional pKi = 5.4 5.4 - 0
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 336 4 2 8 1.8 Nc1nc(-c2ccco2)c2nnn(Cc3cccc(C(=O)O)c3)c2n1 10.1016/j.ejmech.2010.04.039
19003740 194865 None 2 Human Functional pKi = 7.4 7.4 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 276 5 1 5 1.6 CCCn1c(=O)c2nc(C3CC3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
CHEMBL53737 194865 None 2 Human Functional pKi = 7.4 7.4 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 276 5 1 5 1.6 CCCn1c(=O)c2nc(C3CC3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
10387088 59474 None 0 Rat Functional pKi = 7.4 7.4 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 414 10 2 7 2.6 CCCCn1c(=O)c2nc(-c3ccc(OCC(=O)O)cc3)[nH]c2n(CCCC)c1=O 10.1021/jm990421v
CHEMBL17123 59474 None 0 Rat Functional pKi = 7.4 7.4 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 414 10 2 7 2.6 CCCCn1c(=O)c2nc(-c3ccc(OCC(=O)O)cc3)[nH]c2n(CCCC)c1=O 10.1021/jm990421v
11995251 200643 None 0 Human Functional pKi = 6.4 6.4 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 362 6 2 6 2.1 CCCn1c(=O)c2nc(C3CCC(C(=O)O)CC3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
CHEMBL57503 200643 None 0 Human Functional pKi = 6.4 6.4 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 362 6 2 6 2.1 CCCn1c(=O)c2nc(C3CCC(C(=O)O)CC3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
9870719 57434 None 0 Rat Functional pKi = 6.4 6.4 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 503 10 2 8 3.6 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4cccc(C(C)=O)c4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL16534 57434 None 0 Rat Functional pKi = 6.4 6.4 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 503 10 2 8 3.6 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4cccc(C(C)=O)c4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
45275719 89806 None 0 Human Functional pKi = 6.4 6.4 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 335 3 1 5 5.0 Cc1ccc(-c2nc(N)c3cc(C(C)c4ccccc4)sc3n2)o1 10.1016/j.bmcl.2013.02.078
CHEMBL2377112 89806 None 0 Human Functional pKi = 6.4 6.4 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 335 3 1 5 5.0 Cc1ccc(-c2nc(N)c3cc(C(C)c4ccccc4)sc3n2)o1 10.1016/j.bmcl.2013.02.078
10792296 98719 None 0 Rat Functional pKi = 7.4 7.4 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 529 9 2 7 4.4 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(C(F)(F)F)cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL277386 98719 None 0 Rat Functional pKi = 7.4 7.4 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 529 9 2 7 4.4 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(C(F)(F)F)cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
2519 779 None 49 Human Functional pKi = 4.4 4.4 -17782 8
Antagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assayAntagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assay
ChEMBL 194 0 0 6 -1.0 Cn1cnc2c1c(=O)n(C)c(=O)n2C 10.1016/j.bmcl.2013.03.070
2519.0 779 None 49 Human Functional pKi = 4.4 4.4 -17782 8
Antagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assayAntagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assay
ChEMBL 194 0 0 6 -1.0 Cn1cnc2c1c(=O)n(C)c(=O)n2C 10.1016/j.bmcl.2013.03.070
407 779 None 49 Human Functional pKi = 4.4 4.4 -17782 8
Antagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assayAntagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assay
ChEMBL 194 0 0 6 -1.0 Cn1cnc2c1c(=O)n(C)c(=O)n2C 10.1016/j.bmcl.2013.03.070
463 779 None 49 Human Functional pKi = 4.4 4.4 -17782 8
Antagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assayAntagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assay
ChEMBL 194 0 0 6 -1.0 Cn1cnc2c1c(=O)n(C)c(=O)n2C 10.1016/j.bmcl.2013.03.070
CHEMBL113 779 None 49 Human Functional pKi = 4.4 4.4 -17782 8
Antagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assayAntagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assay
ChEMBL 194 0 0 6 -1.0 Cn1cnc2c1c(=O)n(C)c(=O)n2C 10.1016/j.bmcl.2013.03.070
DB00201 779 None 49 Human Functional pKi = 4.4 4.4 -17782 8
Antagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assayAntagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assay
ChEMBL 194 0 0 6 -1.0 Cn1cnc2c1c(=O)n(C)c(=O)n2C 10.1016/j.bmcl.2013.03.070
11568203 96297 None 0 Human Functional pKi = 6.4 6.4 - 0
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 432 5 1 7 2.8 CCCn1c(=O)c2[nH]c(-c3cnn(Cc4cccc(C(F)(F)F)c4)c3)nc2n(C)c1=O 10.1016/j.ejmech.2010.04.039
CHEMBL260975 96297 None 0 Human Functional pKi = 6.4 6.4 - 0
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 432 5 1 7 2.8 CCCn1c(=O)c2[nH]c(-c3cnn(Cc4cccc(C(F)(F)F)c4)c3)nc2n(C)c1=O 10.1016/j.ejmech.2010.04.039
46889173 7646 None 0 Human Functional pKi = 7.3 7.3 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 415 7 2 6 3.0 CCN(CC)CCNC(=O)c1ccc2c(c1)-c1nc(N)nc(-c3ccccc3)c1C2=O 10.1016/j.bmcl.2010.03.024
CHEMBL1088261 7646 None 0 Human Functional pKi = 7.3 7.3 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 415 7 2 6 3.0 CCN(CC)CCNC(=O)c1ccc2c(c1)-c1nc(N)nc(-c3ccccc3)c1C2=O 10.1016/j.bmcl.2010.03.024
450 2970 None 7 Human Functional pKi = 6.4 6.4 - 0
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 525 10 3 6 3.6 CC(=O)NCCNc1nc(nc2c1cc([nH]2)C(=O)N1CCN(CC1)CCCc1ccccc1)c1ccccc1 10.1016/j.ejmech.2010.04.039
454 2970 None 7 Human Functional pKi = 6.4 6.4 - 0
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 525 10 3 6 3.6 CC(=O)NCCNc1nc(nc2c1cc([nH]2)C(=O)N1CCN(CC1)CCCc1ccccc1)c1ccccc1 10.1016/j.ejmech.2010.04.039
5311041 2970 None 7 Human Functional pKi = 6.4 6.4 - 0
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 525 10 3 6 3.6 CC(=O)NCCNc1nc(nc2c1cc([nH]2)C(=O)N1CCN(CC1)CCCc1ccccc1)c1ccccc1 10.1016/j.ejmech.2010.04.039
CHEMBL485862 2970 None 7 Human Functional pKi = 6.4 6.4 - 0
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 525 10 3 6 3.6 CC(=O)NCCNc1nc(nc2c1cc([nH]2)C(=O)N1CCN(CC1)CCCc1ccccc1)c1ccccc1 10.1016/j.ejmech.2010.04.039
14539598 118436 None 0 Rat Functional pKi = 4.4 4.4 - 0
Agonistic activity against Adenosine A1 receptor on rat whole-brain membranesAgonistic activity against Adenosine A1 receptor on rat whole-brain membranes
ChEMBL 504 7 5 10 2.9 OC[C@H]1O[C@@H](n2cnc3c(NCc4cccc5ccccc45)nc(NC4CCCCC4)nc32)[C@H](O)[C@@H]1O 10.1016/s0960-894x(00)00017-2
CHEMBL341031 118436 None 0 Rat Functional pKi = 4.4 4.4 - 0
Agonistic activity against Adenosine A1 receptor on rat whole-brain membranesAgonistic activity against Adenosine A1 receptor on rat whole-brain membranes
ChEMBL 504 7 5 10 2.9 OC[C@H]1O[C@@H](n2cnc3c(NCc4cccc5ccccc45)nc(NC4CCCCC4)nc32)[C@H](O)[C@@H]1O 10.1016/s0960-894x(00)00017-2
46888850 8709 None 0 Human Functional pKi = 7.3 7.3 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 449 5 2 8 2.1 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(NCCN3CCS(=O)(=O)CC3)ccc1C2=O 10.1016/j.bmcl.2010.03.024
CHEMBL1095811 8709 None 0 Human Functional pKi = 7.3 7.3 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 449 5 2 8 2.1 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(NCCN3CCS(=O)(=O)CC3)ccc1C2=O 10.1016/j.bmcl.2010.03.024
46888923 7488 None 0 Human Functional pKi = 6.3 6.3 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 434 7 1 6 4.6 CC(C)N(CCOc1ccc2c(c1)-c1nc(N)nc(-c3ccc(F)cc3)c1C2=O)C(C)C 10.1016/j.bmcl.2010.03.024
CHEMBL1087080 7488 None 0 Human Functional pKi = 6.3 6.3 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 434 7 1 6 4.6 CC(C)N(CCOc1ccc2c(c1)-c1nc(N)nc(-c3ccc(F)cc3)c1C2=O)C(C)C 10.1016/j.bmcl.2010.03.024
25268841 8663 None 12 Human Functional pKi = 7.3 7.3 4 2
Antagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP productionAntagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP production
ChEMBL 402 5 1 7 2.6 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(OCCN3CCOCC3)ccc1C2=O 10.1021/jm201640m
CHEMBL1095488 8663 None 12 Human Functional pKi = 7.3 7.3 4 2
Antagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP productionAntagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP production
ChEMBL 402 5 1 7 2.6 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(OCCN3CCOCC3)ccc1C2=O 10.1021/jm201640m
25268841 8663 None 12 Human Functional pKi = 7.3 7.3 4 2
Antagonist activity at human recombinant adenosine A1 receptor by cAMP assayAntagonist activity at human recombinant adenosine A1 receptor by cAMP assay
ChEMBL 402 5 1 7 2.6 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(OCCN3CCOCC3)ccc1C2=O 10.1021/jm4011669
CHEMBL1095488 8663 None 12 Human Functional pKi = 7.3 7.3 4 2
Antagonist activity at human recombinant adenosine A1 receptor by cAMP assayAntagonist activity at human recombinant adenosine A1 receptor by cAMP assay
ChEMBL 402 5 1 7 2.6 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(OCCN3CCOCC3)ccc1C2=O 10.1021/jm4011669
25268841 8663 None 12 Human Functional pKi = 7.3 7.3 4 2
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 402 5 1 7 2.6 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(OCCN3CCOCC3)ccc1C2=O 10.1016/j.bmcl.2010.03.024
CHEMBL1095488 8663 None 12 Human Functional pKi = 7.3 7.3 4 2
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 402 5 1 7 2.6 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(OCCN3CCOCC3)ccc1C2=O 10.1016/j.bmcl.2010.03.024
9957239 59434 None 0 Human Functional pKi = 5.3 5.3 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 490 7 2 6 4.8 O=C(O)/C=C/c1ccc(-c2nc3c(=O)n(CC4CCCCC4)c(=O)n(CC4CCCCC4)c3[nH]2)cc1 10.1021/jm990421v
CHEMBL17103 59434 None 0 Human Functional pKi = 5.3 5.3 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 490 7 2 6 4.8 O=C(O)/C=C/c1ccc(-c2nc3c(=O)n(CC4CCCCC4)c(=O)n(CC4CCCCC4)c3[nH]2)cc1 10.1021/jm990421v
45274328 89823 None 0 Human Functional pKi = 7.3 7.3 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 372 3 1 6 5.0 Cc1csc(-c2nc(N)c3cc(Cc4ccccc4Cl)sc3n2)n1 10.1016/j.bmcl.2013.02.078
CHEMBL2377232 89823 None 0 Human Functional pKi = 7.3 7.3 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 372 3 1 6 5.0 Cc1csc(-c2nc(N)c3cc(Cc4ccccc4Cl)sc3n2)n1 10.1016/j.bmcl.2013.02.078
10720065 98450 None 0 Human Functional pKi = 7.3 7.3 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 495 9 2 7 4.0 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(Cl)cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL275427 98450 None 0 Human Functional pKi = 7.3 7.3 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 495 9 2 7 4.0 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(Cl)cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
44572355 179690 None 0 Human Functional pKi = 5.3 5.3 - 0
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 269 2 1 5 1.8 CC(C)Cn1c(Br)nc2c(N)ncnc21 10.1016/j.ejmech.2010.04.039
CHEMBL474207 179690 None 0 Human Functional pKi = 5.3 5.3 - 0
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 269 2 1 5 1.8 CC(C)Cn1c(Br)nc2c(N)ncnc21 10.1016/j.ejmech.2010.04.039
59277997 89828 None 0 Human Functional pKi = 6.3 6.3 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 231 1 1 5 2.8 Cc1ccc(-c2nc(N)c3ccsc3n2)o1 10.1016/j.bmcl.2013.02.078
CHEMBL2377237 89828 None 0 Human Functional pKi = 6.3 6.3 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 231 1 1 5 2.8 Cc1ccc(-c2nc(N)c3ccsc3n2)o1 10.1016/j.bmcl.2013.02.078
9912816 98487 None 0 Rat Functional pKi = 8.3 8.3 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 475 10 2 7 3.1 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)NCc4ccccc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL275605 98487 None 0 Rat Functional pKi = 8.3 8.3 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 475 10 2 7 3.1 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)NCc4ccccc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
56954334 82139 None 0 Human Functional pKi = 8.3 8.3 - 0
Antagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP productionAntagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP production
ChEMBL 389 3 1 6 3.8 N#Cc1cncc(Cc2ccc3c(c2)-c2nc(N)nc(-c4ccccc4)c2C3=O)c1 10.1021/jm201640m
CHEMBL2165808 82139 None 0 Human Functional pKi = 8.3 8.3 - 0
Antagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP productionAntagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP production
ChEMBL 389 3 1 6 3.8 N#Cc1cncc(Cc2ccc3c(c2)-c2nc(N)nc(-c4ccccc4)c2C3=O)c1 10.1021/jm201640m
CHEMBL5089483 217699 None 0 Human Functional pKi = 8.3 8.3 - 0
Antagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 min followed by forskolin stimulation and further incubated for 30 mins in presence of NECA by alphascreen LANCE assayAntagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 min followed by forskolin stimulation and further incubated for 30 mins in presence of NECA by alphascreen LANCE assay
ChEMBL None None None CCCCn1c(=O)c2nc(C34CCC(C(=O)NCCCCN=[N+]=[N-])(CC3)CC4)[nH]c2n(CCCNC(=O)c2ccc(S(=O)(=O)F)cc2)c1=O 10.1021/acs.jmedchem.0c02169
67195703 158108 None 0 Human Functional pKi = 8.3 8.3 - 0
Antagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assayAntagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assay
ChEMBL 377 5 2 5 4.5 CCCn1c(Oc2cccc3cc[nH]c23)nc2nc(C3CCCC3)[nH]c2c1=O 10.1016/j.bmc.2017.02.029
CHEMBL4085564 158108 None 0 Human Functional pKi = 8.3 8.3 - 0
Antagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assayAntagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assay
ChEMBL 377 5 2 5 4.5 CCCn1c(Oc2cccc3cc[nH]c23)nc2nc(C3CCCC3)[nH]c2c1=O 10.1016/j.bmc.2017.02.029
541759 170138 None 0 Rat Functional pKi = 8.2 8.2 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 477 9 3 8 3.1 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(O)cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL444281 170138 None 0 Rat Functional pKi = 8.2 8.2 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 477 9 3 8 3.1 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(O)cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
70655981 158022 None 0 Human Functional pKi = 8.2 8.2 - 0
Antagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assayAntagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assay
ChEMBL 406 5 1 5 5.0 CCCn1c(Oc2cccc(C(F)(F)F)c2)nc2nc(C3CCCC3)[nH]c2c1=O 10.1016/j.bmc.2017.02.029
CHEMBL4084453 158022 None 0 Human Functional pKi = 8.2 8.2 - 0
Antagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assayAntagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assay
ChEMBL 406 5 1 5 5.0 CCCn1c(Oc2cccc(C(F)(F)F)c2)nc2nc(C3CCCC3)[nH]c2c1=O 10.1016/j.bmc.2017.02.029
44299582 199443 None 0 Human Functional pKi = 7.3 7.3 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 333 5 2 6 1.7 CCCn1c(=O)c2nc(C3CCCC(N)C3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
CHEMBL56673 199443 None 0 Human Functional pKi = 7.3 7.3 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 333 5 2 6 1.7 CCCn1c(=O)c2nc(C3CCCC(N)C3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
135921140 11347 None 0 Rat Functional pKi = 6.3 6.3 - 0
Inhibition against Adenosine A1 receptor of rat fat cell membranes (functional antagonist activity)Inhibition against Adenosine A1 receptor of rat fat cell membranes (functional antagonist activity)
ChEMBL 267 1 1 4 1.7 Cn1c(-c2ccccc2)nc2c1C1=NCCN1C(=O)N2 10.1021/jm011093d
CHEMBL117962 11347 None 0 Rat Functional pKi = 6.3 6.3 - 0
Inhibition against Adenosine A1 receptor of rat fat cell membranes (functional antagonist activity)Inhibition against Adenosine A1 receptor of rat fat cell membranes (functional antagonist activity)
ChEMBL 267 1 1 4 1.7 Cn1c(-c2ccccc2)nc2c1C1=NCCN1C(=O)N2 10.1021/jm011093d
45274426 89817 None 0 Human Functional pKi = 6.3 6.3 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 387 5 1 6 5.1 COc1ccccc1Cc1cc2c(N)nc(-c3ccc(C(F)F)o3)nc2s1 10.1016/j.bmcl.2013.02.078
CHEMBL2377226 89817 None 0 Human Functional pKi = 6.3 6.3 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 387 5 1 6 5.1 COc1ccccc1Cc1cc2c(N)nc(-c3ccc(C(F)F)o3)nc2s1 10.1016/j.bmcl.2013.02.078
71602912 89829 None 0 Human Functional pKi = 6.3 6.3 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 307 2 1 5 4.5 Cc1ccc(-c2nc(N)c3cc(-c4ccccc4)sc3n2)o1 10.1016/j.bmcl.2013.02.078
CHEMBL2377238 89829 None 0 Human Functional pKi = 6.3 6.3 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 307 2 1 5 4.5 Cc1ccc(-c2nc(N)c3cc(-c4ccccc4)sc3n2)o1 10.1016/j.bmcl.2013.02.078
24827444 96397 None 0 Human Functional pKi = 6.3 6.3 - 0
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 365 5 1 8 1.6 CCCn1c(=O)c2[nH]c(-c3cnn(-c4cccnc4)c3)nc2n(CC)c1=O 10.1016/j.ejmech.2010.04.039
CHEMBL261526 96397 None 0 Human Functional pKi = 6.3 6.3 - 0
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 365 5 1 8 1.6 CCCn1c(=O)c2[nH]c(-c3cnn(-c4cccnc4)c3)nc2n(CC)c1=O 10.1016/j.ejmech.2010.04.039
14788232 200084 None 0 Human Functional pKi = 7.3 7.3 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 432 9 1 7 1.6 CCCn1c(=O)c2nc(C3CCCC3C(=O)N(C)CCN(C)C)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
CHEMBL57076 200084 None 0 Human Functional pKi = 7.3 7.3 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 432 9 1 7 1.6 CCCn1c(=O)c2nc(C3CCCC3C(=O)N(C)CCN(C)C)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
9912816 98487 None 0 Human Functional pKi = 7.3 7.3 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 475 10 2 7 3.1 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)NCc4ccccc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL275605 98487 None 0 Human Functional pKi = 7.3 7.3 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 475 10 2 7 3.1 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)NCc4ccccc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
11690712 77821 None 0 Human Functional pKi = 7.3 7.3 - 0
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 439 7 3 6 2.0 CCCn1c(=O)[nH]c2[nH]c(-c3ccc(S(=O)(=O)NCc4ccccc4)cc3)nc2c1=O 10.1016/j.ejmech.2010.04.039
CHEMBL209230 77821 None 0 Human Functional pKi = 7.3 7.3 - 0
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 439 7 3 6 2.0 CCCn1c(=O)[nH]c2[nH]c(-c3ccc(S(=O)(=O)NCc4ccccc4)cc3)nc2c1=O 10.1016/j.ejmech.2010.04.039
10839296 58160 None 1 Human Functional pKi = 7.2 7.2 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 506 10 2 9 3.3 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc([N+](=O)[O-])cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL16787 58160 None 1 Human Functional pKi = 7.2 7.2 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 506 10 2 9 3.3 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc([N+](=O)[O-])cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
46888822 9015 None 0 Human Functional pKi = 7.2 7.2 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 373 5 1 6 2.9 CN(C)CCN(C)c1ccc2c(c1)-c1nc(N)nc(-c3ccccc3)c1C2=O 10.1016/j.bmcl.2010.03.024
CHEMBL1098457 9015 None 0 Human Functional pKi = 7.2 7.2 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 373 5 1 6 2.9 CN(C)CCN(C)c1ccc2c(c1)-c1nc(N)nc(-c3ccccc3)c1C2=O 10.1016/j.bmcl.2010.03.024
126079 4100 None 29 Rat Functional pKi = 7.2 7.2 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 386 8 2 7 1.8 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)O 10.1021/jm990421v
451 4100 None 29 Rat Functional pKi = 7.2 7.2 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 386 8 2 7 1.8 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)O 10.1021/jm990421v
CHEMBL27041 4100 None 29 Rat Functional pKi = 7.2 7.2 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 386 8 2 7 1.8 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)O 10.1021/jm990421v
25242440 7512 None 0 Human Functional pKi = 7.2 7.2 - 0
Antagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP productionAntagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP production
ChEMBL 399 2 1 6 2.3 CN1CCN(C(=O)c2ccc3c(c2)-c2nc(N)nc(-c4ccccc4)c2C3=O)CC1 10.1021/jm201640m
CHEMBL1087185 7512 None 0 Human Functional pKi = 7.2 7.2 - 0
Antagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP productionAntagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP production
ChEMBL 399 2 1 6 2.3 CN1CCN(C(=O)c2ccc3c(c2)-c2nc(N)nc(-c4ccccc4)c2C3=O)CC1 10.1021/jm201640m
25242440 7512 None 0 Human Functional pKi = 7.2 7.2 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 399 2 1 6 2.3 CN1CCN(C(=O)c2ccc3c(c2)-c2nc(N)nc(-c4ccccc4)c2C3=O)CC1 10.1016/j.bmcl.2010.03.024
CHEMBL1087185 7512 None 0 Human Functional pKi = 7.2 7.2 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 399 2 1 6 2.3 CN1CCN(C(=O)c2ccc3c(c2)-c2nc(N)nc(-c4ccccc4)c2C3=O)CC1 10.1016/j.bmcl.2010.03.024
CHEMBL5089727 217713 None 0 Human Functional pKi = 6.2 6.2 - 0
Antagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 min followed by forskolin stimulation and further incubated for 30 mins in presence of NECA by alphascreen LANCE assayAntagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 min followed by forskolin stimulation and further incubated for 30 mins in presence of NECA by alphascreen LANCE assay
ChEMBL None None None C#CCNC(=O)C12CCC(c3nc4c(=O)n(CCCC)c(=O)n(CCCNC(=O)c5ccc(S(=O)(=O)F)cc5)c4[nH]3)(CC1)CC2 10.1021/acs.jmedchem.0c02169
11995251 200643 None 0 Human Functional pKi = 7.2 7.2 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 362 6 2 6 2.1 CCCn1c(=O)c2nc(C3CCC(C(=O)O)CC3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
CHEMBL57503 200643 None 0 Human Functional pKi = 7.2 7.2 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 362 6 2 6 2.1 CCCn1c(=O)c2nc(C3CCC(C(=O)O)CC3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
25188209 178864 None 0 Human Functional pKi = 6.2 6.2 - 0
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 311 3 1 8 1.6 Nc1nc(-c2ncco2)c2nnn(Cc3ccccc3F)c2n1 10.1016/j.ejmech.2010.04.039
CHEMBL468701 178864 None 0 Human Functional pKi = 6.2 6.2 - 0
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 311 3 1 8 1.6 Nc1nc(-c2ncco2)c2nnn(Cc3ccccc3F)c2n1 10.1016/j.ejmech.2010.04.039
56954335 82129 None 0 Human Functional pKi = 8.2 8.2 - 0
Antagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP productionAntagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP production
ChEMBL 382 3 1 5 4.1 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(Cc3cncc(F)c3)ccc1C2=O 10.1021/jm201640m
CHEMBL2165799 82129 None 0 Human Functional pKi = 8.2 8.2 - 0
Antagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP productionAntagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP production
ChEMBL 382 3 1 5 4.1 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(Cc3cncc(F)c3)ccc1C2=O 10.1021/jm201640m
127036696 136562 None 0 Rat Functional pKi = 8.2 8.2 - 0
Antagonist activity at rat adenosine A1 receptorAntagonist activity at rat adenosine A1 receptor
ChEMBL 362 3 1 5 3.9 Cc1ccc(-c2cc(-c3cccc(C(=O)N4CCCCC4)c3)nc(N)n2)o1 10.1016/j.ejmech.2022.114378
CHEMBL3735985 136562 None 0 Rat Functional pKi = 8.2 8.2 - 0
Antagonist activity at rat adenosine A1 receptorAntagonist activity at rat adenosine A1 receptor
ChEMBL 362 3 1 5 3.9 Cc1ccc(-c2cc(-c3cccc(C(=O)N4CCCCC4)c3)nc(N)n2)o1 10.1016/j.ejmech.2022.114378
10720065 98450 None 0 Rat Functional pKi = 8.2 8.2 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 495 9 2 7 4.0 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(Cl)cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL275427 98450 None 0 Rat Functional pKi = 8.2 8.2 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 495 9 2 7 4.0 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(Cl)cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
404 4098 None 26 Human Functional pKi = 8.2 8.2 - 2
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 428 10 3 8 0.8 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)NCCN 10.1021/jm990421v
432 4098 None 26 Human Functional pKi = 8.2 8.2 - 2
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 428 10 3 8 0.8 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)NCCN 10.1021/jm990421v
5697 4098 None 26 Human Functional pKi = 8.2 8.2 - 2
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 428 10 3 8 0.8 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)NCCN 10.1021/jm990421v
CHEMBL273094 4098 None 26 Human Functional pKi = 8.2 8.2 - 2
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 428 10 3 8 0.8 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)NCCN 10.1021/jm990421v
46888929 7463 None 0 Human Functional pKi = 8.2 8.2 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 280 1 1 6 2.4 Nc1nc(-c2nccs2)c2c(n1)-c1ccccc1C2=O 10.1016/j.bmcl.2010.03.042
CHEMBL1086847 7463 None 0 Human Functional pKi = 8.2 8.2 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 280 1 1 6 2.4 Nc1nc(-c2nccs2)c2c(n1)-c1ccccc1C2=O 10.1016/j.bmcl.2010.03.042
46888924 7489 None 0 Human Functional pKi = 6.2 6.2 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 404 5 1 6 3.6 Nc1nc(-c2ccc(F)cc2)c2c(n1)-c1cc(OCCN3CCCC3)ccc1C2=O 10.1016/j.bmcl.2010.03.024
CHEMBL1087081 7489 None 0 Human Functional pKi = 6.2 6.2 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 404 5 1 6 3.6 Nc1nc(-c2ccc(F)cc2)c2c(n1)-c1cc(OCCN3CCCC3)ccc1C2=O 10.1016/j.bmcl.2010.03.024
9957239 59434 None 0 Rat Functional pKi = 6.2 6.2 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 490 7 2 6 4.8 O=C(O)/C=C/c1ccc(-c2nc3c(=O)n(CC4CCCCC4)c(=O)n(CC4CCCCC4)c3[nH]2)cc1 10.1021/jm990421v
CHEMBL17103 59434 None 0 Rat Functional pKi = 6.2 6.2 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 490 7 2 6 4.8 O=C(O)/C=C/c1ccc(-c2nc3c(=O)n(CC4CCCCC4)c(=O)n(CC4CCCCC4)c3[nH]2)cc1 10.1021/jm990421v
10792296 98719 None 0 Human Functional pKi = 7.2 7.2 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 529 9 2 7 4.4 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(C(F)(F)F)cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL277386 98719 None 0 Human Functional pKi = 7.2 7.2 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 529 9 2 7 4.4 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(C(F)(F)F)cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
45274225 89798 None 0 Human Functional pKi = 6.2 6.2 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 319 3 1 6 3.3 Nc1nc(-c2ncccn2)nc2sc(Cc3ccccc3)cc12 10.1016/j.bmcl.2013.02.078
CHEMBL2377104 89798 None 0 Human Functional pKi = 6.2 6.2 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 319 3 1 6 3.3 Nc1nc(-c2ncccn2)nc2sc(Cc3ccccc3)cc12 10.1016/j.bmcl.2013.02.078
11610869 80287 None 0 Rat Functional pKi = 7.2 7.2 - 0
Antagonist activity against rat adenosine A1 receptorAntagonist activity against rat adenosine A1 receptor
ChEMBL 393 5 3 8 -1.0 Cn1c(=O)c2nc(-c3ccc(S(=O)(=O)NCC(=O)O)cc3)[nH]c2n(C)c1=O 10.1016/j.ejmech.2010.04.039
CHEMBL213878 80287 None 0 Rat Functional pKi = 7.2 7.2 - 0
Antagonist activity against rat adenosine A1 receptorAntagonist activity against rat adenosine A1 receptor
ChEMBL 393 5 3 8 -1.0 Cn1c(=O)c2nc(-c3ccc(S(=O)(=O)NCC(=O)O)cc3)[nH]c2n(C)c1=O 10.1016/j.ejmech.2010.04.039
9871761 59501 None 0 Rat Functional pKi = 7.2 7.2 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 533 11 4 9 1.2 CCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(CC(=O)NCCN)cc4)cc3)[nH]c2n(CC)c1=O 10.1021/jm990421v
CHEMBL17141 59501 None 0 Rat Functional pKi = 7.2 7.2 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 533 11 4 9 1.2 CCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(CC(=O)NCCN)cc4)cc3)[nH]c2n(CC)c1=O 10.1021/jm990421v
46889126 7670 None 0 Human Functional pKi = 7.2 7.2 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 389 4 2 6 3.2 Nc1nc(-c2ccc(F)cc2)c2c(n1)-c1cc(CNN3CCCC3)ccc1C2=O 10.1016/j.bmcl.2010.03.042
CHEMBL1088533 7670 None 0 Human Functional pKi = 7.2 7.2 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 389 4 2 6 3.2 Nc1nc(-c2ccc(F)cc2)c2c(n1)-c1cc(CNN3CCCC3)ccc1C2=O 10.1016/j.bmcl.2010.03.042
14788235 201309 None 0 Human Functional pKi = 6.2 6.2 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 334 6 2 6 1.3 CCCn1c(=O)c2nc(C3CCC3C(=O)O)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
CHEMBL58380 201309 None 0 Human Functional pKi = 6.2 6.2 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 334 6 2 6 1.3 CCCn1c(=O)c2nc(C3CCC3C(=O)O)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
46889229 7490 None 0 Human Functional pKi = 7.2 7.2 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 413 3 1 6 2.7 CCN1CCN(C(=O)c2ccc3c(c2)-c2nc(N)nc(-c4ccccc4)c2C3=O)CC1 10.1016/j.bmcl.2010.03.024
CHEMBL1087084 7490 None 0 Human Functional pKi = 7.2 7.2 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 413 3 1 6 2.7 CCN1CCN(C(=O)c2ccc3c(c2)-c2nc(N)nc(-c4ccccc4)c2C3=O)CC1 10.1016/j.bmcl.2010.03.024
2153 3800 None 72 Human Functional pKi = 5.2 5.2 -3 5
Antagonist activity at adenosine A1 receptor (unknown origin)Antagonist activity at adenosine A1 receptor (unknown origin)
ChEMBL 180 0 1 5 -1.0 Cn1c(=O)n(C)c2c(c1=O)[nH]cn2 10.1016/j.ejmech.2021.113907
2153.0 3800 None 72 Human Functional pKi = 5.2 5.2 -3 5
Antagonist activity at adenosine A1 receptor (unknown origin)Antagonist activity at adenosine A1 receptor (unknown origin)
ChEMBL 180 0 1 5 -1.0 Cn1c(=O)n(C)c2c(c1=O)[nH]cn2 10.1016/j.ejmech.2021.113907
2620 3800 None 72 Human Functional pKi = 5.2 5.2 -3 5
Antagonist activity at adenosine A1 receptor (unknown origin)Antagonist activity at adenosine A1 receptor (unknown origin)
ChEMBL 180 0 1 5 -1.0 Cn1c(=O)n(C)c2c(c1=O)[nH]cn2 10.1016/j.ejmech.2021.113907
413 3800 None 72 Human Functional pKi = 5.2 5.2 -3 5
Antagonist activity at adenosine A1 receptor (unknown origin)Antagonist activity at adenosine A1 receptor (unknown origin)
ChEMBL 180 0 1 5 -1.0 Cn1c(=O)n(C)c2c(c1=O)[nH]cn2 10.1016/j.ejmech.2021.113907
CHEMBL190 3800 None 72 Human Functional pKi = 5.2 5.2 -3 5
Antagonist activity at adenosine A1 receptor (unknown origin)Antagonist activity at adenosine A1 receptor (unknown origin)
ChEMBL 180 0 1 5 -1.0 Cn1c(=O)n(C)c2c(c1=O)[nH]cn2 10.1016/j.ejmech.2021.113907
DB00277 3800 None 72 Human Functional pKi = 5.2 5.2 -3 5
Antagonist activity at adenosine A1 receptor (unknown origin)Antagonist activity at adenosine A1 receptor (unknown origin)
ChEMBL 180 0 1 5 -1.0 Cn1c(=O)n(C)c2c(c1=O)[nH]cn2 10.1016/j.ejmech.2021.113907
10624626 163232 None 0 Rat Functional pKi = 6.2 6.2 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 482 8 2 7 3.1 O=C(O)COc1ccc(-c2nc3c(=O)n(Cc4ccccc4)c(=O)n(Cc4ccccc4)c3[nH]2)cc1 10.1021/jm990421v
CHEMBL417812 163232 None 0 Rat Functional pKi = 6.2 6.2 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 482 8 2 7 3.1 O=C(O)COc1ccc(-c2nc3c(=O)n(Cc4ccccc4)c(=O)n(Cc4ccccc4)c3[nH]2)cc1 10.1021/jm990421v
14000479 51011 None 1 Human Functional pKi = 7.2 7.2 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 318 6 1 5 2.4 CCCn1c(=O)c2nc(CC3CCCC3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
CHEMBL157833 51011 None 1 Human Functional pKi = 7.2 7.2 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 318 6 1 5 2.4 CCCn1c(=O)c2nc(CC3CCCC3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
9850900 98404 None 0 Human Functional pKi = 6.2 6.2 - 0
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 565 12 1 7 5.0 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)N(Cc4ccccc4)Cc4ccccc4)cc3)[nH]c2n(CCC)c1=O 10.1016/j.ejmech.2010.04.039
CHEMBL275149 98404 None 0 Human Functional pKi = 6.2 6.2 - 0
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 565 12 1 7 5.0 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)N(Cc4ccccc4)Cc4ccccc4)cc3)[nH]c2n(CCC)c1=O 10.1016/j.ejmech.2010.04.039
9850900 98404 None 0 Human Functional pKi = 6.2 6.2 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 565 12 1 7 5.0 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)N(Cc4ccccc4)Cc4ccccc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL275149 98404 None 0 Human Functional pKi = 6.2 6.2 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 565 12 1 7 5.0 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)N(Cc4ccccc4)Cc4ccccc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
10840167 59196 None 0 Rat Functional pKi = 8.1 8.1 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 539 9 2 7 4.2 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(Br)cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL17003 59196 None 0 Rat Functional pKi = 8.1 8.1 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 539 9 2 7 4.2 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(Br)cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
9892149 59644 None 0 Rat Functional pKi = 8.1 8.1 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 499 9 2 7 4.2 CCCn1c(=O)c2nc(-c3ccc(/C=C/C(=O)Nc4ccccc4C(C)=O)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL17202 59644 None 0 Rat Functional pKi = 8.1 8.1 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 499 9 2 7 4.2 CCCn1c(=O)c2nc(-c3ccc(/C=C/C(=O)Nc4ccccc4C(C)=O)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
11995352 198818 None 0 Human Functional pKi = 7.2 7.2 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 375 6 2 6 1.9 CCCn1c(=O)c2nc(C3CCC(NC(C)=O)CC3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
CHEMBL56251 198818 None 0 Human Functional pKi = 7.2 7.2 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 375 6 2 6 1.9 CCCn1c(=O)c2nc(C3CCC(NC(C)=O)CC3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
5613 3685 None 30 Human Functional pKi = 7.1 7.1 - 1
Antagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assayAntagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assay
ChEMBL 272 4 1 8 0.9 CCCCc1nc(N)c2c(n1)n(C)c(n2)n1nccn1 10.1016/j.bmcl.2013.03.070
9860294 3685 None 30 Human Functional pKi = 7.1 7.1 - 1
Antagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assayAntagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assay
ChEMBL 272 4 1 8 0.9 CCCCc1nc(N)c2c(n1)n(C)c(n2)n1nccn1 10.1016/j.bmcl.2013.03.070
CHEMBL197669 3685 None 30 Human Functional pKi = 7.1 7.1 - 1
Antagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assayAntagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assay
ChEMBL 272 4 1 8 0.9 CCCCc1nc(N)c2c(n1)n(C)c(n2)n1nccn1 10.1016/j.bmcl.2013.03.070
46889097 9075 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 399 4 2 7 2.6 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(CNN3CCC(=O)CC3)ccc1C2=O 10.1016/j.bmcl.2010.03.042
CHEMBL1099028 9075 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 399 4 2 7 2.6 Nc1nc(-c2ccccc2)c2c(n1)-c1cc(CNN3CCC(=O)CC3)ccc1C2=O 10.1016/j.bmcl.2010.03.042
10840167 59196 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 539 9 2 7 4.2 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(Br)cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
CHEMBL17003 59196 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.Antagonist activity against recombinant human adenosine A1 receptor expressed in HEK293 cells in presence of [125I]IABA radioligand.
ChEMBL 539 9 2 7 4.2 CCCn1c(=O)c2nc(-c3ccc(OCC(=O)Nc4ccc(Br)cc4)cc3)[nH]c2n(CCC)c1=O 10.1021/jm990421v
10267860 176928 None 0 Human Functional pKi = 6.1 6.1 - 0
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 317 3 1 8 2.0 N#Cc1ccc(Cn2nnc3c(-c4ccco4)nc(N)nc32)cc1 10.1016/j.ejmech.2010.04.039
CHEMBL461007 176928 None 0 Human Functional pKi = 6.1 6.1 - 0
Antagonist activity against human adenosine A1 receptorAntagonist activity against human adenosine A1 receptor
ChEMBL 317 3 1 8 2.0 N#Cc1ccc(Cn2nnc3c(-c4ccco4)nc(N)nc32)cc1 10.1016/j.ejmech.2010.04.039
46889042 7568 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 397 3 1 7 2.6 N#Cc1cccc(-c2nc(N)nc3c2C(=O)c2cccc(CN4CCOCC4)c2-3)c1 10.1016/j.bmcl.2010.03.042
CHEMBL1087708 7568 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 397 3 1 7 2.6 N#Cc1cccc(-c2nc(N)nc3c2C(=O)c2cccc(CN4CCOCC4)c2-3)c1 10.1016/j.bmcl.2010.03.042
541903 57964 None 0 Rat Functional pKi = 6.1 6.1 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 382 8 2 7 1.4 C=CCn1c(=O)c2nc(-c3ccc(OCC(=O)O)cc3)[nH]c2n(CC=C)c1=O 10.1021/jm990421v
CHEMBL16724 57964 None 0 Rat Functional pKi = 6.1 6.1 - 0
Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.Antagonist activity against adenosine A1 receptor in rat brain membrane in presence of [3H]R-PIA radioligand.
ChEMBL 382 8 2 7 1.4 C=CCn1c(=O)c2nc(-c3ccc(OCC(=O)O)cc3)[nH]c2n(CC=C)c1=O 10.1021/jm990421v
14788231 163226 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 305 5 1 6 1.3 CCCn1c(=O)c2nc(N3CCCC3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
CHEMBL417770 163226 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 305 5 1 6 1.3 CCCn1c(=O)c2nc(N3CCCC3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
176407 4148 None 56 Human Functional pKi = 6.1 6.1 - 2
Antagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assayAntagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assay
ChEMBL 337 5 3 9 1.7 Oc1ccc(cc1)CCNc1nc(N)n2c(n1)nc(n2)c1ccco1 10.1016/j.bmcl.2013.03.070
405 4148 None 56 Human Functional pKi = 6.1 6.1 - 2
Antagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assayAntagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assay
ChEMBL 337 5 3 9 1.7 Oc1ccc(cc1)CCNc1nc(N)n2c(n1)nc(n2)c1ccco1 10.1016/j.bmcl.2013.03.070
CHEMBL113142 4148 None 56 Human Functional pKi = 6.1 6.1 - 2
Antagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assayAntagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assay
ChEMBL 337 5 3 9 1.7 Oc1ccc(cc1)CCNc1nc(N)n2c(n1)nc(n2)c1ccco1 10.1016/j.bmcl.2013.03.070
DB08770 4148 None 56 Human Functional pKi = 6.1 6.1 - 2
Antagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assayAntagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assay
ChEMBL 337 5 3 9 1.7 Oc1ccc(cc1)CCNc1nc(N)n2c(n1)nc(n2)c1ccco1 10.1016/j.bmcl.2013.03.070
14788210 25243 None 0 Human Functional pKi = 8.1 8.1 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 389 7 2 6 2.1 CCCn1c(=O)c2nc([C@H]3CC[C@H](CNC(C)=O)CC3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
CHEMBL134837 25243 None 0 Human Functional pKi = 8.1 8.1 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 389 7 2 6 2.1 CCCn1c(=O)c2nc([C@H]3CC[C@H](CNC(C)=O)CC3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
14788223 194828 None 0 Human Functional pKi = 8.1 8.1 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 319 6 2 6 2.1 CCCn1c(=O)c2nc(NC3CCCC3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
CHEMBL53453 194828 None 0 Human Functional pKi = 8.1 8.1 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 319 6 2 6 2.1 CCCn1c(=O)c2nc(NC3CCCC3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
CHEMBL5073669 216789 None 0 Human Functional pKi = 8.1 8.1 - 0
Antagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of NECA-induced cAMP accumulation in presence of forskolin measured after 40 mins by alpha screen LANCE assayAntagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of NECA-induced cAMP accumulation in presence of forskolin measured after 40 mins by alpha screen LANCE assay
ChEMBL None None None CCCCn1c(=O)c2nc(C34CCC(C(=O)NCCCN=[N+]=[N-])(CC3)CC4)[nH]c2n(CCCNC(=O)c2ccc(S(=O)(=O)F)cc2)c1=O 10.1021/acs.jmedchem.0c02169
404 4098 None 26 Human Functional pKi = 8.1 8.1 - 2
Antagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assayAntagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assay
ChEMBL 428 10 3 8 0.8 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)NCCN 10.1016/j.bmcl.2013.03.070
432 4098 None 26 Human Functional pKi = 8.1 8.1 - 2
Antagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assayAntagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assay
ChEMBL 428 10 3 8 0.8 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)NCCN 10.1016/j.bmcl.2013.03.070
5697 4098 None 26 Human Functional pKi = 8.1 8.1 - 2
Antagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assayAntagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assay
ChEMBL 428 10 3 8 0.8 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)NCCN 10.1016/j.bmcl.2013.03.070
CHEMBL273094 4098 None 26 Human Functional pKi = 8.1 8.1 - 2
Antagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assayAntagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assay
ChEMBL 428 10 3 8 0.8 CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccc(cc1)OCC(=O)NCCN 10.1016/j.bmcl.2013.03.070
11449747 63312 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 310 4 2 6 2.5 Cc1cccc(-c2c(C#N)c(N)nc(SCCO)c2C#N)c1 10.1021/jm201706b
CHEMBL179300 63312 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 310 4 2 6 2.5 Cc1cccc(-c2c(C#N)c(N)nc(SCCO)c2C#N)c1 10.1021/jm201706b
71603089 89796 None 0 Human Functional pKi = 6.1 6.1 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 318 3 1 5 3.9 Nc1nc(-c2ccncc2)nc2sc(Cc3ccccc3)cc12 10.1016/j.bmcl.2013.02.078
CHEMBL2377102 89796 None 0 Human Functional pKi = 6.1 6.1 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 318 3 1 5 3.9 Nc1nc(-c2ccncc2)nc2sc(Cc3ccccc3)cc12 10.1016/j.bmcl.2013.02.078
14788226 163269 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 370 5 1 5 3.2 CCCn1c(=O)c2nc(C34CC5CC(CC(C5)C3)C4)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
CHEMBL418101 163269 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 370 5 1 5 3.2 CCCn1c(=O)c2nc(C34CC5CC(CC(C5)C3)C4)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
9868615 66194 None 0 Human Functional pKi = 6.1 6.1 - 0
Antagonist activity at human adenosine A1 receptorAntagonist activity at human adenosine A1 receptor
ChEMBL 455 6 1 10 1.9 CN(CCN1CCN(c2ccc(F)cc2F)CC1)c1nc(N)n2nc(-c3ccco3)nc2n1 10.1016/j.ejmech.2022.114378
CHEMBL184309 66194 None 0 Human Functional pKi = 6.1 6.1 - 0
Antagonist activity at human adenosine A1 receptorAntagonist activity at human adenosine A1 receptor
ChEMBL 455 6 1 10 1.9 CN(CCN1CCN(c2ccc(F)cc2F)CC1)c1nc(N)n2nc(-c3ccco3)nc2n1 10.1016/j.ejmech.2022.114378
46889231 7492 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 427 3 1 6 3.1 CC(C)N1CCN(C(=O)c2ccc3c(c2)-c2nc(N)nc(-c4ccccc4)c2C3=O)CC1 10.1016/j.bmcl.2010.03.024
CHEMBL1087086 7492 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 427 3 1 6 3.1 CC(C)N1CCN(C(=O)c2ccc3c(c2)-c2nc(N)nc(-c4ccccc4)c2C3=O)CC1 10.1016/j.bmcl.2010.03.024
4882 2099 None 54 Human Functional pKi = 6.1 6.1 -100 5
Antagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assayAntagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assay
ChEMBL 384 6 0 8 2.1 COc1cc(/C=C/c2nc3c(n2C)c(=O)n(c(=O)n3CC)CC)ccc1OC 10.1016/j.bmcl.2013.03.070
5311037 2099 None 54 Human Functional pKi = 6.1 6.1 -100 5
Antagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assayAntagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assay
ChEMBL 384 6 0 8 2.1 COc1cc(/C=C/c2nc3c(n2C)c(=O)n(c(=O)n3CC)CC)ccc1OC 10.1016/j.bmcl.2013.03.070
5311037.0 2099 None 54 Human Functional pKi = 6.1 6.1 -100 5
Antagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assayAntagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assay
ChEMBL 384 6 0 8 2.1 COc1cc(/C=C/c2nc3c(n2C)c(=O)n(c(=O)n3CC)CC)ccc1OC 10.1016/j.bmcl.2013.03.070
5608 2099 None 54 Human Functional pKi = 6.1 6.1 -100 5
Antagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assayAntagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assay
ChEMBL 384 6 0 8 2.1 COc1cc(/C=C/c2nc3c(n2C)c(=O)n(c(=O)n3CC)CC)ccc1OC 10.1016/j.bmcl.2013.03.070
CHEMBL431770 2099 None 54 Human Functional pKi = 6.1 6.1 -100 5
Antagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assayAntagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assay
ChEMBL 384 6 0 8 2.1 COc1cc(/C=C/c2nc3c(n2C)c(=O)n(c(=O)n3CC)CC)ccc1OC 10.1016/j.bmcl.2013.03.070
DB11757 2099 None 54 Human Functional pKi = 6.1 6.1 -100 5
Antagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assayAntagonist activity at human adenosine A1 receptor assessed as cAMP level by cell based assay
ChEMBL 384 6 0 8 2.1 COc1cc(/C=C/c2nc3c(n2C)c(=O)n(c(=O)n3CC)CC)ccc1OC 10.1016/j.bmcl.2013.03.070
14788213 100782 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 403 8 2 6 2.5 CCCNC(=O)C1CCC(c2nc3c(=O)n(CCC)c(=O)n(CCC)c3[nH]2)CC1 10.1021/jm00169a012
CHEMBL292661 100782 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 403 8 2 6 2.5 CCCNC(=O)C1CCC(c2nc3c(=O)n(CCC)c(=O)n(CCC)c3[nH]2)CC1 10.1021/jm00169a012
14788211 101135 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 446 9 1 7 2.0 CCCn1c(=O)c2nc(C3CCC(C(=O)N(C)CCN(C)C)CC3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
CHEMBL294869 101135 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 446 9 1 7 2.0 CCCn1c(=O)c2nc(C3CCC(C(=O)N(C)CCN(C)C)CC3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
46861770 7570 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 374 3 1 5 3.7 Nc1nc(-c2ccc(F)cc2)c2c(n1)-c1c(CN3CCCC3)cccc1C2=O 10.1016/j.bmcl.2010.03.042
CHEMBL1087710 7570 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 374 3 1 5 3.7 Nc1nc(-c2ccc(F)cc2)c2c(n1)-c1c(CN3CCCC3)cccc1C2=O 10.1016/j.bmcl.2010.03.042
46889071 7682 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 400 4 2 7 2.2 CN1CCN(NCc2ccc3c(c2)-c2nc(N)nc(-c4ccccc4)c2C3=O)CC1 10.1016/j.bmcl.2010.03.042
CHEMBL1088665 7682 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 400 4 2 7 2.2 CN1CCN(NCc2ccc3c(c2)-c2nc(N)nc(-c4ccccc4)c2C3=O)CC1 10.1016/j.bmcl.2010.03.042
45275824 89814 None 0 Human Functional pKi = 6.1 6.1 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 347 4 1 5 5.0 Nc1nc(-c2ccc(C3CC3)o2)nc2sc(Cc3ccccc3)cc12 10.1016/j.bmcl.2013.02.078
CHEMBL2377223 89814 None 0 Human Functional pKi = 6.1 6.1 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 347 4 1 5 5.0 Nc1nc(-c2ccc(C3CC3)o2)nc2sc(Cc3ccccc3)cc12 10.1016/j.bmcl.2013.02.078
CHEMBL5085088 217436 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 min followed by forskolin stimulation and further incubated for 30 mins in presence of NECA by alphascreen LANCE assayAntagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 min followed by forskolin stimulation and further incubated for 30 mins in presence of NECA by alphascreen LANCE assay
ChEMBL None None None CCCCn1c(=O)c2nc(C34CCC(C(=O)NCCCN=[N+]=[N-])(CC3)CC4)[nH]c2n(CCCNC(=O)c2ccc(S(=O)(=O)O)cc2)c1=O 10.1021/acs.jmedchem.0c02169
24810000 82135 None 13 Human Functional pKi = 8.1 8.1 - 0
Antagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP productionAntagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP production
ChEMBL 324 3 1 5 3.3 CC(C)n1cc(-c2ncc(N)nc2-c2ccc(F)cc2)ccc1=O 10.1021/jm201640m
CHEMBL2165804 82135 None 13 Human Functional pKi = 8.1 8.1 - 0
Antagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP productionAntagonist activity at human Adenosine receptor A1 assessed as inhibition of cAMP production
ChEMBL 324 3 1 5 3.3 CC(C)n1cc(-c2ncc(N)nc2-c2ccc(F)cc2)ccc1=O 10.1021/jm201640m
52934152 156657 None 0 Human Functional pKi = 8.0 8.0 - 0
Antagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assayAntagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assay
ChEMBL 346 5 2 6 2.5 CCCn1c(OC2CCC(O)C2)nc2nc(C3CCCC3)[nH]c2c1=O 10.1016/j.bmc.2017.02.029
CHEMBL4068469 156657 None 0 Human Functional pKi = 8.0 8.0 - 0
Antagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assayAntagonist activity at human adenosine A1 receptor expressed in HEK293 cells assessed as reduction in CPA-mediated inhibition of forskolin-stimulated cAMP level preincubated for 15 mins followed by CPA treatment for 15 mins and subsequent addition of forskolin measured after 30 mins by HTRF assay
ChEMBL 346 5 2 6 2.5 CCCn1c(OC2CCC(O)C2)nc2nc(C3CCCC3)[nH]c2c1=O 10.1016/j.bmc.2017.02.029
14788203 201553 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 333 5 2 6 1.7 CCCn1c(=O)c2nc(C3CCC(N)CC3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
CHEMBL58879 201553 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity against adenosine A1 receptor in human plateletsAntagonist activity against adenosine A1 receptor in human platelets
ChEMBL 333 5 2 6 1.7 CCCn1c(=O)c2nc(C3CCC(N)CC3)[nH]c2n(CCC)c1=O 10.1021/jm00169a012
45274324 89797 None 0 Human Functional pKi = 7.0 7.0 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 319 3 1 6 3.3 Nc1nc(-c2cnccn2)nc2sc(Cc3ccccc3)cc12 10.1016/j.bmcl.2013.02.078
CHEMBL2377103 89797 None 0 Human Functional pKi = 7.0 7.0 - 0
Antagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assayAntagonist activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as inhibition of R-PIA/forskolin-induced cAMP accumulation incubated for 15 mins prior to R-PIA/forskolin challenge measured after 5.5 to 6 hrs by beta-galactosidase reporter gene assay
ChEMBL 319 3 1 6 3.3 Nc1nc(-c2cnccn2)nc2sc(Cc3ccccc3)cc12 10.1016/j.bmcl.2013.02.078
CHEMBL5076572 216938 None 0 Human Functional pKi = 7.0 7.0 - 0
Antagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 min followed by forskolin stimulation and further incubated for 30 mins in presence of NECA by alphascreen LANCE assayAntagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 min followed by forskolin stimulation and further incubated for 30 mins in presence of NECA by alphascreen LANCE assay
ChEMBL None None None C#CCNC(=O)C12CCC(c3nc4c(=O)n(CCCC)c(=O)n(CCC)c4[nH]3)(CC1)CC2 10.1021/acs.jmedchem.0c02169
CHEMBL5074615 216809 None 0 Human Functional pKi = 7.0 7.0 - 0
Antagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 min followed by forskolin stimulation and further incubated for 30 mins in presence of NECA by alphascreen LANCE assayAntagonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cell membrane assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 10 min followed by forskolin stimulation and further incubated for 30 mins in presence of NECA by alphascreen LANCE assay
ChEMBL None None None CCCCn1c(=O)c2nc(C34CCC(C(=O)OC)(CC3)CC4)[nH]c2n(CCCNC(=O)c2ccc(S(=O)(=O)O)cc2)c1=O 10.1021/acs.jmedchem.0c02169
46888991 7567 None 0 Human Functional pKi = 7.0 7.0 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 385 3 1 6 2.7 CN1CCN(Cc2cccc3c2-c2nc(N)nc(-c4ccccc4)c2C3=O)CC1 10.1016/j.bmcl.2010.03.042
CHEMBL1087702 7567 None 0 Human Functional pKi = 7.0 7.0 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 385 3 1 6 2.7 CN1CCN(Cc2cccc3c2-c2nc(N)nc(-c4ccccc4)c2C3=O)CC1 10.1016/j.bmcl.2010.03.042
46889172 7645 None 0 Human Functional pKi = 7.0 7.0 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 429 7 1 6 3.4 CCN(CC)CCN(C)C(=O)c1ccc2c(c1)-c1nc(N)nc(-c3ccccc3)c1C2=O 10.1016/j.bmcl.2010.03.024
CHEMBL1088260 7645 None 0 Human Functional pKi = 7.0 7.0 - 0
Antagonistic activity at adenosine A1 receptorAntagonistic activity at adenosine A1 receptor
ChEMBL 429 7 1 6 3.4 CCN(CC)CCN(C)C(=O)c1ccc2c(c1)-c1nc(N)nc(-c3ccccc3)c1C2=O 10.1016/j.bmcl.2010.03.024
46889018 7588 None 0 Human Functional pKi = 7.0 7.0 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 384 3 1 5 4.3 Nc1nc(-c2ccccc2)c2c(n1)-c1c(CN3CCCCCC3)cccc1C2=O 10.1016/j.bmcl.2010.03.042
CHEMBL1087820 7588 None 0 Human Functional pKi = 7.0 7.0 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 384 3 1 5 4.3 Nc1nc(-c2ccccc2)c2c(n1)-c1c(CN3CCCCCC3)cccc1C2=O 10.1016/j.bmcl.2010.03.042
46889070 7639 None 0 Human Functional pKi = 7.0 7.0 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 403 4 2 6 3.6 Nc1nc(-c2ccc(F)cc2)c2c(n1)-c1cc(CNN3CCCCC3)ccc1C2=O 10.1016/j.bmcl.2010.03.042
CHEMBL1088237 7639 None 0 Human Functional pKi = 7.0 7.0 - 0
Antagonist activity at adenosine A1 receptorAntagonist activity at adenosine A1 receptor
ChEMBL 403 4 2 6 3.6 Nc1nc(-c2ccc(F)cc2)c2c(n1)-c1cc(CNN3CCCCC3)ccc1C2=O 10.1016/j.bmcl.2010.03.042
219024 3300 None 47 Human Functional pEC50 = 8.4 8.4 1 5
NoneNone
Drug Central 390 4 5 12 -2.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(nc2N)n1ncc(c1)C(=O)NC None
219024.0 3300 None 47 Human Functional pEC50 = 8.4 8.4 1 5
NoneNone
Drug Central 390 4 5 12 -2.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(nc2N)n1ncc(c1)C(=O)NC None
2362 3300 None 47 Human Functional pEC50 = 8.4 8.4 1 5
NoneNone
Drug Central 390 4 5 12 -2.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(nc2N)n1ncc(c1)C(=O)NC None
5596 3300 None 47 Human Functional pEC50 = 8.4 8.4 1 5
NoneNone
Drug Central 390 4 5 12 -2.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(nc2N)n1ncc(c1)C(=O)NC None
CHEMBL317052 3300 None 47 Human Functional pEC50 = 8.4 8.4 1 5
NoneNone
Drug Central 390 4 5 12 -2.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(nc2N)n1ncc(c1)C(=O)NC None
DB06213 3300 None 47 Human Functional pEC50 = 8.4 8.4 1 5
NoneNone
Drug Central 390 4 5 12 -2.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(nc2N)n1ncc(c1)C(=O)NC None
5480 202112 None 54 Human Functional pEC50 = 8.3 8.3 - 1
CHO-K1 cells stably expressing the human A1ARCHO-K1 cells stably expressing the human A1AR
Drug Central 316 4 1 5 3.1 CCOC(=O)c1c(N)sc2c1CCN(Cc1ccccc1)C2 None
CHEMBL592943 202112 None 54 Human Functional pEC50 = 8.3 8.3 - 1
CHO-K1 cells stably expressing the human A1ARCHO-K1 cells stably expressing the human A1AR
Drug Central 316 4 1 5 3.1 CCOC(=O)c1c(N)sc2c1CCN(Cc1ccccc1)C2 None
2844 283 None 61 Human Functional pEC50 = 8.2 8.2 1 5
NoneNone
Drug Central 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N None
60961 283 None 61 Human Functional pEC50 = 8.2 8.2 1 5
NoneNone
Drug Central 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N None
60961.0 283 None 61 Human Functional pEC50 = 8.2 8.2 1 5
NoneNone
Drug Central 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N None
90 283 None 61 Human Functional pEC50 = 8.2 8.2 1 5
NoneNone
Drug Central 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N None
CHEMBL477 283 None 61 Human Functional pEC50 = 8.2 8.2 1 5
NoneNone
Drug Central 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N None
DB00640 283 None 61 Human Functional pEC50 = 8.2 8.2 1 5
NoneNone
Drug Central 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N None
11221 791 None 45 Human Functional pEC50 = 10 10.0 - 1
UnclassifiedUnclassified
Guide to Pharmacology 519 8 2 9 5.5 OCCOc1ccc(cc1)c1c(C#N)c(SCc2csc(n2)c2ccc(cc2)Cl)nc(c1C#N)N 22081230
9936489 791 None 45 Human Functional pEC50 = 10 10.0 - 1
UnclassifiedUnclassified
Guide to Pharmacology 519 8 2 9 5.5 OCCOc1ccc(cc1)c1c(C#N)c(SCc2csc(n2)c2ccc(cc2)Cl)nc(c1C#N)N 22081230
CHEMBL3235279 791 None 45 Human Functional pEC50 = 10 10.0 - 1
UnclassifiedUnclassified
Guide to Pharmacology 519 8 2 9 5.5 OCCOc1ccc(cc1)c1c(C#N)c(SCc2csc(n2)c2ccc(cc2)Cl)nc(c1C#N)N 22081230
DB16118 791 None 45 Human Functional pEC50 = 10 10.0 - 1
UnclassifiedUnclassified
Guide to Pharmacology 519 8 2 9 5.5 OCCOc1ccc(cc1)c1c(C#N)c(SCc2csc(n2)c2ccc(cc2)Cl)nc(c1C#N)N 22081230
11222 2760 None 0 Human Functional pEC50 = 10 10.0 - 1
UnclassifiedUnclassified
Guide to Pharmacology 573 9 1 9 6.5 OCCOc1ccc(cc1)c1c(C#N)c(SCc2csc(n2)c2ccc(cc2)Cl)nc(c1C#N)N1CCCC1 28488817
46847262 2760 None 0 Human Functional pEC50 = 10 10.0 - 1
UnclassifiedUnclassified
Guide to Pharmacology 573 9 1 9 6.5 OCCOc1ccc(cc1)c1c(C#N)c(SCc2csc(n2)c2ccc(cc2)Cl)nc(c1C#N)N1CCCC1 28488817
9880 30949 None 40 Rat Functional pIC50 = 8.1 8.1 125 4
NoneNone
Drug Central 416 2 0 4 4.6 CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C None
CHEMBL139835 30949 None 40 Rat Functional pIC50 = 8.1 8.1 125 4
NoneNone
Drug Central 416 2 0 4 4.6 CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C None
11617054 2378 None 1 Human Functional pIC50 = 7.1 7.1 - 1
UnclassifiedUnclassified
Guide to Pharmacology 340 3 1 3 5.3 C1CCC(C1)c1[nH]c2c(n1)nc(nc2c1ccccc1)c1ccccc1 29486053
9813 2378 None 1 Human Functional pIC50 = 7.1 7.1 - 1
UnclassifiedUnclassified
Guide to Pharmacology 340 3 1 3 5.3 C1CCC(C1)c1[nH]c2c(n1)nc(nc2c1ccccc1)c1ccccc1 29486053
CHEMBL207824 2378 None 1 Human Functional pIC50 = 7.1 7.1 - 1
UnclassifiedUnclassified
Guide to Pharmacology 340 3 1 3 5.3 C1CCC(C1)c1[nH]c2c(n1)nc(nc2c1ccccc1)c1ccccc1 29486053




Ligands (move mouse cursor over ligand name to see structure) Receptor Activity Chemical information
Sel. page Common
name
GPCRdb
ID
Reference
ligand
Vendors

Species

Assay
Type
Activity
Type
Activity
Relation
Activity
Value
p-value
(-log)
Fold
selectivity
Tested
GPCRs
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

135400189 44589 None 42 Human Binding pAC50 = 6 6.0 - 0
Binding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation countingBinding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting
ChEMBL 488 8 1 8 2.1 CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12 10.1038/s41467-023-40064-9
CHEMBL1520 44589 None 42 Human Binding pAC50 = 6 6.0 - 0
Binding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation countingBinding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting
ChEMBL 488 8 1 8 2.1 CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12 10.1038/s41467-023-40064-9
4004 14426 None 33 Human Binding pAC50 = 4.9 4.9 - 1
Binding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation countingBinding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting
ChEMBL 330 9 0 8 2.1 CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC 10.1038/s41467-023-40064-9
CHEMBL1200468 14426 None 33 Human Binding pAC50 = 4.9 4.9 - 1
Binding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation countingBinding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting
ChEMBL 330 9 0 8 2.1 CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC 10.1038/s41467-023-40064-9
4485 69401 None 70 Human Binding pAC50 = 4.9 4.9 -3 8
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 346 4 1 7 2.2 COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-] 10.1038/s41467-023-40064-9
CHEMBL193 69401 None 70 Human Binding pAC50 = 4.9 4.9 -3 8
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 346 4 1 7 2.2 COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-] 10.1038/s41467-023-40064-9
23725625 192739 None 72 Human Binding pAC50 = 4.9 4.9 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 434 4 1 4 2.3 O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1 10.1038/s41467-023-40064-9
CHEMBL521686 192739 None 72 Human Binding pAC50 = 4.9 4.9 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 434 4 1 4 2.3 O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1 10.1038/s41467-023-40064-9
89683805 154523 None 55 Human Binding pAC50 = 5.9 5.9 - 0
Binding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation countingBinding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting
ChEMBL 473 6 3 8 4.3 CC(C)(O)CNc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1 10.1038/s41467-023-40064-9
CHEMBL3989908 154523 None 55 Human Binding pAC50 = 5.9 5.9 - 0
Binding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation countingBinding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting
ChEMBL 473 6 3 8 4.3 CC(C)(O)CNc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1 10.1038/s41467-023-40064-9
4756 16656 None 34 Human Binding pAC50 = 4.9 4.9 - 0
Binding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation countingBinding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting
ChEMBL 213 2 2 5 2.7 Nc1ccc(/N=N/c2ccccc2)c(N)n1 10.1038/s41467-023-40064-9
CHEMBL1201022 16656 None 34 Human Binding pAC50 = 4.9 4.9 - 0
Binding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation countingBinding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting
ChEMBL 213 2 2 5 2.7 Nc1ccc(/N=N/c2ccccc2)c(N)n1 10.1038/s41467-023-40064-9
CHEMBL1242 16656 None 34 Human Binding pAC50 = 4.9 4.9 - 0
Binding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation countingBinding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting
ChEMBL 213 2 2 5 2.7 Nc1ccc(/N=N/c2ccccc2)c(N)n1 10.1038/s41467-023-40064-9
11980903 14498 None 13 Human Binding pAC50 = 4.9 4.9 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 382 4 0 2 5.3 Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1 10.1038/s41467-023-40064-9
22526 14498 None 13 Human Binding pAC50 = 4.9 4.9 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 382 4 0 2 5.3 Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1 10.1038/s41467-023-40064-9
5281035 14498 None 13 Human Binding pAC50 = 4.9 4.9 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 382 4 0 2 5.3 Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1201303 14498 None 13 Human Binding pAC50 = 4.9 4.9 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 382 4 0 2 5.3 Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1 10.1038/s41467-023-40064-9
54897 196925 None 42 Human Binding pAC50 = 4.8 4.8 - 0
Binding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation countingBinding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting
ChEMBL 403 7 0 3 5.5 CCCN(CCC)C(=O)Cc1c(-c2ccc(Cl)cc2)nc2ccc(Cl)cn12 10.1038/s41467-023-40064-9
CHEMBL54349 196925 None 42 Human Binding pAC50 = 4.8 4.8 - 0
Binding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation countingBinding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting
ChEMBL 403 7 0 3 5.5 CCCN(CCC)C(=O)Cc1c(-c2ccc(Cl)cc2)nc2ccc(Cl)cn12 10.1038/s41467-023-40064-9
4046 2483 None 21 Human Binding pAC50 = 5.8 5.8 -6 2
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
4252 2483 None 21 Human Binding pAC50 = 5.8 5.8 -6 2
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
CHEMBL416956 2483 None 21 Human Binding pAC50 = 5.8 5.8 -6 2
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
DB00358 2483 None 21 Human Binding pAC50 = 5.8 5.8 -6 2
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
1549120 198942 None 55 Human Binding pAC50 = 4.8 4.8 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 319 4 1 4 2.9 CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL56337 198942 None 55 Human Binding pAC50 = 4.8 4.8 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 319 4 1 4 2.9 CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1 10.1038/s41467-023-40064-9
3561 19084 None 29 Human Binding pAC50 = 4.8 4.8 - 11
Binding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation countingBinding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting
ChEMBL 360 2 0 1 4.4 Clc1cc(Cl)c(OCC#CI)cc1Cl 10.1038/s41467-023-40064-9
CHEMBL1289 19084 None 29 Human Binding pAC50 = 4.8 4.8 - 11
Binding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation countingBinding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting
ChEMBL 360 2 0 1 4.4 Clc1cc(Cl)c(OCC#CI)cc1Cl 10.1038/s41467-023-40064-9
4659569 22338 None 65 Human Binding pAC50 = 4.8 4.8 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 273 3 2 5 2.5 Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1 10.1038/s41467-023-40064-9
CHEMBL1324 22338 None 65 Human Binding pAC50 = 4.8 4.8 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 273 3 2 5 2.5 Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1 10.1038/s41467-023-40064-9
3883 183641 None 69 Human Binding pAC50 = 4.8 4.8 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 369 5 1 4 3.5 Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c1nc2ccccc2[nH]1 10.1038/s41467-023-40064-9
CHEMBL480 183641 None 69 Human Binding pAC50 = 4.8 4.8 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 369 5 1 4 3.5 Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c1nc2ccccc2[nH]1 10.1038/s41467-023-40064-9
3007 155775 None 17 Human Binding pAC50 = 4.8 4.8 - 6
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 135 2 1 1 1.6 CC(N)Cc1ccccc1 10.1038/s41467-023-40064-9
3007.0 155775 None 17 Human Binding pAC50 = 4.8 4.8 - 6
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 135 2 1 1 1.6 CC(N)Cc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL405 155775 None 17 Human Binding pAC50 = 4.8 4.8 - 6
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 135 2 1 1 1.6 CC(N)Cc1ccccc1 10.1038/s41467-023-40064-9
DB00182 155775 None 17 Human Binding pAC50 = 4.8 4.8 - 6
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 135 2 1 1 1.6 CC(N)Cc1ccccc1 10.1038/s41467-023-40064-9
6237 86838 None 41 Human Binding pAC50 = 4.7 4.7 - 0
Binding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation countingBinding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting
ChEMBL 518 3 1 3 5.1 CCc1oc2ccccc2c1C(=O)c1cc(I)c(O)c(I)c1 10.1038/s41467-023-40064-9
CHEMBL232201 86838 None 41 Human Binding pAC50 = 4.7 4.7 - 0
Binding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation countingBinding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting
ChEMBL 518 3 1 3 5.1 CCc1oc2ccccc2c1C(=O)c1cc(I)c(O)c(I)c1 10.1038/s41467-023-40064-9
135398735 137055 None 20 Human Binding pAC50 = 4.7 4.7 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 822 4 6 15 4.3 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
136262914 137055 None 20 Human Binding pAC50 = 4.7 4.7 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 822 4 6 15 4.3 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
CHEMBL374478 137055 None 20 Human Binding pAC50 = 4.7 4.7 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 822 4 6 15 4.3 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
4046 2483 None 21 Human Binding pAC50 = 5.7 5.7 -6 2
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
4252 2483 None 21 Human Binding pAC50 = 5.7 5.7 -6 2
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
CHEMBL416956 2483 None 21 Human Binding pAC50 = 5.7 5.7 -6 2
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
DB00358 2483 None 21 Human Binding pAC50 = 5.7 5.7 -6 2
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
3671 70369 None 66 Human Binding pAC50 = 4.7 4.7 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 230 3 0 3 3.3 CC(C)C(=O)c1c(C(C)C)nn2ccccc12 10.1038/s41467-023-40064-9
CHEMBL19449 70369 None 66 Human Binding pAC50 = 4.7 4.7 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 230 3 0 3 3.3 CC(C)C(=O)c1c(C(C)C)nn2ccccc12 10.1038/s41467-023-40064-9
4499 59795 None 61 Human Binding pAC50 = 4.7 4.7 - 2
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 388 6 1 7 3.2 COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-] 10.1038/s41467-023-40064-9
CHEMBL1726 59795 None 61 Human Binding pAC50 = 4.7 4.7 - 2
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 388 6 1 7 3.2 COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-] 10.1038/s41467-023-40064-9
2237 3162 None 53 Human Binding pAC50 = 4.7 4.7 - 3
Binding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation countingBinding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting
ChEMBL 481 9 2 7 4.6 O=C(c1ccc(cc1)OCCCCc1ccccc1)Nc1cccc2c1oc(cc2=O)c1[nH]nnn1 10.1038/s41467-023-40064-9
3634 3162 None 53 Human Binding pAC50 = 4.7 4.7 - 3
Binding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation countingBinding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting
ChEMBL 481 9 2 7 4.6 O=C(c1ccc(cc1)OCCCCc1ccccc1)Nc1cccc2c1oc(cc2=O)c1[nH]nnn1 10.1038/s41467-023-40064-9
4887 3162 None 53 Human Binding pAC50 = 4.7 4.7 - 3
Binding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation countingBinding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting
ChEMBL 481 9 2 7 4.6 O=C(c1ccc(cc1)OCCCCc1ccccc1)Nc1cccc2c1oc(cc2=O)c1[nH]nnn1 10.1038/s41467-023-40064-9
4887.0 3162 None 53 Human Binding pAC50 = 4.7 4.7 - 3
Binding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation countingBinding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting
ChEMBL 481 9 2 7 4.6 O=C(c1ccc(cc1)OCCCCc1ccccc1)Nc1cccc2c1oc(cc2=O)c1[nH]nnn1 10.1038/s41467-023-40064-9
CHEMBL21333 3162 None 53 Human Binding pAC50 = 4.7 4.7 - 3
Binding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation countingBinding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting
ChEMBL 481 9 2 7 4.6 O=C(c1ccc(cc1)OCCCCc1ccccc1)Nc1cccc2c1oc(cc2=O)c1[nH]nnn1 10.1038/s41467-023-40064-9
DB01411 3162 None 53 Human Binding pAC50 = 4.7 4.7 - 3
Binding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation countingBinding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting
ChEMBL 481 9 2 7 4.6 O=C(c1ccc(cc1)OCCCCc1ccccc1)Nc1cccc2c1oc(cc2=O)c1[nH]nnn1 10.1038/s41467-023-40064-9
135564886 14499 None 5 Human Binding pAC50 = 4.7 4.7 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
135673376 14499 None 5 Human Binding pAC50 = 4.7 4.7 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
137157436 14499 None 5 Human Binding pAC50 = 4.7 4.7 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
145948239 14499 None 5 Human Binding pAC50 = 4.7 4.7 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
71587099 14499 None 5 Human Binding pAC50 = 4.7 4.7 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
CHEMBL1201304 14499 None 5 Human Binding pAC50 = 4.7 4.7 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
5029 15552 None 54 Human Binding pAC50 = 4.7 4.7 - 4
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 359 8 1 5 3.0 COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C 10.1038/s41467-023-40064-9
CHEMBL1219 15552 None 54 Human Binding pAC50 = 4.7 4.7 - 4
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 359 8 1 5 3.0 COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C 10.1038/s41467-023-40064-9
193962 103848 None 63 Human Binding pAC50 = 4.7 4.7 - 0
Binding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation countingBinding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting
ChEMBL 434 4 2 7 4.7 Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br 10.1038/s41467-023-40064-9
CHEMBL308954 103848 None 63 Human Binding pAC50 = 4.7 4.7 - 0
Binding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation countingBinding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting
ChEMBL 434 4 2 7 4.7 Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br 10.1038/s41467-023-40064-9
119182 60427 None 59 Human Binding pAC50 = 5.6 5.6 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 303 2 3 8 -0.3 Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F 10.1038/s41467-023-40064-9
CHEMBL1750 60427 None 59 Human Binding pAC50 = 5.6 5.6 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 303 2 3 8 -0.3 Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F 10.1038/s41467-023-40064-9
4882 2099 None 54 Human Binding pAC50 = 4.6 4.6 -144 6
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 384 6 0 8 2.1 COc1cc(/C=C/c2nc3c(n2C)c(=O)n(c(=O)n3CC)CC)ccc1OC 10.1038/s41467-023-40064-9
5311037 2099 None 54 Human Binding pAC50 = 4.6 4.6 -144 6
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 384 6 0 8 2.1 COc1cc(/C=C/c2nc3c(n2C)c(=O)n(c(=O)n3CC)CC)ccc1OC 10.1038/s41467-023-40064-9
5311037.0 2099 None 54 Human Binding pAC50 = 4.6 4.6 -144 6
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 384 6 0 8 2.1 COc1cc(/C=C/c2nc3c(n2C)c(=O)n(c(=O)n3CC)CC)ccc1OC 10.1038/s41467-023-40064-9
5608 2099 None 54 Human Binding pAC50 = 4.6 4.6 -144 6
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 384 6 0 8 2.1 COc1cc(/C=C/c2nc3c(n2C)c(=O)n(c(=O)n3CC)CC)ccc1OC 10.1038/s41467-023-40064-9
CHEMBL431770 2099 None 54 Human Binding pAC50 = 4.6 4.6 -144 6
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 384 6 0 8 2.1 COc1cc(/C=C/c2nc3c(n2C)c(=O)n(c(=O)n3CC)CC)ccc1OC 10.1038/s41467-023-40064-9
DB11757 2099 None 54 Human Binding pAC50 = 4.6 4.6 -144 6
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 384 6 0 8 2.1 COc1cc(/C=C/c2nc3c(n2C)c(=O)n(c(=O)n3CC)CC)ccc1OC 10.1038/s41467-023-40064-9
60726 5588 None 49 Human Binding pAC50 = 4.6 4.6 - 0
Binding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation countingBinding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting
ChEMBL 333 4 2 3 2.9 Nc1c(CC(=O)O)cccc1C(=O)c1ccc(Br)cc1 10.1038/s41467-023-40064-9
CHEMBL1077 5588 None 49 Human Binding pAC50 = 4.6 4.6 - 0
Binding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation countingBinding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting
ChEMBL 333 4 2 3 2.9 Nc1c(CC(=O)O)cccc1C(=O)c1ccc(Br)cc1 10.1038/s41467-023-40064-9
CHEMBL2103737 78169 None 0 Human Binding pAC50 = 4.6 4.6 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL None None None None 10.1038/s41467-023-40064-9
26248 161633 None 72 Human Binding pAC50 = 4.6 4.6 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 368 3 1 7 2.0 CC(=O)Oc1cccc2c1C(=O)c1c(OC(C)=O)cc(C(=O)O)cc1C2=O 10.1038/s41467-023-40064-9
CHEMBL41286 161633 None 72 Human Binding pAC50 = 4.6 4.6 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 368 3 1 7 2.0 CC(=O)Oc1cccc2c1C(=O)c1c(OC(C)=O)cc(C(=O)O)cc1C2=O 10.1038/s41467-023-40064-9
54671203 35019 None 41 Human Binding pAC50 = 4.6 4.6 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 444 2 6 9 -0.3 C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21 10.1038/s41467-023-40064-9
CHEMBL1433 35019 None 41 Human Binding pAC50 = 4.6 4.6 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 444 2 6 9 -0.3 C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21 10.1038/s41467-023-40064-9
6914273 14494 None 30 Human Binding pAC50 = 4.6 4.6 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 314 4 1 6 1.7 O=C1CN(/N=C/c2ccc(-c3ccc([N+](=O)[O-])cc3)o2)C(=O)N1 10.1038/s41467-023-40064-9
CHEMBL1201288 14494 None 30 Human Binding pAC50 = 4.6 4.6 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 314 4 1 6 1.7 O=C1CN(/N=C/c2ccc(-c3ccc([N+](=O)[O-])cc3)o2)C(=O)N1 10.1038/s41467-023-40064-9
4495 198991 None 63 Human Binding pAC50 = 4.6 4.6 - 30
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 308 5 1 5 2.8 CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL56367 198991 None 63 Human Binding pAC50 = 4.6 4.6 - 30
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 308 5 1 5 2.8 CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1 10.1038/s41467-023-40064-9
41946 46184 None 16 Human Binding pAC50 = 4.6 4.6 - 0
Binding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation countingBinding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting
ChEMBL 276 3 2 5 1.2 CCOC(=O)c1c(C)cc2c(CO)n[nH]c(=O)c2c1C 10.1038/s41467-023-40064-9
CHEMBL153427 46184 None 16 Human Binding pAC50 = 4.6 4.6 - 0
Binding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation countingBinding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting
ChEMBL 276 3 2 5 1.2 CCOC(=O)c1c(C)cc2c(CO)n[nH]c(=O)c2c1C 10.1038/s41467-023-40064-9
119607 208661 None 64 Human Binding pAC50 = 4.6 4.6 - 28
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 314 3 1 4 3.0 Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1 10.1038/s41467-023-40064-9
CHEMBL865 208661 None 64 Human Binding pAC50 = 4.6 4.6 - 28
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 314 3 1 4 3.0 Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1 10.1038/s41467-023-40064-9
25151352 140693 None 56 Human Binding pAC50 = 4.6 4.6 - 0
Binding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation countingBinding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting
ChEMBL 417 5 2 4 5.2 FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1 10.1038/s41467-023-40064-9
CHEMBL3813873 140693 None 56 Human Binding pAC50 = 4.6 4.6 - 0
Binding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation countingBinding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting
ChEMBL 417 5 2 4 5.2 FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1 10.1038/s41467-023-40064-9
71743 78296 None 47 Human Binding pAC50 = 4.5 4.5 - 0
Binding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation countingBinding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting
ChEMBL 353 3 0 4 3.6 O=C(Oc1ccc2c(c1)CCCN2C(=O)C(Cl)Cl)c1ccco1 10.1038/s41467-023-40064-9
CHEMBL2107014 78296 None 47 Human Binding pAC50 = 4.5 4.5 - 0
Binding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation countingBinding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting
ChEMBL 353 3 0 4 3.6 O=C(Oc1ccc2c(c1)CCCN2C(=O)C(Cl)Cl)c1ccco1 10.1038/s41467-023-40064-9
5920 47289 None 62 Human Binding pAC50 = 5.5 5.5 - 1
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 651 5 3 4 4.0 N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O 10.1038/s41467-023-40064-9
7048703 47289 None 62 Human Binding pAC50 = 5.5 5.5 - 1
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 651 5 3 4 4.0 N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O 10.1038/s41467-023-40064-9
CHEMBL1544 47289 None 62 Human Binding pAC50 = 5.5 5.5 - 1
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 651 5 3 4 4.0 N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O 10.1038/s41467-023-40064-9
443955 206828 None 60 Human Binding pAC50 = 4.5 4.5 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 350 3 0 4 4.1 CCOC(=O)C1=C[C@]2(CC)CCCN3CCc4c(n1c1ccccc41)[C@@H]32 10.1038/s41467-023-40064-9
CHEMBL71752 206828 None 60 Human Binding pAC50 = 4.5 4.5 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 350 3 0 4 4.1 CCOC(=O)C1=C[C@]2(CC)CCCN3CCc4c(n1c1ccccc41)[C@@H]32 10.1038/s41467-023-40064-9
4463 199955 None 72 Human Binding pAC50 = 4.5 4.5 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 266 1 1 4 2.7 Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1 10.1038/s41467-023-40064-9
CHEMBL57 199955 None 72 Human Binding pAC50 = 4.5 4.5 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 266 1 1 4 2.7 Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1 10.1038/s41467-023-40064-9
439693 51199 None 39 Human Binding pAC50 = 6.4 6.4 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 268 2 4 8 -1.2 OC[C@H]1O[C@@H](n2cnc3c2N=CNC[C@H]3O)C[C@@H]1O 10.1038/s41467-023-40064-9
CHEMBL1580 51199 None 39 Human Binding pAC50 = 6.4 6.4 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 268 2 4 8 -1.2 OC[C@H]1O[C@@H](n2cnc3c2N=CNC[C@H]3O)C[C@@H]1O 10.1038/s41467-023-40064-9
4046 2483 None 21 Human Binding pAC50 = 5.3 5.3 -6 2
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
4252 2483 None 21 Human Binding pAC50 = 5.3 5.3 -6 2
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
CHEMBL416956 2483 None 21 Human Binding pAC50 = 5.3 5.3 -6 2
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
DB00358 2483 None 21 Human Binding pAC50 = 5.3 5.3 -6 2
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
2194 63103 None 64 Human Binding pAC50 = 5.2 5.2 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 240 2 0 4 4.2 COc1ccc(-c2cc(=S)ss2)cc1 10.1038/s41467-023-40064-9
CHEMBL178862 63103 None 64 Human Binding pAC50 = 5.2 5.2 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 240 2 0 4 4.2 COc1ccc(-c2cc(=S)ss2)cc1 10.1038/s41467-023-40064-9
5329102 194838 None 50 Human Binding pAC50 = 5.2 5.2 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 398 7 3 3 3.3 CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C 10.1038/s41467-023-40064-9
CHEMBL535 194838 None 50 Human Binding pAC50 = 5.2 5.2 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 398 7 3 3 3.3 CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C 10.1038/s41467-023-40064-9
4485 69401 None 70 Human Binding pAC50 = 5.2 5.2 -3 8
Binding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation countingBinding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting
ChEMBL 346 4 1 7 2.2 COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-] 10.1038/s41467-023-40064-9
CHEMBL193 69401 None 70 Human Binding pAC50 = 5.2 5.2 -3 8
Binding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation countingBinding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting
ChEMBL 346 4 1 7 2.2 COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-] 10.1038/s41467-023-40064-9
135398744 68684 None 51 Human Binding pAC50 = 5.2 5.2 -1 3
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 474 7 1 8 1.6 CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12 10.1038/s41467-023-40064-9
CHEMBL192 68684 None 51 Human Binding pAC50 = 5.2 5.2 -1 3
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 474 7 1 8 1.6 CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12 10.1038/s41467-023-40064-9
41684 31229 None 62 Human Binding pAC50 = 5.2 5.2 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 307 4 1 7 2.2 CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1 10.1038/s41467-023-40064-9
CHEMBL1401 31229 None 62 Human Binding pAC50 = 5.2 5.2 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 307 4 1 7 2.2 CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1 10.1038/s41467-023-40064-9
16722836 18992 None 63 Human Binding pAC50 = 5.1 5.1 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 524 10 3 8 4.8 Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1 10.1038/s41467-023-40064-9
CHEMBL1287853 18992 None 63 Human Binding pAC50 = 5.1 5.1 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 524 10 3 8 4.8 Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1 10.1038/s41467-023-40064-9
6436173 55132 None 30 Human Binding pAC50 = 5.1 5.1 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 785 2 5 13 6.2 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
CHEMBL1617 55132 None 30 Human Binding pAC50 = 5.1 5.1 - 0
Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 785 2 5 13 6.2 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
377 2758 None 42 Human Binding pEC50 = 9.3 9.3 -91 15
Irreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 minsIrreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 mins
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.6b01561
425 2758 None 42 Human Binding pEC50 = 9.3 9.3 -91 15
Irreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 minsIrreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 mins
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.6b01561
448222 2758 None 42 Human Binding pEC50 = 9.3 9.3 -91 15
Irreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 minsIrreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 mins
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.6b01561
CHEMBL464859 2758 None 42 Human Binding pEC50 = 9.3 9.3 -91 15
Irreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 minsIrreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 mins
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.6b01561
132991435 180904 None 0 Human Binding pEC50 = 9 9.0 - 0
Irreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 minsIrreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 mins
ChEMBL 558 8 5 12 0.8 O=C(NCc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1)c1ccc(S(=O)(=O)F)cc1 10.1021/acs.jmedchem.6b01561
CHEMBL4756472 180904 None 0 Human Binding pEC50 = 9 9.0 - 0
Irreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 minsIrreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 mins
ChEMBL 558 8 5 12 0.8 O=C(NCc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1)c1ccc(S(=O)(=O)F)cc1 10.1021/acs.jmedchem.6b01561
132991434 180064 None 0 Human Binding pEC50 = 8.8 8.8 - 0
Irreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 minsIrreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 mins
ChEMBL 564 8 6 12 2.4 OC[C@H]1O[C@@H](n2cnc3c(Nc4ccc(CNC(=S)Nc5ccc(N=C=S)cc5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.6b01561
CHEMBL4746617 180064 None 0 Human Binding pEC50 = 8.8 8.8 - 0
Irreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 minsIrreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 mins
ChEMBL 564 8 6 12 2.4 OC[C@H]1O[C@@H](n2cnc3c(Nc4ccc(CNC(=S)Nc5ccc(N=C=S)cc5)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.6b01561
162656900 180967 None 0 Human Binding pEC50 = 8.8 8.8 - 0
Irreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 minsIrreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 mins
ChEMBL 504 7 5 10 1.3 O=C(NCc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1)C1=CC2C=CC1CC2 10.1021/acs.jmedchem.6b01561
CHEMBL4757317 180967 None 0 Human Binding pEC50 = 8.8 8.8 - 0
Irreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 minsIrreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 mins
ChEMBL 504 7 5 10 1.3 O=C(NCc1ccc(Nc2ncnc3c2ncn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1)C1=CC2C=CC1CC2 10.1021/acs.jmedchem.6b01561
690622 11211 None 23 Human Binding pEC50 = 8.7 8.7 - 0
AE maximal score at Adenosine A1 receptorAE maximal score at Adenosine A1 receptor
ChEMBL 232 1 1 4 2.5 COc1ccc2c(c1)CCc1sc(N)nc1-2 10.1016/s0960-894x(02)00236-6
CHEMBL1178726 11211 None 23 Human Binding pEC50 = 8.7 8.7 - 0
AE maximal score at Adenosine A1 receptorAE maximal score at Adenosine A1 receptor
ChEMBL 232 1 1 4 2.5 COc1ccc2c(c1)CCc1sc(N)nc1-2 10.1016/s0960-894x(02)00236-6
CHEMBL38779 11211 None 23 Human Binding pEC50 = 8.7 8.7 - 0
AE maximal score at Adenosine A1 receptorAE maximal score at Adenosine A1 receptor
ChEMBL 232 1 1 4 2.5 COc1ccc2c(c1)CCc1sc(N)nc1-2 10.1016/s0960-894x(02)00236-6
377 2758 None 42 Human Binding pEC50 = 6 6.0 -91 15
Agonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assayAgonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.5b01402
425 2758 None 42 Human Binding pEC50 = 6 6.0 -91 15
Agonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assayAgonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.5b01402
448222 2758 None 42 Human Binding pEC50 = 6 6.0 -91 15
Agonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assayAgonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.5b01402
CHEMBL464859 2758 None 42 Human Binding pEC50 = 6 6.0 -91 15
Agonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assayAgonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.5b01402
127025959 138366 None 0 Human Binding pEC50 = 6 6.0 - 0
Agonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assayAgonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assay
ChEMBL 482 8 4 10 1.1 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4OCc4ccccc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.5b01402
CHEMBL3770679 138366 None 0 Human Binding pEC50 = 6 6.0 - 0
Agonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assayAgonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assay
ChEMBL 482 8 4 10 1.1 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4OCc4ccccc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.5b01402
127026252 138273 None 0 Human Binding pEC50 = 4 4.0 - 0
Agonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assayAgonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assay
ChEMBL 458 5 5 10 0.1 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NC45CC6CC(CC(O)(C6)C4)C5)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.5b01402
CHEMBL3769641 138273 None 0 Human Binding pEC50 = 4 4.0 - 0
Agonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assayAgonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assay
ChEMBL 458 5 5 10 0.1 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NC45CC6CC(CC(O)(C6)C4)C5)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.5b01402
135976467 204659 None 0 Human Binding pEC50 = 4 4.0 - 1
Binding against Human Adenosine A1 receptorBinding against Human Adenosine A1 receptor
ChEMBL 384 3 4 10 -0.7 NC1=Nc2c(ncn2C2O[C@@H](CO)[C@H](O)[C@@H]2O)C2=N[C@H](c3ccccc3)CN12 10.1016/s0960-894x(98)00102-4
CHEMBL609645 204659 None 0 Human Binding pEC50 = 4 4.0 - 1
Binding against Human Adenosine A1 receptorBinding against Human Adenosine A1 receptor
ChEMBL 384 3 4 10 -0.7 NC1=Nc2c(ncn2C2O[C@@H](CO)[C@H](O)[C@@H]2O)C2=N[C@H](c3ccccc3)CN12 10.1016/s0960-894x(98)00102-4
46203193 8004 None 0 Human Binding pEC50 = 7.0 7.0 - 1
Displacement of [3H]CCPA from human adenosine A1 receptor expressed in CHO cells by scintillation countingDisplacement of [3H]CCPA from human adenosine A1 receptor expressed in CHO cells by scintillation counting
ChEMBL 753 13 5 14 5.0 Nc1sc2c(c1C(=O)c1ccc(Cl)c(Cl)c1)CCN(CCCCCOc1ccc(Nc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc1)C2 10.1021/jm901252a
CHEMBL1090683 8004 None 0 Human Binding pEC50 = 7.0 7.0 - 1
Displacement of [3H]CCPA from human adenosine A1 receptor expressed in CHO cells by scintillation countingDisplacement of [3H]CCPA from human adenosine A1 receptor expressed in CHO cells by scintillation counting
ChEMBL 753 13 5 14 5.0 Nc1sc2c(c1C(=O)c1ccc(Cl)c(Cl)c1)CCN(CCCCCOc1ccc(Nc3ncnc4c3ncn4[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc1)C2 10.1021/jm901252a
5480 202112 None 54 Human Binding pEC50 = 5.0 5.0 - 0
Allosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assayAllosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assay
ChEMBL 316 4 1 5 3.1 CCOC(=O)c1c(N)sc2c1CCN(Cc1ccccc1)C2 10.1016/j.bmc.2009.08.024
CHEMBL592943 202112 None 54 Human Binding pEC50 = 5.0 5.0 - 0
Allosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assayAllosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assay
ChEMBL 316 4 1 5 3.1 CCOC(=O)c1c(N)sc2c1CCN(Cc1ccccc1)C2 10.1016/j.bmc.2009.08.024
12426504 163671 None 0 Rat Binding pEC50 = 5.0 5.0 - 0
Enhanced 0.5 nM [3H]CCPA dissociation from adenosine A1 receptor of rat brain cortex membranes compared to 100 uM CPAEnhanced 0.5 nM [3H]CCPA dissociation from adenosine A1 receptor of rat brain cortex membranes compared to 100 uM CPA
ChEMBL 291 2 1 3 4.1 Nc1sc2c(c1C(=O)c1cccc(Cl)c1)CCCC2 10.1021/jm991051d
CHEMBL420323 163671 None 0 Rat Binding pEC50 = 5.0 5.0 - 0
Enhanced 0.5 nM [3H]CCPA dissociation from adenosine A1 receptor of rat brain cortex membranes compared to 100 uM CPAEnhanced 0.5 nM [3H]CCPA dissociation from adenosine A1 receptor of rat brain cortex membranes compared to 100 uM CPA
ChEMBL 291 2 1 3 4.1 Nc1sc2c(c1C(=O)c1cccc(Cl)c1)CCCC2 10.1021/jm991051d
46876595 204946 None 0 Guinea pig Binding pEC50 = 5.0 5.0 - 0
In vitro prolonging of the stimulus-QRS interval in guinea pig heart.In vitro prolonging of the stimulus-QRS interval in guinea pig heart.
ChEMBL 379 7 5 11 -0.1 CCC(/C=N/Nc1nc(N)c2ncn(C3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1)CC 10.1021/jm00102a007
CHEMBL611314 204946 None 0 Guinea pig Binding pEC50 = 5.0 5.0 - 0
In vitro prolonging of the stimulus-QRS interval in guinea pig heart.In vitro prolonging of the stimulus-QRS interval in guinea pig heart.
ChEMBL 379 7 5 11 -0.1 CCC(/C=N/Nc1nc(N)c2ncn(C3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1)CC 10.1021/jm00102a007
700447 188738 None 2 Human Binding pEC50 = 5.0 5.0 - 0
Modulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociationModulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociation
ChEMBL 237 2 1 4 3.2 Cc1sc(N)c(C(=O)c2cccs2)c1C 10.1021/jm800557d
CHEMBL503024 188738 None 2 Human Binding pEC50 = 5.0 5.0 - 0
Modulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociationModulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociation
ChEMBL 237 2 1 4 3.2 Cc1sc(N)c(C(=O)c2cccs2)c1C 10.1021/jm800557d
2814020 102301 None 2 Rat Binding pEC50 = 5.0 5.0 - 0
Enhanced 0.5 nM [3H]CCPA dissociation from adenosine A1 receptor of rat brain cortex membranes compared to 100 uM CPAEnhanced 0.5 nM [3H]CCPA dissociation from adenosine A1 receptor of rat brain cortex membranes compared to 100 uM CPA
ChEMBL 382 4 1 4 4.8 Nc1sc2c(c1C(=O)c1ccc(Cl)cc1)CCN(Cc1ccccc1)C2 10.1021/jm991051d
CHEMBL303124 102301 None 2 Rat Binding pEC50 = 5.0 5.0 - 0
Enhanced 0.5 nM [3H]CCPA dissociation from adenosine A1 receptor of rat brain cortex membranes compared to 100 uM CPAEnhanced 0.5 nM [3H]CCPA dissociation from adenosine A1 receptor of rat brain cortex membranes compared to 100 uM CPA
ChEMBL 382 4 1 4 4.8 Nc1sc2c(c1C(=O)c1ccc(Cl)cc1)CCN(Cc1ccccc1)C2 10.1021/jm991051d
46876615 204382 None 0 Guinea pig Binding pEC50 = 4.9 4.9 - 0
In vitro prolonging of the stimulus-QRS interval in guinea pig heart.In vitro prolonging of the stimulus-QRS interval in guinea pig heart.
ChEMBL 351 6 5 11 -0.8 CCC/C=N/Nc1nc(N)c2ncn(C3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00102a007
CHEMBL607585 204382 None 0 Guinea pig Binding pEC50 = 4.9 4.9 - 0
In vitro prolonging of the stimulus-QRS interval in guinea pig heart.In vitro prolonging of the stimulus-QRS interval in guinea pig heart.
ChEMBL 351 6 5 11 -0.8 CCC/C=N/Nc1nc(N)c2ncn(C3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00102a007
46227350 14176 None 0 Human Binding pEC50 = 4.9 4.9 - 0
Allosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assayAllosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assay
ChEMBL 302 3 3 5 2.1 CN1CCc2c(sc(N)c2C(=O)NNc2ccccc2)C1 10.1016/j.bmc.2009.08.024
CHEMBL1198627 14176 None 0 Human Binding pEC50 = 4.9 4.9 - 0
Allosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assayAllosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assay
ChEMBL 302 3 3 5 2.1 CN1CCc2c(sc(N)c2C(=O)NNc2ccccc2)C1 10.1016/j.bmc.2009.08.024
CHEMBL609297 14176 None 0 Human Binding pEC50 = 4.9 4.9 - 0
Allosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assayAllosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assay
ChEMBL 302 3 3 5 2.1 CN1CCc2c(sc(N)c2C(=O)NNc2ccccc2)C1 10.1016/j.bmc.2009.08.024
1897978 204445 None 29 Human Binding pEC50 = 4.9 4.9 - 0
Allosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assayAllosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assay
ChEMBL 212 1 2 4 1.0 CN1CCc2c(sc(N)c2C(=O)O)C1 10.1016/j.bmc.2009.08.024
1897979 204445 None 29 Human Binding pEC50 = 4.9 4.9 - 0
Allosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assayAllosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assay
ChEMBL 212 1 2 4 1.0 CN1CCc2c(sc(N)c2C(=O)O)C1 10.1016/j.bmc.2009.08.024
CHEMBL608105 204445 None 29 Human Binding pEC50 = 4.9 4.9 - 0
Allosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assayAllosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assay
ChEMBL 212 1 2 4 1.0 CN1CCc2c(sc(N)c2C(=O)O)C1 10.1016/j.bmc.2009.08.024
212359 14149 None 30 Human Binding pEC50 = 4.9 4.9 - 0
Allosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assayAllosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assay
ChEMBL 226 2 2 5 1.2 CCOC(=O)c1c(N)sc2c1CCNC2 10.1016/j.bmc.2009.08.024
CHEMBL1198107 14149 None 30 Human Binding pEC50 = 4.9 4.9 - 0
Allosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assayAllosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assay
ChEMBL 226 2 2 5 1.2 CCOC(=O)c1c(N)sc2c1CCNC2 10.1016/j.bmc.2009.08.024
CHEMBL595965 14149 None 30 Human Binding pEC50 = 4.9 4.9 - 0
Allosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assayAllosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assay
ChEMBL 226 2 2 5 1.2 CCOC(=O)c1c(N)sc2c1CCNC2 10.1016/j.bmc.2009.08.024
414 3382 None 22 Human Binding pEC50 = 5.9 5.9 -10 12
Displacement of [3H]DPCPX from human recombinant adenosine A1 receptor expressed in CHO cellsDisplacement of [3H]DPCPX from human recombinant adenosine A1 receptor expressed in CHO cells
ChEMBL 385 6 4 9 0.5 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N[C@@H](Cc1ccccc1)C 10.1021/np058114h
93205 3382 None 22 Human Binding pEC50 = 5.9 5.9 -10 12
Displacement of [3H]DPCPX from human recombinant adenosine A1 receptor expressed in CHO cellsDisplacement of [3H]DPCPX from human recombinant adenosine A1 receptor expressed in CHO cells
ChEMBL 385 6 4 9 0.5 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N[C@@H](Cc1ccccc1)C 10.1021/np058114h
CHEMBL139000 3382 None 22 Human Binding pEC50 = 5.9 5.9 -10 12
Displacement of [3H]DPCPX from human recombinant adenosine A1 receptor expressed in CHO cellsDisplacement of [3H]DPCPX from human recombinant adenosine A1 receptor expressed in CHO cells
ChEMBL 385 6 4 9 0.5 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N[C@@H](Cc1ccccc1)C 10.1021/np058114h
20109827 14138 None 2 Human Binding pEC50 = 4.9 4.9 - 0
Allosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assayAllosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assay
ChEMBL 301 3 2 4 2.2 CN1CCc2c(sc(N)c2C(=O)NCc2ccccc2)C1 10.1016/j.bmc.2009.08.024
CHEMBL1198067 14138 None 2 Human Binding pEC50 = 4.9 4.9 - 0
Allosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assayAllosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assay
ChEMBL 301 3 2 4 2.2 CN1CCc2c(sc(N)c2C(=O)NCc2ccccc2)C1 10.1016/j.bmc.2009.08.024
CHEMBL594547 14138 None 2 Human Binding pEC50 = 4.9 4.9 - 0
Allosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assayAllosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assay
ChEMBL 301 3 2 4 2.2 CN1CCc2c(sc(N)c2C(=O)NCc2ccccc2)C1 10.1016/j.bmc.2009.08.024
46876626 204420 None 0 Guinea pig Binding pEC50 = 4.9 4.9 - 0
In vitro prolonging of the stimulus-QRS interval in guinea pig heart.In vitro prolonging of the stimulus-QRS interval in guinea pig heart.
ChEMBL 337 4 5 11 -1.2 CC(C)=NNc1nc(N)c2ncn(C3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00102a007
CHEMBL607877 204420 None 0 Guinea pig Binding pEC50 = 4.9 4.9 - 0
In vitro prolonging of the stimulus-QRS interval in guinea pig heart.In vitro prolonging of the stimulus-QRS interval in guinea pig heart.
ChEMBL 337 4 5 11 -1.2 CC(C)=NNc1nc(N)c2ncn(C3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00102a007
46227379 202300 None 48 Human Binding pEC50 = 4.9 4.9 - 0
Allosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assayAllosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assay
ChEMBL 298 1 2 5 2.3 CC(C)(C)OC(=O)N1CCc2c(sc(N)c2C(=O)O)C1 10.1016/j.bmc.2009.08.024
CHEMBL594321 202300 None 48 Human Binding pEC50 = 4.9 4.9 - 0
Allosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assayAllosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assay
ChEMBL 298 1 2 5 2.3 CC(C)(C)OC(=O)N1CCc2c(sc(N)c2C(=O)O)C1 10.1016/j.bmc.2009.08.024
44320650 208817 None 0 Guinea pig Binding pEC50 = 4.9 4.9 - 1
In vitro prolonging of the stimulus-QRS interval in guinea pig heart.In vitro prolonging of the stimulus-QRS interval in guinea pig heart.
ChEMBL 392 6 5 10 0.4 Nc1nc(NCCC2CCCCC2)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a007
CHEMBL87459 208817 None 0 Guinea pig Binding pEC50 = 4.9 4.9 - 1
In vitro prolonging of the stimulus-QRS interval in guinea pig heart.In vitro prolonging of the stimulus-QRS interval in guinea pig heart.
ChEMBL 392 6 5 10 0.4 Nc1nc(NCCC2CCCCC2)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a007
44374566 56274 None 0 Rat Binding pEC50 = 5.9 5.9 - 0
[S]GTP gamma-S binding against adenosine A1 receptor in rat brain[S]GTP gamma-S binding against adenosine A1 receptor in rat brain
ChEMBL 385 5 3 9 1.0 CC(C)(OC[C@@H]1O[C@H](n2cnc3c(N)ncnc32)[C@@H](O)[C@@H]1O)c1ccccc1 10.1016/s0960-894x(98)00102-4
CHEMBL162752 56274 None 0 Rat Binding pEC50 = 5.9 5.9 - 0
[S]GTP gamma-S binding against adenosine A1 receptor in rat brain[S]GTP gamma-S binding against adenosine A1 receptor in rat brain
ChEMBL 385 5 3 9 1.0 CC(C)(OC[C@@H]1O[C@H](n2cnc3c(N)ncnc32)[C@@H](O)[C@@H]1O)c1ccccc1 10.1016/s0960-894x(98)00102-4
46876654 204385 None 0 Guinea pig Binding pEC50 = 4.9 4.9 - 0
In vitro prolonging of the stimulus-QRS interval in guinea pig heart.In vitro prolonging of the stimulus-QRS interval in guinea pig heart.
ChEMBL 351 5 5 11 -0.9 CC(C)/C=N/Nc1nc(N)c2ncn(C3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00102a007
CHEMBL607599 204385 None 0 Guinea pig Binding pEC50 = 4.9 4.9 - 0
In vitro prolonging of the stimulus-QRS interval in guinea pig heart.In vitro prolonging of the stimulus-QRS interval in guinea pig heart.
ChEMBL 351 5 5 11 -0.9 CC(C)/C=N/Nc1nc(N)c2ncn(C3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00102a007
25130169 172501 None 0 Human Binding pEC50 = 4.9 4.9 - 0
Modulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociationModulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociation
ChEMBL 360 4 1 9 2.1 CCOC(=O)c1nn(-c2ccc([N+](=O)[O-])cc2)c(=O)c2c(N)scc12 10.1021/jm800557d
CHEMBL447654 172501 None 0 Human Binding pEC50 = 4.9 4.9 - 0
Modulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociationModulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociation
ChEMBL 360 4 1 9 2.1 CCOC(=O)c1nn(-c2ccc([N+](=O)[O-])cc2)c(=O)c2c(N)scc12 10.1021/jm800557d
46227384 14129 None 0 Human Binding pEC50 = 4.9 4.9 - 0
Allosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assayAllosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assay
ChEMBL 377 5 2 4 3.8 Nc1sc2c(c1C(=O)NCc1ccccc1)CCN(Cc1ccccc1)C2 10.1016/j.bmc.2009.08.024
CHEMBL1198035 14129 None 0 Human Binding pEC50 = 4.9 4.9 - 0
Allosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assayAllosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assay
ChEMBL 377 5 2 4 3.8 Nc1sc2c(c1C(=O)NCc1ccccc1)CCN(Cc1ccccc1)C2 10.1016/j.bmc.2009.08.024
CHEMBL593637 14129 None 0 Human Binding pEC50 = 4.9 4.9 - 0
Allosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assayAllosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assay
ChEMBL 377 5 2 4 3.8 Nc1sc2c(c1C(=O)NCc1ccccc1)CCN(Cc1ccccc1)C2 10.1016/j.bmc.2009.08.024
46227337 14142 None 0 Human Binding pEC50 = 4.9 4.9 - 0
Allosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assayAllosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assay
ChEMBL 335 3 2 4 2.9 CN1CCc2c(sc(N)c2C(=O)NCc2cccc(Cl)c2)C1 10.1016/j.bmc.2009.08.024
CHEMBL1198078 14142 None 0 Human Binding pEC50 = 4.9 4.9 - 0
Allosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assayAllosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assay
ChEMBL 335 3 2 4 2.9 CN1CCc2c(sc(N)c2C(=O)NCc2cccc(Cl)c2)C1 10.1016/j.bmc.2009.08.024
CHEMBL594809 14142 None 0 Human Binding pEC50 = 4.9 4.9 - 0
Allosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assayAllosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assay
ChEMBL 335 3 2 4 2.9 CN1CCc2c(sc(N)c2C(=O)NCc2cccc(Cl)c2)C1 10.1016/j.bmc.2009.08.024
2794740 202266 None 51 Human Binding pEC50 = 4.9 4.9 - 1
Allosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assayAllosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assay
ChEMBL 326 2 1 6 2.8 CCOC(=O)c1c(N)sc2c1CCN(C(=O)OC(C)(C)C)C2 10.1016/j.bmc.2009.08.024
CHEMBL594119 202266 None 51 Human Binding pEC50 = 4.9 4.9 - 1
Allosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assayAllosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assay
ChEMBL 326 2 1 6 2.8 CCOC(=O)c1c(N)sc2c1CCN(C(=O)OC(C)(C)C)C2 10.1016/j.bmc.2009.08.024
46876088 204607 None 0 Guinea pig Binding pEC50 = 4.9 4.9 - 0
In vitro prolonging of the stimulus-QRS interval in guinea pig heart.In vitro prolonging of the stimulus-QRS interval in guinea pig heart.
ChEMBL 337 5 5 11 -1.2 CC/C=N/Nc1nc(N)c2ncn(C3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00102a007
CHEMBL609231 204607 None 0 Guinea pig Binding pEC50 = 4.9 4.9 - 0
In vitro prolonging of the stimulus-QRS interval in guinea pig heart.In vitro prolonging of the stimulus-QRS interval in guinea pig heart.
ChEMBL 337 5 5 11 -1.2 CC/C=N/Nc1nc(N)c2ncn(C3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00102a007
122028 3037 None 41 Human Binding pEC50 = 4.9 4.9 9549 2
Allosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assayAllosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assay
ChEMBL 299 2 1 3 4.2 Nc1sc(c(c1C(=O)c1cccc(c1)C(F)(F)F)C)C 10.1016/j.bmc.2009.08.024
9445 3037 None 41 Human Binding pEC50 = 4.9 4.9 9549 2
Allosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assayAllosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assay
ChEMBL 299 2 1 3 4.2 Nc1sc(c(c1C(=O)c1cccc(c1)C(F)(F)F)C)C 10.1016/j.bmc.2009.08.024
CHEMBL59532 3037 None 41 Human Binding pEC50 = 4.9 4.9 9549 2
Allosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assayAllosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assay
ChEMBL 299 2 1 3 4.2 Nc1sc(c(c1C(=O)c1cccc(c1)C(F)(F)F)C)C 10.1016/j.bmc.2009.08.024
122028 3037 None 41 Human Binding pEC50 = 4.9 4.9 9549 2
Modulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociationModulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociation
ChEMBL 299 2 1 3 4.2 Nc1sc(c(c1C(=O)c1cccc(c1)C(F)(F)F)C)C 10.1021/jm800557d
9445 3037 None 41 Human Binding pEC50 = 4.9 4.9 9549 2
Modulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociationModulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociation
ChEMBL 299 2 1 3 4.2 Nc1sc(c(c1C(=O)c1cccc(c1)C(F)(F)F)C)C 10.1021/jm800557d
CHEMBL59532 3037 None 41 Human Binding pEC50 = 4.9 4.9 9549 2
Modulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociationModulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociation
ChEMBL 299 2 1 3 4.2 Nc1sc(c(c1C(=O)c1cccc(c1)C(F)(F)F)C)C 10.1021/jm800557d
647821 176969 None 22 Human Binding pEC50 = 4.9 4.9 - 1
Modulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociationModulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociation
ChEMBL 315 3 1 7 2.2 CCOC(=O)c1nn(-c2ccccc2)c(=O)c2c(N)scc12 10.1021/jm800557d
CHEMBL461431 176969 None 22 Human Binding pEC50 = 4.9 4.9 - 1
Modulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociationModulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociation
ChEMBL 315 3 1 7 2.2 CCOC(=O)c1nn(-c2ccccc2)c(=O)c2c(N)scc12 10.1021/jm800557d
122028 3037 None 41 Rat Binding pEC50 = 4.8 4.8 -9549 2
Enhanced 0.5 nM [3H]CCPA dissociation from adenosine A1 receptor of rat brain cortex membranes compared to 100 uM CPAEnhanced 0.5 nM [3H]CCPA dissociation from adenosine A1 receptor of rat brain cortex membranes compared to 100 uM CPA
ChEMBL 299 2 1 3 4.2 Nc1sc(c(c1C(=O)c1cccc(c1)C(F)(F)F)C)C 10.1021/jm991051d
9445 3037 None 41 Rat Binding pEC50 = 4.8 4.8 -9549 2
Enhanced 0.5 nM [3H]CCPA dissociation from adenosine A1 receptor of rat brain cortex membranes compared to 100 uM CPAEnhanced 0.5 nM [3H]CCPA dissociation from adenosine A1 receptor of rat brain cortex membranes compared to 100 uM CPA
ChEMBL 299 2 1 3 4.2 Nc1sc(c(c1C(=O)c1cccc(c1)C(F)(F)F)C)C 10.1021/jm991051d
CHEMBL59532 3037 None 41 Rat Binding pEC50 = 4.8 4.8 -9549 2
Enhanced 0.5 nM [3H]CCPA dissociation from adenosine A1 receptor of rat brain cortex membranes compared to 100 uM CPAEnhanced 0.5 nM [3H]CCPA dissociation from adenosine A1 receptor of rat brain cortex membranes compared to 100 uM CPA
ChEMBL 299 2 1 3 4.2 Nc1sc(c(c1C(=O)c1cccc(c1)C(F)(F)F)C)C 10.1021/jm991051d
162654925 180682 None 0 Human Binding pEC50 = 7.8 7.8 - 0
Irreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 minsIrreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 mins
ChEMBL 498 11 5 10 1.0 O=C(NCCCCCCNc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)C1=CC2C=CC1CC2 10.1021/acs.jmedchem.6b01561
CHEMBL4754123 180682 None 0 Human Binding pEC50 = 7.8 7.8 - 0
Irreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 minsIrreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 mins
ChEMBL 498 11 5 10 1.0 O=C(NCCCCCCNc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)C1=CC2C=CC1CC2 10.1021/acs.jmedchem.6b01561
10786179 15165 None 0 Rat Binding pEC50 = 4.8 4.8 - 0
Enhanced 0.5 nM [3H]CCPA dissociation from adenosine A1 receptor of rat brain cortex membranes compared to 100 uM CPAEnhanced 0.5 nM [3H]CCPA dissociation from adenosine A1 receptor of rat brain cortex membranes compared to 100 uM CPA
ChEMBL 382 4 1 4 4.8 Nc1sc2c(c1C(=O)c1ccccc1)CCN(Cc1cccc(Cl)c1)C2 10.1021/jm991051d
CHEMBL120996 15165 None 0 Rat Binding pEC50 = 4.8 4.8 - 0
Enhanced 0.5 nM [3H]CCPA dissociation from adenosine A1 receptor of rat brain cortex membranes compared to 100 uM CPAEnhanced 0.5 nM [3H]CCPA dissociation from adenosine A1 receptor of rat brain cortex membranes compared to 100 uM CPA
ChEMBL 382 4 1 4 4.8 Nc1sc2c(c1C(=O)c1ccccc1)CCN(Cc1cccc(Cl)c1)C2 10.1021/jm991051d
562794 204799 None 47 Human Binding pEC50 = 4.8 4.8 - 0
Allosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assayAllosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assay
ChEMBL 269 2 1 4 2.8 N#Cc1c(N)sc2c1CCN(Cc1ccccc1)C2 10.1016/j.bmc.2009.08.024
CHEMBL610485 204799 None 47 Human Binding pEC50 = 4.8 4.8 - 0
Allosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assayAllosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assay
ChEMBL 269 2 1 4 2.8 N#Cc1c(N)sc2c1CCN(Cc1ccccc1)C2 10.1016/j.bmc.2009.08.024
46227392 14166 None 0 Human Binding pEC50 = 4.8 4.8 - 0
Allosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assayAllosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assay
ChEMBL 445 5 2 4 4.8 Nc1sc2c(c1C(=O)NCc1cccc(C(F)(F)F)c1)CCN(Cc1ccccc1)C2 10.1016/j.bmc.2009.08.024
CHEMBL1198506 14166 None 0 Human Binding pEC50 = 4.8 4.8 - 0
Allosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assayAllosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assay
ChEMBL 445 5 2 4 4.8 Nc1sc2c(c1C(=O)NCc1cccc(C(F)(F)F)c1)CCN(Cc1ccccc1)C2 10.1016/j.bmc.2009.08.024
CHEMBL606345 14166 None 0 Human Binding pEC50 = 4.8 4.8 - 0
Allosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assayAllosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assay
ChEMBL 445 5 2 4 4.8 Nc1sc2c(c1C(=O)NCc1cccc(C(F)(F)F)c1)CCN(Cc1ccccc1)C2 10.1016/j.bmc.2009.08.024
162646999 179611 None 0 Human Binding pEC50 = 6.8 6.8 - 0
Irreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 minsIrreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 mins
ChEMBL 352 6 4 11 -1.0 OC[C@H]1O[C@@H](n2cnc3c(NCCN=C=S)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.6b01561
CHEMBL4741163 179611 None 0 Human Binding pEC50 = 6.8 6.8 - 0
Irreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 minsIrreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 mins
ChEMBL 352 6 4 11 -1.0 OC[C@H]1O[C@@H](n2cnc3c(NCCN=C=S)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.6b01561
16202442 138414 None 1 Human Binding pEC50 = 5.8 5.8 -1 2
Agonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assayAgonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assay
ChEMBL 441 7 4 10 1.0 OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4OCc4ccccc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.5b01402
CHEMBL3771208 138414 None 1 Human Binding pEC50 = 5.8 5.8 -1 2
Agonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assayAgonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assay
ChEMBL 441 7 4 10 1.0 OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4OCc4ccccc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.5b01402
127025957 138413 None 0 Human Binding pEC50 = 4.8 4.8 - 0
Agonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assayAgonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assay
ChEMBL 442 5 4 9 0.8 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NC4C5CC6CC(C5)CC4C6)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.5b01402
CHEMBL3771184 138413 None 0 Human Binding pEC50 = 4.8 4.8 - 0
Agonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assayAgonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assay
ChEMBL 442 5 4 9 0.8 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NC4C5CC6CC(C5)CC4C6)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.5b01402
10179175 138417 None 0 Human Binding pEC50 = 4.8 4.8 - 0
Agonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assayAgonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assay
ChEMBL 401 4 4 9 0.8 OC[C@H]1O[C@@H](n2cnc3c(NC45CC6CC(CC(C6)C4)C5)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.5b01402
CHEMBL3771290 138417 None 0 Human Binding pEC50 = 4.8 4.8 - 0
Agonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assayAgonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assay
ChEMBL 401 4 4 9 0.8 OC[C@H]1O[C@@H](n2cnc3c(NC45CC6CC(CC(C6)C4)C5)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.5b01402
20696356 38672 None 0 Rat Binding pEC50 = 7.8 7.8 - 1
[S]GTP gamma-S binding against adenosine A1 receptor in rat brain[S]GTP gamma-S binding against adenosine A1 receptor in rat brain
ChEMBL 385 5 3 9 1.0 CC(C)(OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)c1ccccc1 10.1016/s0960-894x(98)00102-4
CHEMBL146549 38672 None 0 Rat Binding pEC50 = 7.8 7.8 - 1
[S]GTP gamma-S binding against adenosine A1 receptor in rat brain[S]GTP gamma-S binding against adenosine A1 receptor in rat brain
ChEMBL 385 5 3 9 1.0 CC(C)(OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)c1ccccc1 10.1016/s0960-894x(98)00102-4
10086671 120193 None 0 Human Binding pEC50 = 5.8 5.8 - 0
Effective concentration for displacement of [3H]-CCPA from human adenosine A1 receptor after 60 minEffective concentration for displacement of [3H]-CCPA from human adenosine A1 receptor after 60 min
ChEMBL 309 3 0 4 4.1 CC/N=c1\nc(-c2ccc(C)cc2)n(-c2ccc(C)cc2)s1 10.1021/jm030863d
CHEMBL351194 120193 None 0 Human Binding pEC50 = 5.8 5.8 - 0
Effective concentration for displacement of [3H]-CCPA from human adenosine A1 receptor after 60 minEffective concentration for displacement of [3H]-CCPA from human adenosine A1 receptor after 60 min
ChEMBL 309 3 0 4 4.1 CC/N=c1\nc(-c2ccc(C)cc2)n(-c2ccc(C)cc2)s1 10.1021/jm030863d
855847 100642 None 22 Rat Binding pEC50 = 4.8 4.8 - 0
Enhanced 0.5 nM [3H]CCPA dissociation from adenosine A1 receptor of rat brain cortex membranes compared to 100 uM CPAEnhanced 0.5 nM [3H]CCPA dissociation from adenosine A1 receptor of rat brain cortex membranes compared to 100 uM CPA
ChEMBL 335 2 1 3 4.2 Nc1sc2c(c1C(=O)c1ccc(Br)cc1)CCCC2 10.1021/jm991051d
CHEMBL291670 100642 None 22 Rat Binding pEC50 = 4.8 4.8 - 0
Enhanced 0.5 nM [3H]CCPA dissociation from adenosine A1 receptor of rat brain cortex membranes compared to 100 uM CPAEnhanced 0.5 nM [3H]CCPA dissociation from adenosine A1 receptor of rat brain cortex membranes compared to 100 uM CPA
ChEMBL 335 2 1 3 4.2 Nc1sc2c(c1C(=O)c1ccc(Br)cc1)CCCC2 10.1021/jm991051d
46876602 205038 None 0 Guinea pig Binding pEC50 = 4.8 4.8 - 0
In vitro prolonging of the stimulus-QRS interval in guinea pig heart.In vitro prolonging of the stimulus-QRS interval in guinea pig heart.
ChEMBL 365 6 5 11 -0.4 CCC/C(C)=N/Nc1nc(N)c2ncn(C3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00102a007
CHEMBL611921 205038 None 0 Guinea pig Binding pEC50 = 4.8 4.8 - 0
In vitro prolonging of the stimulus-QRS interval in guinea pig heart.In vitro prolonging of the stimulus-QRS interval in guinea pig heart.
ChEMBL 365 6 5 11 -0.4 CCC/C(C)=N/Nc1nc(N)c2ncn(C3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00102a007
122028 3037 None 41 Human Binding pEC50 = 5.8 5.8 9549 2
Displacement of [3H]CCPA from human adenosine A1 receptor expressed in CHO cells by scintillation countingDisplacement of [3H]CCPA from human adenosine A1 receptor expressed in CHO cells by scintillation counting
ChEMBL 299 2 1 3 4.2 Nc1sc(c(c1C(=O)c1cccc(c1)C(F)(F)F)C)C 10.1021/jm901252a
9445 3037 None 41 Human Binding pEC50 = 5.8 5.8 9549 2
Displacement of [3H]CCPA from human adenosine A1 receptor expressed in CHO cells by scintillation countingDisplacement of [3H]CCPA from human adenosine A1 receptor expressed in CHO cells by scintillation counting
ChEMBL 299 2 1 3 4.2 Nc1sc(c(c1C(=O)c1cccc(c1)C(F)(F)F)C)C 10.1021/jm901252a
CHEMBL59532 3037 None 41 Human Binding pEC50 = 5.8 5.8 9549 2
Displacement of [3H]CCPA from human adenosine A1 receptor expressed in CHO cells by scintillation countingDisplacement of [3H]CCPA from human adenosine A1 receptor expressed in CHO cells by scintillation counting
ChEMBL 299 2 1 3 4.2 Nc1sc(c(c1C(=O)c1cccc(c1)C(F)(F)F)C)C 10.1021/jm901252a
700289 11209 None 42 Human Binding pEC50 = 4.8 4.8 - 0
Effective concentration against Adenosine A1 receptorEffective concentration against Adenosine A1 receptor
ChEMBL 202 0 1 3 2.5 Nc1nc2c(s1)CCc1ccccc1-2 10.1016/s0960-894x(02)00236-6
CHEMBL1178715 11209 None 42 Human Binding pEC50 = 4.8 4.8 - 0
Effective concentration against Adenosine A1 receptorEffective concentration against Adenosine A1 receptor
ChEMBL 202 0 1 3 2.5 Nc1nc2c(s1)CCc1ccccc1-2 10.1016/s0960-894x(02)00236-6
CHEMBL38400 11209 None 42 Human Binding pEC50 = 4.8 4.8 - 0
Effective concentration against Adenosine A1 receptorEffective concentration against Adenosine A1 receptor
ChEMBL 202 0 1 3 2.5 Nc1nc2c(s1)CCc1ccccc1-2 10.1016/s0960-894x(02)00236-6
10287616 12024 None 0 Human Binding pEC50 = 4.8 4.8 - 0
Effective concentration against Adenosine A1 receptorEffective concentration against Adenosine A1 receptor
ChEMBL 278 3 1 6 2.3 COc1cc2c(c(OC)c1OC)Cc1sc(N)nc1-2 10.1016/s0960-894x(02)00236-6
CHEMBL1183331 12024 None 0 Human Binding pEC50 = 4.8 4.8 - 0
Effective concentration against Adenosine A1 receptorEffective concentration against Adenosine A1 receptor
ChEMBL 278 3 1 6 2.3 COc1cc2c(c(OC)c1OC)Cc1sc(N)nc1-2 10.1016/s0960-894x(02)00236-6
CHEMBL290778 12024 None 0 Human Binding pEC50 = 4.8 4.8 - 0
Effective concentration against Adenosine A1 receptorEffective concentration against Adenosine A1 receptor
ChEMBL 278 3 1 6 2.3 COc1cc2c(c(OC)c1OC)Cc1sc(N)nc1-2 10.1016/s0960-894x(02)00236-6
122028 3037 None 41 Human Binding pEC50 = 5.8 5.8 9549 2
Displacement of [3H]CCPA from human adenosine A1 receptor expressed in CHO cells by scintillation countingDisplacement of [3H]CCPA from human adenosine A1 receptor expressed in CHO cells by scintillation counting
ChEMBL 299 2 1 3 4.2 Nc1sc(c(c1C(=O)c1cccc(c1)C(F)(F)F)C)C 10.1021/jm901252a
9445 3037 None 41 Human Binding pEC50 = 5.8 5.8 9549 2
Displacement of [3H]CCPA from human adenosine A1 receptor expressed in CHO cells by scintillation countingDisplacement of [3H]CCPA from human adenosine A1 receptor expressed in CHO cells by scintillation counting
ChEMBL 299 2 1 3 4.2 Nc1sc(c(c1C(=O)c1cccc(c1)C(F)(F)F)C)C 10.1021/jm901252a
CHEMBL59532 3037 None 41 Human Binding pEC50 = 5.8 5.8 9549 2
Displacement of [3H]CCPA from human adenosine A1 receptor expressed in CHO cells by scintillation countingDisplacement of [3H]CCPA from human adenosine A1 receptor expressed in CHO cells by scintillation counting
ChEMBL 299 2 1 3 4.2 Nc1sc(c(c1C(=O)c1cccc(c1)C(F)(F)F)C)C 10.1021/jm901252a
46876608 204410 None 0 Guinea pig Binding pEC50 = 4.8 4.8 - 0
In vitro prolonging of the stimulus-QRS interval in guinea pig heart.In vitro prolonging of the stimulus-QRS interval in guinea pig heart.
ChEMBL 389 5 5 11 -0.1 Nc1nc(N/N=C/C2=CCCCC2)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a007
CHEMBL607796 204410 None 0 Guinea pig Binding pEC50 = 4.8 4.8 - 0
In vitro prolonging of the stimulus-QRS interval in guinea pig heart.In vitro prolonging of the stimulus-QRS interval in guinea pig heart.
ChEMBL 389 5 5 11 -0.1 Nc1nc(N/N=C/C2=CCCCC2)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a007
162645916 179602 None 0 Human Binding pEC50 = 7.7 7.7 - 0
Irreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 minsIrreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 mins
ChEMBL 414 6 4 11 0.8 OC[C@H]1O[C@@H](n2cnc3c(Nc4ccc(CN=C=S)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.6b01561
CHEMBL4741079 179602 None 0 Human Binding pEC50 = 7.7 7.7 - 0
Irreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 minsIrreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 mins
ChEMBL 414 6 4 11 0.8 OC[C@H]1O[C@@H](n2cnc3c(Nc4ccc(CN=C=S)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.6b01561
162666575 182421 None 0 Human Binding pEC50 = 7.7 7.7 - 0
Irreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 minsIrreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 mins
ChEMBL 558 12 6 12 2.1 OC[C@H]1O[C@@H](n2cnc3c(NCCCCCCNC(=S)Nc4ccc(N=C=S)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.6b01561
CHEMBL4784284 182421 None 0 Human Binding pEC50 = 7.7 7.7 - 0
Irreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 minsIrreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 mins
ChEMBL 558 12 6 12 2.1 OC[C@H]1O[C@@H](n2cnc3c(NCCCCCCNC(=S)Nc4ccc(N=C=S)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.6b01561
123807 871 None 35 Human Binding pEC50 = 6.7 6.7 -15 13
Agonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assayAgonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assay
ChEMBL 369 4 4 9 0.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1 10.1021/acs.jmedchem.5b01402
374 871 None 35 Human Binding pEC50 = 6.7 6.7 -15 13
Agonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assayAgonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assay
ChEMBL 369 4 4 9 0.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1 10.1021/acs.jmedchem.5b01402
379 871 None 35 Human Binding pEC50 = 6.7 6.7 -15 13
Agonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assayAgonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assay
ChEMBL 369 4 4 9 0.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1 10.1021/acs.jmedchem.5b01402
CHEMBL284969 871 None 35 Human Binding pEC50 = 6.7 6.7 -15 13
Agonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assayAgonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assay
ChEMBL 369 4 4 9 0.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(Cl)nc2NC1CCCC1 10.1021/acs.jmedchem.5b01402
162647672 179913 None 0 Human Binding pEC50 = 6.7 6.7 - 0
Irreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 minsIrreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 mins
ChEMBL 552 12 5 12 0.5 O=C(NCCCCCCNc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)c1ccc(S(=O)(=O)F)cc1 10.1021/acs.jmedchem.6b01561
CHEMBL4744914 179913 None 0 Human Binding pEC50 = 6.7 6.7 - 0
Irreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 minsIrreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 mins
ChEMBL 552 12 5 12 0.5 O=C(NCCCCCCNc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)c1ccc(S(=O)(=O)F)cc1 10.1021/acs.jmedchem.6b01561
46876582 204794 None 0 Guinea pig Binding pEC50 = 4.7 4.7 - 0
In vitro prolonging of the stimulus-QRS interval in guinea pig heart.In vitro prolonging of the stimulus-QRS interval in guinea pig heart.
ChEMBL 297 3 6 11 -2.7 NNc1nc(N)c2ncn(C3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00102a007
CHEMBL610444 204794 None 0 Guinea pig Binding pEC50 = 4.7 4.7 - 0
In vitro prolonging of the stimulus-QRS interval in guinea pig heart.In vitro prolonging of the stimulus-QRS interval in guinea pig heart.
ChEMBL 297 3 6 11 -2.7 NNc1nc(N)c2ncn(C3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00102a007
46876581 204793 None 0 Guinea pig Binding pEC50 = 4.7 4.7 - 0
In vitro prolonging of the stimulus-QRS interval in guinea pig heart.In vitro prolonging of the stimulus-QRS interval in guinea pig heart.
ChEMBL 401 5 5 11 -0.2 Nc1nc(N/N=C/C2=CC3CCC2C3)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a007
CHEMBL610443 204793 None 0 Guinea pig Binding pEC50 = 4.7 4.7 - 0
In vitro prolonging of the stimulus-QRS interval in guinea pig heart.In vitro prolonging of the stimulus-QRS interval in guinea pig heart.
ChEMBL 401 5 5 11 -0.2 Nc1nc(N/N=C/C2=CC3CCC2C3)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a007
9976077 79418 None 1 Guinea pig Binding pEC50 = 4.7 4.7 - 2
In vitro prolonging of the stimulus-QRS interval in guinea pig heart.In vitro prolonging of the stimulus-QRS interval in guinea pig heart.
ChEMBL 365 6 5 11 -0.5 CC(C)C/C=N/Nc1nc(N)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00102a007
CHEMBL2113592 79418 None 1 Guinea pig Binding pEC50 = 4.7 4.7 - 2
In vitro prolonging of the stimulus-QRS interval in guinea pig heart.In vitro prolonging of the stimulus-QRS interval in guinea pig heart.
ChEMBL 365 6 5 11 -0.5 CC(C)C/C=N/Nc1nc(N)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00102a007
153605593 173725 None 0 Human Binding pEC50 = 6.7 6.7 -5 5
Agonist activity at human A1A adenosine receptor expressed in CHOKI cells assessed as induction of beta-arrestin2 recruitment after 60 minsAgonist activity at human A1A adenosine receptor expressed in CHOKI cells assessed as induction of beta-arrestin2 recruitment after 60 mins
ChEMBL 389 6 4 9 0.8 OC[C@H]1O[C@@H](n2cnc3c(NC(C4CCC4)C4CCC4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.8b01662
CHEMBL4533718 173725 None 0 Human Binding pEC50 = 6.7 6.7 -5 5
Agonist activity at human A1A adenosine receptor expressed in CHOKI cells assessed as induction of beta-arrestin2 recruitment after 60 minsAgonist activity at human A1A adenosine receptor expressed in CHOKI cells assessed as induction of beta-arrestin2 recruitment after 60 mins
ChEMBL 389 6 4 9 0.8 OC[C@H]1O[C@@H](n2cnc3c(NC(C4CCC4)C4CCC4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.8b01662
44320649 106685 None 0 Guinea pig Binding pEC50 = 4.6 4.6 - 0
In vitro prolonging of the stimulus-QRS interval in guinea pig heart.In vitro prolonging of the stimulus-QRS interval in guinea pig heart.
ChEMBL 390 6 5 10 0.3 Nc1nc(NCCC2=CCCCC2)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a007
CHEMBL314313 106685 None 0 Guinea pig Binding pEC50 = 4.6 4.6 - 0
In vitro prolonging of the stimulus-QRS interval in guinea pig heart.In vitro prolonging of the stimulus-QRS interval in guinea pig heart.
ChEMBL 390 6 5 10 0.3 Nc1nc(NCCC2=CCCCC2)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O 10.1021/jm00102a007
10469918 55215 None 0 Human Binding pEC50 = 5.6 5.6 - 0
Effective concentration for displacement of [3H]-CCPA from human adenosine A1 receptor after 60 minEffective concentration for displacement of [3H]-CCPA from human adenosine A1 receptor after 60 min
ChEMBL 297 3 0 5 3.1 C/N=c1\nc(-c2ccccc2)n(-c2ccc(OC)cc2)s1 10.1021/jm030863d
CHEMBL161767 55215 None 0 Human Binding pEC50 = 5.6 5.6 - 0
Effective concentration for displacement of [3H]-CCPA from human adenosine A1 receptor after 60 minEffective concentration for displacement of [3H]-CCPA from human adenosine A1 receptor after 60 min
ChEMBL 297 3 0 5 3.1 C/N=c1\nc(-c2ccccc2)n(-c2ccc(OC)cc2)s1 10.1021/jm030863d
155536619 172304 None 0 Human Binding pEC50 = 5.6 5.6 -19 4
Agonist activity at human A1A adenosine receptor expressed in CHOKI cells assessed as induction of beta-arrestin2 recruitment after 60 minsAgonist activity at human A1A adenosine receptor expressed in CHOKI cells assessed as induction of beta-arrestin2 recruitment after 60 mins
ChEMBL 254 3 4 7 -2.3 NC(=O)c1ncn([C@H]2[C@H](O)[C@H](O)[C@]3(CO)C[C@H]23)n1 10.1021/acs.jmedchem.8b01662
CHEMBL4473739 172304 None 0 Human Binding pEC50 = 5.6 5.6 -19 4
Agonist activity at human A1A adenosine receptor expressed in CHOKI cells assessed as induction of beta-arrestin2 recruitment after 60 minsAgonist activity at human A1A adenosine receptor expressed in CHOKI cells assessed as induction of beta-arrestin2 recruitment after 60 mins
ChEMBL 254 3 4 7 -2.3 NC(=O)c1ncn([C@H]2[C@H](O)[C@H](O)[C@]3(CO)C[C@H]23)n1 10.1021/acs.jmedchem.8b01662
162653533 180606 None 0 Human Binding pEC50 = 7.6 7.6 - 0
Irreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 minsIrreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 mins
ChEMBL 614 16 6 12 3.7 OC[C@H]1O[C@@H](n2cnc3c(NCCCCCCCCCCNC(=S)Nc4ccc(N=C=S)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.6b01561
CHEMBL4753282 180606 None 0 Human Binding pEC50 = 7.6 7.6 - 0
Irreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 minsIrreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 mins
ChEMBL 614 16 6 12 3.7 OC[C@H]1O[C@@H](n2cnc3c(NCCCCCCCCCCNC(=S)Nc4ccc(N=C=S)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.6b01561
162654943 180700 None 0 Human Binding pEC50 = 7.6 7.6 - 0
Irreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 minsIrreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 mins
ChEMBL 554 15 5 10 2.6 O=C(NCCCCCCCCCCNc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)C1=CC2C=CC1CC2 10.1021/acs.jmedchem.6b01561
CHEMBL4754372 180700 None 0 Human Binding pEC50 = 7.6 7.6 - 0
Irreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 minsIrreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 mins
ChEMBL 554 15 5 10 2.6 O=C(NCCCCCCCCCCNc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)C1=CC2C=CC1CC2 10.1021/acs.jmedchem.6b01561
25130170 177059 None 0 Human Binding pEC50 = 5.6 5.6 - 1
Modulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociationModulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociation
ChEMBL 373 4 1 9 2.1 CCOC(=O)c1nn(-c2ccc(OC(C)=O)cc2)c(=O)c2c(N)scc12 10.1021/jm800557d
CHEMBL462281 177059 None 0 Human Binding pEC50 = 5.6 5.6 - 1
Modulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociationModulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociation
ChEMBL 373 4 1 9 2.1 CCOC(=O)c1nn(-c2ccc(OC(C)=O)cc2)c(=O)c2c(N)scc12 10.1021/jm800557d
2844 283 None 61 Human Binding pEC50 = 5.6 5.6 -8 8
Agonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assayAgonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assay
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.5b01402
60961 283 None 61 Human Binding pEC50 = 5.6 5.6 -8 8
Agonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assayAgonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assay
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.5b01402
60961.0 283 None 61 Human Binding pEC50 = 5.6 5.6 -8 8
Agonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assayAgonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assay
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.5b01402
90 283 None 61 Human Binding pEC50 = 5.6 5.6 -8 8
Agonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assayAgonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assay
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.5b01402
CHEMBL477 283 None 61 Human Binding pEC50 = 5.6 5.6 -8 8
Agonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assayAgonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assay
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.5b01402
DB00640 283 None 61 Human Binding pEC50 = 5.6 5.6 -8 8
Agonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assayAgonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assay
ChEMBL 267 2 4 9 -2.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1021/acs.jmedchem.5b01402
46876584 204850 None 0 Guinea pig Binding pEC50 = 4.6 4.6 - 0
In vitro prolonging of the stimulus-QRS interval in guinea pig heart.In vitro prolonging of the stimulus-QRS interval in guinea pig heart.
ChEMBL 365 4 5 11 -0.5 CC(C)(C)/C=N/Nc1nc(N)c2ncn(C3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00102a007
CHEMBL610727 204850 None 0 Guinea pig Binding pEC50 = 4.6 4.6 - 0
In vitro prolonging of the stimulus-QRS interval in guinea pig heart.In vitro prolonging of the stimulus-QRS interval in guinea pig heart.
ChEMBL 365 4 5 11 -0.5 CC(C)(C)/C=N/Nc1nc(N)c2ncn(C3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00102a007
46876527 205033 None 0 Guinea pig Binding pEC50 = 4.6 4.6 - 0
In vitro prolonging of the stimulus-QRS interval in guinea pig heart.In vitro prolonging of the stimulus-QRS interval in guinea pig heart.
ChEMBL 365 7 5 11 -0.4 CCCC/C=N/Nc1nc(N)c2ncn(C3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00102a007
CHEMBL611916 205033 None 0 Guinea pig Binding pEC50 = 4.6 4.6 - 0
In vitro prolonging of the stimulus-QRS interval in guinea pig heart.In vitro prolonging of the stimulus-QRS interval in guinea pig heart.
ChEMBL 365 7 5 11 -0.4 CCCC/C=N/Nc1nc(N)c2ncn(C3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00102a007
46876528 205034 None 0 Guinea pig Binding pEC50 = 4.6 4.6 - 0
In vitro prolonging of the stimulus-QRS interval in guinea pig heart.In vitro prolonging of the stimulus-QRS interval in guinea pig heart.
ChEMBL 429 5 5 11 0.4 CC1(C)C2CC=C(/C=N/Nc3nc(N)c4ncn(C5O[C@H](CO)[C@@H](O)[C@H]5O)c4n3)C1C2 10.1021/jm00102a007
CHEMBL611917 205034 None 0 Guinea pig Binding pEC50 = 4.6 4.6 - 0
In vitro prolonging of the stimulus-QRS interval in guinea pig heart.In vitro prolonging of the stimulus-QRS interval in guinea pig heart.
ChEMBL 429 5 5 11 0.4 CC1(C)C2CC=C(/C=N/Nc3nc(N)c4ncn(C5O[C@H](CO)[C@@H](O)[C@H]5O)c4n3)C1C2 10.1021/jm00102a007
9839953 193523 None 0 Human Binding pEC50 = 5.6 5.6 - 0
Modulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociationModulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociation
ChEMBL 317 3 2 7 1.7 COc1ccc(-n2nc(C(=O)O)c3csc(N)c3c2=O)cc1 10.1021/jm800557d
CHEMBL525953 193523 None 0 Human Binding pEC50 = 5.6 5.6 - 0
Modulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociationModulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociation
ChEMBL 317 3 2 7 1.7 COc1ccc(-n2nc(C(=O)O)c3csc(N)c3c2=O)cc1 10.1021/jm800557d
2288678 176993 None 8 Human Binding pEC50 = 5.6 5.6 - 0
Modulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociationModulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociation
ChEMBL 383 3 1 7 3.2 CCOC(=O)c1nn(-c2cccc(C(F)(F)F)c2)c(=O)c2c(N)scc12 10.1021/jm800557d
CHEMBL461646 176993 None 8 Human Binding pEC50 = 5.6 5.6 - 0
Modulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociationModulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociation
ChEMBL 383 3 1 7 3.2 CCOC(=O)c1nn(-c2cccc(C(F)(F)F)c2)c(=O)c2c(N)scc12 10.1021/jm800557d
20696356 38672 None 0 Human Binding pEC50 = 7.6 7.6 - 1
Binding against human adenosine A1 receptorBinding against human adenosine A1 receptor
ChEMBL 385 5 3 9 1.0 CC(C)(OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)c1ccccc1 10.1016/s0960-894x(98)00102-4
CHEMBL146549 38672 None 0 Human Binding pEC50 = 7.6 7.6 - 1
Binding against human adenosine A1 receptorBinding against human adenosine A1 receptor
ChEMBL 385 5 3 9 1.0 CC(C)(OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)c1ccccc1 10.1016/s0960-894x(98)00102-4
682802 55337 None 13 Human Binding pEC50 = 5.6 5.6 - 0
Effective concentration for displacement of [3H]-CCPA from human adenosine A1 receptor after 60 minEffective concentration for displacement of [3H]-CCPA from human adenosine A1 receptor after 60 min
ChEMBL 267 2 0 4 3.1 C/N=c1\nc(-c2ccccc2)n(-c2ccccc2)s1 10.1021/jm030863d
CHEMBL161867 55337 None 13 Human Binding pEC50 = 5.6 5.6 - 0
Effective concentration for displacement of [3H]-CCPA from human adenosine A1 receptor after 60 minEffective concentration for displacement of [3H]-CCPA from human adenosine A1 receptor after 60 min
ChEMBL 267 2 0 4 3.1 C/N=c1\nc(-c2ccccc2)n(-c2ccccc2)s1 10.1021/jm030863d
162675239 183414 None 0 Human Binding pEC50 = 8.5 8.5 - 0
Irreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 minsIrreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 mins
ChEMBL 502 8 6 12 0.6 OC[C@H]1O[C@@H](n2cnc3c(NCCNC(=S)Nc4ccc(N=C=S)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.6b01561
CHEMBL4797145 183414 None 0 Human Binding pEC50 = 8.5 8.5 - 0
Irreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 minsIrreversible agonist activity at human adenosine A1 receptor expressed in Flp-In-CHO cells assessed as stimulation of ERK1/2 phosphorylation incubated for 5 mins
ChEMBL 502 8 6 12 0.6 OC[C@H]1O[C@@H](n2cnc3c(NCCNC(=S)Nc4ccc(N=C=S)cc4)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.6b01561
377 2758 None 42 Human Binding pEC50 = 7.5 7.5 -91 15
Agonist activity at human adenosine A1 receptor expressed in CHO cells by GTPPgammaS binding assayAgonist activity at human adenosine A1 receptor expressed in CHO cells by GTPPgammaS binding assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1016/j.bmcl.2009.11.131
425 2758 None 42 Human Binding pEC50 = 7.5 7.5 -91 15
Agonist activity at human adenosine A1 receptor expressed in CHO cells by GTPPgammaS binding assayAgonist activity at human adenosine A1 receptor expressed in CHO cells by GTPPgammaS binding assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1016/j.bmcl.2009.11.131
448222 2758 None 42 Human Binding pEC50 = 7.5 7.5 -91 15
Agonist activity at human adenosine A1 receptor expressed in CHO cells by GTPPgammaS binding assayAgonist activity at human adenosine A1 receptor expressed in CHO cells by GTPPgammaS binding assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1016/j.bmcl.2009.11.131
CHEMBL464859 2758 None 42 Human Binding pEC50 = 7.5 7.5 -91 15
Agonist activity at human adenosine A1 receptor expressed in CHO cells by GTPPgammaS binding assayAgonist activity at human adenosine A1 receptor expressed in CHO cells by GTPPgammaS binding assay
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1016/j.bmcl.2009.11.131
377 2758 None 42 Human Binding pEC50 = 7.5 7.5 -91 15
Agonist activity at Homo sapiens (human) adenosine A1 receptor expressed in CHO cellsAgonist activity at Homo sapiens (human) adenosine A1 receptor expressed in CHO cells
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1007/s00044-004-0013-y
425 2758 None 42 Human Binding pEC50 = 7.5 7.5 -91 15
Agonist activity at Homo sapiens (human) adenosine A1 receptor expressed in CHO cellsAgonist activity at Homo sapiens (human) adenosine A1 receptor expressed in CHO cells
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1007/s00044-004-0013-y
448222 2758 None 42 Human Binding pEC50 = 7.5 7.5 -91 15
Agonist activity at Homo sapiens (human) adenosine A1 receptor expressed in CHO cellsAgonist activity at Homo sapiens (human) adenosine A1 receptor expressed in CHO cells
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1007/s00044-004-0013-y
CHEMBL464859 2758 None 42 Human Binding pEC50 = 7.5 7.5 -91 15
Agonist activity at Homo sapiens (human) adenosine A1 receptor expressed in CHO cellsAgonist activity at Homo sapiens (human) adenosine A1 receptor expressed in CHO cells
ChEMBL 308 3 4 9 -1.8 CCNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N 10.1007/s00044-004-0013-y
127026257 138329 None 0 Human Binding pEC50 = 6.5 6.5 - 0
Agonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assayAgonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assay
ChEMBL 392 5 5 10 -1.1 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4O)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.5b01402
CHEMBL3770310 138329 None 0 Human Binding pEC50 = 6.5 6.5 - 0
Agonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assayAgonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assay
ChEMBL 392 5 5 10 -1.1 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4O)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.5b01402
10575601 16393 None 0 Rat Binding pEC50 = 4.5 4.5 - 0
Enhanced 0.5 nM [3H]CCPA dissociation from adenosine A1 receptor of rat brain cortex membranes compared to 100 uM CPAEnhanced 0.5 nM [3H]CCPA dissociation from adenosine A1 receptor of rat brain cortex membranes compared to 100 uM CPA
ChEMBL 450 4 1 4 6.1 Nc1sc2c(c1C(=O)c1ccc(Cl)cc1)CCN(Cc1ccc(Cl)c(Cl)c1)C2 10.1021/jm991051d
CHEMBL123002 16393 None 0 Rat Binding pEC50 = 4.5 4.5 - 0
Enhanced 0.5 nM [3H]CCPA dissociation from adenosine A1 receptor of rat brain cortex membranes compared to 100 uM CPAEnhanced 0.5 nM [3H]CCPA dissociation from adenosine A1 receptor of rat brain cortex membranes compared to 100 uM CPA
ChEMBL 450 4 1 4 6.1 Nc1sc2c(c1C(=O)c1ccc(Cl)cc1)CCN(Cc1ccc(Cl)c(Cl)c1)C2 10.1021/jm991051d
754850 113344 None 35 Rat Binding pEC50 = 4.5 4.5 - 0
Enhanced 0.5 nM [3H]CCPA dissociation from adenosine A1 receptor of rat brain cortex membranes compared to 100 uM CPAEnhanced 0.5 nM [3H]CCPA dissociation from adenosine A1 receptor of rat brain cortex membranes compared to 100 uM CPA
ChEMBL 271 2 1 3 3.7 Cc1ccc(C(=O)c2c(N)sc3c2CCCC3)cc1 10.1021/jm991051d
CHEMBL331504 113344 None 35 Rat Binding pEC50 = 4.5 4.5 - 0
Enhanced 0.5 nM [3H]CCPA dissociation from adenosine A1 receptor of rat brain cortex membranes compared to 100 uM CPAEnhanced 0.5 nM [3H]CCPA dissociation from adenosine A1 receptor of rat brain cortex membranes compared to 100 uM CPA
ChEMBL 271 2 1 3 3.7 Cc1ccc(C(=O)c2c(N)sc3c2CCCC3)cc1 10.1021/jm991051d
5595 662 None 22 Guinea pig Binding pEC50 = 5.5 5.5 - 6
In vitro prolonging of the stimulus-QRS interval in guinea pig heart.In vitro prolonging of the stimulus-QRS interval in guinea pig heart.
ChEMBL 391 5 5 11 -0.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(N/N=C/C1CCCCC1)nc2N 10.1021/jm00102a007
9576912 662 None 22 Guinea pig Binding pEC50 = 5.5 5.5 - 6
In vitro prolonging of the stimulus-QRS interval in guinea pig heart.In vitro prolonging of the stimulus-QRS interval in guinea pig heart.
ChEMBL 391 5 5 11 -0.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(N/N=C/C1CCCCC1)nc2N 10.1021/jm00102a007
CHEMBL1950554 662 None 22 Guinea pig Binding pEC50 = 5.5 5.5 - 6
In vitro prolonging of the stimulus-QRS interval in guinea pig heart.In vitro prolonging of the stimulus-QRS interval in guinea pig heart.
ChEMBL 391 5 5 11 -0.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(N/N=C/C1CCCCC1)nc2N 10.1021/jm00102a007
DB04853 662 None 22 Guinea pig Binding pEC50 = 5.5 5.5 - 6
In vitro prolonging of the stimulus-QRS interval in guinea pig heart.In vitro prolonging of the stimulus-QRS interval in guinea pig heart.
ChEMBL 391 5 5 11 -0.0 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(N/N=C/C1CCCCC1)nc2N 10.1021/jm00102a007
46876614 204417 None 0 Guinea pig Binding pEC50 = 5.4 5.4 - 0
In vitro prolonging of the stimulus-QRS interval in guinea pig heart.In vitro prolonging of the stimulus-QRS interval in guinea pig heart.
ChEMBL 323 4 5 11 -1.6 C/C=N/Nc1nc(N)c2ncn(C3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00102a007
CHEMBL607873 204417 None 0 Guinea pig Binding pEC50 = 5.4 5.4 - 0
In vitro prolonging of the stimulus-QRS interval in guinea pig heart.In vitro prolonging of the stimulus-QRS interval in guinea pig heart.
ChEMBL 323 4 5 11 -1.6 C/C=N/Nc1nc(N)c2ncn(C3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1021/jm00102a007
46204158 8427 None 0 Human Binding pEC50 = 5.4 5.4 - 0
Displacement of [3H]CCPA from human adenosine A1 receptor expressed in CHO cells by scintillation countingDisplacement of [3H]CCPA from human adenosine A1 receptor expressed in CHO cells by scintillation counting
ChEMBL 505 8 1 7 5.6 Nc1sc2c(c1C(=O)c1ccc(Cl)c(Cl)c1)CCN(CCCOc1ccc([N+](=O)[O-])cc1)C2 10.1021/jm901252a
CHEMBL1093487 8427 None 0 Human Binding pEC50 = 5.4 5.4 - 0
Displacement of [3H]CCPA from human adenosine A1 receptor expressed in CHO cells by scintillation countingDisplacement of [3H]CCPA from human adenosine A1 receptor expressed in CHO cells by scintillation counting
ChEMBL 505 8 1 7 5.6 Nc1sc2c(c1C(=O)c1ccc(Cl)c(Cl)c1)CCN(CCCOc1ccc([N+](=O)[O-])cc1)C2 10.1021/jm901252a
46204158 8427 None 0 Human Binding pEC50 = 5.4 5.4 - 0
Displacement of [3H]CCPA from human adenosine A1 receptor expressed in CHO cells by scintillation countingDisplacement of [3H]CCPA from human adenosine A1 receptor expressed in CHO cells by scintillation counting
ChEMBL 505 8 1 7 5.6 Nc1sc2c(c1C(=O)c1ccc(Cl)c(Cl)c1)CCN(CCCOc1ccc([N+](=O)[O-])cc1)C2 10.1021/jm901252a
CHEMBL1093487 8427 None 0 Human Binding pEC50 = 5.4 5.4 - 0
Displacement of [3H]CCPA from human adenosine A1 receptor expressed in CHO cells by scintillation countingDisplacement of [3H]CCPA from human adenosine A1 receptor expressed in CHO cells by scintillation counting
ChEMBL 505 8 1 7 5.6 Nc1sc2c(c1C(=O)c1ccc(Cl)c(Cl)c1)CCN(CCCOc1ccc([N+](=O)[O-])cc1)C2 10.1021/jm901252a
13187667 11212 None 38 Human Binding pEC50 = 4.4 4.4 - 0
Effective concentration against Adenosine A1 receptorEffective concentration against Adenosine A1 receptor
ChEMBL 188 0 1 3 2.3 Nc1nc2c(s1)Cc1ccccc1-2 10.1016/s0960-894x(02)00236-6
CHEMBL1178727 11212 None 38 Human Binding pEC50 = 4.4 4.4 - 0
Effective concentration against Adenosine A1 receptorEffective concentration against Adenosine A1 receptor
ChEMBL 188 0 1 3 2.3 Nc1nc2c(s1)Cc1ccccc1-2 10.1016/s0960-894x(02)00236-6
CHEMBL38834 11212 None 38 Human Binding pEC50 = 4.4 4.4 - 0
Effective concentration against Adenosine A1 receptorEffective concentration against Adenosine A1 receptor
ChEMBL 188 0 1 3 2.3 Nc1nc2c(s1)Cc1ccccc1-2 10.1016/s0960-894x(02)00236-6
737136 187614 None 32 Human Binding pEC50 = 5.4 5.4 - 0
Modulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociationModulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociation
ChEMBL 275 3 3 4 2.0 Cc1c(C(=O)Nc2ccccc2)sc(N)c1C(N)=O 10.1021/jm800557d
CHEMBL494292 187614 None 32 Human Binding pEC50 = 5.4 5.4 - 0
Modulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociationModulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociation
ChEMBL 275 3 3 4 2.0 Cc1c(C(=O)Nc2ccccc2)sc(N)c1C(N)=O 10.1021/jm800557d
127026251 138362 None 0 Human Binding pEC50 = 5.4 5.4 - 0
Agonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assayAgonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assay
ChEMBL 442 5 4 9 1.0 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NC45CC6CC(CC(C6)C4)C5)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.5b01402
CHEMBL3770664 138362 None 0 Human Binding pEC50 = 5.4 5.4 - 0
Agonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assayAgonist activity at human Adenosine A1 receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphai1 after 16 hrs by beta galactosidase reporter gene assay
ChEMBL 442 5 4 9 1.0 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NC45CC6CC(CC(C6)C4)C5)ncnc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.5b01402
46230290 203847 None 0 Human Binding pEC50 = 5.4 5.4 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells by GTPPgammaS binding assayAgonist activity at human adenosine A1 receptor expressed in CHO cells by GTPPgammaS binding assay
ChEMBL 552 13 5 13 2.1 CCC(CC)CNc1nc(NCCc2cn(CC)cn2)nc2c1ncn2[C@@H]1C[C@H](n2cc(CO)cn2)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2009.11.131
CHEMBL604591 203847 None 0 Human Binding pEC50 = 5.4 5.4 - 1
Agonist activity at human adenosine A1 receptor expressed in CHO cells by GTPPgammaS binding assayAgonist activity at human adenosine A1 receptor expressed in CHO cells by GTPPgammaS binding assay
ChEMBL 552 13 5 13 2.1 CCC(CC)CNc1nc(NCCc2cn(CC)cn2)nc2c1ncn2[C@@H]1C[C@H](n2cc(CO)cn2)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2009.11.131
10236772 11210 None 2 Human Binding pEC50 = 5.4 5.4 - 0
Effective concentration against Adenosine A1 receptorEffective concentration against Adenosine A1 receptor
ChEMBL 202 0 1 3 2.6 Cc1ccc2c(c1)-c1nc(N)sc1C2 10.1016/s0960-894x(02)00236-6
CHEMBL1178716 11210 None 2 Human Binding pEC50 = 5.4 5.4 - 0
Effective concentration against Adenosine A1 receptorEffective concentration against Adenosine A1 receptor
ChEMBL 202 0 1 3 2.6 Cc1ccc2c(c1)-c1nc(N)sc1C2 10.1016/s0960-894x(02)00236-6
CHEMBL38437 11210 None 2 Human Binding pEC50 = 5.4 5.4 - 0
Effective concentration against Adenosine A1 receptorEffective concentration against Adenosine A1 receptor
ChEMBL 202 0 1 3 2.6 Cc1ccc2c(c1)-c1nc(N)sc1C2 10.1016/s0960-894x(02)00236-6
719449 176864 None 13 Human Binding pEC50 = 5.4 5.4 - 1
Modulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociationModulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociation
ChEMBL 345 4 1 8 2.2 CCOC(=O)c1nn(-c2ccc(OC)cc2)c(=O)c2c(N)scc12 10.1021/jm800557d
CHEMBL460366 176864 None 13 Human Binding pEC50 = 5.4 5.4 - 1
Modulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociationModulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociation
ChEMBL 345 4 1 8 2.2 CCOC(=O)c1nn(-c2ccc(OC)cc2)c(=O)c2c(N)scc12 10.1021/jm800557d
39079816 14122 None 1 Human Binding pEC50 = 5.4 5.4 - 0
Allosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assayAllosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assay
ChEMBL 226 1 3 5 -0.1 CN1CCc2c(sc(N)c2C(=O)NN)C1 10.1016/j.bmc.2009.08.024
CHEMBL1198012 14122 None 1 Human Binding pEC50 = 5.4 5.4 - 0
Allosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assayAllosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assay
ChEMBL 226 1 3 5 -0.1 CN1CCc2c(sc(N)c2C(=O)NN)C1 10.1016/j.bmc.2009.08.024
CHEMBL593181 14122 None 1 Human Binding pEC50 = 5.4 5.4 - 0
Allosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assayAllosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assay
ChEMBL 226 1 3 5 -0.1 CN1CCc2c(sc(N)c2C(=O)NN)C1 10.1016/j.bmc.2009.08.024
44286649 12021 None 0 Human Binding pEC50 = 5.4 5.4 - 0
Effective concentration against Adenosine A1 receptorEffective concentration against Adenosine A1 receptor
ChEMBL 300 2 1